country,term,count
AR,NEUTROPENIA,8
AR,BLINDNESS,1
AR,BLOOD CHLORIDE INCREASED,1
AR,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
AR,BLOOD PRESSURE INCREASED,1
AR,BRONCHITIS,1
AR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
AR,COLON ADENOMA,1
AR,CONDITION AGGRAVATED,1
AR,CONGESTIVE CARDIOMYOPATHY,1
AR,COUGH,1
AR,EMOTIONAL DISORDER,1
AR,ERYSIPELAS,1
AR,LEUKOPENIA,1
AR,LOSS OF CONSCIOUSNESS,1
AR,MALIGNANT NEOPLASM PROGRESSION,1
AR,METASTASES TO BONE,1
AR,PAIN,1
AR,PERIPHERAL SENSORY NEUROPATHY,1
AR,PULMONARY MASS,1
AR,PYREXIA,1
AR,RHEUMATOID ARTHRITIS,1
AR,SNEEZING,1
AR,TIME PERCEPTION ALTERED,1
AR,UVEITIS,1
AR,VISUAL IMPAIRMENT,1
AR,WEIGHT INCREASED,1
AW,ABNORMAL BEHAVIOUR,1
AW,HAEMORRHAGE INTRACRANIAL,1
AW,HEAD INJURY,1
AW,INSOMNIA,1
AU,TOXICITY TO VARIOUS AGENTS,20
AU,PAIN,18
AU,RESPIRATORY DEPRESSION,15
AU,NAUSEA,14
AU,HYPOTENSION,13
AU,INTENTIONAL OVERDOSE,13
AU,VOMITING,12
AU,DIZZINESS,11
AU,FALL,11
AU,PNEUMONIA,10
AU,CONFUSIONAL STATE,9
AU,DEPRESSED LEVEL OF CONSCIOUSNESS,9
AU,FATIGUE,9
AU,HYPERAMMONAEMIC ENCEPHALOPATHY,9
AU,SUPRAVENTRICULAR TACHYCARDIA,9
AU,DRUG INEFFECTIVE,8
AU,PYREXIA,8
AU,TREMOR,8
AU,CONDITION AGGRAVATED,7
AU,DEPRESSION,7
AU,PATHOLOGICAL GAMBLING,7
AU,ARTHRALGIA,6
AU,DIARRHOEA,6
AU,DRUG-INDUCED LIVER INJURY,6
AU,DYSPNOEA,6
AU,HEADACHE,6
AU,LIVER FUNCTION TEST ABNORMAL,6
AU,LOWER RESPIRATORY TRACT INFECTION,6
AU,MEMORY IMPAIRMENT,6
AU,RASH,6
AU,SOMNOLENCE,6
AU,ACUTE KIDNEY INJURY,5
AU,AGITATION,5
AU,ATRIAL FIBRILLATION,5
AU,CEREBROVASCULAR ACCIDENT,5
AU,DELIRIUM,5
AU,DRY MOUTH,5
AU,FEELING ABNORMAL,5
AU,HYPERHIDROSIS,5
AU,LIMB DISCOMFORT,5
AU,PARAESTHESIA,5
AU,PRURITUS,5
AU,SEPSIS,5
AU,VISION BLURRED,5
AU,ANAEMIA,4
AU,BALANCE DISORDER,4
AU,CHEST PAIN,4
AU,DEATH,4
AU,DRUG DEPENDENCE,4
AU,DYSPEPSIA,4
AU,GAIT DISTURBANCE,4
AU,HALLUCINATION,4
AU,HYPERTENSION,4
AU,INFECTION,4
AU,INFLUENZA LIKE ILLNESS,4
AU,MALAISE,4
AU,MUSCULAR WEAKNESS,4
AU,OVERDOSE,4
AU,PERIPHERAL SWELLING,4
AU,POLYURIA,4
AU,RESPIRATORY FAILURE,4
AU,SEIZURE,4
AU,UNEVALUABLE EVENT,4
AU,URINARY TRACT INFECTION,4
AU,URTICARIA,4
AU,ABDOMINAL DISCOMFORT,3
AU,ACUTE RESPIRATORY DISTRESS SYNDROME,3
AU,ADRENAL INSUFFICIENCY,3
AU,ASTHENIA,3
AU,ATAXIA,3
AU,BACK PAIN,3
AU,CHILLS,3
AU,COMPLETED SUICIDE,3
AU,CONSTIPATION,3
AU,CONVULSION,3
AU,DEHYDRATION,3
AU,DELUSION,3
AU,DISEASE RECURRENCE,3
AU,EPILEPSY,3
AU,ERYTHEMA,3
AU,EYE PAIN,3
AU,GASTROINTESTINAL HAEMORRHAGE,3
AU,HYPERKALAEMIA,3
AU,HYPOCALCAEMIA,3
AU,HYPOKALAEMIA,3
AU,INTENTIONAL PRODUCT MISUSE,3
AU,LETHARGY,3
AU,MOBILITY DECREASED,3
AU,MUSCLE SPASMS,3
AU,NERVOUS SYSTEM DISORDER,3
AU,NEURALGIA,3
AU,NEUROPATHY PERIPHERAL,3
AU,OESOPHAGEAL PERFORATION,3
AU,OSTEOARTHRITIS,3
AU,PAIN IN EXTREMITY,3
AU,PHOTOPHOBIA,3
AU,WEIGHT INCREASED,3
AU,WITHDRAWAL SYNDROME,3
AU,ACUTE MYOCARDIAL INFARCTION,2
AU,AGGRESSION,2
AU,ALOPECIA,2
AU,ANEURYSM ARTERIOVENOUS,2
AU,ANGIOEDEMA,2
AU,ANXIETY,2
AU,BLISTER,2
AU,BLOOD GLUCOSE INCREASED,2
AU,BREAST CANCER,2
AU,BURNING SENSATION,2
AU,CAPILLARY LEAK SYNDROME,2
AU,CARDIAC FAILURE,2
AU,CARDIAC FAILURE CONGESTIVE,2
AU,CLONUS,2
AU,COMA,2
AU,CONJUNCTIVITIS VIRAL,2
AU,DRUG DOSE OMISSION,2
AU,DRUG HYPERSENSITIVITY,2
AU,DRUG WITHDRAWAL SYNDROME,2
AU,DYSPHAGIA,2
AU,FACE OEDEMA,2
AU,FEMORAL NECK FRACTURE,2
AU,FOETAL EXPOSURE DURING PREGNANCY,2
AU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
AU,GASTRITIS,2
AU,GASTROOESOPHAGEAL REFLUX DISEASE,2
AU,GENERAL PHYSICAL HEALTH DETERIORATION,2
AU,HAEMATOCHEZIA,2
AU,HAEMATURIA,2
AU,HEPATIC ENCEPHALOPATHY,2
AU,HEPATIC FUNCTION ABNORMAL,2
AU,HOT FLUSH,2
AU,HYPERCOAGULATION,2
AU,HYPERTONIA,2
AU,HYPOPHAGIA,2
AU,HYPOXIA,2
AU,INSOMNIA,2
AU,INTENTIONAL SELF-INJURY,2
AU,INTRAOCULAR PRESSURE INCREASED,2
AU,LOSS OF CONSCIOUSNESS,2
AU,MALIGNANT NEOPLASM PROGRESSION,2
AU,MEDICATION ERROR,2
AU,MIGRAINE,2
AU,MOOD ALTERED,2
AU,MULTIPLE FRACTURES,2
AU,MUSCLE RIGIDITY,2
AU,MUSCULOSKELETAL STIFFNESS,2
AU,MYOCARDIAL INFARCTION,2
AU,MYOCARDITIS,2
AU,MYOCLONUS,2
AU,NEUTROPENIA,2
AU,NIGHT SWEATS,2
AU,OEDEMA PERIPHERAL,2
AU,PARALYSIS,2
AU,PLEURAL EFFUSION,2
AU,PSORIATIC ARTHROPATHY,2
AU,PULMONARY OEDEMA,2
AU,RENAL FAILURE ACUTE,2
AU,RENAL FAILURE CHRONIC,2
AU,RENAL IMPAIRMENT,2
AU,RESTLESS LEGS SYNDROME,2
AU,SEPTIC SHOCK,2
AU,SEROTONIN SYNDROME,2
AU,SKIN ULCER,2
AU,SLEEP APNOEA SYNDROME,2
AU,SPEECH DISORDER,2
AU,SPINAL CORD COMPRESSION,2
AU,SPINAL PAIN,2
AU,SUICIDAL IDEATION,2
AU,TACHYCARDIA,2
AU,TOOTH DISORDER,2
AU,TRANSIENT ISCHAEMIC ATTACK,2
AU,VITAMIN D DEFICIENCY,2
AU,WEIGHT DECREASED,2
AU,WHITE BLOOD CELL COUNT DECREASED,2
AU,ABASIA,1
AU,ABDOMINAL PAIN,1
AU,ABNORMAL DREAMS,1
AU,ABORTION SPONTANEOUS,1
AU,ACIDOSIS,1
AU,ACUTE CORONARY SYNDROME,1
AU,ACUTE LUNG INJURY,1
AU,ADVERSE DRUG REACTION,1
AU,AGRANULOCYTOSIS,1
AU,ALTERED STATE OF CONSCIOUSNESS,1
AU,AMNESIA,1
AU,ANAPHYLACTIC REACTION,1
AU,ANGINA PECTORIS,1
AU,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,1
AU,APATHY,1
AU,APHASIA,1
AU,APNOEA,1
AU,APPLICATION SITE ODOUR,1
AU,APPLICATION SITE PAIN,1
AU,ARRHYTHMIA SUPRAVENTRICULAR,1
AU,ARTERIAL THROMBOSIS,1
AU,ASCITES,1
AU,ASTHMA,1
AU,ATRIAL FLUTTER,1
AU,AUTOIMMUNE THYROIDITIS,1
AU,AZOTAEMIA,1
AU,BLINDNESS,1
AU,BLOOD ALBUMIN DECREASED,1
AU,BLOOD ALKALINE PHOSPHATASE INCREASED,1
AU,BLOOD BILIRUBIN INCREASED,1
AU,BLOOD CALCIUM DECREASED,1
AU,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
AU,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
AU,BRAIN INJURY,1
AU,BREAST DISORDER,1
AU,BRUXISM,1
AU,BUNDLE BRANCH BLOCK RIGHT,1
AU,CAESAREAN SECTION,1
AU,CARDIAC ARREST,1
AU,CAROTID ARTERY DISEASE,1
AU,CAROTID BRUIT,1
AU,CELLULITIS,1
AU,CEREBELLAR INFARCTION,1
AU,CEREBRAL ATROPHY,1
AU,CEREBRAL HYPOPERFUSION,1
AU,CEREBRAL INFARCTION,1
AU,CEREBRAL ISCHAEMIA,1
AU,CHEST DISCOMFORT,1
AU,CHOLELITHIASIS,1
AU,CHRONIC KIDNEY DISEASE,1
AU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
AU,CIRCUMORAL OEDEMA,1
AU,COAGULATION TEST ABNORMAL,1
AU,COGNITIVE DISORDER,1
AU,COLD SWEAT,1
AU,COLITIS,1
AU,CONGENITAL ANOMALY IN OFFSPRING,1
AU,CONGENITAL ARTERIAL MALFORMATION,1
AU,COUGH,1
AU,CREATININE RENAL CLEARANCE DECREASED,1
AU,CROHN^S DISEASE,1
AU,CYANOSIS,1
AU,DECREASED ACTIVITY,1
AU,DEEP VEIN THROMBOSIS,1
AU,DEMENTIA,1
AU,DEMENTIA WITH LEWY BODIES,1
AU,DENTAL CARIES,1
AU,DEPERSONALISATION/DEREALISATION DISORDER,1
AU,DEPRESSED MOOD,1
AU,DIABETES MELLITUS INADEQUATE CONTROL,1
AU,DIASTOLIC DYSFUNCTION,1
AU,DIPLOPIA,1
AU,DISORIENTATION,1
AU,DISTURBANCE IN ATTENTION,1
AU,DIVERTICULITIS,1
AU,DRUG ABUSE,1
AU,DRUG DISPENSING ERROR,1
AU,DRUG INTOLERANCE,1
AU,DRUG LEVEL INCREASED,1
AU,DRUG USE DISORDER,1
AU,DRY EYE,1
AU,DYSARTHRIA,1
AU,DYSGEUSIA,1
AU,DYSPNOEA EXERTIONAL,1
AU,DYSSTASIA,1
AU,EAR INFECTION,1
AU,EATING DISORDER,1
AU,ELECTROCARDIOGRAM QT PROLONGED,1
AU,ELECTROLYTE IMBALANCE,1
AU,EMPHYSEMA,1
AU,ENTEROCOCCAL SEPSIS,1
AU,ENTEROCOLITIS FUNGAL,1
AU,EPISTAXIS,1
AU,EUPHORIC MOOD,1
AU,EXPOSURE DURING PREGNANCY,1
AU,EXTRASYSTOLES,1
AU,EXTREMITY NECROSIS,1
AU,FANCONI SYNDROME ACQUIRED,1
AU,FEBRILE NEUTROPENIA,1
AU,FEELING COLD,1
AU,FIBRIN D DIMER INCREASED,1
AU,FIBROMYALGIA,1
AU,FLUID OVERLOAD,1
AU,FLUID RETENTION,1
AU,FLUSHING,1
AU,FOETAL MALFORMATION,1
AU,FOREIGN BODY IN RESPIRATORY TRACT,1
AU,FORMICATION,1
AU,GAIT INABILITY,1
AU,GASTRIC ULCER,1
AU,GASTROENTERITIS,1
AU,GOUT,1
AU,GRANULOCYTOPENIA,1
AU,H1N1 INFLUENZA,1
AU,HAEMODILUTION,1
AU,HAEMODYNAMIC INSTABILITY,1
AU,HAEMOGLOBIN DECREASED,1
AU,HAIR TEXTURE ABNORMAL,1
AU,HEAD TITUBATION,1
AU,HEART RATE ABNORMAL,1
AU,HEART RATE IRREGULAR,1
AU,HEPATITIS,1
AU,HEPATOTOXICITY,1
AU,HIATUS HERNIA STRANGULATED,1
AU,HOMICIDAL IDEATION,1
AU,HOSPITALISATION,1
AU,HUMERUS FRACTURE,1
AU,HYPERBILIRUBINAEMIA,1
AU,HYPERKERATOSIS,1
AU,HYPERSENSITIVITY VASCULITIS,1
AU,HYPERSOMNIA,1
AU,HYPOAESTHESIA,1
AU,HYPOALBUMINAEMIA,1
AU,HYPOGLYCAEMIA,1
AU,HYPONATRAEMIA,1
AU,HYPOTHYROIDISM,1
AU,IDIOPATHIC PULMONARY FIBROSIS,1
AU,ILL-DEFINED DISORDER,1
AU,IMPAIRED HEALING,1
AU,IMPAIRED WORK ABILITY,1
AU,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
AU,INCORRECT DOSAGE ADMINISTERED,1
AU,INCORRECT PRODUCT STORAGE,1
AU,INFECTIOUS COLITIS,1
AU,INTERVERTEBRAL DISC DEGENERATION,1
AU,INTRACRANIAL TUMOUR HAEMORRHAGE,1
AU,JAUNDICE,1
AU,JOINT DISLOCATION,1
AU,JOINT DISLOCATION REDUCTION,1
AU,KIDNEY INFECTION,1
AU,LACRIMATION INCREASED,1
AU,LEUKOENCEPHALOPATHY,1
AU,LIBIDO DECREASED,1
AU,LIP ULCERATION,1
AU,LISTERIOSIS,1
AU,LOWER LIMB FRACTURE,1
AU,LUNG INFECTION,1
AU,LYMPHOMA,1
AU,MAJOR DEPRESSION,1
AU,MALABSORPTION FROM INJECTION SITE,1
AU,MATERNAL DRUGS AFFECTING FOETUS,1
AU,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
AU,MELAENA,1
AU,MENTAL DISORDER,1
AU,MENTAL STATUS CHANGES,1
AU,METABOLIC ALKALOSIS,1
AU,METASTASES TO BONE,1
AU,METASTASES TO LIVER,1
AU,MIOSIS,1
AU,MUCOUS STOOLS,1
AU,MULTI-ORGAN FAILURE,1
AU,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
AU,MUSCULOSKELETAL CHEST PAIN,1
AU,MUSCULOSKELETAL DISORDER,1
AU,MYALGIA,1
AU,MYDRIASIS,1
AU,NASOPHARYNGITIS,1
AU,NEPHROTIC SYNDROME,1
AU,NERVE ROOT COMPRESSION,1
AU,NEUTROPENIC SEPSIS,1
AU,NEUTROPHIL COUNT DECREASED,1
AU,OEDEMA,1
AU,ONYCHOMADESIS,1
AU,OSTEOMYELITIS,1
AU,OSTEONECROSIS OF JAW,1
AU,OSTEOPOROSIS,1
AU,PANCREATIC CARCINOMA,1
AU,PANCREATITIS,1
AU,PANCREATITIS NECROTISING,1
AU,PANCYTOPENIA,1
AU,PANIC ATTACK,1
AU,PARKINSONISM,1
AU,PERIORBITAL OEDEMA,1
AU,PERIPHERAL COLDNESS,1
AU,PHOTOSENSITIVITY REACTION,1
AU,PHYSICAL DISABILITY,1
AU,PIGMENTATION DISORDER,1
AU,PLATELET COUNT DECREASED,1
AU,PNEUMONIA ASPIRATION,1
AU,POLYDIPSIA,1
AU,POST PROCEDURAL INFECTION,1
AU,POSTOPERATIVE WOUND INFECTION,1
AU,PRESCRIBED OVERDOSE,1
AU,PRODUCT PACKAGING ISSUE,1
AU,PRODUCT QUALITY ISSUE,1
AU,PRODUCT USE ISSUE,1
AU,PRODUCTIVE COUGH,1
AU,PULMONARY EMBOLISM,1
AU,PULMONARY FUNCTION TEST DECREASED,1
AU,PULMONARY HAEMORRHAGE,1
AU,PURPURA,1
AU,RASH MACULO-PAPULAR,1
AU,RASH PRURITIC,1
AU,RENAL CYST,1
AU,RENAL FAILURE,1
AU,RESPIRATORY DISORDER,1
AU,RESPIRATORY RATE DECREASED,1
AU,RESTLESSNESS,1
AU,RHINORRHOEA,1
AU,RIB FRACTURE,1
AU,SCLERODERMA,1
AU,SCROTAL ULCER,1
AU,SEDATION,1
AU,SENSATION OF HEAVINESS,1
AU,SENSITIVITY OF TEETH,1
AU,SILICON GRANULOMA,1
AU,SKIN CANCER,1
AU,SKIN DISCOLOURATION,1
AU,SKIN DISORDER,1
AU,SKIN HYPERTROPHY,1
AU,SKIN INFECTION,1
AU,SLEEP TERROR,1
AU,SOMATIC DELUSION,1
AU,SQUAMOUS CELL CARCINOMA,1
AU,SQUAMOUS CELL CARCINOMA OF SKIN,1
AU,STERNAL FRACTURE,1
AU,STIFF PERSON SYNDROME,1
AU,SUBDURAL HAEMATOMA,1
AU,SUDDEN DEATH,1
AU,SUICIDE ATTEMPT,1
AU,SWELLING,1
AU,SWELLING FACE,1
AU,SYNCOPE,1
AU,SYNOVIAL CYST,1
AU,SYSTEMIC CANDIDA,1
AU,SYSTEMIC LUPUS ERYTHEMATOSUS,1
AU,TENDONITIS,1
AU,THROMBOCYTOPENIA,1
AU,THROMBOSIS,1
AU,TONGUE INJURY,1
AU,TOOTH ABSCESS,1
AU,TOOTH EXTRACTION,1
AU,TOXIC NODULAR GOITRE,1
AU,TRISMUS,1
AU,TUMOUR HAEMORRHAGE,1
AU,TYPE I HYPERSENSITIVITY,1
AU,UPPER GASTROINTESTINAL HAEMORRHAGE,1
AU,UPPER LIMB FRACTURE,1
AU,UPPER RESPIRATORY TRACT INFECTION,1
AU,VENTRICULAR TACHYCARDIA,1
AU,VERTIGO,1
AU,VIITH NERVE PARALYSIS,1
AU,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
AU,VISUAL IMPAIRMENT,1
AU,WHEEZING,1
AU,WOUND DRAINAGE,1
AT,GENERAL PHYSICAL HEALTH DETERIORATION,12
AT,LACTIC ACIDOSIS,12
AT,NAUSEA,12
AT,HEADACHE,9
AT,VOMITING,9
AT,ABDOMINAL PAIN UPPER,8
AT,CONDITION AGGRAVATED,7
AT,FALL,7
AT,PLEURAL EFFUSION,7
AT,WEIGHT DECREASED,7
AT,COUGH,6
AT,DIABETIC KETOACIDOSIS,6
AT,DIZZINESS,6
AT,FATIGUE,6
AT,GAIT DISTURBANCE,6
AT,OEDEMA PERIPHERAL,6
AT,PAIN IN EXTREMITY,6
AT,PALPITATIONS,6
AT,POLYNEUROPATHY,6
AT,ATAXIA,5
AT,BLOOD PRESSURE FLUCTUATION,5
AT,DEPRESSED MOOD,5
AT,DYSPNOEA,5
AT,ERYTHEMA,5
AT,HYPONATRAEMIA,5
AT,KETOACIDOSIS,5
AT,MUSCULAR WEAKNESS,5
AT,PAIN,5
AT,POLLAKIURIA,5
AT,REFLUX LARYNGITIS,5
AT,SENSORY LOSS,5
AT,SLEEP DISORDER,5
AT,ASTHENIA,4
AT,CHEST PAIN,4
AT,DEATH,4
AT,DELIRIUM,4
AT,DRY MOUTH,4
AT,GASTROOESOPHAGEAL REFLUX DISEASE,4
AT,LEUKOPENIA,4
AT,PNEUMONIA ASPIRATION,4
AT,PULMONARY EMBOLISM,4
AT,SALIVARY HYPERSECRETION,4
AT,SEDATION,4
AT,ANAEMIA,3
AT,ARTHRALGIA,3
AT,ATRIAL FIBRILLATION,3
AT,BACK PAIN,3
AT,BLOOD PRESSURE INCREASED,3
AT,DYSPNOEA EXERTIONAL,3
AT,HAEMORRHAGE,3
AT,HYPOKALAEMIA,3
AT,LUNG DISORDER,3
AT,MYALGIA,3
AT,MYELOFIBROSIS,3
AT,SPLENOMEGALY,3
AT,THROMBOCYTOPENIA,3
AT,ABSCESS,2
AT,ACUTE KIDNEY INJURY,2
AT,ALANINE AMINOTRANSFERASE INCREASED,2
AT,ANAPHYLACTIC REACTION,2
AT,AORTIC ARTERIOSCLEROSIS,2
AT,AORTIC STENOSIS,2
AT,ARTERIOSCLEROSIS,2
AT,ASPARTATE AMINOTRANSFERASE INCREASED,2
AT,BLOOD GLUCOSE INCREASED,2
AT,BLOOD URIC ACID INCREASED,2
AT,BODY TEMPERATURE INCREASED,2
AT,BONE PAIN,2
AT,C-REACTIVE PROTEIN INCREASED,2
AT,CARDIOMYOPATHY,2
AT,CHOLELITHIASIS,2
AT,DECREASED APPETITE,2
AT,DIVERTICULUM INTESTINAL HAEMORRHAGIC,2
AT,DRUG INEFFECTIVE,2
AT,DRUG PRESCRIBING ERROR,2
AT,FISTULA,2
AT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
AT,GASTRITIS,2
AT,HAEMATOMA,2
AT,HEMIPARESIS,2
AT,HEPATIC CIRRHOSIS,2
AT,HYPERHIDROSIS,2
AT,HYPOCALCAEMIA,2
AT,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
AT,INFLUENZA LIKE ILLNESS,2
AT,ISCHAEMIC STROKE,2
AT,JUGULAR VEIN THROMBOSIS,2
AT,LIP BLISTER,2
AT,LIVER FUNCTION TEST ABNORMAL,2
AT,LOCALISED OEDEMA,2
AT,METASTASES TO BONE,2
AT,MITRAL VALVE INCOMPETENCE,2
AT,MYOCARDIAL INFARCTION,2
AT,NIGHT SWEATS,2
AT,OSTEOARTHRITIS,2
AT,PARAESTHESIA,2
AT,PNEUMONIA,2
AT,PULMONARY CONGESTION,2
AT,PYREXIA,2
AT,RESPIRATORY DEPRESSION,2
AT,SEPSIS,2
AT,SEPTIC SHOCK,2
AT,SPINAL OSTEOARTHRITIS,2
AT,STATUS EPILEPTICUS,2
AT,SUBCLAVIAN VEIN THROMBOSIS,2
AT,TACHYPNOEA,2
AT,VASCULITIS,2
AT,WAIST CIRCUMFERENCE INCREASED,2
AT,WHITE BLOOD CELL COUNT INCREASED,2
AT,ABDOMINAL DISCOMFORT,1
AT,ABDOMINAL PAIN,1
AT,ABDOMINAL RIGIDITY,1
AT,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
AT,ACUTE MYELOID LEUKAEMIA,1
AT,ACUTE MYOCARDIAL INFARCTION,1
AT,ALCOHOL POISONING,1
AT,ANAL ABSCESS,1
AT,ANEURYSM,1
AT,APATHY,1
AT,APHTHOUS STOMATITIS,1
AT,ARRHYTHMIA,1
AT,ARRHYTHMIA SUPRAVENTRICULAR,1
AT,ARTERIAL THERAPEUTIC PROCEDURE,1
AT,ASCITES,1
AT,BACTERIAL TEST POSITIVE,1
AT,BASAL GANGLIA HAEMORRHAGE,1
AT,BLINDNESS,1
AT,BLOOD ALKALINE PHOSPHATASE INCREASED,1
AT,BLOOD BILIRUBIN INCREASED,1
AT,BLOOD CREATININE INCREASED,1
AT,BLOOD GLUCOSE FLUCTUATION,1
AT,BLOOD LACTATE DEHYDROGENASE INCREASED,1
AT,BLOOD PRESSURE DECREASED,1
AT,BRAIN OEDEMA,1
AT,BREAST CANCER METASTATIC,1
AT,BREAST HAEMORRHAGE,1
AT,CACHEXIA,1
AT,CARDIAC ARREST,1
AT,CARDIAC DEATH,1
AT,CARDIAC FAILURE,1
AT,CARDIOMEGALY,1
AT,CARDIOPULMONARY FAILURE,1
AT,CAROTID ARTERIOSCLEROSIS,1
AT,CERVIX CARCINOMA,1
AT,CHEST X-RAY ABNORMAL,1
AT,CHRONIC KIDNEY DISEASE,1
AT,COLORECTAL CANCER METASTATIC,1
AT,CONVULSIVE THRESHOLD LOWERED,1
AT,COR PULMONALE,1
AT,CORONARY ARTERY DISEASE,1
AT,DEHYDRATION,1
AT,DELUSION,1
AT,DEPRESSION,1
AT,DEVICE DISLOCATION,1
AT,DIABETES MELLITUS,1
AT,DIABETIC FOOT INFECTION,1
AT,DIFFUSE ALVEOLAR DAMAGE,1
AT,DIFFUSE LARGE B-CELL LYMPHOMA,1
AT,DIPLEGIA,1
AT,DIVERTICULITIS,1
AT,DRUG HYPERSENSITIVITY,1
AT,DRY THROAT,1
AT,DYSARTHRIA,1
AT,DYSPHONIA,1
AT,EMBOLISM,1
AT,ENCEPHALITIS,1
AT,ENDOPHTHALMITIS,1
AT,ENTEROCOCCUS TEST POSITIVE,1
AT,ERUCTATION,1
AT,ESCHERICHIA URINARY TRACT INFECTION,1
AT,EUGLYCAEMIC DIABETIC KETOACIDOSIS,1
AT,FACE OEDEMA,1
AT,FEELING ABNORMAL,1
AT,GASTROENTERITIS,1
AT,GASTROINTESTINAL HAEMORRHAGE,1
AT,GLAUCOMA,1
AT,GRAND MAL CONVULSION,1
AT,GROIN PAIN,1
AT,HAEMOGLOBIN DECREASED,1
AT,HEART RATE INCREASED,1
AT,HEART VALVE STENOSIS,1
AT,HEPATIC ENZYME INCREASED,1
AT,HERPES ZOSTER,1
AT,HERPES ZOSTER MENINGITIS,1
AT,HYDROTHORAX,1
AT,HYPERBILIRUBINAEMIA,1
AT,HYPERLIPIDAEMIA,1
AT,HYPERTENSION,1
AT,HYPERTONIA,1
AT,HYPERVENTILATION,1
AT,HYPOMANIA,1
AT,HYPOTHYROIDISM,1
AT,HYPOXIA,1
AT,INFECTED DERMAL CYST,1
AT,INFECTION,1
AT,INFLAMMATION,1
AT,INSOMNIA,1
AT,INTENTIONAL PRODUCT MISUSE,1
AT,INTERVERTEBRAL DISC PROTRUSION,1
AT,KUSSMAUL RESPIRATION,1
AT,LARYNGEAL OEDEMA,1
AT,LEG AMPUTATION,1
AT,LETHARGY,1
AT,LIVER DISORDER,1
AT,LYMPHOCYTE PERCENTAGE DECREASED,1
AT,LYMPHOPENIA,1
AT,MAJOR DEPRESSION,1
AT,MENTAL DISORDER,1
AT,MENTAL IMPAIRMENT,1
AT,METASTASES TO ADRENALS,1
AT,METASTASES TO LYMPH NODES,1
AT,METASTASIS,1
AT,MOBILITY DECREASED,1
AT,MOUTH ULCERATION,1
AT,MUCOSAL INFLAMMATION,1
AT,MULTIPLE SCLEROSIS RELAPSE,1
AT,MYOCARDIAL ISCHAEMIA,1
AT,MYOCLONUS,1
AT,NASOPHARYNGITIS,1
AT,NECK PAIN,1
AT,NEOPLASM PROGRESSION,1
AT,NEUROPATHY PERIPHERAL,1
AT,NEUTROPENIA,1
AT,NEUTROPHIL PERCENTAGE INCREASED,1
AT,NO THERAPEUTIC RESPONSE,1
AT,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,1
AT,OSTEITIS,1
AT,OSTEONECROSIS,1
AT,OSTEONECROSIS OF JAW,1
AT,PACEMAKER GENERATED ARRHYTHMIA,1
AT,PANIC DISORDER,1
AT,PARALYSIS,1
AT,PARTIAL SEIZURES,1
AT,PATHOLOGICAL FRACTURE,1
AT,PERICARDIAL EFFUSION,1
AT,PERIPHERAL VASCULAR DISORDER,1
AT,PHLEBITIS,1
AT,PLATELET COUNT DECREASED,1
AT,PLATELET COUNT INCREASED,1
AT,PLEURAL DISORDER,1
AT,POSITRON EMISSION TOMOGRAM ABNORMAL,1
AT,POST PROCEDURAL HAEMORRHAGE,1
AT,PRODUCT QUALITY ISSUE,1
AT,PRODUCT USE ISSUE,1
AT,PROSTATE CANCER,1
AT,PROTHROMBIN TIME PROLONGED,1
AT,PRURITUS,1
AT,PULMONARY FIBROSIS,1
AT,PULMONARY OEDEMA,1
AT,REGURGITATION,1
AT,RESPIRATORY DISTRESS,1
AT,RESTLESS LEGS SYNDROME,1
AT,RIGHT VENTRICULAR DILATATION,1
AT,SECOND PRIMARY MALIGNANCY,1
AT,SEROTONIN SYNDROME,1
AT,SERUM FERRITIN INCREASED,1
AT,SKIN INJURY,1
AT,SLOW SPEECH,1
AT,SOMATISATION DISORDER,1
AT,SOMNOLENCE,1
AT,SPINAL DISORDER,1
AT,SPINAL PAIN,1
AT,STOMATITIS,1
AT,SUICIDAL IDEATION,1
AT,SYNCOPE,1
AT,SYSTOLIC DYSFUNCTION,1
AT,TACHYCARDIA,1
AT,THALAMUS HAEMORRHAGE,1
AT,THERAPY CESSATION,1
AT,THROMBOSIS,1
AT,TOE AMPUTATION,1
AT,TONIC CONVULSION,1
AT,TOOTH DISORDER,1
AT,TOOTH LOSS,1
AT,TRANSAMINASES INCREASED,1
AT,TRANSIENT ISCHAEMIC ATTACK,1
AT,TREATMENT NONCOMPLIANCE,1
AT,TREMOR,1
AT,UMBILICAL HERNIA,1
AT,URINARY TRACT INFECTION,1
AT,UVEITIS,1
AT,VENOUS RECANALISATION,1
AT,VERTEBRAL FORAMINAL STENOSIS,1
AT,VERTIGO,1
AT,WEIGHT INCREASED,1
BY,MALIGNANT NEOPLASM PROGRESSION,3
BY,ANXIETY,2
BY,ASTHENIA,2
BY,CHOKING,2
BY,CONSTIPATION,2
BY,DECREASED APPETITE,2
BY,DYSPHAGIA,2
BY,GENERAL PHYSICAL HEALTH DETERIORATION,2
BY,PAIN,2
BY,BONE PAIN,1
BY,DYSPNOEA,1
BY,PANIC ATTACK,1
BE,HYPOTHERMIA,6
BE,APATHY,5
BE,DECREASED APPETITE,5
BE,HYPOTENSION,5
BE,ABDOMINAL PAIN,4
BE,FALL,4
BE,INCORRECT DOSE ADMINISTERED,4
BE,MOTOR DYSFUNCTION,4
BE,OXYGEN SATURATION DECREASED,4
BE,MALAISE,3
BE,WEIGHT DECREASED,3
BE,AMNESIA,2
BE,ANXIETY,2
BE,BRAIN OEDEMA,2
BE,CEREBROVASCULAR ACCIDENT,2
BE,CONFUSIONAL STATE,2
BE,DELIRIUM,2
BE,DYSKINESIA,2
BE,FATIGUE,2
BE,FLUSHING,2
BE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
BE,HAEMORRHAGIC STROKE,2
BE,LOSS OF CONSCIOUSNESS,2
BE,MENTAL DISORDER,2
BE,MENTAL STATUS CHANGES,2
BE,NAUSEA,2
BE,STRESS,2
BE,SUDDEN DEATH,2
BE,SYNCOPE,2
BE,THROMBOCYTOPENIA,2
BE,TREMOR,2
BE,VOMITING,2
BE,ABDOMINAL DISTENSION,1
BE,ABDOMINAL NEOPLASM,1
BE,ABNORMAL SENSATION IN EYE,1
BE,AGITATION,1
BE,ALANINE AMINOTRANSFERASE INCREASED,1
BE,ALTERED STATE OF CONSCIOUSNESS,1
BE,ANAEMIA,1
BE,ANAPHYLACTIC REACTION,1
BE,ANAPHYLACTIC SHOCK,1
BE,ANGIOEDEMA,1
BE,ARTHRALGIA,1
BE,ASPARTATE AMINOTRANSFERASE INCREASED,1
BE,ASTHENIA,1
BE,BALANCE DISORDER,1
BE,BILIRUBIN CONJUGATED INCREASED,1
BE,BLINDNESS,1
BE,BLOOD ALKALINE PHOSPHATASE INCREASED,1
BE,BLOOD BILIRUBIN INCREASED,1
BE,BLOOD BILIRUBIN UNCONJUGATED INCREASED,1
BE,BLOOD CHOLESTEROL INCREASED,1
BE,BLOOD GLUCOSE INCREASED,1
BE,BREAST CANCER IN SITU,1
BE,BRONCHOPULMONARY ASPERGILLOSIS,1
BE,CARPAL TUNNEL SYNDROME,1
BE,CEREBRAL HAEMORRHAGE,1
BE,CHEST X-RAY ABNORMAL,1
BE,CHOLECYSTITIS,1
BE,COMA,1
BE,COMPLEX PARTIAL SEIZURES,1
BE,CONDITION AGGRAVATED,1
BE,CONSCIOUSNESS FLUCTUATING,1
BE,CYSTITIS RADIATION,1
BE,DELUSION,1
BE,DEMYELINATING POLYNEUROPATHY,1
BE,DEVICE DISLOCATION,1
BE,DEVICE ISSUE,1
BE,DIARRHOEA,1
BE,DISABILITY,1
BE,DISEASE PROGRESSION,1
BE,DISORIENTATION,1
BE,DISTURBANCE IN ATTENTION,1
BE,DIZZINESS,1
BE,DRUG EFFECT INCOMPLETE,1
BE,DRUG-INDUCED LIVER INJURY,1
BE,DYSPEPSIA,1
BE,EOSINOPHILIA,1
BE,EPILEPSY,1
BE,ERYSIPELAS,1
BE,ERYTHROPENIA,1
BE,FAECES DISCOLOURED,1
BE,FEELING ABNORMAL,1
BE,FREEZING PHENOMENON,1
BE,GAIT DISTURBANCE,1
BE,GAIT INABILITY,1
BE,GENERAL PHYSICAL HEALTH DETERIORATION,1
BE,HALLUCINATION,1
BE,HEADACHE,1
BE,HEPATIC ENZYME INCREASED,1
BE,HEPATITIS TOXIC,1
BE,HIGH DENSITY LIPOPROTEIN INCREASED,1
BE,HYPERTENSION,1
BE,HYPERVOLAEMIA,1
BE,HYPOKALAEMIA,1
BE,HYPOPHAGIA,1
BE,HYPOXIA,1
BE,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
BE,INFLUENZA LIKE ILLNESS,1
BE,INFUSION RELATED REACTION,1
BE,INJECTION SITE HYPERTROPHY,1
BE,INTENTIONAL PRODUCT MISUSE,1
BE,INVASIVE DUCTAL BREAST CARCINOMA,1
BE,LETHARGY,1
BE,LEUKOPENIA,1
BE,LOW DENSITY LIPOPROTEIN INCREASED,1
BE,LYMPHOMA,1
BE,MALIGNANT NEOPLASM PROGRESSION,1
BE,MALNUTRITION,1
BE,MOBILITY DECREASED,1
BE,MOVEMENT DISORDER,1
BE,MUCORMYCOSIS,1
BE,MULTIPLE FRACTURES,1
BE,MUSCLE SPASMS,1
BE,MUSCLE TWITCHING,1
BE,NERVOUSNESS,1
BE,NEUTROPHIL COUNT INCREASED,1
BE,ON AND OFF PHENOMENON,1
BE,OSTEOARTHRITIS,1
BE,OSTEONECROSIS OF JAW,1
BE,PALPITATIONS,1
BE,PARAESTHESIA,1
BE,PARKINSONIAN GAIT,1
BE,PERIPHERAL SENSORY NEUROPATHY,1
BE,PHARYNGEAL OEDEMA,1
BE,PILONIDAL CYST,1
BE,PLATELET COUNT DECREASED,1
BE,PNEUMONIA ASPIRATION,1
BE,POOR QUALITY SLEEP,1
BE,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
BE,PRESCRIBED UNDERDOSE,1
BE,RASH,1
BE,RIB FRACTURE,1
BE,SEDATION COMPLICATION,1
BE,SHOCK HAEMORRHAGIC,1
BE,SKIN EXFOLIATION,1
BE,SMALL INTESTINAL HAEMORRHAGE,1
BE,SOMNOLENCE,1
BE,SPEECH DISORDER,1
BE,STAPHYLOCOCCAL SEPSIS,1
BE,STAPHYLOCOCCAL SKIN INFECTION,1
BE,STARING,1
BE,STATUS EPILEPTICUS,1
BE,STOMA SITE ERYTHEMA,1
BE,STOMA SITE HYPERGRANULATION,1
BE,STOMA SITE INFECTION,1
BE,STOMA SITE PAIN,1
BE,STRESS FRACTURE,1
BE,SUPRAVENTRICULAR EXTRASYSTOLES,1
BE,THERAPEUTIC RESPONSE DECREASED,1
BE,TOXICITY TO VARIOUS AGENTS,1
BE,TRANSAMINASES INCREASED,1
BE,TRANSIENT ISCHAEMIC ATTACK,1
BE,UNRESPONSIVE TO STIMULI,1
BE,URINARY BLADDER HAEMORRHAGE,1
BE,URINARY TRACT INFECTION,1
BE,URTICARIA,1
BE,VENTRICULAR EXTRASYSTOLES,1
BE,VERTIGO,1
BA,DIZZINESS,1
BA,LOSS OF CONSCIOUSNESS,1
BA,PRODUCT USE ISSUE,1
BR,PAIN,47
BR,MALAISE,38
BR,PAIN IN EXTREMITY,35
BR,ARTHRALGIA,32
BR,HEADACHE,32
BR,DRUG INEFFECTIVE,30
BR,DIZZINESS,27
BR,DYSPNOEA,27
BR,ASTHENIA,26
BR,FALL,23
BR,NAUSEA,23
BR,PYREXIA,23
BR,URINARY TRACT INFECTION,23
BR,PNEUMONIA,22
BR,WEIGHT DECREASED,22
BR,VOMITING,21
BR,BACK PAIN,20
BR,FATIGUE,20
BR,GAIT DISTURBANCE,20
BR,ANAEMIA,16
BR,DEPRESSION,16
BR,INFLUENZA,16
BR,MUSCULAR WEAKNESS,16
BR,PRURITUS,16
BR,SWELLING,16
BR,DECREASED APPETITE,15
BR,DIABETES MELLITUS,15
BR,INSOMNIA,15
BR,MULTIPLE SCLEROSIS RELAPSE,15
BR,VISUAL IMPAIRMENT,15
BR,COUGH,14
BR,HYPERTENSION,14
BR,HYPOAESTHESIA,14
BR,INJECTION SITE PAIN,13
BR,SOMNOLENCE,13
BR,TREMOR,13
BR,WEIGHT INCREASED,13
BR,DIARRHOEA,12
BR,MEMORY IMPAIRMENT,12
BR,PERIPHERAL SWELLING,12
BR,CARDIAC DISORDER,11
BR,CONDITION AGGRAVATED,11
BR,ERYTHEMA,11
BR,HYPERSENSITIVITY,11
BR,RHEUMATOID ARTHRITIS,11
BR,ABDOMINAL DISTENSION,10
BR,ABDOMINAL PAIN,10
BR,CONSTIPATION,10
BR,DRY MOUTH,10
BR,INFECTION,10
BR,NERVOUSNESS,10
BR,NEUROPATHY PERIPHERAL,10
BR,SYNCOPE,10
BR,ABASIA,9
BR,CEREBROVASCULAR ACCIDENT,9
BR,FEELING ABNORMAL,9
BR,MOVEMENT DISORDER,9
BR,RENAL DISORDER,9
BR,SPEECH DISORDER,9
BR,THROMBOSIS,9
BR,VISION BLURRED,9
BR,ARTHROPATHY,8
BR,BURNING SENSATION,8
BR,CATARACT,8
BR,DIABETIC NEUROPATHY,8
BR,DYSSTASIA,8
BR,IMMUNODEFICIENCY,8
BR,JOINT SWELLING,8
BR,MOBILITY DECREASED,8
BR,SINUSITIS,8
BR,ANXIETY,7
BR,ARTHRITIS,7
BR,BLOOD GLUCOSE INCREASED,7
BR,CONFUSIONAL STATE,7
BR,DYSPHONIA,7
BR,ERYSIPELAS,7
BR,HYPOTENSION,7
BR,INTERVERTEBRAL DISC PROTRUSION,7
BR,OSTEOARTHRITIS,7
BR,PARAESTHESIA,7
BR,VISUAL ACUITY REDUCED,7
BR,BLOOD PRESSURE ABNORMAL,6
BR,BLOOD PRESSURE FLUCTUATION,6
BR,CHEST PAIN,6
BR,DEATH,6
BR,HAEMORRHAGE,6
BR,HYPERGLYCAEMIA,6
BR,LOCALISED INFECTION,6
BR,NECK PAIN,6
BR,PRODUCT USE ISSUE,6
BR,RASH,6
BR,SEIZURE,6
BR,SPINAL PAIN,6
BR,WOUND,6
BR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,6
BR,ABDOMINAL PAIN UPPER,5
BR,AGITATION,5
BR,AMNESIA,5
BR,ARRHYTHMIA,5
BR,BLOOD PRESSURE DECREASED,5
BR,BLOOD PRESSURE INCREASED,5
BR,BONE PAIN,5
BR,CHILLS,5
BR,CHOLELITHIASIS,5
BR,CRYING,5
BR,DECREASED IMMUNE RESPONSIVENESS,5
BR,DISEASE PROGRESSION,5
BR,DRUG DOSE OMISSION,5
BR,DRY SKIN,5
BR,DYSPHAGIA,5
BR,EATING DISORDER,5
BR,FEELING COLD,5
BR,FOOT DEFORMITY,5
BR,GASTROINTESTINAL PAIN,5
BR,HYPOGLYCAEMIA,5
BR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,5
BR,INFARCTION,5
BR,INFUSION RELATED REACTION,5
BR,INJECTION SITE ERYTHEMA,5
BR,LOCAL SWELLING,5
BR,LUNG DISORDER,5
BR,LUNG INFECTION,5
BR,MALIGNANT NEOPLASM PROGRESSION,5
BR,NERVOUS SYSTEM DISORDER,5
BR,NODULE,5
BR,NOSOCOMIAL INFECTION,5
BR,OROPHARYNGEAL PAIN,5
BR,RENAL FAILURE,5
BR,RENAL IMPAIRMENT,5
BR,SKIN DISCOLOURATION,5
BR,SKIN EXFOLIATION,5
BR,UPPER LIMB FRACTURE,5
BR,ALOPECIA,4
BR,BACTERIAL INFECTION,4
BR,BALANCE DISORDER,4
BR,BLINDNESS,4
BR,BODY HEIGHT DECREASED,4
BR,CONCOMITANT DISEASE AGGRAVATED,4
BR,DEHYDRATION,4
BR,DERMATITIS,4
BR,DRUG ADMINISTRATION ERROR,4
BR,DRUG HYPERSENSITIVITY,4
BR,DRY EYE,4
BR,DYSGEUSIA,4
BR,EAR PAIN,4
BR,FEELING HOT,4
BR,FEMUR FRACTURE,4
BR,FIBROMYALGIA,4
BR,GASTRIC DISORDER,4
BR,HAEMOGLOBIN DECREASED,4
BR,HEPATIC STEATOSIS,4
BR,HYPERHIDROSIS,4
BR,ILL-DEFINED DISORDER,4
BR,IMPAIRED HEALING,4
BR,INFLAMMATION,4
BR,INJECTION SITE DISCOLOURATION,4
BR,INJURY,4
BR,INTENTIONAL PRODUCT MISUSE,4
BR,LACRIMATION INCREASED,4
BR,LIVER DISORDER,4
BR,LOSS OF CONSCIOUSNESS,4
BR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,4
BR,MULTIPLE SCLEROSIS,4
BR,MUSCLE SPASMS,4
BR,MUSCULOSKELETAL STIFFNESS,4
BR,OCULAR HYPERAEMIA,4
BR,OESOPHAGITIS,4
BR,PAIN IN JAW,4
BR,RESPIRATORY FAILURE,4
BR,RETINAL DETACHMENT,4
BR,RHINITIS,4
BR,RIB FRACTURE,4
BR,SKIN ULCER,4
BR,TACHYCARDIA,4
BR,THERAPEUTIC RESPONSE UNEXPECTED,4
BR,ACTIVITIES OF DAILY LIVING IMPAIRED,3
BR,AGGRESSION,3
BR,ANEURYSM,3
BR,BLISTER,3
BR,BLOOD TEST ABNORMAL,3
BR,BURSITIS,3
BR,CARDIAC ARREST,3
BR,CARDIAC FAILURE,3
BR,CHROMATURIA,3
BR,COLITIS ULCERATIVE,3
BR,COMA,3
BR,DISORIENTATION,3
BR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,3
BR,DRUG INTOLERANCE,3
BR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,3
BR,EYE DISORDER,3
BR,FEBRILE NEUTROPENIA,3
BR,FEEDING DISORDER,3
BR,GASTRITIS,3
BR,GENERAL PHYSICAL HEALTH DETERIORATION,3
BR,GENERALISED ERYTHEMA,3
BR,HALLUCINATION_ VISUAL,3
BR,HEART RATE DECREASED,3
BR,HEART RATE INCREASED,3
BR,HEMIPLEGIA,3
BR,HEPATIC FUNCTION ABNORMAL,3
BR,HYPERTENSIVE CRISIS,3
BR,HYPOACUSIS,3
BR,HYPOKINESIA,3
BR,HYPOPHAGIA,3
BR,INJECTION SITE HAEMATOMA,3
BR,JAUNDICE,3
BR,LIMB DEFORMITY,3
BR,LIMB DISCOMFORT,3
BR,LIMB INJURY,3
BR,MOOD ALTERED,3
BR,MUSCLE TWITCHING,3
BR,MYOCARDIAL INFARCTION,3
BR,NEOPLASM,3
BR,NEOPLASM PROGRESSION,3
BR,OEDEMA PERIPHERAL,3
BR,OSTEOPOROSIS,3
BR,OVERDOSE,3
BR,PLATELET COUNT DECREASED,3
BR,POLLAKIURIA,3
BR,PRODUCT AVAILABILITY ISSUE,3
BR,PSYCHOMOTOR HYPERACTIVITY,3
BR,PULMONARY EMBOLISM,3
BR,PULMONARY FIBROSIS,3
BR,PULMONARY OEDEMA,3
BR,RED BLOOD CELL COUNT DECREASED,3
BR,RENAL CANCER,3
BR,SCIATIC NERVE INJURY,3
BR,SENSORY DISTURBANCE,3
BR,SEPSIS,3
BR,STEVENS-JOHNSON SYNDROME,3
BR,THIRST,3
BR,TYPE 2 DIABETES MELLITUS,3
BR,URINARY INCONTINENCE,3
BR,WHITE BLOOD CELL COUNT DECREASED,3
BR,ABNORMAL BEHAVIOUR,2
BR,ACUTE KIDNEY INJURY,2
BR,ALANINE AMINOTRANSFERASE INCREASED,2
BR,ANGINA PECTORIS,2
BR,ANGIOPATHY,2
BR,APHONIA,2
BR,APHTHOUS STOMATITIS,2
BR,APPLICATION SITE ERYTHEMA,2
BR,ASPARTATE AMINOTRANSFERASE INCREASED,2
BR,ASTHMA,2
BR,BACK INJURY,2
BR,BEDRIDDEN,2
BR,BILIRUBIN CONJUGATED INCREASED,2
BR,BLOOD ALKALINE PHOSPHATASE INCREASED,2
BR,BLOOD BILIRUBIN INCREASED,2
BR,BLOOD CHOLESTEROL ABNORMAL,2
BR,BLOOD DISORDER,2
BR,BLOOD GLUCOSE ABNORMAL,2
BR,BLOOD POTASSIUM DECREASED,2
BR,BLOOD TRIGLYCERIDES ABNORMAL,2
BR,BLOOD URINE PRESENT,2
BR,BRAIN NEOPLASM,2
BR,BREAST CANCER,2
BR,BRONCHOSPASM,2
BR,CAROTID ARTERY OCCLUSION,2
BR,CATARACT OPERATION,2
BR,CENTRAL NERVOUS SYSTEM LESION,2
BR,CHEST DISCOMFORT,2
BR,CHOKING,2
BR,CHRONIC KIDNEY DISEASE,2
BR,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,2
BR,COLITIS,2
BR,CONVULSION,2
BR,CORONARY ARTERY DISEASE,2
BR,CYANOSIS,2
BR,DELIRIUM,2
BR,DEMYELINATING POLYNEUROPATHY,2
BR,DEPRESSED LEVEL OF CONSCIOUSNESS,2
BR,DEPRESSED MOOD,2
BR,DERMATITIS CONTACT,2
BR,DISCOMFORT,2
BR,DRUG DEPENDENCE,2
BR,DRUG EFFECT DECREASED,2
BR,DRUG EFFECT INCOMPLETE,2
BR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
BR,DRUG-INDUCED LIVER INJURY,2
BR,DYSURIA,2
BR,EMOTIONAL DISORDER,2
BR,EMPHYSEMA,2
BR,ENTERITIS INFECTIOUS,2
BR,EYE HAEMORRHAGE,2
BR,EYE PAIN,2
BR,EYE PRURITUS,2
BR,EYE SWELLING,2
BR,EYELID CYST,2
BR,FLATULENCE,2
BR,GAIT INABILITY,2
BR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
BR,GASTROINTESTINAL DISORDER,2
BR,GENERALISED OEDEMA,2
BR,GLAUCOMA,2
BR,HAEMATOCRIT DECREASED,2
BR,HAEMATOMA,2
BR,HELICOBACTER INFECTION,2
BR,HEPATIC ENZYME ABNORMAL,2
BR,HEPATIC FAILURE,2
BR,HEPATITIS,2
BR,HERPES VIRUS INFECTION,2
BR,HERPES ZOSTER,2
BR,HOSPITALISATION,2
BR,HUNGER,2
BR,HYPERAEMIA,2
BR,HYPERTHYROIDISM,2
BR,IMMUNE SYSTEM DISORDER,2
BR,INCORRECT DOSE ADMINISTERED,2
BR,INFLUENZA LIKE ILLNESS,2
BR,INFREQUENT BOWEL MOVEMENTS,2
BR,INJECTION SITE BRUISING,2
BR,INJECTION SITE HYPERSENSITIVITY,2
BR,INJECTION SITE INDURATION,2
BR,INJECTION SITE INFECTION,2
BR,IRRITABILITY,2
BR,JOINT DISLOCATION,2
BR,JOINT LOCK,2
BR,JOINT RANGE OF MOTION DECREASED,2
BR,LABYRINTHITIS,2
BR,LYMPHOCYTE COUNT DECREASED,2
BR,MEDICATION ERROR,2
BR,METASTASES TO BONE,2
BR,METASTASES TO LIVER,2
BR,MINERAL DEFICIENCY,2
BR,MULTI-ORGAN FAILURE,2
BR,MUSCULOSKELETAL DISORDER,2
BR,MUSCULOSKELETAL PAIN,2
BR,MYALGIA,2
BR,NEOPLASM MALIGNANT,2
BR,NEURODEGENERATIVE DISORDER,2
BR,OBESITY,2
BR,OSTEOMYELITIS,2
BR,PANIC DISORDER,2
BR,PARKINSON^S DISEASE,2
BR,PERICARDIAL EFFUSION,2
BR,PERIPHERAL COLDNESS,2
BR,PHARYNGITIS,2
BR,PRODUCT PHYSICAL ISSUE,2
BR,PRODUCT QUALITY ISSUE,2
BR,PRODUCT STORAGE ERROR,2
BR,PULMONARY MASS,2
BR,PULMONARY SEPSIS,2
BR,PURULENT DISCHARGE,2
BR,PYOMYOSITIS,2
BR,RASH ERYTHEMATOUS,2
BR,RASH MACULAR,2
BR,RENAL INJURY,2
BR,RESPIRATORY TRACT INFECTION,2
BR,RETCHING,2
BR,SENSATION OF FOREIGN BODY,2
BR,SEPTIC SHOCK,2
BR,SJOGREN^S SYNDROME,2
BR,SPINAL COLUMN INJURY,2
BR,SPINAL DISORDER,2
BR,SPINAL FRACTURE,2
BR,SUICIDE ATTEMPT,2
BR,SWELLING FACE,2
BR,SYSTEMIC LUPUS ERYTHEMATOSUS,2
BR,TENDONITIS,2
BR,THERAPEUTIC PRODUCT INEFFECTIVE,2
BR,THERAPEUTIC RESPONSE DECREASED,2
BR,THINKING ABNORMAL,2
BR,THROAT TIGHTNESS,2
BR,THROMBOCYTOPENIA,2
BR,TONGUE DISORDER,2
BR,TRIGEMINAL NEURALGIA,2
BR,URTICARIA,2
BR,VARICOSE ULCERATION,2
BR,VENOUS OCCLUSION,2
BR,VIRAL INFECTION,2
BR,VITAMIN D DEFICIENCY,2
BR,WALKING DISABILITY,2
BR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
BR,YELLOW SKIN,2
BR,ABDOMINAL DISCOMFORT,1
BR,ABDOMINAL HERNIA,1
BR,ABDOMINAL PAIN LOWER,1
BR,ABNORMAL SENSATION IN EYE,1
BR,ABSCESS,1
BR,ACNE,1
BR,ACOUSTIC SHOCK,1
BR,ACUTE PULMONARY OEDEMA,1
BR,ACUTE RESPIRATORY FAILURE,1
BR,ADHESION,1
BR,ADVERSE EVENT,1
BR,AGEUSIA,1
BR,ALANINE AMINOTRANSFERASE ABNORMAL,1
BR,ALCOHOL ABUSE,1
BR,AMERICAN TRYPANOSOMIASIS,1
BR,AMMONIA INCREASED,1
BR,ANAL SPHINCTER ATONY,1
BR,ANGIOSARCOMA,1
BR,ANKYLOSING SPONDYLITIS,1
BR,ANURIA,1
BR,AORTIC ANEURYSM,1
BR,AORTIC VALVE INCOMPETENCE,1
BR,APHASIA,1
BR,APNOEA,1
BR,APPARENT DEATH,1
BR,APPLICATION SITE PAIN,1
BR,APPLICATION SITE PRURITUS,1
BR,ARTERIAL OCCLUSIVE DISEASE,1
BR,ARTHRITIS INFECTIVE,1
BR,ASCITES,1
BR,ASPHYXIA,1
BR,ASTHENOPIA,1
BR,ASTHMATIC CRISIS,1
BR,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,1
BR,ATYPICAL PNEUMONIA,1
BR,AXILLARY VEIN THROMBOSIS,1
BR,AZOTAEMIA,1
BR,BACTERIAL TEST POSITIVE,1
BR,BENIGN HEPATIC NEOPLASM,1
BR,BENIGN NEOPLASM,1
BR,BLADDER DILATATION,1
BR,BLADDER DISORDER,1
BR,BLADDER MASS,1
BR,BLINDNESS TRANSIENT,1
BR,BLISTER INFECTED,1
BR,BLOOD BILIRUBIN ABNORMAL,1
BR,BLOOD CREATINE DECREASED,1
BR,BLOOD CREATININE INCREASED,1
BR,BLOOD GLUCOSE DECREASED,1
BR,BLOOD GLUCOSE FLUCTUATION,1
BR,BLOOD GROWTH HORMONE ABNORMAL,1
BR,BLOOD IRON INCREASED,1
BR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
BR,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
BR,BLOOD SODIUM DECREASED,1
BR,BODY HEIGHT INCREASED,1
BR,BODY TEMPERATURE INCREASED,1
BR,BONE DECALCIFICATION,1
BR,BONE LESION,1
BR,BONE MARROW DISORDER,1
BR,BONE NEOPLASM,1
BR,BRADYCARDIA,1
BR,BRADYPNOEA,1
BR,BRAIN HYPOXIA,1
BR,BREAST CANCER METASTATIC,1
BR,BREAST MASS,1
BR,BRONCHITIS,1
BR,CALCULUS BLADDER,1
BR,CANCER PAIN,1
BR,CARCINOID TUMOUR,1
BR,CARDIAC VALVE REPLACEMENT COMPLICATION,1
BR,CARDIO-RESPIRATORY ARREST,1
BR,CARDIOMYOPATHY,1
BR,CARPAL TUNNEL SYNDROME,1
BR,CATARRH,1
BR,CATHETER SITE INFLAMMATION,1
BR,CEREBRAL ATROPHY,1
BR,CEREBRAL DISORDER,1
BR,CHOLECYSTITIS,1
BR,CHOLURIA,1
BR,CHONDROPATHY,1
BR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
BR,COAGULOPATHY,1
BR,COGNITIVE DISORDER,1
BR,COLD SWEAT,1
BR,COMPLICATION ASSOCIATED WITH DEVICE,1
BR,COORDINATION ABNORMAL,1
BR,CORONARY ARTERY OCCLUSION,1
BR,CRYSTAL URINE PRESENT,1
BR,CYST,1
BR,CYSTITIS,1
BR,CYTOMEGALOVIRUS TEST POSITIVE,1
BR,DEEP VEIN THROMBOSIS,1
BR,DEFAECATION URGENCY,1
BR,DEFICIENCY OF BILE SECRETION,1
BR,DEFORMITY,1
BR,DELUSION,1
BR,DEMENTIA ALZHEIMER^S TYPE,1
BR,DENTAL CARIES,1
BR,DENTAL OPERATION,1
BR,DENTOFACIAL ANOMALY,1
BR,DEPRESSION SUICIDAL,1
BR,DERMATITIS ALLERGIC,1
BR,DERMATITIS BULLOUS,1
BR,DERMATOMYOSITIS,1
BR,DEVICE DISLOCATION,1
BR,DEVICE MALFUNCTION,1
BR,DIABETES MELLITUS INADEQUATE CONTROL,1
BR,DIABETIC COMPLICATION,1
BR,DIABETIC RETINOPATHY,1
BR,DIASTOLIC DYSFUNCTION,1
BR,DIET REFUSAL,1
BR,DIPLEGIA,1
BR,DIPLOPIA,1
BR,DISABILITY,1
BR,DISTURBANCE IN ATTENTION,1
BR,DISTURBANCE IN SOCIAL BEHAVIOUR,1
BR,DROOLING,1
BR,DRUG ABUSE,1
BR,DRUG PRESCRIBING ERROR,1
BR,DYSARTHRIA,1
BR,DYSENTERY,1
BR,DYSKINESIA,1
BR,DYSPEPSIA,1
BR,EAR CONGESTION,1
BR,EAR DISORDER,1
BR,ELECTROCARDIOGRAM QT PROLONGED,1
BR,ENDODONTIC PROCEDURE,1
BR,ENTEROBACTER INFECTION,1
BR,ENZYME LEVEL INCREASED,1
BR,EPILEPSY,1
BR,ESCHERICHIA INFECTION,1
BR,EXTREMITY NECROSIS,1
BR,EYE INFECTION,1
BR,EYE IRRITATION,1
BR,EYE LASER SURGERY,1
BR,EYE OEDEMA,1
BR,EYELID OEDEMA,1
BR,EYELID PTOSIS,1
BR,FACIAL PAIN,1
BR,FACIAL PARESIS,1
BR,FEELING DRUNK,1
BR,FEELING OF BODY TEMPERATURE CHANGE,1
BR,FEELING OF DESPAIR,1
BR,FINGER DEFORMITY,1
BR,FLUID INTAKE REDUCED,1
BR,FLUID RETENTION,1
BR,FORMICATION,1
BR,FRACTURE,1
BR,FRACTURED COCCYX,1
BR,FREQUENT BOWEL MOVEMENTS,1
BR,FUNGAL INFECTION,1
BR,FURUNCLE,1
BR,GALLBLADDER NEOPLASM,1
BR,GASTRIC ULCER HAEMORRHAGE,1
BR,GASTROENTERITIS,1
BR,GASTROINTESTINAL HAEMORRHAGE,1
BR,GASTROINTESTINAL INFECTION,1
BR,GASTROINTESTINAL MOTILITY DISORDER,1
BR,GASTROINTESTINAL NEOPLASM,1
BR,GASTROOESOPHAGEAL REFLUX DISEASE,1
BR,GENE MUTATION,1
BR,GINGIVAL BLEEDING,1
BR,GINGIVITIS,1
BR,GLIOSIS,1
BR,GLOSSODYNIA,1
BR,GLUCOSE TOLERANCE IMPAIRED,1
BR,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
BR,GROWTH FAILURE,1
BR,H1N1 INFLUENZA,1
BR,HAEMATOCHEZIA,1
BR,HAEMATOLOGICAL MALIGNANCY,1
BR,HAEMODIALYSIS,1
BR,HAEMOGLOBIN URINE PRESENT,1
BR,HAEMOLYSIS,1
BR,HAEMOPTYSIS,1
BR,HAND FRACTURE,1
BR,HEMIPARESIS,1
BR,HEPATIC ENCEPHALOPATHY,1
BR,HEPATIC ENZYME INCREASED,1
BR,HEPATIC NEOPLASM,1
BR,HEPATIC PAIN,1
BR,HEPATITIS C,1
BR,HEPATOMEGALY,1
BR,HERPES SIMPLEX ENCEPHALITIS,1
BR,HERPES ZOSTER CUTANEOUS DISSEMINATED,1
BR,HIATUS HERNIA,1
BR,HYPERCALCAEMIA,1
BR,HYPERCHLORHYDRIA,1
BR,HYPERKALAEMIA,1
BR,HYPERKERATOSIS,1
BR,HYPERLIPIDAEMIA,1
BR,HYPOAESTHESIA ORAL,1
BR,HYPOKALAEMIA,1
BR,HYPOMANIA,1
BR,HYPOTHYROIDISM,1
BR,ILEAL STENOSIS,1
BR,IMPAIRED WORK ABILITY,1
BR,INCORRECT PRODUCT STORAGE,1
BR,INCREASED APPETITE,1
BR,INFLAMMATORY CARCINOMA OF THE BREAST,1
BR,INFUSION SITE BRUISING,1
BR,INFUSION SITE INFECTION,1
BR,INGUINAL MASS,1
BR,INJECTION SITE HAEMORRHAGE,1
BR,INJECTION SITE HYPERTROPHY,1
BR,INJECTION SITE MASS,1
BR,INJECTION SITE OEDEMA,1
BR,INJECTION SITE PRURITUS,1
BR,INJECTION SITE REACTION,1
BR,INJECTION SITE SWELLING,1
BR,INJECTION SITE URTICARIA,1
BR,INJECTION SITE VESICLES,1
BR,INJECTION SITE WARMTH,1
BR,INTENTIONAL PRODUCT USE ISSUE,1
BR,INTENTIONAL UNDERDOSE,1
BR,INTERSTITIAL LUNG DISEASE,1
BR,INTERVERTEBRAL DISC DEGENERATION,1
BR,INTESTINAL HAEMORRHAGE,1
BR,INTESTINAL ISCHAEMIA,1
BR,INTESTINAL MASS,1
BR,INTESTINAL OBSTRUCTION,1
BR,INTRA-ABDOMINAL FLUID COLLECTION,1
BR,INTRACARDIAC THROMBUS,1
BR,INVASIVE DUCTAL BREAST CARCINOMA,1
BR,JOINT INJURY,1
BR,JOINT STIFFNESS,1
BR,KIDNEY INFECTION,1
BR,KLEBSIELLA INFECTION,1
BR,KNEE ARTHROPLASTY,1
BR,LARYNGEAL NEOPLASM,1
BR,LATENT TUBERCULOSIS,1
BR,LETHARGY,1
BR,LHERMITTE^S SIGN,1
BR,LIGAMENT DISORDER,1
BR,LIMB ASYMMETRY,1
BR,LIP DISCOLOURATION,1
BR,LOSS OF CONTROL OF LEGS,1
BR,LOWER LIMB FRACTURE,1
BR,LUMBAR VERTEBRAL FRACTURE,1
BR,LYMPH NODE TUBERCULOSIS,1
BR,LYMPHADENOPATHY,1
BR,LYMPHATIC SYSTEM NEOPLASM,1
BR,MALIGNANT MELANOMA,1
BR,MALNUTRITION,1
BR,MASTICATION DISORDER,1
BR,MENINGIOMA,1
BR,MENINGITIS BACTERIAL,1
BR,MENTAL DISORDER,1
BR,METAMORPHOPSIA,1
BR,METASTASIS,1
BR,METASTATIC RENAL CELL CARCINOMA,1
BR,MICTURITION DISORDER,1
BR,MIGRAINE,1
BR,MITRAL VALVE INCOMPETENCE,1
BR,MONOPARESIS,1
BR,MOTOR DYSFUNCTION,1
BR,MOUTH INJURY,1
BR,MUCOSAL INFLAMMATION,1
BR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
BR,MUSCLE ATROPHY,1
BR,MUSCLE CONTRACTURE,1
BR,MUSCLE MASS,1
BR,MUSCLE RIGIDITY,1
BR,MUSCLE SPASTICITY,1
BR,MUSCULOSKELETAL DISCOMFORT,1
BR,NASAL OBSTRUCTION,1
BR,NASAL PRURITUS,1
BR,NASOPHARYNGITIS,1
BR,NEGATIVE THOUGHTS,1
BR,NEPHROLITHIASIS,1
BR,NEURALGIA,1
BR,NEUROGENIC BLADDER,1
BR,NEUROTOXICITY,1
BR,NEUTROPENIA,1
BR,NEUTROPENIC INFECTION,1
BR,NON-SMALL CELL LUNG CANCER,1
BR,OCULAR ICTERUS,1
BR,OPHTHALMOPLEGIA,1
BR,OPPORTUNISTIC INFECTION,1
BR,OPTIC NERVE DISORDER,1
BR,OPTIC NEURITIS,1
BR,ORAL DISORDER,1
BR,ORAL MUCOSAL BLISTERING,1
BR,ORAL MUCOSAL ERYTHEMA,1
BR,ORAL PAIN,1
BR,OSTEONECROSIS,1
BR,OXYGEN CONSUMPTION DECREASED,1
BR,OXYGEN SATURATION DECREASED,1
BR,PALLOR,1
BR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
BR,PANCREATIC DISORDER,1
BR,PANCREATITIS ACUTE,1
BR,PANIC ATTACK,1
BR,PAPILLARY THYROID CANCER,1
BR,PARAESTHESIA ORAL,1
BR,PARALYSIS,1
BR,PARAPARESIS,1
BR,PARATHYROID TUMOUR MALIGNANT,1
BR,PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA,1
BR,PATIENT DISSATISFACTION WITH TREATMENT,1
BR,PERFORMANCE STATUS DECREASED,1
BR,PERIPHERAL MOTOR NEUROPATHY,1
BR,PERIPHERAL SENSORIMOTOR NEUROPATHY,1
BR,PHARYNGEAL DISORDER,1
BR,PHLEBITIS,1
BR,PHOTOSENSITIVITY REACTION,1
BR,PIGMENTATION DISORDER,1
BR,PILOERECTION,1
BR,PILONIDAL CYST,1
BR,PLASMA CELL MYELOMA,1
BR,PLEURAL EFFUSION,1
BR,PNEUMONITIS,1
BR,PNEUMOTHORAX,1
BR,POLYNEUROPATHY,1
BR,POOR QUALITY SLEEP,1
BR,PORTAL HYPERTENSION,1
BR,PORTAL VEIN THROMBOSIS,1
BR,POST PROCEDURAL COMPLICATION,1
BR,POST PROCEDURAL INFECTION,1
BR,POST PROCEDURAL SWELLING,1
BR,POST-TRAUMATIC STRESS DISORDER,1
BR,POSTMENOPAUSAL HAEMORRHAGE,1
BR,POSTOPERATIVE WOUND INFECTION,1
BR,PREMATURE DELIVERY,1
BR,PRESCRIBED OVERDOSE,1
BR,PRESCRIBED UNDERDOSE,1
BR,PROCEDURAL PAIN,1
BR,PROCTITIS,1
BR,PRODUCT DROPPER ISSUE,1
BR,PRODUCT USE IN UNAPPROVED INDICATION,1
BR,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
BR,PROSTATOMEGALY,1
BR,PRURITUS GENERALISED,1
BR,PSEUDOMONAS TEST POSITIVE,1
BR,PSYCHIATRIC DECOMPENSATION,1
BR,PSYCHOTIC DISORDER,1
BR,PULMONARY HYPERTENSION,1
BR,RADIOTHERAPY TO BRAIN,1
BR,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,1
BR,RENAL CANCER METASTATIC,1
BR,RENAL CELL CARCINOMA,1
BR,RENAL COLIC,1
BR,RENAL NEOPLASM,1
BR,RENAL PAIN,1
BR,RESPIRATORY ARREST,1
BR,RESPIRATORY DISORDER,1
BR,RESPIRATORY DISTRESS,1
BR,RESPIRATORY TRACT INFECTION BACTERIAL,1
BR,RESTLESSNESS,1
BR,RETICULOCYTE COUNT ABNORMAL,1
BR,RETICULOCYTE COUNT INCREASED,1
BR,RETINAL HAEMORRHAGE,1
BR,RETINAL VEIN OCCLUSION,1
BR,RHEUMATIC DISORDER,1
BR,ROTATOR CUFF SYNDROME,1
BR,SALIVARY HYPERSECRETION,1
BR,SCIATICA,1
BR,SECRETION DISCHARGE,1
BR,SELF INJURIOUS BEHAVIOUR,1
BR,SENSORY LOSS,1
BR,SHOCK,1
BR,SKIN BURNING SENSATION,1
BR,SKIN CANCER,1
BR,SKIN DISORDER,1
BR,SKIN FISSURES,1
BR,SKIN HYPERTROPHY,1
BR,SKIN INDURATION,1
BR,SKIN INFECTION,1
BR,SKIN IRRITATION,1
BR,SKIN NECROSIS,1
BR,SKIN SENSITISATION,1
BR,SKULL FRACTURE,1
BR,SLEEP APNOEA SYNDROME,1
BR,SLEEP DISORDER,1
BR,SNEEZING,1
BR,SPINAL CORD DISORDER,1
BR,SPINAL CORD INJURY CERVICAL,1
BR,SPINAL MUSCULAR ATROPHY,1
BR,SPINAL OPERATION,1
BR,SPINAL OSTEOARTHRITIS,1
BR,SPLEEN DISORDER,1
BR,SQUAMOUS CELL CARCINOMA,1
BR,STRESS,1
BR,STROKE IN EVOLUTION,1
BR,SUBCLAVIAN VEIN THROMBOSIS,1
BR,SUBSTANCE USE,1
BR,SUICIDAL IDEATION,1
BR,SUPERFICIAL INJURY OF EYE,1
BR,SURGERY,1
BR,SYNOVITIS,1
BR,TEMPERATURE INTOLERANCE,1
BR,THROAT IRRITATION,1
BR,THROMBOPHLEBITIS SUPERFICIAL,1
BR,THROMBOSIS MESENTERIC VESSEL,1
BR,THYROID MASS,1
BR,THYROID NEOPLASM,1
BR,THYROID OPERATION,1
BR,TOOTH EXTRACTION,1
BR,TOOTH FRACTURE,1
BR,TOOTHACHE,1
BR,TOXICITY TO VARIOUS AGENTS,1
BR,TRANSAMINASES INCREASED,1
BR,TRAUMATIC LUNG INJURY,1
BR,TREATMENT FAILURE,1
BR,TREATMENT NONCOMPLIANCE,1
BR,TUBERCULOSIS,1
BR,TUBULOINTERSTITIAL NEPHRITIS,1
BR,TYPE 1 DIABETES MELLITUS,1
BR,ULCERATIVE KERATITIS,1
BR,UNDERDOSE,1
BR,UNDERWEIGHT,1
BR,UNEVALUABLE EVENT,1
BR,UNEVALUABLE INVESTIGATION,1
BR,UNRESPONSIVE TO STIMULI,1
BR,URINARY BLADDER HAEMORRHAGE,1
BR,URINARY TRACT INFECTION BACTERIAL,1
BR,URINE ABNORMALITY,1
BR,URINE KETONE BODY PRESENT,1
BR,URINE LEUKOCYTE ESTERASE POSITIVE,1
BR,UTERINE DISORDER,1
BR,VAGINAL INFECTION,1
BR,VARICOSE VEIN,1
BR,VASCULAR ACCESS SITE COMPLICATION,1
BR,VASCULAR OPERATION,1
BR,VASCULAR RUPTURE,1
BR,VENOUS INSUFFICIENCY,1
BR,VERTIGO,1
BR,VESSEL PUNCTURE SITE REACTION,1
BR,VIROLOGIC FAILURE,1
BR,VITAL FUNCTIONS ABNORMAL,1
BR,VITAMIN B12 ABNORMAL,1
BR,VITAMIN D ABNORMAL,1
BR,VITAMIN D DECREASED,1
BR,VITRECTOMY,1
BR,VULVOVAGINAL DRYNESS,1
BR,WALKING AID USER,1
BR,WEIGHT ABNORMAL,1
BR,WEIGHT FLUCTUATION,1
BR,WEIGHT GAIN POOR,1
BR,WHITE BLOOD CELLS URINE,1
BR,WOUND INFECTION,1
BR,WOUND SECRETION,1
BR,WRIST FRACTURE,1
CM,CONDITION AGGRAVATED,1
CM,DRUG INEFFECTIVE,1
CM,GASTROINTESTINAL DISORDER,1
CM,HEADACHE,1
CM,INFECTION,1
CM,MOBILITY DECREASED,1
CM,NAUSEA,1
CM,PNEUMOTHORAX,1
CM,SPINAL FRACTURE,1
CM,VOMITING,1
CA,DRUG INEFFECTIVE,244
CA,FATIGUE,222
CA,PAIN,205
CA,ARTHRALGIA,187
CA,DIARRHOEA,182
CA,NAUSEA,180
CA,RHEUMATOID ARTHRITIS,155
CA,PAIN IN EXTREMITY,150
CA,HEADACHE,145
CA,PNEUMONIA,133
CA,DYSPNOEA,124
CA,MALAISE,120
CA,DIZZINESS,116
CA,FALL,111
CA,VOMITING,107
CA,ASTHENIA,98
CA,CONDITION AGGRAVATED,94
CA,ABDOMINAL PAIN,90
CA,DEATH,87
CA,NASOPHARYNGITIS,87
CA,PERIPHERAL SWELLING,85
CA,BACK PAIN,84
CA,WEIGHT DECREASED,84
CA,JOINT SWELLING,80
CA,COUGH,78
CA,BLOOD PRESSURE INCREASED,76
CA,INSOMNIA,76
CA,DRUG INTOLERANCE,73
CA,INFUSION RELATED REACTION,72
CA,PYREXIA,71
CA,WEIGHT INCREASED,69
CA,OSTEOARTHRITIS,68
CA,HYPOTENSION,64
CA,DEHYDRATION,63
CA,INFECTION,63
CA,GAIT DISTURBANCE,60
CA,TOXICITY TO VARIOUS AGENTS,58
CA,CHEST PAIN,57
CA,MUSCULOSKELETAL STIFFNESS,57
CA,DECREASED APPETITE,56
CA,HYPOAESTHESIA,55
CA,DEPRESSION,53
CA,RASH,51
CA,HYPERTENSION,50
CA,MUSCULOSKELETAL PAIN,50
CA,SOMNOLENCE,50
CA,ANXIETY,49
CA,PRURITUS,49
CA,MOBILITY DECREASED,47
CA,ANAEMIA,46
CA,PRODUCT USE ISSUE,46
CA,URINARY TRACT INFECTION,45
CA,ARTHRITIS,44
CA,INFLUENZA,44
CA,ABDOMINAL PAIN UPPER,43
CA,HERPES ZOSTER,43
CA,DRUG HYPERSENSITIVITY,42
CA,GASTROINTESTINAL DISORDER,41
CA,HEART RATE INCREASED,41
CA,HYPERHIDROSIS,41
CA,NECK PAIN,41
CA,ARTHROPATHY,40
CA,CONTUSION,40
CA,MUSCLE SPASMS,40
CA,SLEEP DISORDER,40
CA,BLOOD CREATININE INCREASED,39
CA,CHILLS,39
CA,CONFUSIONAL STATE,39
CA,OROPHARYNGEAL PAIN,39
CA,PARAESTHESIA,39
CA,LOSS OF CONSCIOUSNESS,38
CA,CROHN^S DISEASE,37
CA,HAEMOGLOBIN DECREASED,37
CA,RENAL IMPAIRMENT,37
CA,CONSTIPATION,36
CA,OVERDOSE,36
CA,OXYGEN SATURATION DECREASED,36
CA,CHEST DISCOMFORT,35
CA,FEELING ABNORMAL,35
CA,BALANCE DISORDER,34
CA,DRUG EFFECT DECREASED,34
CA,DRY EYE,34
CA,DYSPHAGIA,34
CA,TREMOR,34
CA,SINUSITIS,33
CA,ERYTHEMA,32
CA,MUSCULAR WEAKNESS,32
CA,PRODUCTIVE COUGH,32
CA,FOETAL EXPOSURE DURING PREGNANCY,31
CA,LYMPHADENOPATHY,31
CA,OEDEMA PERIPHERAL,31
CA,SEPSIS,31
CA,ANAPHYLACTIC REACTION,30
CA,FLUSHING,30
CA,SKIN LESION,30
CA,STRESS,30
CA,CELLULITIS,29
CA,MYOCARDIAL INFARCTION,29
CA,PALPITATIONS,29
CA,DRUG EFFECT INCOMPLETE,28
CA,FIBROMYALGIA,28
CA,LOWER RESPIRATORY TRACT INFECTION,28
CA,ALOPECIA,27
CA,BRONCHITIS,27
CA,HEART RATE DECREASED,27
CA,HYPERSENSITIVITY,27
CA,OSTEOPENIA,27
CA,ABDOMINAL DISCOMFORT,26
CA,DYSPNOEA EXERTIONAL,26
CA,VISION BLURRED,26
CA,AMNESIA,25
CA,BLOOD PRESSURE FLUCTUATION,25
CA,GASTROOESOPHAGEAL REFLUX DISEASE,25
CA,HAND DEFORMITY,25
CA,LOCALISED INFECTION,25
CA,MENTAL DISORDER,25
CA,SUICIDAL IDEATION,25
CA,TREATMENT FAILURE,25
CA,ABDOMINAL DISTENSION,24
CA,DEAFNESS NEUROSENSORY,24
CA,HAEMATOCHEZIA,24
CA,INJECTION SITE PAIN,24
CA,MYALGIA,24
CA,NEURALGIA,24
CA,BLOOD PRESSURE SYSTOLIC INCREASED,23
CA,CYST,23
CA,INFLUENZA LIKE ILLNESS,23
CA,JOINT RANGE OF MOTION DECREASED,23
CA,NEPHROLITHIASIS,23
CA,VISUAL IMPAIRMENT,23
CA,ACTIVITIES OF DAILY LIVING IMPAIRED,22
CA,BURNING SENSATION,22
CA,DRUG DOSE OMISSION,22
CA,HERNIA,22
CA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,22
CA,LUNG INFECTION,22
CA,PRESBYACUSIS,22
CA,SWELLING,22
CA,ANGINA PECTORIS,21
CA,BODY TEMPERATURE DECREASED,21
CA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,21
CA,DIABETES MELLITUS,21
CA,HAEMORRHAGE,21
CA,MEMORY IMPAIRMENT,21
CA,MIGRAINE,21
CA,PLATELET COUNT DECREASED,21
CA,CARDIAC FAILURE CONGESTIVE,20
CA,CYSTITIS,20
CA,MALIGNANT NEOPLASM PROGRESSION,20
CA,PULMONARY OEDEMA,20
CA,SEIZURE,20
CA,SYNCOPE,20
CA,BONE PAIN,19
CA,DISEASE PROGRESSION,19
CA,DRY MOUTH,19
CA,GENERAL PHYSICAL HEALTH DETERIORATION,19
CA,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,19
CA,OEDEMA,19
CA,PLEURAL FIBROSIS,19
CA,PULMONARY EMBOLISM,19
CA,RENAL FAILURE,19
CA,WHITE BLOOD CELL COUNT DECREASED,19
CA,ARRHYTHMIA,18
CA,BLOOD PRESSURE DECREASED,18
CA,CATARACT,18
CA,DYSPEPSIA,18
CA,HOSPITALISATION,18
CA,LUNG DISORDER,18
CA,PAIN IN JAW,18
CA,RESPIRATORY FAILURE,18
CA,SKIN ULCER,18
CA,ASTHMA,17
CA,BACK DISORDER,17
CA,BLISTER,17
CA,CONVULSION,17
CA,DRUG WITHDRAWAL SYNDROME,17
CA,IMPAIRED HEALING,17
CA,LOCAL SWELLING,17
CA,NEUTROPENIA,17
CA,RHINORRHOEA,17
CA,DRY SKIN,16
CA,EYE PAIN,16
CA,FOOT FRACTURE,16
CA,KIDNEY INFECTION,16
CA,NECK MASS,16
CA,PRODUCT USE IN UNAPPROVED INDICATION,16
CA,SURGERY,16
CA,DYSURIA,15
CA,EPIGASTRIC DISCOMFORT,15
CA,HAEMOPTYSIS,15
CA,HEPATIC ENZYME INCREASED,15
CA,MATERNAL EXPOSURE DURING PREGNANCY,15
CA,NEONATAL BEHAVIOURAL SYNDROME,15
CA,NIGHT SWEATS,15
CA,POLLAKIURIA,15
CA,PRESYNCOPE,15
CA,ROAD TRAFFIC ACCIDENT,15
CA,TOOTH DISORDER,15
CA,VERTIGO,15
CA,WHEEZING,15
CA,WOUND,15
CA,ACUTE KIDNEY INJURY,14
CA,AGITATION,14
CA,BLOOD ALBUMIN DECREASED,14
CA,BLOOD GLUCOSE INCREASED,14
CA,C-REACTIVE PROTEIN INCREASED,14
CA,CARDIAC DISORDER,14
CA,DEPRESSED MOOD,14
CA,HEART RATE IRREGULAR,14
CA,HOT FLUSH,14
CA,JOINT INJURY,14
CA,LIMB DISCOMFORT,14
CA,MULTIPLE SCLEROSIS RELAPSE,14
CA,NEUTROPHIL COUNT DECREASED,14
CA,OSTEOPOROSIS,14
CA,RASH PRURITIC,14
CA,RIB FRACTURE,14
CA,TACHYCARDIA,14
CA,THROMBOCYTOSIS,14
CA,ARTHRITIS INFECTIVE,13
CA,ASPARTATE AMINOTRANSFERASE INCREASED,13
CA,COMA,13
CA,DELIRIUM,13
CA,DRUG WITHDRAWAL SYNDROME NEONATAL,13
CA,EPISTAXIS,13
CA,FEELING HOT,13
CA,FREQUENT BOWEL MOVEMENTS,13
CA,INTERSTITIAL LUNG DISEASE,13
CA,LETHARGY,13
CA,LIVER DISORDER,13
CA,NASAL CONGESTION,13
CA,PLEURAL THICKENING,13
CA,RECTAL HAEMORRHAGE,13
CA,SLEEP APNOEA SYNDROME,13
CA,URTICARIA,13
CA,ABASIA,12
CA,ADVERSE DRUG REACTION,12
CA,APHONIA,12
CA,BLOOD POTASSIUM INCREASED,12
CA,BURSITIS,12
CA,CARDIAC MURMUR,12
CA,EXOSTOSIS,12
CA,FEMUR FRACTURE,12
CA,INFLAMMATION,12
CA,NEUROPATHY PERIPHERAL,12
CA,OBESITY,12
CA,SCAR,12
CA,SCIATICA,12
CA,ADVERSE REACTION,11
CA,ATRIAL FIBRILLATION,11
CA,BLOOD PRESSURE DIASTOLIC DECREASED,11
CA,BONE DISORDER,11
CA,CEREBROVASCULAR ACCIDENT,11
CA,DEPRESSED LEVEL OF CONSCIOUSNESS,11
CA,FLUID RETENTION,11
CA,HALLUCINATION,11
CA,HYPERKERATOSIS,11
CA,HYPOKALAEMIA,11
CA,INJECTION SITE ERYTHEMA,11
CA,INTESTINAL OBSTRUCTION,11
CA,LIMB INJURY,11
CA,LOWER LIMB FRACTURE,11
CA,OSTEOMYELITIS,11
CA,PAIN OF SKIN,11
CA,ROTATOR CUFF SYNDROME,11
CA,SEPTIC SHOCK,11
CA,SYSTEMIC LUPUS ERYTHEMATOSUS,11
CA,TOOTH ABSCESS,11
CA,TYPE 2 DIABETES MELLITUS,11
CA,UNRESPONSIVE TO STIMULI,11
CA,WHITE BLOOD CELL COUNT INCREASED,11
CA,ANKYLOSING SPONDYLITIS,10
CA,BONE CYST,10
CA,CHOLELITHIASIS,10
CA,CLOSTRIDIUM DIFFICILE INFECTION,10
CA,DEEP VEIN THROMBOSIS,10
CA,DENTAL CARIES,10
CA,DYSPHONIA,10
CA,EAR PAIN,10
CA,FLATULENCE,10
CA,GAIT INABILITY,10
CA,HYPERSOMNIA,10
CA,HYPOKINESIA,10
CA,JOINT STIFFNESS,10
CA,KNEE ARTHROPLASTY,10
CA,MOVEMENT DISORDER,10
CA,MUSCULOSKELETAL CHEST PAIN,10
CA,MUSCULOSKELETAL DISCOMFORT,10
CA,NERVOUSNESS,10
CA,OSTEOSCLEROSIS,10
CA,PALLOR,10
CA,PANCREATITIS,10
CA,POOR QUALITY SLEEP,10
CA,POST PROCEDURAL INFECTION,10
CA,PRURITUS GENERALISED,10
CA,RENAL DISORDER,10
CA,SCOLIOSIS,10
CA,SENSORY LOSS,10
CA,SPINAL OPERATION,10
CA,SUICIDE ATTEMPT,10
CA,SYNOVITIS,10
CA,ASCITES,9
CA,BLOOD IRON DECREASED,9
CA,BRADYCARDIA,9
CA,CARPAL TUNNEL SYNDROME,9
CA,DEFORMITY,9
CA,DISTURBANCE IN ATTENTION,9
CA,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,9
CA,DYSSTASIA,9
CA,EXPOSURE DURING PREGNANCY,9
CA,GALLBLADDER DISORDER,9
CA,GOUT,9
CA,HYPOXIA,9
CA,INJECTION SITE MASS,9
CA,LUNG NEOPLASM MALIGNANT,9
CA,LYMPHOCYTE COUNT DECREASED,9
CA,MASS,9
CA,MULTIPLE SCLEROSIS,9
CA,NERVE COMPRESSION,9
CA,PERIPHERAL VENOUS DISEASE,9
CA,PNEUMOTHORAX,9
CA,POOR VENOUS ACCESS,9
CA,RASH ERYTHEMATOUS,9
CA,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,9
CA,RENAL CYST,9
CA,SCLERODERMA,9
CA,SCRATCH,9
CA,SPINAL FRACTURE,9
CA,SPINAL PAIN,9
CA,SPUTUM DISCOLOURED,9
CA,STAPHYLOCOCCAL INFECTION,9
CA,SWELLING FACE,9
CA,THERAPEUTIC RESPONSE DECREASED,9
CA,THROMBOCYTOPENIA,9
CA,UPPER RESPIRATORY TRACT INFECTION,9
CA,VIRAL UPPER RESPIRATORY TRACT INFECTION,9
CA,WOUND INFECTION,9
CA,ABDOMINAL PAIN LOWER,8
CA,ABSCESS,8
CA,BLINDNESS,8
CA,BLOOD MAGNESIUM INCREASED,8
CA,BLOOD PRESSURE ABNORMAL,8
CA,BODY TEMPERATURE INCREASED,8
CA,BREAST CANCER METASTATIC,8
CA,CONCUSSION,8
CA,CORONARY ARTERY DISEASE,8
CA,CRYING,8
CA,DIPLOPIA,8
CA,DISORIENTATION,8
CA,DIVERTICULUM,8
CA,DRUG SCREEN POSITIVE,8
CA,DYSKINESIA,8
CA,EATING DISORDER,8
CA,FAECES DISCOLOURED,8
CA,FEEDING DISORDER,8
CA,FINGER DEFORMITY,8
CA,FLANK PAIN,8
CA,GASTRIC DISORDER,8
CA,GASTROINTESTINAL INFECTION,8
CA,HEAD DISCOMFORT,8
CA,INJECTION SITE BRUISING,8
CA,INJECTION SITE REACTION,8
CA,INTERNATIONAL NORMALISED RATIO INCREASED,8
CA,INTERVERTEBRAL DISC PROTRUSION,8
CA,IRITIS,8
CA,IRRITABILITY,8
CA,JOINT DISLOCATION,8
CA,LIVER FUNCTION TEST INCREASED,8
CA,MALIGNANT MELANOMA,8
CA,NEOPLASM MALIGNANT,8
CA,NEOPLASM PROGRESSION,8
CA,ORTHOSTATIC HYPOTENSION,8
CA,PELVIC FRACTURE,8
CA,POST PROCEDURAL COMPLICATION,8
CA,PULMONARY CONGESTION,8
CA,RESPIRATORY DISORDER,8
CA,SEROTONIN SYNDROME,8
CA,SKIN DISORDER,8
CA,SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION,8
CA,SPINAL COLUMN STENOSIS,8
CA,THROAT IRRITATION,8
CA,TINNITUS,8
CA,ULCER,8
CA,ADVERSE EVENT,7
CA,ANKLE FRACTURE,7
CA,BLADDER DISORDER,7
CA,BLOOD CHOLESTEROL INCREASED,7
CA,C-REACTIVE PROTEIN ABNORMAL,7
CA,CENTRAL NERVOUS SYSTEM LESION,7
CA,CHOKING,7
CA,CONTRAINDICATED PRODUCT ADMINISTERED,7
CA,DIVERTICULAR PERFORATION,7
CA,DRUG LEVEL ABOVE THERAPEUTIC,7
CA,EYE SWELLING,7
CA,FEBRILE NEUTROPENIA,7
CA,FOOT DEFORMITY,7
CA,GASTRITIS,7
CA,HAEMATURIA,7
CA,HIP FRACTURE,7
CA,HUMERUS FRACTURE,7
CA,ILL-DEFINED DISORDER,7
CA,INCORRECT DRUG ADMINISTRATION DURATION,7
CA,INTERVERTEBRAL DISC DISORDER,7
CA,INTESTINAL PERFORATION,7
CA,IRRITABLE BOWEL SYNDROME,7
CA,LACRIMATION INCREASED,7
CA,LIP DRY,7
CA,LYMPHOEDEMA,7
CA,MICTURITION URGENCY,7
CA,MULTI-ORGAN FAILURE,7
CA,MUSCLE TIGHTNESS,7
CA,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,7
CA,PANIC ATTACK,7
CA,PARANOIA,7
CA,PLASMA CELL MYELOMA,7
CA,POLYP,7
CA,PRODUCT SUBSTITUTION ISSUE,7
CA,PSORIASIS,7
CA,RAYNAUD^S PHENOMENON,7
CA,RENAL FAILURE ACUTE,7
CA,RESPIRATORY ARREST,7
CA,RETROPERITONEAL HAEMATOMA,7
CA,RHABDOMYOLYSIS,7
CA,SINUS DISORDER,7
CA,SKIN CANCER,7
CA,SKIN DISCOLOURATION,7
CA,SKIN EXFOLIATION,7
CA,SKIN FISSURES,7
CA,SPEECH DISORDER,7
CA,STOMATITIS,7
CA,THROMBOSIS,7
CA,TRANSIENT ISCHAEMIC ATTACK,7
CA,URINARY INCONTINENCE,7
CA,URINARY RETENTION,7
CA,VISUAL ACUITY REDUCED,7
CA,WRIST DEFORMITY,7
CA,ANTINUCLEAR ANTIBODY POSITIVE,6
CA,ARTHRITIS BACTERIAL,6
CA,ARTHRODESIS,6
CA,ATELECTASIS,6
CA,BACK INJURY,6
CA,BRAIN INJURY,6
CA,BREAST MASS,6
CA,CANDIDA INFECTION,6
CA,CARDIAC FAILURE,6
CA,CEREBRAL HAEMORRHAGE,6
CA,COGNITIVE DISORDER,6
CA,COLD SWEAT,6
CA,COLITIS ISCHAEMIC,6
CA,COLITIS ULCERATIVE,6
CA,DERMATITIS,6
CA,DERMATITIS ALLERGIC,6
CA,DIVERTICULITIS,6
CA,EAR INFECTION,6
CA,ECZEMA,6
CA,ELECTROCARDIOGRAM QT PROLONGED,6
CA,EMOTIONAL DISORDER,6
CA,FEELING OF BODY TEMPERATURE CHANGE,6
CA,HAEMATOMA,6
CA,HAEMORRHOIDS,6
CA,HEPATIC CIRRHOSIS,6
CA,HYPOGLYCAEMIA,6
CA,INFECTION SUSCEPTIBILITY INCREASED,6
CA,INJECTION SITE HAEMORRHAGE,6
CA,INJECTION SITE SWELLING,6
CA,INTERVERTEBRAL DISC DEGENERATION,6
CA,JAUNDICE,6
CA,LEFT VENTRICULAR DYSFUNCTION,6
CA,LIVER FUNCTION TEST ABNORMAL,6
CA,LYMPHOMA,6
CA,MYASTHENIA GRAVIS,6
CA,NODULE,6
CA,OPTIC NEURITIS,6
CA,OSTEONECROSIS,6
CA,PERIPHERAL COLDNESS,6
CA,PHOTOPSIA,6
CA,PLEURAL EFFUSION,6
CA,PROCTALGIA,6
CA,PULMONARY FIBROSIS,6
CA,PULMONARY MASS,6
CA,RESPIRATORY RATE INCREASED,6
CA,RESTLESS LEGS SYNDROME,6
CA,SPINAL FUSION SURGERY,6
CA,SPLENOMEGALY,6
CA,TENDONITIS,6
CA,TOXICOLOGIC TEST ABNORMAL,6
CA,UNDERDOSE,6
CA,UPPER LIMB FRACTURE,6
CA,UROSEPSIS,6
CA,VIRAL INFECTION,6
CA,WEIGHT LOSS POOR,6
CA,WITHDRAWAL SYNDROME,6
CA,WRIST FRACTURE,6
CA,APNOEA,5
CA,BLADDER PAIN,5
CA,BLOOD MAGNESIUM DECREASED,5
CA,BLOOD URINE PRESENT,5
CA,BONE EROSION,5
CA,BRAIN OEDEMA,5
CA,BREAST CANCER,5
CA,CARDIAC ARREST,5
CA,CARDIOMYOPATHY,5
CA,CHOLECYSTITIS,5
CA,CHROMATURIA,5
CA,COMPLETED SUICIDE,5
CA,COORDINATION ABNORMAL,5
CA,COSTOCHONDRITIS,5
CA,DIABETIC KETOACIDOSIS,5
CA,DISCOMFORT,5
CA,DRUG ABUSE,5
CA,ECCHYMOSIS,5
CA,ELECTROLYTE IMBALANCE,5
CA,EYE HAEMORRHAGE,5
CA,FEELING COLD,5
CA,FULL BLOOD COUNT DECREASED,5
CA,FUNGAL INFECTION,5
CA,GROIN PAIN,5
CA,HEAD INJURY,5
CA,HYPERAESTHESIA,5
CA,HYPERGLYCAEMIA,5
CA,HYPOTHYROIDISM,5
CA,INCORRECT DOSE ADMINISTERED,5
CA,INTENTIONAL OVERDOSE,5
CA,ISCHAEMIC STROKE,5
CA,KYPHOSIS,5
CA,LACERATION,5
CA,METABOLIC ACIDOSIS,5
CA,MOOD SWINGS,5
CA,MUSCULOSKELETAL DISORDER,5
CA,MYOSITIS,5
CA,NERVOUS SYSTEM DISORDER,5
CA,ONYCHOMYCOSIS,5
CA,ORAL HERPES,5
CA,PNEUMONITIS,5
CA,PROCEDURAL PAIN,5
CA,PRODUCT QUALITY ISSUE,5
CA,PULMONARY HAEMORRHAGE,5
CA,RED BLOOD CELL COUNT DECREASED,5
CA,RESPIRATORY DISTRESS,5
CA,SACROILIITIS,5
CA,SINUS CONGESTION,5
CA,SKIN HAEMORRHAGE,5
CA,SKIN INFECTION,5
CA,SPINAL OSTEOARTHRITIS,5
CA,STATUS EPILEPTICUS,5
CA,STREPTOCOCCAL INFECTION,5
CA,TELANGIECTASIA,5
CA,TENDERNESS,5
CA,TENDON DISORDER,5
CA,UVEITIS,5
CA,VENTRICULAR SEPTAL DEFECT,5
CA,WOUND COMPLICATION,5
CA,ABNORMAL FAECES,4
CA,ACUTE CORONARY SYNDROME,4
CA,ACUTE MYOCARDIAL INFARCTION,4
CA,AFFECT LABILITY,4
CA,AGGRESSION,4
CA,ALCOHOL ABUSE,4
CA,ANAL FISSURE,4
CA,ANALGESIC DRUG LEVEL ABOVE THERAPEUTIC,4
CA,ANGER,4
CA,ANTIDEPRESSANT DRUG LEVEL ABOVE THERAPEUTIC,4
CA,APATHY,4
CA,APHASIA,4
CA,ATAXIA,4
CA,BILE DUCT STONE,4
CA,BLADDER TRANSITIONAL CELL CARCINOMA,4
CA,BLOOD POTASSIUM DECREASED,4
CA,BLOOD PRESSURE DIASTOLIC INCREASED,4
CA,BREATH SOUNDS ABNORMAL,4
CA,CHOLECYSTECTOMY,4
CA,CHONDROPATHY,4
CA,CHRONIC KIDNEY DISEASE,4
CA,COLITIS,4
CA,DEMENTIA,4
CA,DEVICE RELATED INFECTION,4
CA,DRUG DEPENDENCE,4
CA,DRY THROAT,4
CA,DYSARTHRIA,4
CA,DYSGEUSIA,4
CA,EAR DISCOMFORT,4
CA,ELECTRIC SHOCK,4
CA,EMOTIONAL DISTRESS,4
CA,EMPTY SELLA SYNDROME,4
CA,ENTEROCOCCAL INFECTION,4
CA,ERECTILE DYSFUNCTION,4
CA,ERUCTATION,4
CA,EYE INFECTION,4
CA,EYE INFLAMMATION,4
CA,EYE IRRITATION,4
CA,EYELID PTOSIS,4
CA,FISTULA,4
CA,FORCED EXPIRATORY VOLUME DECREASED,4
CA,FURUNCLE,4
CA,GASTROENTERITIS VIRAL,4
CA,GASTROINTESTINAL HAEMORRHAGE,4
CA,HAEMATEMESIS,4
CA,HEART VALVE STENOSIS,4
CA,HEMIPARESIS,4
CA,HEPATIC FUNCTION ABNORMAL,4
CA,HEPATIC LESION,4
CA,HEPATIC PAIN,4
CA,HEPATIC STEATOSIS,4
CA,HYPOACUSIS,4
CA,HYPOCALCAEMIA,4
CA,HYPONATRAEMIA,4
CA,HYPOPHAGIA,4
CA,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,4
CA,HYSTERECTOMY,4
CA,IMMUNE SYSTEM DISORDER,4
CA,IMMUNODEFICIENCY,4
CA,IMPAIRED WORK ABILITY,4
CA,INCREASED APPETITE,4
CA,INGROWING NAIL,4
CA,INSULIN-LIKE GROWTH FACTOR INCREASED,4
CA,INTENTIONAL PRODUCT MISUSE,4
CA,KNEE DEFORMITY,4
CA,LEUKOPENIA,4
CA,LIVEDO RETICULARIS,4
CA,MALNUTRITION,4
CA,MENORRHAGIA,4
CA,MENTAL IMPAIRMENT,4
CA,MIXED CONNECTIVE TISSUE DISEASE,4
CA,MOOD ALTERED,4
CA,MOTOR DYSFUNCTION,4
CA,MOUTH ULCERATION,4
CA,MUCOUS STOOLS,4
CA,NERVE INJURY,4
CA,NIGHTMARE,4
CA,ONYCHOLYSIS,4
CA,ORAL PAIN,4
CA,OROPHARYNGEAL DISCOMFORT,4
CA,PANCYTOPENIA,4
CA,PAPILLOEDEMA,4
CA,PARAESTHESIA ORAL,4
CA,PELVIC PAIN,4
CA,PHARYNGITIS,4
CA,PHOTOPHOBIA,4
CA,PITUITARY TUMOUR BENIGN,4
CA,POST HERPETIC NEURALGIA,4
CA,PSORIATIC ARTHROPATHY,4
CA,PSYCHIATRIC SYMPTOM,4
CA,PSYCHOTIC DISORDER,4
CA,PULMONARY FUNCTION TEST DECREASED,4
CA,PULSELESS ELECTRICAL ACTIVITY,4
CA,PURULENT DISCHARGE,4
CA,PYLORIC STENOSIS,4
CA,QUALITY OF LIFE DECREASED,4
CA,RASH GENERALISED,4
CA,ROSACEA,4
CA,SCAB,4
CA,SCLERODACTYLIA,4
CA,SECRETION DISCHARGE,4
CA,SINUS PAIN,4
CA,SKIN HYPERTROPHY,4
CA,SOCIAL AVOIDANT BEHAVIOUR,4
CA,SPINAL COMPRESSION FRACTURE,4
CA,STAPHYLOCOCCAL SKIN INFECTION,4
CA,SUDDEN CARDIAC DEATH,4
CA,TERMINAL STATE,4
CA,TESTIS CANCER,4
CA,THERAPEUTIC RESPONSE UNEXPECTED,4
CA,TOOTH INFECTION,4
CA,TRISMUS,4
CA,UPPER RESPIRATORY TRACT CONGESTION,4
CA,VAGINAL HAEMORRHAGE,4
CA,VERTEBRAL FORAMINAL STENOSIS,4
CA,WALKING AID USER,4
CA,WRONG TECHNIQUE IN DRUG USAGE PROCESS,4
CA,ABDOMINAL ABSCESS,3
CA,ABNORMAL BEHAVIOUR,3
CA,ACCIDENT,3
CA,ACCIDENT AT WORK,3
CA,ACROCHORDON,3
CA,ACUTE HEPATIC FAILURE,3
CA,ALANINE AMINOTRANSFERASE INCREASED,3
CA,ALCOHOL USE,3
CA,ANGIOEDEMA,3
CA,ANORECTAL DISCOMFORT,3
CA,APHTHOUS ULCER,3
CA,APPENDICITIS,3
CA,ASTIGMATISM,3
CA,AUTOIMMUNE THYROIDITIS,3
CA,BASAL CELL CARCINOMA,3
CA,BLADDER PROLAPSE,3
CA,BLINDNESS UNILATERAL,3
CA,BLOOD ALKALINE PHOSPHATASE INCREASED,3
CA,BLOOD ELECTROLYTES DECREASED,3
CA,BLOOD GLUCOSE ABNORMAL,3
CA,BLOOD GLUCOSE DECREASED,3
CA,BLOOD GLUCOSE FLUCTUATION,3
CA,BLOOD GROWTH HORMONE INCREASED,3
CA,BLOOD IMMUNOGLOBULIN E DECREASED,3
CA,BLOOD IMMUNOGLOBULIN E INCREASED,3
CA,BLOOD IMMUNOGLOBULIN M DECREASED,3
CA,BLOOD SODIUM DECREASED,3
CA,BLOOD THYROID STIMULATING HORMONE INCREASED,3
CA,BONE DENSITY ABNORMAL,3
CA,BRAIN HERNIATION,3
CA,BREAST PAIN,3
CA,BRONCHIAL WALL THICKENING,3
CA,BRONCHOSPASM,3
CA,BURSA REMOVAL,3
CA,CARDIAC VALVE DISEASE,3
CA,CARDIOGENIC SHOCK,3
CA,CARDIOVASCULAR DISORDER,3
CA,CEREBRAL DISORDER,3
CA,COLECTOMY,3
CA,COMPLICATION ASSOCIATED WITH DEVICE,3
CA,CONCOMITANT DISEASE PROGRESSION,3
CA,CROUP INFECTIOUS,3
CA,DETOXIFICATION,3
CA,DEVICE DISLOCATION,3
CA,DEVICE FAILURE,3
CA,DEVICE OCCLUSION,3
CA,DISEASE RECURRENCE,3
CA,DRUG LEVEL INCREASED,3
CA,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,3
CA,DRUG USE DISORDER,3
CA,DRUG-INDUCED LIVER INJURY,3
CA,EMPHYSEMA,3
CA,EYE DISORDER,3
CA,EYE PRURITUS,3
CA,EYELID OEDEMA,3
CA,FACE OEDEMA,3
CA,FACIAL PAIN,3
CA,FEAR,3
CA,FEEDING DISORDER NEONATAL,3
CA,FLAGELLATE DERMATITIS,3
CA,FOOD ALLERGY,3
CA,FRACTURE,3
CA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
CA,GASTRIC INFECTION,3
CA,GASTROENTERITIS,3
CA,GASTROINTESTINAL MOTILITY DISORDER,3
CA,GASTROINTESTINAL OBSTRUCTION,3
CA,GASTROINTESTINAL PAIN,3
CA,GENERALISED OEDEMA,3
CA,GINGIVITIS,3
CA,GLAUCOMA,3
CA,GLOMERULAR FILTRATION RATE DECREASED,3
CA,HAEMATOCRIT DECREASED,3
CA,HAEMORRHAGE INTRACRANIAL,3
CA,HELICOBACTER INFECTION,3
CA,HEPATIC NEOPLASM,3
CA,HIP ARTHROPLASTY,3
CA,HYPERREFLEXIA,3
CA,HYPNOTHERAPY,3
CA,HYPOAESTHESIA ORAL,3
CA,HYPOTONIA,3
CA,INCORRECT ROUTE OF DRUG ADMINISTRATION,3
CA,INFUSION SITE DISCHARGE,3
CA,INFUSION SITE ERYTHEMA,3
CA,INFUSION SITE PAIN,3
CA,INJECTION SITE SCAR,3
CA,INTENTIONAL UNDERDOSE,3
CA,INTESTINAL RESECTION,3
CA,INTESTINAL STENOSIS,3
CA,INTRACRANIAL ANEURYSM,3
CA,ISCHAEMIC CEREBRAL INFARCTION,3
CA,JAW DISORDER,3
CA,JOINT EFFUSION,3
CA,LABYRINTHITIS,3
CA,LARYNGEAL MASS,3
CA,LEUKOCYTOSIS,3
CA,MEDICATION ERROR,3
CA,METABOLIC SURGERY,3
CA,MIDDLE INSOMNIA,3
CA,MULTIPLE FRACTURES,3
CA,MUSCLE STRAIN,3
CA,MYELODYSPLASTIC SYNDROME,3
CA,MYOCLONUS,3
CA,NASAL DRYNESS,3
CA,NEEDLE ISSUE,3
CA,NEONATAL RESPIRATORY DISTRESS SYNDROME,3
CA,NEOPLASM,3
CA,NEUROGENIC BLADDER,3
CA,NEUROLEPTIC MALIGNANT SYNDROME,3
CA,OCULAR DISCOMFORT,3
CA,ORAL CANDIDIASIS,3
CA,ORGAN FAILURE,3
CA,OVARIAN CYST,3
CA,PANCREATIC CYST,3
CA,PERIPHERAL ISCHAEMIA,3
CA,PHARYNGEAL OEDEMA,3
CA,PHARYNGITIS STREPTOCOCCAL,3
CA,PHYSICAL DISABILITY,3
CA,PILOERECTION,3
CA,PLANTAR FASCIITIS,3
CA,PLEURISY,3
CA,PNEUMOCYSTIS JIROVECII PNEUMONIA,3
CA,POLYPECTOMY,3
CA,PROCEDURAL COMPLICATION,3
CA,PROSTATE CANCER,3
CA,PROSTATE CANCER METASTATIC,3
CA,PULMONARY FUNCTION TEST ABNORMAL,3
CA,PULMONARY THROMBOSIS,3
CA,PYELONEPHRITIS,3
CA,RENAL FUNCTION TEST ABNORMAL,3
CA,RENAL PAIN,3
CA,RESPIRATORY SYNCYTIAL VIRUS INFECTION,3
CA,RETINAL DETACHMENT,3
CA,RHINITIS,3
CA,SARCOIDOSIS,3
CA,SHOCK,3
CA,SINGLE FUNCTIONAL KIDNEY,3
CA,SINUS HEADACHE,3
CA,SKULL FRACTURE,3
CA,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,3
CA,SPINAL DISORDER,3
CA,SPONDYLOLISTHESIS,3
CA,SPUTUM RETENTION,3
CA,STILL^S DISEASE,3
CA,TENSION,3
CA,THROAT TIGHTNESS,3
CA,TOE OPERATION,3
CA,TOOTH FRACTURE,3
CA,TOOTHACHE,3
CA,TRANSFUSION,3
CA,TREATMENT NONCOMPLIANCE,3
CA,TROPONIN INCREASED,3
CA,URETERIC OBSTRUCTION,3
CA,URINE ABNORMALITY,3
CA,URINE OUTPUT DECREASED,3
CA,UTERINE LEIOMYOMA,3
CA,VARICOSE VEIN,3
CA,VASCULITIS,3
CA,WEIGHT FLUCTUATION,3
CA,ABDOMINAL INFECTION,2
CA,ABDOMINAL RIGIDITY,2
CA,ABNORMAL DREAMS,2
CA,ABORTION SPONTANEOUS,2
CA,ABSCESS OF SALIVARY GLAND,2
CA,ABSCESS ORAL,2
CA,ACCIDENTAL OVERDOSE,2
CA,ACNE,2
CA,ACROMEGALY,2
CA,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,2
CA,ADRENAL ADENOMA,2
CA,ADRENAL MASS,2
CA,AFFECTIVE DISORDER,2
CA,ALVEOLITIS,2
CA,AMMONIA INCREASED,2
CA,ANAPHYLACTIC SHOCK,2
CA,ANENCEPHALY,2
CA,ANGINA UNSTABLE,2
CA,ANORECTAL DISORDER,2
CA,ANURIA,2
CA,AORTIC VALVE INCOMPETENCE,2
CA,ARTERIAL OCCLUSIVE DISEASE,2
CA,ARTERIAL RUPTURE,2
CA,ARTERIOSCLEROSIS,2
CA,ARTERIOSCLEROSIS CORONARY ARTERY,2
CA,ARTHROPOD BITE,2
CA,ASPIRATION,2
CA,AUTOIMMUNE DISORDER,2
CA,AVULSION FRACTURE,2
CA,AZOTAEMIA,2
CA,BACTERIAL INFECTION,2
CA,BENIGN BREAST NEOPLASM,2
CA,BILIRUBIN CONJUGATED INCREASED,2
CA,BLOOD ALKALINE PHOSPHATASE DECREASED,2
CA,BLOOD CALCIUM INCREASED,2
CA,BLOOD COUNT ABNORMAL,2
CA,BLOOD CREATINE INCREASED,2
CA,BLOOD LACTATE DEHYDROGENASE INCREASED,2
CA,BLOOD PRESSURE DIASTOLIC ABNORMAL,2
CA,BLOOD PRESSURE SYSTOLIC ABNORMAL,2
CA,BLOOD PRESSURE SYSTOLIC DECREASED,2
CA,BLOOD TEST ABNORMAL,2
CA,BODY HEIGHT DECREASED,2
CA,BONE DENSITY DECREASED,2
CA,BONE MARROW DISORDER,2
CA,BONE MARROW FAILURE,2
CA,BRAIN NEOPLASM,2
CA,BREAST CANCER FEMALE,2
CA,BRONCHIAL DISORDER,2
CA,BRONCHITIS CHRONIC,2
CA,BURNOUT SYNDROME,2
CA,BURSA DISORDER,2
CA,CARDIAC ASSISTANCE DEVICE USER,2
CA,CARDIAC PACEMAKER REPLACEMENT,2
CA,CATATONIA,2
CA,CATHETER SITE INFECTION,2
CA,CATHETER SITE INFLAMMATION,2
CA,CATHETER SITE PAIN,2
CA,CERVICAL VERTEBRAL FRACTURE,2
CA,CHOLECYSTITIS INFECTIVE,2
CA,CLOSTRIDIUM DIFFICILE COLITIS,2
CA,CLUMSINESS,2
CA,COAGULOPATHY,2
CA,COELIAC DISEASE,2
CA,COLONOSCOPY,2
CA,COMPRESSION FRACTURE,2
CA,COMPULSIVE SHOPPING,2
CA,CORONARY ARTERY OCCLUSION,2
CA,CREPITATIONS,2
CA,CRYPTORCHISM,2
CA,CUSHING^S SYNDROME,2
CA,CYANOSIS,2
CA,DARK CIRCLES UNDER EYES,2
CA,DEAFNESS,2
CA,DECREASED ACTIVITY,2
CA,DECREASED IMMUNE RESPONSIVENESS,2
CA,DECUBITUS ULCER,2
CA,DEMENTIA ALZHEIMER^S TYPE,2
CA,DEPRESSIVE SYMPTOM,2
CA,DERMATITIS EXFOLIATIVE,2
CA,DEVICE ISSUE,2
CA,DEVICE LEAKAGE,2
CA,DIABETIC NEUROPATHY,2
CA,DIARRHOEA HAEMORRHAGIC,2
CA,DILATATION VENTRICULAR,2
CA,DISABILITY ASSESSMENT SCALE SCORE INCREASED,2
CA,DRUG ADMINISTRATION ERROR,2
CA,DUODENAL ULCER,2
CA,DUODENOGASTRIC REFLUX,2
CA,DYSLIPIDAEMIA,2
CA,DYSMETRIA,2
CA,DYSPHEMIA,2
CA,DYSTONIA,2
CA,EAR PRURITUS,2
CA,EJECTION FRACTION DECREASED,2
CA,ENDOMETRIOSIS,2
CA,ERYTHEMA MULTIFORME,2
CA,EXCORIATION,2
CA,EXPOSURE DURING BREAST FEEDING,2
CA,EXTRASYSTOLES,2
CA,EYE LASER SURGERY,2
CA,EYELID PAIN,2
CA,FACIAL BONES FRACTURE,2
CA,FAECAL INCONTINENCE,2
CA,FAECES SOFT,2
CA,FANCONI SYNDROME ACQUIRED,2
CA,FEELING JITTERY,2
CA,FIBRIN D DIMER INCREASED,2
CA,FINE MOTOR SKILL DYSFUNCTION,2
CA,FLUID OVERLOAD,2
CA,FOETAL GROWTH RESTRICTION,2
CA,FOLLICULITIS,2
CA,FOOD CRAVING,2
CA,FOOD INTERACTION,2
CA,FOOD POISONING,2
CA,FOOT OPERATION,2
CA,FOREIGN BODY SENSATION IN EYES,2
CA,GASTRIC CANCER,2
CA,GASTRIC CANCER RECURRENT,2
CA,GASTRIC DILATATION,2
CA,GASTRIC POLYPS,2
CA,GASTROINTESTINAL TUBE INSERTION,2
CA,GINGIVAL SWELLING,2
CA,GLIOBLASTOMA,2
CA,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
CA,GRAND MAL CONVULSION,2
CA,GRANULOMA,2
CA,GYNAECOMASTIA,2
CA,HAEMARTHROSIS,2
CA,HAEMOGLOBIN ABNORMAL,2
CA,HAEMORRHAGE SUBCUTANEOUS,2
CA,HALLUCINATION_ AUDITORY,2
CA,HAND FRACTURE,2
CA,HEAD DEFORMITY,2
CA,HEPARIN-INDUCED THROMBOCYTOPENIA,2
CA,HEPATIC FAILURE,2
CA,HEPATIC FIBROSIS,2
CA,HEPATITIS C,2
CA,HEPATOMEGALY,2
CA,HERNIA REPAIR,2
CA,HERPES VIRUS INFECTION,2
CA,HIATUS HERNIA,2
CA,HIRSUTISM,2
CA,HLA MARKER STUDY POSITIVE,2
CA,HOMICIDAL IDEATION,2
CA,HYPERKALAEMIA,2
CA,HYPERLIPIDAEMIA,2
CA,HYPERMOBILITY SYNDROME,2
CA,HYPERTENSIVE HEART DISEASE,2
CA,HYPOMAGNESAEMIA,2
CA,HYPOPNOEA,2
CA,IMMUNOSUPPRESSION,2
CA,IMPULSIVE BEHAVIOUR,2
CA,INCOHERENT,2
CA,INCREASED TENDENCY TO BRUISE,2
CA,INCREASED UPPER AIRWAY SECRETION,2
CA,INFECTED BITE,2
CA,INFECTED SKIN ULCER,2
CA,INFLAMMATORY BOWEL DISEASE,2
CA,INJECTION RELATED REACTION,2
CA,INJECTION SITE ABSCESS,2
CA,INJECTION SITE DISCOLOURATION,2
CA,INJECTION SITE EXTRAVASATION,2
CA,INJECTION SITE INDURATION,2
CA,INTERCEPTED DRUG PRESCRIBING ERROR,2
CA,INTERNATIONAL NORMALISED RATIO DECREASED,2
CA,INTERVERTEBRAL DISC SPACE NARROWING,2
CA,INTESTINAL FISTULA,2
CA,INTESTINAL ISCHAEMIA,2
CA,INTESTINAL OPERATION,2
CL,AFFECTIVE DISORDER,1
CL,AMNESIA,1
CL,ANXIETY,1
CL,ARTHRALGIA,1
CL,BONE PAIN,1
CL,CEREBROVASCULAR ACCIDENT,1
CL,CONTUSION,1
CL,DECREASED APPETITE,1
CL,DEPRESSED MOOD,1
CL,DISORIENTATION,1
CL,DIZZINESS,1
CL,DRUG DOSE OMISSION,1
CL,DYSARTHRIA,1
CL,FALL,1
CL,FATIGUE,1
CL,GAIT DISTURBANCE,1
CL,HAEMORRHAGE,1
CL,HEADACHE,1
CL,HEMIPARESIS,1
CL,HYPERSOMNIA,1
CL,IMPAIRED HEALING,1
CL,INFLAMMATION,1
CL,INSOMNIA,1
CL,MALAISE,1
CL,MALIGNANT NEOPLASM PROGRESSION,1
CL,MEMORY IMPAIRMENT,1
CL,MENTAL DISORDER,1
CL,METASTASES TO BONE,1
CL,METASTASIS,1
CL,OSTEOARTHRITIS,1
CL,PAIN,1
CL,PAIN IN EXTREMITY,1
CL,SOMNOLENCE,1
CL,SPEECH DISORDER,1
CL,SWELLING,1
CL,TRIGEMINAL NERVE DISORDER,1
CL,VISUAL IMPAIRMENT,1
CL,WOUND,1
CN,HEPATIC FUNCTION ABNORMAL,8
CN,HYPERAESTHESIA,8
CN,SOMNOLENCE,6
CN,DIZZINESS,4
CN,DRUG INEFFECTIVE,4
CN,LOSS OF CONSCIOUSNESS,4
CN,RASH,4
CN,VOMITING,4
CN,ASTHENIA,3
CN,DERMATITIS,3
CN,FACE OEDEMA,3
CN,INADEQUATE ANALGESIA,3
CN,SEIZURE,3
CN,ABDOMINAL DISCOMFORT,2
CN,ACCIDENTAL OVERDOSE,2
CN,ALANINE AMINOTRANSFERASE INCREASED,2
CN,ANXIETY,2
CN,ASPARTATE AMINOTRANSFERASE INCREASED,2
CN,BLOOD ALKALINE PHOSPHATASE INCREASED,2
CN,CONSCIOUSNESS FLUCTUATING,2
CN,CONSTIPATION,2
CN,DISEASE PROGRESSION,2
CN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
CN,ERYTHEMA,2
CN,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
CN,GENERALISED OEDEMA,2
CN,HEART RATE INCREASED,2
CN,INTESTINAL FISTULA,2
CN,INTESTINAL HAEMORRHAGE,2
CN,MYOCLONUS,2
CN,PAPULE,2
CN,PYREXIA,2
CN,SYNCOPE,2
CN,THERAPEUTIC RESPONSE UNEXPECTED,2
CN,ABASIA,1
CN,ABDOMINAL PAIN,1
CN,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
CN,CARDIAC FAILURE,1
CN,CENTRAL NERVOUS SYSTEM INFECTION,1
CN,CEREBRAL ATROPHY,1
CN,CEREBRAL INFARCTION,1
CN,CERVIX CARCINOMA,1
CN,COMA,1
CN,COMPRESSION FRACTURE,1
CN,CONDITION AGGRAVATED,1
CN,COUGH,1
CN,CYANOSIS,1
CN,DECREASED APPETITE,1
CN,DELIRIUM,1
CN,DEPRESSION,1
CN,DERMATITIS ALLERGIC,1
CN,DRUG DEPENDENCE,1
CN,DRUG WITHDRAWAL SYNDROME,1
CN,DRUG-INDUCED LIVER INJURY,1
CN,DYSKINESIA,1
CN,ELECTROENCEPHALOGRAM ABNORMAL,1
CN,ERYTHEMA MULTIFORME,1
CN,EYELID DISORDER,1
CN,FEELING JITTERY,1
CN,GAIT DISTURBANCE,1
CN,GASTROINTESTINAL HAEMORRHAGE,1
CN,GAZE PALSY,1
CN,HALLUCINATION,1
CN,HYPOAESTHESIA,1
CN,INCORRECT DOSE ADMINISTERED,1
CN,INTENTIONAL PRODUCT MISUSE,1
CN,IRRITABILITY,1
CN,LIVER DISORDER,1
CN,MALAISE,1
CN,MALIGNANT NEOPLASM PROGRESSION,1
CN,MENTAL DISORDER,1
CN,MUSCLE TWITCHING,1
CN,MUSCULOSKELETAL STIFFNESS,1
CN,MYALGIA,1
CN,NERVOUSNESS,1
CN,OEDEMA PERIPHERAL,1
CN,OVERDOSE,1
CN,PAIN,1
CN,PALLOR,1
CN,PNEUMONIA FUNGAL,1
CN,POOR QUALITY SLEEP,1
CN,POTENTIATING DRUG INTERACTION,1
CN,PRODUCT USE ISSUE,1
CN,PRODUCTIVE COUGH,1
CN,PRURITUS,1
CN,RASH PUSTULAR,1
CN,RESPIRATORY DEPRESSION,1
CN,RESTLESSNESS,1
CN,SEDATION,1
CN,SINUS TACHYCARDIA,1
CN,SKIN EROSION,1
CN,SOCIAL AVOIDANT BEHAVIOUR,1
CN,STATUS EPILEPTICUS,1
CN,THERAPEUTIC RESPONSE DECREASED,1
CN,TIC,1
CN,TOXICITY TO VARIOUS AGENTS,1
CN,TRANSAMINASES INCREASED,1
CN,UNDERDOSE,1
CN,UNRESPONSIVE TO STIMULI,1
CN,VERTIGO,1
CN,WEIGHT DECREASED,1
CN,WHEEZING,1
CO,DRUG INEFFECTIVE,7
CO,URINARY TRACT INFECTION,6
CO,HEADACHE,5
CO,PAIN IN EXTREMITY,5
CO,BACK PAIN,4
CO,PYREXIA,4
CO,TUBERCULIN TEST POSITIVE,4
CO,ARTHRALGIA,3
CO,ASTHENIA,3
CO,ATAXIA,3
CO,CARDIAC DISORDER,3
CO,DIZZINESS,3
CO,HYPERAMMONAEMIC ENCEPHALOPATHY,3
CO,INFLUENZA,3
CO,PNEUMONIA,3
CO,ABDOMINAL PAIN UPPER,2
CO,CENTRAL NERVOUS SYSTEM LESION,2
CO,CHILLS,2
CO,DISCOMFORT,2
CO,ERYTHEMA,2
CO,FALL,2
CO,FATIGUE,2
CO,GASTROINTESTINAL HAEMORRHAGE,2
CO,HYPOAESTHESIA,2
CO,HYPOTENSION,2
CO,INJECTION SITE HAEMATOMA,2
CO,INJECTION SITE SWELLING,2
CO,INJECTION SITE URTICARIA,2
CO,INTERVERTEBRAL DISC PROTRUSION,2
CO,LUNG DISORDER,2
CO,MALAISE,2
CO,MUSCULOSKELETAL DISORDER,2
CO,NOSOCOMIAL INFECTION,2
CO,OEDEMA,2
CO,PULMONARY OEDEMA,2
CO,SOMNOLENCE,2
CO,STATUS EPILEPTICUS,2
CO,SYNCOPE,2
CO,TRANSIENT ISCHAEMIC ATTACK,2
CO,UPPER LIMB FRACTURE,2
CO,VASCULAR CALCIFICATION,2
CO,ABDOMINAL DISCOMFORT,1
CO,ACCIDENT,1
CO,ACETABULUM FRACTURE,1
CO,ACUTE MYOCARDIAL INFARCTION,1
CO,ADVERSE DRUG REACTION,1
CO,ARTHROPATHY,1
CO,ASPHYXIA,1
CO,BILIARY CYST,1
CO,BLADDER DISORDER,1
CO,BLINDNESS UNILATERAL,1
CO,BLOOD GLUCOSE ABNORMAL,1
CO,BLOOD POTASSIUM DECREASED,1
CO,BLOOD TEST ABNORMAL,1
CO,BONE CANCER,1
CO,CARDIAC ARREST,1
CO,CEREBROVASCULAR ACCIDENT,1
CO,CHOKING,1
CO,CONTUSION,1
CO,DEATH,1
CO,DECREASED APPETITE,1
CO,DECREASED IMMUNE RESPONSIVENESS,1
CO,DEPRESSED MOOD,1
CO,DERMATITIS ALLERGIC,1
CO,DEVICE MALFUNCTION,1
CO,DIABETES MELLITUS,1
CO,DRY SKIN,1
CO,DYSKINESIA,1
CO,DYSPHAGIA,1
CO,DYSPNOEA,1
CO,DYSURIA,1
CO,EATING DISORDER,1
CO,EPILEPSY,1
CO,EYE IRRITATION,1
CO,EYE PAIN,1
CO,FEMUR FRACTURE,1
CO,FIBROMYALGIA,1
CO,GAIT DISTURBANCE,1
CO,GASTROINTESTINAL INFECTION,1
CO,GENERAL PHYSICAL HEALTH DETERIORATION,1
CO,HAEMORRHAGE,1
CO,HEPATITIS,1
CO,HIP FRACTURE,1
CO,HYPERGLYCAEMIA,1
CO,HYPERHIDROSIS,1
CO,HYPERLACTACIDAEMIA,1
CO,HYPERTENSION,1
CO,HYPOPHAGIA,1
CO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
CO,INCONTINENCE,1
CO,INFECTION,1
CO,INTESTINAL ISCHAEMIA,1
CO,ISCHAEMIC STROKE,1
CO,LABORATORY TEST ABNORMAL,1
CO,LACRIMATION INCREASED,1
CO,LIMB DISCOMFORT,1
CO,LOSS OF CONSCIOUSNESS,1
CO,LOWER GASTROINTESTINAL HAEMORRHAGE,1
CO,LOWER LIMB FRACTURE,1
CO,MALIGNANT NEOPLASM OF EYE,1
CO,MALIGNANT NEOPLASM PROGRESSION,1
CO,METABOLIC ACIDOSIS,1
CO,MIGRAINE,1
CO,MULTIMORBIDITY,1
CO,MUSCLE RIGIDITY,1
CO,MUSCLE SPASMS,1
CO,MUSCULAR WEAKNESS,1
CO,MYELITIS,1
CO,MYOCARDIAL INFARCTION,1
CO,MYOCARDIAL ISCHAEMIA,1
CO,NERVE COMPRESSION,1
CO,NERVOUS SYSTEM DISORDER,1
CO,NONINFECTIOUS PERITONITIS,1
CO,PAIN,1
CO,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
CO,PERITONEAL DIALYSIS COMPLICATION,1
CO,PERITONITIS BACTERIAL,1
CO,PLATELET COUNT DECREASED,1
CO,PNEUMONITIS,1
CO,POLYNEUROPATHY,1
CO,POTENTIATING DRUG INTERACTION,1
CO,PRESCRIBED OVERDOSE,1
CO,QUADRIPLEGIA,1
CO,RASH,1
CO,RECTAL HAEMORRHAGE,1
CO,RESPIRATORY FAILURE,1
CO,RIB FRACTURE,1
CO,SEIZURE,1
CO,SENSORY DISTURBANCE,1
CO,SLEEP APNOEA SYNDROME,1
CO,SPEECH DISORDER,1
CO,SPINAL COLUMN INJURY,1
CO,SPINAL DISORDER,1
CO,SUPERINFECTION,1
CO,SWELLING,1
CO,TACHYCARDIA,1
CO,TENDERNESS,1
CO,THERMAL BURN,1
CO,TREATMENT FAILURE,1
CO,ULCER,1
CO,URINARY INCONTINENCE,1
CO,URINARY TRACT INFECTION BACTERIAL,1
CO,UROSEPSIS,1
CO,VAGINAL HAEMORRHAGE,1
CO,VOMITING,1
CR,FATIGUE,3
CR,DEPRESSION,2
CR,DRUG INEFFECTIVE,2
CR,DYSARTHRIA,2
CR,DYSPHONIA,2
CR,HEADACHE,2
CR,MOBILITY DECREASED,2
CR,NAUSEA,2
CR,PAIN,2
CR,STRESS,2
CR,ABDOMINAL DISCOMFORT,1
CR,ABDOMINAL PAIN,1
CR,ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL,1
CR,ALTERED STATE OF CONSCIOUSNESS,1
CR,AMNESIA,1
CR,ANAEMIA,1
CR,ANAPHYLACTIC REACTION,1
CR,ANXIETY,1
CR,APHONIA,1
CR,ASTHENIA,1
CR,BLOOD GLUCOSE ABNORMAL,1
CR,BODY TEMPERATURE INCREASED,1
CR,BRONCHOSPASM,1
CR,CHEST DISCOMFORT,1
CR,CHOLELITHIASIS,1
CR,COGNITIVE DISORDER,1
CR,COMA,1
CR,DEATH,1
CR,DECREASED APPETITE,1
CR,DECREASED INTEREST,1
CR,DIARRHOEA,1
CR,DISEASE PROGRESSION,1
CR,DRUG INTOLERANCE,1
CR,DYSGEUSIA,1
CR,DYSKINESIA,1
CR,DYSSTASIA,1
CR,EAR PAIN,1
CR,EMOTIONAL DISORDER,1
CR,EYE PAIN,1
CR,FEELING ABNORMAL,1
CR,FINE MOTOR SKILL DYSFUNCTION,1
CR,GAIT DISTURBANCE,1
CR,GASTRIC DISORDER,1
CR,GASTROOESOPHAGEAL REFLUX DISEASE,1
CR,HAEMATOCRIT ABNORMAL,1
CR,HAEMOGLOBIN DECREASED,1
CR,HYPERCHLORHYDRIA,1
CR,HYPOACUSIS,1
CR,HYPOVITAMINOSIS,1
CR,HYPOXIA,1
CR,INFLAMMATION,1
CR,INSOMNIA,1
CR,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
CR,IRRITABLE BOWEL SYNDROME,1
CR,LAZINESS,1
CR,LEUKOPENIA,1
CR,LIMB DISCOMFORT,1
CR,LYMPHOCYTE COUNT DECREASED,1
CR,MALAISE,1
CR,MICTURITION URGENCY,1
CR,MIGRAINE,1
CR,MOUTH INJURY,1
CR,MOVEMENT DISORDER,1
CR,MUSCLE SPASMS,1
CR,MUSCLE SPASTICITY,1
CR,NEOPLASM MALIGNANT,1
CR,NEUROGENIC BLADDER,1
CR,NEUTROPENIA,1
CR,NYSTAGMUS,1
CR,OBESITY,1
CR,OCULAR DISCOMFORT,1
CR,OEDEMA,1
CR,OPHTHALMOPLEGIA,1
CR,OPTIC NEURITIS,1
CR,PAIN IN EXTREMITY,1
CR,PANIC ATTACK,1
CR,PARALYSIS,1
CR,PARTIAL SEIZURES,1
CR,PERIPHERAL SWELLING,1
CR,PETECHIAE,1
CR,PHARYNGITIS,1
CR,PHOTOPHOBIA,1
CR,PLATELET COUNT DECREASED,1
CR,PNEUMONIA,1
CR,POISONING,1
CR,POLLAKIURIA,1
CR,PROGRESSIVE MULTIPLE SCLEROSIS,1
CR,PROTHROMBIN LEVEL ABNORMAL,1
CR,PRURITUS,1
CR,PYREXIA,1
CR,RESPIRATORY FATIGUE,1
CR,RETINAL DISORDER,1
CR,SECRETION DISCHARGE,1
CR,SENSITIVITY TO WEATHER CHANGE,1
CR,SOMNOLENCE,1
CR,SPINAL PAIN,1
CR,SPLENOMEGALY,1
CR,STRABISMUS,1
CR,SYSTEMIC MASTOCYTOSIS,1
CR,THROMBOCYTOPENIA,1
CR,TREMOR,1
CR,TRYPTASE INCREASED,1
CR,URINARY INCONTINENCE,1
CR,URINARY TRACT INFECTION,1
CR,URTICARIA,1
CR,VERTIGO,1
CR,VOMITING,1
CR,WEIGHT BEARING DIFFICULTY,1
CR,WEIGHT DECREASED,1
HR,ATRIAL SEPTAL DEFECT,5
HR,EPILEPSY,4
HR,FOETAL EXPOSURE DURING PREGNANCY,4
HR,ATAXIA,3
HR,PSYCHOMOTOR SKILLS IMPAIRED,3
HR,RESTLESSNESS,3
HR,SEVERE MYOCLONIC EPILEPSY OF INFANCY,3
HR,ALOPECIA,2
HR,CONSTIPATION,2
HR,DIPLOPIA,2
HR,DIZZINESS,2
HR,DRY MOUTH,2
HR,FEELING ABNORMAL,2
HR,INSOMNIA,2
HR,INTENTIONAL OVERDOSE,2
HR,OXYGEN SATURATION DECREASED,2
HR,PRURITUS,2
HR,SOMNOLENCE,2
HR,SUICIDE ATTEMPT,2
HR,ALTERED STATE OF CONSCIOUSNESS,1
HR,ANXIETY,1
HR,ASTHENIA,1
HR,COGNITIVE DISORDER,1
HR,CONDITION AGGRAVATED,1
HR,CONFUSIONAL STATE,1
HR,CONVERSION DISORDER,1
HR,DEPRESSION,1
HR,DISTURBANCE IN ATTENTION,1
HR,FOETAL GROWTH RESTRICTION,1
HR,INCREASED BRONCHIAL SECRETION,1
HR,LOSS OF CONSCIOUSNESS,1
HR,MATERNAL EXPOSURE DURING PREGNANCY,1
HR,MOTOR DEVELOPMENTAL DELAY,1
HR,MUSCLE SPASMS,1
HR,MYOCLONIC EPILEPSY,1
HR,NAUSEA,1
HR,NEUROSIS,1
HR,PAIN,1
HR,QUADRIPARESIS,1
HR,SCHIZOPHRENIA,1
HR,SEDATION,1
HR,SENSORY DISTURBANCE,1
HR,SYNCOPE,1
HR,VOMITING,1
CZ,TOXICITY TO VARIOUS AGENTS,5
CZ,ARTHRALGIA,4
CZ,DIABETIC METABOLIC DECOMPENSATION,4
CZ,HEADACHE,4
CZ,NAUSEA,4
CZ,BACK PAIN,3
CZ,CONSTIPATION,3
CZ,DRUG INEFFECTIVE,3
CZ,HYPERHIDROSIS,3
CZ,HYPERTENSION,3
CZ,INSOMNIA,3
CZ,PNEUMONIA,3
CZ,POLYNEUROPATHY,3
CZ,TENSION,3
CZ,URINARY TRACT INFECTION,3
CZ,VERTIGO,3
CZ,BRONCHITIS,2
CZ,DEATH,2
CZ,DERMATITIS ACNEIFORM,2
CZ,DIARRHOEA,2
CZ,DISINHIBITION,2
CZ,DRUG DEPENDENCE,2
CZ,DRUG WITHDRAWAL SYNDROME,2
CZ,DRY MOUTH,2
CZ,EXTRAPYRAMIDAL DISORDER,2
CZ,MATERNAL EXPOSURE DURING PREGNANCY,2
CZ,MULTIPLE SCLEROSIS RELAPSE,2
CZ,MYALGIA,2
CZ,ORTHOSTATIC HYPOTENSION,2
CZ,OSTEOMYELITIS,2
CZ,OVERDOSE,2
CZ,PARAESTHESIA,2
CZ,PLASMA CELL MYELOMA,2
CZ,PULMONARY EMBOLISM,2
CZ,RASH,2
CZ,SKIN TOXICITY,2
CZ,SOMNOLENCE,2
CZ,TRAUMATIC FRACTURE,2
CZ,VISUAL ACUITY REDUCED,2
CZ,VISUAL IMPAIRMENT,2
CZ,ABDOMINAL DISCOMFORT,1
CZ,ADENOCARCINOMA,1
CZ,ANAEMIA,1
CZ,ANXIETY,1
CZ,AREFLEXIA,1
CZ,ASTHENIA,1
CZ,AUTOIMMUNE DISORDER,1
CZ,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
CZ,BONE PAIN,1
CZ,CAESAREAN SECTION,1
CZ,CARDIAC FAILURE,1
CZ,CATARACT,1
CZ,COGNITIVE DISORDER,1
CZ,COLORECTAL CANCER,1
CZ,COMPRESSION FRACTURE,1
CZ,CONDITION AGGRAVATED,1
CZ,COR PULMONALE ACUTE,1
CZ,DEEP VEIN THROMBOSIS,1
CZ,DELIRIUM,1
CZ,DEPENDENT PERSONALITY DISORDER,1
CZ,DEPRESSION,1
CZ,DIABETIC COMPLICATION,1
CZ,DIPLOPIA,1
CZ,DRUG ABUSE,1
CZ,DRUG DOSE OMISSION,1
CZ,DRUG INTOLERANCE,1
CZ,DRUG PRESCRIBING ERROR,1
CZ,DYSARTHRIA,1
CZ,DYSKINESIA,1
CZ,DYSPEPSIA,1
CZ,DYSPNOEA,1
CZ,DYSPNOEA AT REST,1
CZ,DYSURIA,1
CZ,EMOTIONAL DISORDER,1
CZ,ERYSIPELAS,1
CZ,EYE HAEMORRHAGE,1
CZ,FALL,1
CZ,FATIGUE,1
CZ,FLUSHING,1
CZ,FOETAL DISORDER,1
CZ,FOETAL EXPOSURE DURING PREGNANCY,1
CZ,FOOD INTOLERANCE,1
CZ,GASTROINTESTINAL DISORDER,1
CZ,GASTROINTESTINAL INFECTION,1
CZ,GASTROINTESTINAL PAIN,1
CZ,GASTROINTESTINAL STROMAL TUMOUR,1
CZ,GENERAL PHYSICAL HEALTH DETERIORATION,1
CZ,GENITAL DISORDER FEMALE,1
CZ,HAEMANGIOMA,1
CZ,HALLUCINATION_ AUDITORY,1
CZ,HALLUCINATION_ VISUAL,1
CZ,HYPOTENSION,1
CZ,INFLAMMATION,1
CZ,INFLUENZA,1
CZ,INJURY,1
CZ,LENTICULAR OPACITIES,1
CZ,LEUKOCYTURIA,1
CZ,LOCALISED INFECTION,1
CZ,LOWER RESPIRATORY TRACT INFECTION,1
CZ,LUNG INFILTRATION,1
CZ,LYMPHADENOPATHY,1
CZ,LYMPHOCYTE COUNT DECREASED,1
CZ,MALIGNANT NEOPLASM PROGRESSION,1
CZ,MASKED FACIES,1
CZ,MENINGITIS LISTERIA,1
CZ,MIGRAINE,1
CZ,MULTIPLE SCLEROSIS,1
CZ,MUSCULAR WEAKNESS,1
CZ,MUSCULOSKELETAL STIFFNESS,1
CZ,MYOCARDITIS,1
CZ,NAIL DISORDER,1
CZ,NECROTISING RETINITIS,1
CZ,NEURALGIA,1
CZ,NEUTROPENIA,1
CZ,OEDEMA PERIPHERAL,1
CZ,OESOPHAGEAL FOOD IMPACTION,1
CZ,ONYCHOCLASIS,1
CZ,OSTEOARTHRITIS,1
CZ,OSTEOPOROSIS,1
CZ,PERIPHERAL SENSORY NEUROPATHY,1
CZ,PERSECUTORY DELUSION,1
CZ,PETECHIAE,1
CZ,POLLAKIURIA,1
CZ,PRURITUS,1
CZ,PSYCHIATRIC SYMPTOM,1
CZ,PSYCHOMOTOR RETARDATION,1
CZ,PULMONARY INFARCTION,1
CZ,SCHIZOPHRENIA_ PARANOID TYPE,1
CZ,SECOND PRIMARY MALIGNANCY,1
CZ,SKIN DISORDER,1
CZ,SOMATIC HALLUCINATION,1
CZ,SPEECH DISORDER,1
CZ,SUICIDAL IDEATION,1
CZ,TACHYCARDIA,1
CZ,THERAPEUTIC RESPONSE DECREASED,1
CZ,THINKING ABNORMAL,1
CZ,THROMBOCYTOPENIA,1
CZ,THROMBOSIS,1
CZ,UPPER RESPIRATORY TRACT INFECTION,1
CZ,URINARY TRACT INFLAMMATION,1
CZ,URTICARIA,1
CZ,VITREOUS DETACHMENT,1
DK,DIZZINESS,22
DK,HYPOTENSION,18
DK,MEMORY IMPAIRMENT,17
DK,SEDATION,17
DK,DIPLOPIA,14
DK,TOOTH DISORDER,14
DK,DEPRESSED LEVEL OF CONSCIOUSNESS,12
DK,ERECTILE DYSFUNCTION,10
DK,OSTEOPOROSIS,10
DK,BALANCE DISORDER,9
DK,BLOOD CREATININE INCREASED,9
DK,LOSS OF CONSCIOUSNESS,9
DK,FALL,8
DK,OSTEONECROSIS OF JAW,8
DK,UPPER LIMB FRACTURE,8
DK,CONFUSIONAL STATE,7
DK,LOOSE TOOTH,7
DK,NAUSEA,7
DK,OVERDOSE,7
DK,RENAL IMPAIRMENT,7
DK,ANXIETY,6
DK,COGNITIVE DISORDER,6
DK,DENTAL CARIES,6
DK,DRUG INEFFECTIVE,6
DK,DYSPHEMIA,6
DK,DYSPNOEA,6
DK,FATIGUE,6
DK,GLOMERULAR FILTRATION RATE DECREASED,6
DK,TOXICITY TO VARIOUS AGENTS,6
DK,TREMOR,6
DK,VOMITING,6
DK,DYSGEUSIA,5
DK,LUNG INFECTION,5
DK,MALAISE,5
DK,PRURITUS,5
DK,TOOTH FRACTURE,5
DK,TOOTH LOSS,5
DK,WEIGHT INCREASED,5
DK,BLINDNESS,4
DK,CATARACT,4
DK,DISTURBANCE IN ATTENTION,4
DK,ENAMEL ANOMALY,4
DK,FINE MOTOR DELAY,4
DK,GINGIVITIS,4
DK,MUSCLE SPASMS,4
DK,PAIN,4
DK,PAROSMIA,4
DK,RETINAL DEPIGMENTATION,4
DK,SEIZURE,4
DK,SENSORY DISTURBANCE,4
DK,SOMNOLENCE,4
DK,CATARACT OPERATION,3
DK,CYANOSIS,3
DK,DIARRHOEA,3
DK,ELECTROCARDIOGRAM QT PROLONGED,3
DK,HEADACHE,3
DK,INFECTION,3
DK,JAW OPERATION,3
DK,LETHARGY,3
DK,PETIT MAL EPILEPSY,3
DK,RESPIRATORY FAILURE,3
DK,RESTLESSNESS,3
DK,VISUAL IMPAIRMENT,3
DK,ACUTE KIDNEY INJURY,2
DK,ADVERSE DRUG REACTION,2
DK,ASTHENIA,2
DK,BONE MARROW FAILURE,2
DK,CEREBRAL HAEMORRHAGE,2
DK,DRUG ABUSE,2
DK,EMOTIONAL DISTRESS,2
DK,EXPOSED BONE IN JAW,2
DK,EXTRA DOSE ADMINISTERED,2
DK,FOETAL EXPOSURE DURING PREGNANCY,2
DK,HEPATOTOXICITY,2
DK,HYPONATRAEMIA,2
DK,LYMPHADENOPATHY,2
DK,MACULAR OEDEMA,2
DK,MACULOPATHY,2
DK,NERVE INJURY,2
DK,NEUTROPENIA,2
DK,PAIN IN JAW,2
DK,PARAESTHESIA,2
DK,PRODUCT USE ISSUE,2
DK,PYREXIA,2
DK,RASH,2
DK,SLEEP DISORDER,2
DK,SYNCOPE,2
DK,TOOTHACHE,2
DK,VISUAL ACUITY REDUCED,2
DK,WEIGHT DECREASED,2
DK,ABDOMINAL PAIN,1
DK,ABDOMINAL PAIN LOWER,1
DK,ALANINE AMINOTRANSFERASE INCREASED,1
DK,ALTERED STATE OF CONSCIOUSNESS,1
DK,ANAEMIA,1
DK,ANGIOEDEMA,1
DK,APHASIA,1
DK,APPLICATION SITE ERYTHEMA,1
DK,APPLICATION SITE PAIN,1
DK,APPLICATION SITE ULCER,1
DK,ARRHYTHMIA,1
DK,ASPARTATE AMINOTRANSFERASE INCREASED,1
DK,ATAXIA,1
DK,BLOOD ALKALINE PHOSPHATASE INCREASED,1
DK,BLOOD PRESSURE INCREASED,1
DK,BLOOD URINE PRESENT,1
DK,BONE FORMATION INCREASED,1
DK,BRADYCARDIA,1
DK,BRAIN MIDLINE SHIFT,1
DK,BREAST CANCER,1
DK,BUNDLE BRANCH BLOCK LEFT,1
DK,BURNING SENSATION,1
DK,CEREBRAL THROMBOSIS,1
DK,CERVICAL SPINAL STENOSIS,1
DK,CHEST DISCOMFORT,1
DK,CHEST PAIN,1
DK,CIRCULATORY COLLAPSE,1
DK,COLITIS,1
DK,COMMUNICATION DISORDER,1
DK,CONDITION AGGRAVATED,1
DK,CONGENITAL GASTRIC ANOMALY,1
DK,CONSTIPATION,1
DK,COUGH,1
DK,CRYING,1
DK,DECREASED APPETITE,1
DK,DEHYDRATION,1
DK,DEPENDENCE,1
DK,DEPRESSION,1
DK,DERMATITIS ATOPIC,1
DK,DIABETIC KETOACIDOSIS,1
DK,DIFFUSE LARGE B-CELL LYMPHOMA,1
DK,DISSEMINATED INTRAVASCULAR COAGULATION,1
DK,DISSOCIATION,1
DK,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
DK,DRUG DEPENDENCE,1
DK,DRUG DOSE OMISSION,1
DK,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
DK,DRUG TOLERANCE,1
DK,DRY MOUTH,1
DK,DYSPHAGIA,1
DK,EAR PAIN,1
DK,EATING DISORDER,1
DK,ECCHYMOSIS,1
DK,EJECTION FRACTION DECREASED,1
DK,ENTEROCOCCUS TEST POSITIVE,1
DK,EOSINOPHIL COUNT INCREASED,1
DK,EPISTAXIS,1
DK,ERYTHEMA,1
DK,EXTRADURAL HAEMATOMA,1
DK,FAECES DISCOLOURED,1
DK,FEAR,1
DK,FEBRILE NEUTROPENIA,1
DK,FREQUENT BOWEL MOVEMENTS,1
DK,GAIT DISTURBANCE,1
DK,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
DK,GASTRITIS,1
DK,GENERAL PHYSICAL HEALTH DETERIORATION,1
DK,GENITAL HAEMORRHAGE,1
DK,GINGIVAL SWELLING,1
DK,GRAFT INFECTION,1
DK,HAEMATOMA,1
DK,HAEMATURIA,1
DK,HAEMOGLOBIN DECREASED,1
DK,HAEMOLYTIC ANAEMIA,1
DK,HEART RATE INCREASED,1
DK,HENOCH-SCHONLEIN PURPURA NEPHRITIS,1
DK,HEPATIC ENZYME INCREASED,1
DK,HEPATIC FAILURE,1
DK,HEPATIC FUNCTION ABNORMAL,1
DK,HERNIA,1
DK,HERPES ZOSTER INFECTION NEUROLOGICAL,1
DK,HYPERHIDROSIS,1
DK,HYPERKALAEMIA,1
DK,HYPERTENSION,1
DK,HYPERVENTILATION,1
DK,HYPOAESTHESIA,1
DK,HYPOAESTHESIA ORAL,1
DK,HYPOALBUMINAEMIA,1
DK,IMPAIRED QUALITY OF LIFE,1
DK,IMPAIRED WORK ABILITY,1
DK,INFLUENZA LIKE ILLNESS,1
DK,INTERNATIONAL NORMALISED RATIO INCREASED,1
DK,INTERSTITIAL LUNG DISEASE,1
DK,INTERVERTEBRAL DISC PROTRUSION,1
DK,IRON DEFICIENCY ANAEMIA,1
DK,JAUNDICE,1
DK,LACTIC ACIDOSIS,1
DK,LARYNGITIS,1
DK,LEUKOPENIA,1
DK,LIP PAIN,1
DK,LIVER DISORDER,1
DK,LOCAL SWELLING,1
DK,LOCALISED INFECTION,1
DK,LUNG INFILTRATION,1
DK,MALIGNANT NEOPLASM PROGRESSION,1
DK,MASTICATION DISORDER,1
DK,MENSTRUAL DISORDER,1
DK,METASTASES TO CENTRAL NERVOUS SYSTEM,1
DK,MOTOR DYSFUNCTION,1
DK,MOUTH HAEMORRHAGE,1
DK,MOUTH ULCERATION,1
DK,MUCOSAL HAEMORRHAGE,1
DK,MUCOSAL NECROSIS,1
DK,MULTI-ORGAN FAILURE,1
DK,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
DK,MYOCARDITIS,1
DK,NASOPHARYNGITIS,1
DK,NECROTISING SOFT TISSUE INFECTION,1
DK,NEONATAL INFECTION,1
DK,NEOPLASM SKIN,1
DK,NEPHROGENIC SYSTEMIC FIBROSIS,1
DK,NEURALGIA,1
DK,NEUROENDOCRINE CARCINOMA,1
DK,NEUROPATHY PERIPHERAL,1
DK,NIGHT SWEATS,1
DK,OEDEMA,1
DK,OEDEMA PERIPHERAL,1
DK,OESOPHAGEAL INFECTION,1
DK,ORAL DISORDER,1
DK,ORAL FUNGAL INFECTION,1
DK,ORAL PAIN,1
DK,OSTEOARTHRITIS,1
DK,OXYGEN SATURATION DECREASED,1
DK,PAIN IN EXTREMITY,1
DK,PAIN OF SKIN,1
DK,PANCYTOPENIA,1
DK,PARKINSONISM,1
DK,PERIORBITAL OEDEMA,1
DK,PHOBIA,1
DK,PLASMA CELL MYELOMA,1
DK,PLATELET COUNT DECREASED,1
DK,PNEUMONITIS,1
DK,POLYDIPSIA,1
DK,POLYNEUROPATHY,1
DK,POST PROCEDURAL HAEMORRHAGE,1
DK,POST PROCEDURAL OEDEMA,1
DK,POSTOPERATIVE ABSCESS,1
DK,PROSTATE CANCER,1
DK,PROTEINURIA,1
DK,PULMONARY FIBROSIS,1
DK,PULMONARY GRANULOMA,1
DK,PULMONARY OEDEMA,1
DK,RADICULOPATHY,1
DK,RADIUS FRACTURE,1
DK,RECTAL HAEMORRHAGE,1
DK,RENAL DISORDER,1
DK,RENAL FAILURE,1
DK,RESPIRATORY ACIDOSIS,1
DK,RESPIRATORY TRACT INFECTION,1
DK,RESPIRATORY TRACT MALFORMATION,1
DK,SARCOIDOSIS,1
DK,SCOLIOSIS,1
DK,SENSORY LOSS,1
DK,SEPSIS,1
DK,SINUSITIS,1
DK,SKIN ULCER,1
DK,SLEEP APNOEA SYNDROME,1
DK,SMALL FIBRE NEUROPATHY,1
DK,SOCIAL AVOIDANT BEHAVIOUR,1
DK,SPEECH DISORDER,1
DK,SPINAL COLUMN STENOSIS,1
DK,SQUAMOUS CELL CARCINOMA OF SKIN,1
DK,STAPHYLOCOCCAL ABSCESS,1
DK,STOMATITIS,1
DK,STUPOR,1
DK,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,1
DK,SUBARACHNOID HAEMORRHAGE,1
DK,SUBDURAL HAEMATOMA,1
DK,SUICIDAL IDEATION,1
DK,SUICIDE ATTEMPT,1
DK,SURGERY,1
DK,SWELLING,1
DK,TACHYCARDIA,1
DK,TEETH BRITTLE,1
DK,THROMBOCYTOPENIA,1
DK,TINNITUS,1
DK,URINARY TRACT INFECTION,1
DK,VEIN DISORDER,1
DK,VENTRICULAR DYSKINESIA,1
DK,VISION BLURRED,1
DK,VULVAL DISORDER,1
DK,WEIGHT GAIN POOR,1
DK,WHITE BLOOD CELL COUNT DECREASED,1
EC,DEATH,7
EC,CARDIO-RESPIRATORY ARREST,3
EC,URINARY TRACT INFECTION,3
EC,DRUG INEFFECTIVE,2
EC,FALL,2
EC,PNEUMONIA,2
EC,ABASIA,1
EC,ACUTE MYOCARDIAL INFARCTION,1
EC,AMNESIA,1
EC,BODY TEMPERATURE INCREASED,1
EC,CARDIAC FAILURE,1
EC,DECUBITUS ULCER,1
EC,DIALYSIS RELATED COMPLICATION,1
EC,DISEASE PROGRESSION,1
EC,DYSKINESIA,1
EC,EYE SWELLING,1
EC,GASTRITIS,1
EC,GASTROINTESTINAL DISORDER,1
EC,GASTROINTESTINAL PAIN,1
EC,HEAD INJURY,1
EC,HERPES ZOSTER,1
EC,HYPOACUSIS,1
EC,LUNG NEOPLASM,1
EC,LYMPHOMA,1
EC,MALIGNANT NEOPLASM PROGRESSION,1
EC,METAL POISONING,1
EC,METASTASES TO SPINE,1
EC,MYOCARDIAL INFARCTION,1
EC,NEOPLASM MALIGNANT,1
EC,PAIN,1
EC,PROSTATE CANCER,1
EC,PYELONEPHRITIS,1
EC,RENAL DISORDER,1
EC,SOMNOLENCE,1
EC,SPINAL DISORDER,1
EC,TRAUMATIC LUNG INJURY,1
EG,ACUTE KIDNEY INJURY,1
EG,CONFUSIONAL STATE,1
EG,DEAFNESS,1
EG,DRUG LEVEL INCREASED,1
EG,HALLUCINATION,1
EG,MYOCLONUS,1
EE,ENTEROCOLITIS INFECTIOUS,1
EE,HAEMATOMA,1
EE,PAIN,1
EE,PURPURA,1
EE,SKIN ULCER,1
EE,URINARY TRACT INFECTION,1
FI,INTENTIONAL PRODUCT MISUSE,17
FI,TOXICITY TO VARIOUS AGENTS,11
FI,COMA HEPATIC,9
FI,DEATH,9
FI,FATIGUE,9
FI,HEPATIC FAILURE,9
FI,SOMNOLENCE,9
FI,DRUG RESISTANCE,8
FI,ALANINE AMINOTRANSFERASE INCREASED,7
FI,AMMONIA INCREASED,7
FI,BILIRUBIN CONJUGATED INCREASED,7
FI,BLOOD ALKALINE PHOSPHATASE INCREASED,7
FI,BLOOD BILIRUBIN INCREASED,7
FI,BLOOD LACTIC ACID INCREASED,7
FI,FALL,7
FI,INTERNATIONAL NORMALISED RATIO INCREASED,7
FI,ALOPECIA,5
FI,ASTHENIA,5
FI,DYSPNOEA,5
FI,PAIN,5
FI,PYREXIA,5
FI,ANXIETY,4
FI,COMPLETED SUICIDE,4
FI,DIARRHOEA,4
FI,HEADACHE,4
FI,MEMORY IMPAIRMENT,4
FI,NAUSEA,4
FI,AGGRESSION,3
FI,ARTHRALGIA,3
FI,BACK PAIN,3
FI,CONFUSIONAL STATE,3
FI,DIZZINESS,3
FI,DYSARTHRIA,3
FI,MALAISE,3
FI,MENTAL IMPAIRMENT,3
FI,MYALGIA,3
FI,OVERDOSE,3
FI,PALPITATIONS,3
FI,PNEUMONIA,3
FI,PRODUCT USE ISSUE,3
FI,TINNITUS,3
FI,TREMOR,3
FI,ABDOMINAL PAIN,2
FI,ACUTE HEPATIC FAILURE,2
FI,ACUTE KIDNEY INJURY,2
FI,AREFLEXIA,2
FI,BLOOD PRESSURE DECREASED,2
FI,BREAST ENLARGEMENT,2
FI,BRONCHITIS,2
FI,BURNING SENSATION,2
FI,C-REACTIVE PROTEIN INCREASED,2
FI,CEREBRAL INFARCTION,2
FI,CONSTIPATION,2
FI,COORDINATION ABNORMAL,2
FI,COUGH,2
FI,DELUSION,2
FI,DEPRESSION,2
FI,DIPLOPIA,2
FI,DRUG INEFFECTIVE,2
FI,DYSKINESIA,2
FI,DYSPEPSIA,2
FI,DYSPHAGIA,2
FI,ERYTHEMA,2
FI,EYE MOVEMENT DISORDER,2
FI,FACE OEDEMA,2
FI,FEMALE ORGASMIC DISORDER,2
FI,GAIT DISTURBANCE,2
FI,GINGIVITIS,2
FI,HALLUCINATION,2
FI,HALLUCINATION_ OLFACTORY,2
FI,HEPATIC ENZYME INCREASED,2
FI,HYPERHIDROSIS,2
FI,HYPERREFLEXIA,2
FI,HYPOKINESIA,2
FI,HYPOREFLEXIA,2
FI,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
FI,INSOMNIA,2
FI,INTENTIONAL OVERDOSE,2
FI,MOOD SWINGS,2
FI,MUSCLE TWITCHING,2
FI,MUSCULAR WEAKNESS,2
FI,NASAL DRYNESS,2
FI,NASOPHARYNGITIS,2
FI,NERVOUSNESS,2
FI,OROPHARYNGEAL PAIN,2
FI,OSTEONECROSIS OF JAW,2
FI,PARKINSON^S DISEASE,2
FI,PRODUCT QUALITY ISSUE,2
FI,RASH,2
FI,RESPIRATORY TRACT INFECTION,2
FI,SEXUAL DYSFUNCTION,2
FI,STATUS EPILEPTICUS,2
FI,STUPOR,2
FI,TOOTH DISORDER,2
FI,URINARY INCONTINENCE,2
FI,VASODILATATION,2
FI,VIRAL INFECTION,2
FI,VISION BLURRED,2
FI,ACTIVITIES OF DAILY LIVING IMPAIRED,1
FI,ACUTE RESPIRATORY DISTRESS SYNDROME,1
FI,ALPERS^ DISEASE,1
FI,ANAESTHESIA,1
FI,ANGER,1
FI,ANHIDROSIS,1
FI,APPLICATION SITE EXFOLIATION,1
FI,APPLICATION SITE SCAB,1
FI,ARRHYTHMIA,1
FI,BALANCE DISORDER,1
FI,BLOOD PHOSPHORUS DECREASED,1
FI,BODY TEMPERATURE DECREASED,1
FI,BONE PAIN,1
FI,CATHETER SITE DISCHARGE,1
FI,CELL DEATH,1
FI,CEREBELLAR ATROPHY,1
FI,CEREBRAL HAEMORRHAGE,1
FI,CEREBROVASCULAR ACCIDENT,1
FI,COMA SCALE ABNORMAL,1
FI,CYTOMEGALOVIRUS CHORIORETINITIS,1
FI,DANDRUFF,1
FI,DAYDREAMING,1
FI,DECREASED APPETITE,1
FI,DERMATITIS PSORIASIFORM,1
FI,DEVICE ADHESION ISSUE,1
FI,DEVICE ALARM ISSUE,1
FI,DEVICE DISLOCATION,1
FI,DEVICE KINK,1
FI,DEVICE USE ISSUE,1
FI,DRUG ABUSE,1
FI,DRUG DEPENDENCE,1
FI,DRUG DOSE OMISSION,1
FI,DYSPHONIA,1
FI,ELECTROCARDIOGRAM QT PROLONGED,1
FI,ENDOMETRIOSIS,1
FI,FEELING ABNORMAL,1
FI,FEELING DRUNK,1
FI,FREEZING PHENOMENON,1
FI,GASTROINTESTINAL STOMA COMPLICATION,1
FI,GASTROOESOPHAGEAL REFLUX DISEASE,1
FI,GENERAL PHYSICAL HEALTH DETERIORATION,1
FI,HEART RATE DECREASED,1
FI,HEPATIC FIBROSIS,1
FI,HEPATIC NECROSIS,1
FI,HEPATIC STEATOSIS,1
FI,HOSPITALISATION,1
FI,HYPERPARATHYROIDISM,1
FI,HYPERTHYROIDISM,1
FI,HYPOCALCAEMIA,1
FI,HYPOGLYCAEMIA,1
FI,INCORRECT DOSE ADMINISTERED,1
FI,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
FI,INFECTION,1
FI,IRRITABILITY,1
FI,JOINT SWELLING,1
FI,LIGAMENT SPRAIN,1
FI,LISTERIA SEPSIS,1
FI,LIVER TRANSPLANT,1
FI,LOSS OF CONSCIOUSNESS,1
FI,MALIGNANT MELANOMA,1
FI,MIGRAINE,1
FI,MOBILITY DECREASED,1
FI,MOUTH SWELLING,1
FI,MUSCLE CONTRACTIONS INVOLUNTARY,1
FI,NECROTISING RETINITIS,1
FI,NEUROPATHY PERIPHERAL,1
FI,NEUTROPENIA,1
FI,NEUTROPHIL COUNT DECREASED,1
FI,OEDEMA PERIPHERAL,1
FI,ORAL PUSTULE,1
FI,OSTEOMYELITIS,1
FI,OXYGEN SATURATION DECREASED,1
FI,PAIN IN EXTREMITY,1
FI,PALATAL OEDEMA,1
FI,PANCREATITIS,1
FI,PERIPHERAL COLDNESS,1
FI,POISONING,1
FI,POOR QUALITY DRUG ADMINISTERED,1
FI,POOR QUALITY SLEEP,1
FI,PRODUCT LABEL ISSUE,1
FI,PRURITUS,1
FI,PRURITUS GENERALISED,1
FI,PSYCHIATRIC SYMPTOM,1
FI,RESPIRATORY ARREST,1
FI,SCAB,1
FI,SELF-INJURIOUS IDEATION,1
FI,SKIN ABRASION,1
FI,SOCIAL AVOIDANT BEHAVIOUR,1
FI,STOMA SITE DISCHARGE,1
FI,STOMA SITE EXTRAVASATION,1
FI,STOMA SITE INFECTION,1
FI,SWOLLEN TONGUE,1
FI,TEMPERATURE REGULATION DISORDER,1
FI,THERMOHYPOAESTHESIA,1
FI,URINARY TRACT INFECTION,1
FI,URTICARIA,1
FI,VERTIGO,1
FI,VISUAL IMPAIRMENT,1
FI,VOMITING,1
FI,WHEEZING,1
FI,WITHDRAWAL SYNDROME,1
FI,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
FR,ACUTE KIDNEY INJURY,50
FR,CONFUSIONAL STATE,42
FR,HEPATOCELLULAR INJURY,41
FR,PYREXIA,41
FR,FALL,40
FR,SOMNOLENCE,32
FR,VOMITING,27
FR,CONDITION AGGRAVATED,25
FR,DIARRHOEA,25
FR,GENERAL PHYSICAL HEALTH DETERIORATION,25
FR,HEADACHE,25
FR,THROMBOCYTOPENIA,25
FR,ANAEMIA,24
FR,MALAISE,24
FR,COMA,23
FR,RENAL FAILURE,23
FR,CHOLESTASIS,22
FR,HYPONATRAEMIA,22
FR,HYPOTENSION,22
FR,OVERDOSE,22
FR,NAUSEA,21
FR,PANCYTOPENIA,21
FR,RASH MACULO-PAPULAR,21
FR,ASTHENIA,20
FR,ANXIETY,19
FR,RASH,19
FR,DYSPNOEA,18
FR,LUNG DISORDER,18
FR,TREMOR,18
FR,AGITATION,17
FR,CARDIAC FAILURE,17
FR,DEPRESSION,17
FR,FATIGUE,17
FR,AGRANULOCYTOSIS,16
FR,ENCEPHALOPATHY,16
FR,HYPOGLYCAEMIA,16
FR,NEUTROPENIA,16
FR,PAIN,16
FR,PANCREATITIS ACUTE,16
FR,ERYTHEMA,15
FR,VERTIGO,15
FR,HYPERKALAEMIA,14
FR,PARAESTHESIA,14
FR,TOXIC SKIN ERUPTION,14
FR,COMPLETED SUICIDE,13
FR,LACTIC ACIDOSIS,13
FR,MUSCULAR WEAKNESS,13
FR,PNEUMONIA,13
FR,DEATH,12
FR,DIZZINESS,12
FR,HYPOKALAEMIA,12
FR,MATERNAL EXPOSURE DURING PREGNANCY,12
FR,MYOCLONUS,12
FR,URINARY TRACT INFECTION,12
FR,URTICARIA,12
FR,ABDOMINAL PAIN,11
FR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,11
FR,HAEMATOMA,11
FR,LOSS OF CONSCIOUSNESS,11
FR,TACHYCARDIA,11
FR,AGGRESSION,10
FR,BALANCE DISORDER,10
FR,BRADYCARDIA,10
FR,CHILLS,10
FR,DECREASED APPETITE,10
FR,DEHYDRATION,10
FR,DRUG WITHDRAWAL SYNDROME,10
FR,HYPERTENSION,10
FR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,10
FR,INSOMNIA,10
FR,MEMORY IMPAIRMENT,10
FR,PRODUCT USE ISSUE,10
FR,AMNESIA,9
FR,ATRIAL FIBRILLATION,9
FR,DRUG INEFFECTIVE,9
FR,EOSINOPHILIA,9
FR,FEBRILE BONE MARROW APLASIA,9
FR,HALLUCINATION,9
FR,PLEURAL EFFUSION,9
FR,PRURITUS,9
FR,RENAL FAILURE ACUTE,9
FR,SEIZURE,9
FR,ABDOMINAL PAIN UPPER,8
FR,BLOOD ALKALINE PHOSPHATASE INCREASED,8
FR,CARDIO-RESPIRATORY ARREST,8
FR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,8
FR,DYSMORPHISM,8
FR,FOETAL EXPOSURE DURING PREGNANCY,8
FR,GAIT DISTURBANCE,8
FR,HAEMORRHAGE,8
FR,MUSCLE SPASMS,8
FR,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,8
FR,PURPURA,8
FR,SEPSIS,8
FR,SUICIDAL IDEATION,8
FR,SUICIDE ATTEMPT,8
FR,ABNORMAL BEHAVIOUR,7
FR,APHASIA,7
FR,CARDIAC ARREST,7
FR,CONVULSION,7
FR,EPILEPSY,7
FR,HEPATIC FAILURE,7
FR,HYPERTHERMIA,7
FR,HYPOTONIA,7
FR,OBSESSIVE-COMPULSIVE DISORDER,7
FR,OEDEMA PERIPHERAL,7
FR,PAIN IN EXTREMITY,7
FR,PNEUMONIA ASPIRATION,7
FR,RECTAL HAEMORRHAGE,7
FR,RENAL TUBULAR DISORDER,7
FR,RHABDOMYOLYSIS,7
FR,STATUS EPILEPTICUS,7
FR,TOXICITY TO VARIOUS AGENTS,7
FR,URINARY RETENTION,7
FR,ARTHRALGIA,6
FR,ATAXIA,6
FR,CEREBROVASCULAR ACCIDENT,6
FR,CHEST DISCOMFORT,6
FR,DISORIENTATION,6
FR,HAEMOLYTIC ANAEMIA,6
FR,INTENTIONAL OVERDOSE,6
FR,NEUROPATHY PERIPHERAL,6
FR,OXYGEN SATURATION DECREASED,6
FR,PERIPHERAL ISCHAEMIA,6
FR,PRODUCT USE IN UNAPPROVED INDICATION,6
FR,PULMONARY OEDEMA,6
FR,RESPIRATORY DISTRESS,6
FR,SEPTIC SHOCK,6
FR,SHOCK HAEMORRHAGIC,6
FR,VISUAL IMPAIRMENT,6
FR,WEIGHT DECREASED,6
FR,ALTERED STATE OF CONSCIOUSNESS,5
FR,ANURIA,5
FR,ARRHYTHMIA,5
FR,BLOOD BILIRUBIN INCREASED,5
FR,CHEST PAIN,5
FR,CONSTIPATION,5
FR,CREATININE RENAL CLEARANCE DECREASED,5
FR,DIABETES MELLITUS INADEQUATE CONTROL,5
FR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,5
FR,DYSARTHRIA,5
FR,DYSPHAGIA,5
FR,EXPOSURE DURING PREGNANCY,5
FR,FACE OEDEMA,5
FR,GINGIVAL HYPERPLASIA,5
FR,HAEMATURIA,5
FR,HYPERHIDROSIS,5
FR,HYPOTHERMIA,5
FR,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,5
FR,INVASIVE DUCTAL BREAST CARCINOMA,5
FR,MELAENA,5
FR,MUCOSAL INFLAMMATION,5
FR,MULTI-ORGAN FAILURE,5
FR,MYELODYSPLASTIC SYNDROME,5
FR,OBSESSIVE THOUGHTS,5
FR,PANCREATITIS,5
FR,POISONING DELIBERATE,5
FR,POST PROCEDURAL HAEMORRHAGE,5
FR,PRESYNCOPE,5
FR,PSYCHOMOTOR SKILLS IMPAIRED,5
FR,RESPIRATORY FAILURE,5
FR,SHOCK,5
FR,VASCULAR PURPURA,5
FR,VISION BLURRED,5
FR,VISUAL ACUITY REDUCED,5
FR,WEIGHT INCREASED,5
FR,WITHDRAWAL SYNDROME,5
FR,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,4
FR,AGE-RELATED MACULAR DEGENERATION,4
FR,APATHY,4
FR,ASPARTATE AMINOTRANSFERASE INCREASED,4
FR,BLISTER,4
FR,BLOOD ALBUMIN DECREASED,4
FR,BLOOD THYROID STIMULATING HORMONE NORMAL,4
FR,DEEP VEIN THROMBOSIS,4
FR,DEPENDENCE,4
FR,DISTURBANCE IN ATTENTION,4
FR,DROP ATTACKS,4
FR,DRUG LEVEL INCREASED,4
FR,DYSKINESIA,4
FR,ECZEMA,4
FR,EPISTAXIS,4
FR,EXTRAPYRAMIDAL DISORDER,4
FR,FEBRILE NEUTROPENIA,4
FR,FEELING ABNORMAL,4
FR,HEAD INJURY,4
FR,HEPATITIS,4
FR,HEPATITIS CHOLESTATIC,4
FR,INCORRECT DOSE ADMINISTERED,4
FR,INCORRECT DRUG ADMINISTRATION DURATION,4
FR,INFUSION RELATED REACTION,4
FR,LIPASE INCREASED,4
FR,LYMPHOPENIA,4
FR,MALIGNANT NEOPLASM PROGRESSION,4
FR,MENTAL DISORDER,4
FR,MOTOR DYSFUNCTION,4
FR,MULTIPLE CONGENITAL ABNORMALITIES,4
FR,NEURALGIA,4
FR,OEDEMA,4
FR,OLIGURIA,4
FR,ORTHOSTATIC HYPOTENSION,4
FR,PALPITATIONS,4
FR,POLYNEUROPATHY,4
FR,POOR QUALITY SLEEP,4
FR,PSYCHOMOTOR HYPERACTIVITY,4
FR,PULMONARY MASS,4
FR,RADIUS FRACTURE,4
FR,RASH PRURITIC,4
FR,RENAL TUBULAR NECROSIS,4
FR,RESPIRATORY ARREST,4
FR,RESTLESS LEGS SYNDROME,4
FR,RIB FRACTURE,4
FR,STENT PLACEMENT,4
FR,SYNCOPE,4
FR,THROMBECTOMY,4
FR,ABASIA,3
FR,ACIDOSIS,3
FR,ALANINE AMINOTRANSFERASE INCREASED,3
FR,ALOPECIA,3
FR,ANGIOEDEMA,3
FR,ANTEROGRADE AMNESIA,3
FR,APNOEA,3
FR,ATRIOVENTRICULAR BLOCK FIRST DEGREE,3
FR,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,3
FR,BACTERIAL SEPSIS,3
FR,BLADDER DILATATION,3
FR,BLOOD CREATININE INCREASED,3
FR,BLOOD PRESSURE INCREASED,3
FR,BRONCHOSPASM,3
FR,C-REACTIVE PROTEIN INCREASED,3
FR,CARDIAC DISORDER,3
FR,CELL DEATH,3
FR,CHROMATURIA,3
FR,COLITIS,3
FR,COMPULSIVE SHOPPING,3
FR,COUGH,3
FR,CRANIOCEREBRAL INJURY,3
FR,DEPRESSED LEVEL OF CONSCIOUSNESS,3
FR,DERMATITIS EXFOLIATIVE,3
FR,DEVICE RELATED INFECTION,3
FR,DIPLOPIA,3
FR,DISEASE PROGRESSION,3
FR,DRUG PRESCRIBING ERROR,3
FR,DRUG-INDUCED LIVER INJURY,3
FR,DYSSTASIA,3
FR,FUNGAL INFECTION,3
FR,GASTRIC DISORDER,3
FR,GENERAL PHYSICAL CONDITION ABNORMAL,3
FR,GENERALISED OEDEMA,3
FR,GENERALISED TONIC-CLONIC SEIZURE,3
FR,HAEMOGLOBIN DECREASED,3
FR,HAEMORRHAGIC ANAEMIA,3
FR,HAEMOTHORAX,3
FR,HALLUCINATION_ VISUAL,3
FR,HEPATIC CIRRHOSIS,3
FR,HEPATIC ENCEPHALOPATHY,3
FR,HEPATIC SIDEROSIS,3
FR,HOSPITALISATION,3
FR,HYPERAMMONAEMIA,3
FR,HYPOAESTHESIA,3
FR,HYPOMANIA,3
FR,ILEUS PARALYTIC,3
FR,IMPULSE-CONTROL DISORDER,3
FR,INCOHERENT,3
FR,INFECTION,3
FR,INFLUENZA LIKE ILLNESS,3
FR,INJECTION SITE PAIN,3
FR,INTERNATIONAL NORMALISED RATIO INCREASED,3
FR,INTRACRANIAL HAEMATOMA,3
FR,JAUNDICE CHOLESTATIC,3
FR,LARYNGEAL OEDEMA,3
FR,LEG AMPUTATION,3
FR,LIVEDO RETICULARIS,3
FR,LYMPHADENOPATHY,3
FR,MACULAR OEDEMA,3
FR,MAJOR DEPRESSION,3
FR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
FR,MYALGIA,3
FR,NERVOUS SYSTEM DISORDER,3
FR,NEUROLOGICAL EXAMINATION ABNORMAL,3
FR,NIGHT SWEATS,3
FR,OROMANDIBULAR DYSTONIA,3
FR,OSTEOARTHRITIS,3
FR,PACKED RED BLOOD CELL TRANSFUSION,3
FR,PARALYSIS,3
FR,PERICARDIAL HAEMORRHAGE,3
FR,PLASMA CELL MYELOMA,3
FR,PORTAL HYPERTENSION,3
FR,POST PROCEDURAL HAEMATOMA,3
FR,PROTHROMBIN TIME RATIO DECREASED,3
FR,PULMONARY EMBOLISM,3
FR,RASH ERYTHEMATOUS,3
FR,SCIATICA,3
FR,SEROTONIN SYNDROME,3
FR,SUBDURAL HAEMATOMA,3
FR,TALIPES,3
FR,THROMBOTIC MICROANGIOPATHY,3
FR,URINARY INCONTINENCE,3
FR,VARICES OESOPHAGEAL,3
FR,VENTRICULAR SEPTAL DEFECT,3
FR,VISUAL FIELD DEFECT,3
FR,WHITE BLOOD CELL COUNT INCREASED,3
FR,ABORTION INDUCED,2
FR,ACUTE CORONARY SYNDROME,2
FR,ACUTE PULMONARY OEDEMA,2
FR,ACUTE RESPIRATORY FAILURE,2
FR,ALVEOLITIS,2
FR,ANGER,2
FR,ANTI FACTOR VIII ANTIBODY TEST,2
FR,APGAR SCORE LOW,2
FR,APLASIA PURE RED CELL,2
FR,ARTHRITIS,2
FR,ATELECTASIS,2
FR,BACK PAIN,2
FR,BACTERAEMIA,2
FR,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
FR,BLOOD CREATININE DECREASED,2
FR,BLOOD PRESSURE DECREASED,2
FR,BRADYPHRENIA,2
FR,BRADYPNOEA,2
FR,BRONCHITIS,2
FR,BRONCHOPULMONARY ASPERGILLOSIS,2
FR,BUNDLE BRANCH BLOCK RIGHT,2
FR,BURNING SENSATION,2
FR,CARDIAC FAILURE ACUTE,2
FR,CARDIAC TAMPONADE,2
FR,CEREBRAL DISORDER,2
FR,CHEST INJURY,2
FR,CHONDROCALCINOSIS,2
FR,CLEFT PALATE,2
FR,CLONIC CONVULSION,2
FR,COAGULOPATHY,2
FR,COGNITIVE DISORDER,2
FR,CONGENITAL ANOMALY,2
FR,CONGENITAL SKIN DIMPLES,2
FR,CONGESTIVE CARDIOMYOPATHY,2
FR,COORDINATION ABNORMAL,2
FR,CYANOSIS,2
FR,DAYDREAMING,2
FR,DEPRESSED MOOD,2
FR,DERMATITIS BULLOUS,2
FR,DIARRHOEA INFECTIOUS,2
FR,DISABILITY,2
FR,DISSEMINATED INTRAVASCULAR COAGULATION,2
FR,DISTRIBUTIVE SHOCK,2
FR,DRUG DEPENDENCE,2
FR,DRUG ERUPTION,2
FR,DRUG INTOLERANCE,2
FR,DRUG USE DISORDER,2
FR,DRY SKIN,2
FR,DYSGRAPHIA,2
FR,DYSHIDROTIC ECZEMA,2
FR,DYSPRAXIA,2
FR,EATING DISORDER,2
FR,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,2
FR,ELECTROCARDIOGRAM QT PROLONGED,2
FR,EMPHYSEMA,2
FR,EOSINOPHILIC MYOCARDITIS,2
FR,ERYTHEMA MULTIFORME,2
FR,ERYTHEMA NODOSUM,2
FR,EXTRADURAL HAEMATOMA,2
FR,EYELID OEDEMA,2
FR,FAECALOMA,2
FR,FEELING HOT,2
FR,FOETAL DEATH,2
FR,FRACTURE,2
FR,GASTROENTERITIS BACTERIAL,2
FR,GASTROINTESTINAL DISORDER,2
FR,GASTROINTESTINAL HAEMORRHAGE,2
FR,GASTROOESOPHAGEAL REFLUX DISEASE,2
FR,GINGIVAL BLEEDING,2
FR,HAEMATEMESIS,2
FR,HAEMODYNAMIC INSTABILITY,2
FR,HEART RATE INCREASED,2
FR,HEPATIC ENZYME INCREASED,2
FR,HEPATIC STEATOSIS,2
FR,HEPATITIS ACUTE,2
FR,HEPATITIS FULMINANT,2
FR,HOT FLUSH,2
FR,HYPERCALCAEMIA,2
FR,HYPERCAPNIA,2
FR,HYPERTENSIVE CRISIS,2
FR,HYPERTONIA,2
FR,HYPERTRIGLYCERIDAEMIA,2
FR,HYPOGAMMAGLOBULINAEMIA,2
FR,HYPOGLYCAEMIC COMA,2
FR,HYPOTHYROIDISM,2
FR,HYPOVENTILATION,2
FR,HYPOXIA,2
FR,IMPAIRED HEALING,2
FR,INCISION SITE HAEMORRHAGE,2
FR,INFLAMMATION,2
FR,INFLUENZA,2
FR,INJURY,2
FR,INTENTIONAL PRODUCT MISUSE,2
FR,INTESTINAL OBSTRUCTION,2
FR,IRON DEFICIENCY ANAEMIA,2
FR,IRRITABILITY,2
FR,ISCHAEMIC STROKE,2
FR,JAW DISORDER,2
FR,KIDNEY INFECTION,2
FR,LARYNGOMALACIA,2
FR,LEFT ATRIAL DILATATION,2
FR,LEUKOCYTOSIS,2
FR,LEUKOPENIA,2
FR,LICHENOID KERATOSIS,2
FR,LIVER INJURY,2
FR,LOCAL SWELLING,2
FR,LUNG INFECTION,2
FR,MANIA,2
FR,MEDICATION ERROR,2
FR,MOOD ALTERED,2
FR,MULTIPLE SCLEROSIS,2
FR,MULTIPLE SCLEROSIS RELAPSE,2
FR,MUSCLE CONTRACTIONS INVOLUNTARY,2
FR,MUSCULOSKELETAL DISORDER,2
FR,MYDRIASIS,2
FR,MYOCARDIAL INFARCTION,2
FR,NECK PAIN,2
FR,NERVOUSNESS,2
FR,NEUROBLASTOMA,2
FR,NEUTROPHIL COUNT DECREASED,2
FR,OCCUPATIONAL DERMATITIS,2
FR,OEDEMA MOUTH,2
FR,OLIGOHYDRAMNIOS,2
FR,OPISTHOTONUS,2
FR,ORAL DISORDER,2
FR,OSTEONECROSIS OF JAW,2
FR,PALLOR,2
FR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,2
FR,PANIC ATTACK,2
FR,PARKINSON^S DISEASE,2
FR,PARTIAL SEIZURES,2
FR,PECTUS EXCAVATUM,2
FR,PEPTIC ULCER,2
FR,PERICARDIAL EFFUSION,2
FR,PERIPHERAL COLDNESS,2
FR,PERIPHERAL SENSORIMOTOR NEUROPATHY,2
FR,PERIPHERAL SENSORY NEUROPATHY,2
FR,PERSONALITY DISORDER,2
FR,PETECHIAE,2
FR,PHOTOSENSITIVITY REACTION,2
FR,PNEUMOCYSTIS JIROVECII PNEUMONIA,2
FR,POOR SUCKING REFLEX,2
FR,PREMATURE BABY,2
FR,PRESCRIBED UNDERDOSE,2
FR,PRODUCTIVE COUGH,2
FR,PSYCHIATRIC SYMPTOM,2
FR,PSYCHOMOTOR RETARDATION,2
FR,PULMONARY HYPOPLASIA,2
FR,PYELONEPHRITIS,2
FR,RASH PUSTULAR,2
FR,RENAL COLIC,2
FR,RESPIRATORY ACIDOSIS,2
FR,RESPIRATORY DISORDER,2
FR,RESPIRATORY TRACT CONGESTION,2
FR,RHEUMATOID ARTHRITIS,2
FR,ROAD TRAFFIC ACCIDENT,2
FR,SELF ESTEEM DECREASED,2
FR,SENSORY LOSS,2
FR,SKIN DISCOLOURATION,2
FR,SKIN LESION,2
FR,SOCIAL AVOIDANT BEHAVIOUR,2
FR,SQUAMOUS CELL CARCINOMA,2
FR,STAPHYLOCOCCAL INFECTION,2
FR,SUPERFICIAL SPREADING MELANOMA STAGE UNSPECIFIED,2
FR,SUPRAVENTRICULAR TACHYCARDIA,2
FR,SWELLING FACE,2
FR,SYSTEMIC SCLEROSIS,2
FR,TORSADE DE POINTES,2
FR,TOXOPLASMOSIS,2
FR,TRANSAMINASES INCREASED,2
FR,TRAUMATIC HAEMATOMA,2
FR,TUBERCULOSIS,2
FR,UROSEPSIS,2
FR,VENTRICULAR TACHYCARDIA,2
FR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
FR,ABDOMINAL DISCOMFORT,1
FR,ABDOMINAL INFECTION,1
FR,ABORTION SPONTANEOUS,1
FR,ABSCESS LIMB,1
FR,ACCIDENT,1
FR,ACCIDENTAL EXPOSURE TO PRODUCT,1
FR,ACCIDENTAL OVERDOSE,1
FR,ACNE,1
FR,ACNE CYSTIC,1
FR,ACQUIRED GENE MUTATION,1
FR,ACTIVITIES OF DAILY LIVING IMPAIRED,1
FR,ACUTE MYELOID LEUKAEMIA,1
FR,ACUTE PROMYELOCYTIC LEUKAEMIA,1
FR,ACUTE RESPIRATORY DISTRESS SYNDROME,1
FR,ADENOCARCINOMA OF COLON,1
FR,ADRENAL DISORDER,1
FR,AGORAPHOBIA,1
FR,AKATHISIA,1
FR,ALLERGIC HEPATITIS,1
FR,ALVEOLITIS ALLERGIC,1
FR,AMYOTROPHY,1
FR,ANAL ATRESIA,1
FR,ANAL CANCER,1
FR,ANAL INCONTINENCE,1
FR,ANAL SQUAMOUS CELL CARCINOMA,1
FR,ANAL ULCER,1
FR,ANAPHYLACTIC REACTION,1
FR,ANAPHYLACTIC SHOCK,1
FR,ANAPHYLACTOID REACTION,1
FR,ANAPHYLACTOID SHOCK,1
FR,ANGINA PECTORIS,1
FR,ANTI FACTOR VIII ANTIBODY POSITIVE,1
FR,ANTINUCLEAR ANTIBODY INCREASED,1
FR,AORTIC VALVE CALCIFICATION,1
FR,AORTIC VALVE INCOMPETENCE,1
FR,APPENDICITIS,1
FR,AREFLEXIA,1
FR,ARRHYTHMIA SUPRAVENTRICULAR,1
FR,ARTERIAL DISORDER,1
FR,ARTERIAL THROMBOSIS,1
FR,ARTHRITIS BACTERIAL,1
FR,ARTHRITIS INFECTIVE,1
FR,ATRIAL FLUTTER,1
FR,ATRIOVENTRICULAR BLOCK COMPLETE,1
FR,AUTISM SPECTRUM DISORDER,1
FR,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
FR,AXONAL NEUROPATHY,1
FR,B-CELL LYMPHOMA,1
FR,BACK DISORDER,1
FR,BACTERIAL PYELONEPHRITIS,1
FR,BASAL CELL CARCINOMA,1
FR,BEDRIDDEN,1
FR,BICYTOPENIA,1
FR,BIFASCICULAR BLOCK,1
FR,BINGE EATING,1
FR,BIOPSY BONE MARROW,1
FR,BIPOLAR DISORDER,1
FR,BLADDER CANCER STAGE III,1
FR,BLADDER DISORDER,1
FR,BLADDER IRRITATION,1
FR,BLAST CELL COUNT INCREASED,1
FR,BLEPHAROSPASM,1
FR,BLINDNESS,1
FR,BLOOD BICARBONATE INCREASED,1
FR,BLOOD BLISTER,1
FR,BLOOD FOLATE INCREASED,1
FR,BLOOD GLUCOSE INCREASED,1
FR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
FR,BLOOD PARATHYROID HORMONE ABNORMAL,1
FR,BLOOD PRESSURE FLUCTUATION,1
FR,BLOOD PROLACTIN INCREASED,1
FR,BLOOD TESTOSTERONE DECREASED,1
FR,BLOOD THYROID STIMULATING HORMONE INCREASED,1
FR,BONE MARROW FAILURE,1
FR,BONE PAIN,1
FR,BONE SARCOMA,1
FR,BRADYKINESIA,1
FR,BRAIN OEDEMA,1
FR,BREAST CANCER,1
FR,BREAST NEOPLASM,1
FR,BRONCHIOLITIS,1
FR,BRONCHITIS VIRAL,1
FR,BRONCHOPNEUMOPATHY,1
FR,BULIMIA NERVOSA,1
FR,BUNDLE BRANCH BLOCK LEFT,1
FR,BURNS SECOND DEGREE,1
FR,CACHEXIA,1
FR,CALCULUS URINARY,1
FR,CAMPYLOBACTER INFECTION,1
FR,CARDIAC MURMUR,1
FR,CARDIOMYOPATHY,1
FR,CARDIOPULMONARY FAILURE,1
FR,CAROTID ARTERY DISSECTION,1
FR,CATAPLEXY,1
FR,CATARACT,1
FR,CENTRAL NERVOUS SYSTEM LESION,1
FR,CEREBELLAR ATAXIA,1
FR,CEREBRAL ATROPHY,1
FR,CEREBRAL CIRCULATORY FAILURE,1
FR,CEREBRAL CYST,1
FR,CEREBRAL HAEMATOMA,1
FR,CEREBRAL HAEMORRHAGE,1
FR,CEREBRAL HYPOPERFUSION,1
FR,CEREBRAL INFARCTION,1
FR,CHANGE IN SUSTAINED ATTENTION,1
FR,CHOKING,1
FR,CHOLECYSTITIS,1
FR,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
FR,CLAVICLE FRACTURE,1
FR,COARCTATION OF THE AORTA,1
FR,COLITIS ISCHAEMIC,1
FR,COLON CANCER METASTATIC,1
FR,COLONOSCOPY,1
FR,COMMUNICATION DISORDER,1
FR,COMPLEX REGIONAL PAIN SYNDROME,1
FR,CONDUCTION DISORDER,1
FR,CONGENITAL DIAPHRAGMATIC HERNIA,1
FR,CONJUNCTIVAL HAEMORRHAGE,1
FR,CONJUNCTIVITIS,1
FR,CONTRAINDICATED PRODUCT ADMINISTERED,1
FR,CORTISOL FREE URINE DECREASED,1
FR,CYSTITIS,1
FR,CYSTITIS HAEMORRHAGIC,1
FR,CYTOKINE RELEASE SYNDROME,1
FR,CYTOMEGALOVIRUS DUODENITIS,1
FR,DEAFNESS,1
FR,DEAFNESS UNILATERAL,1
FR,DECREASED INTEREST,1
FR,DECUBITUS ULCER,1
FR,DELUSION,1
FR,DEMENTIA ALZHEIMER^S TYPE,1
FR,DEPERSONALISATION,1
FR,DERMATITIS ACNEIFORM,1
FR,DERMO-HYPODERMITIS,1
FR,DEVICE RELATED SEPSIS,1
FR,DIABETES MELLITUS,1
FR,DIABETIC FOOT,1
FR,DIALYSIS,1
FR,DIAPHRAGMATIC HERNIA,1
FR,DISCOMFORT,1
FR,DISINHIBITION,1
FR,DOPAMINE DYSREGULATION SYNDROME,1
FR,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
FR,DRUG ADMINISTRATION ERROR,1
FR,DRUG DISPENSING ERROR,1
FR,DRUG DOSE OMISSION,1
FR,DRUG EFFECT INCREASED,1
FR,DRUG HYPERSENSITIVITY,1
FR,DRUG LEVEL BELOW THERAPEUTIC,1
FR,DRUG SPECIFIC ANTIBODY PRESENT,1
FR,DRY EYE,1
FR,DRY MOUTH,1
FR,DRY THROAT,1
FR,DYSAESTHESIA,1
FR,DYSLIPIDAEMIA,1
FR,DYSPEPSIA,1
FR,DYSPHORIA,1
FR,DYSPNOEA EXERTIONAL,1
FR,EAR_ NOSE AND THROAT EXAMINATION ABNORMAL,1
FR,ECCHYMOSIS,1
FR,EDUCATIONAL PROBLEM,1
FR,EMBOLIA CUTIS MEDICAMENTOSA,1
FR,EMBOLISM,1
FR,ENCEPHALITIS,1
FR,ENTERITIS,1
FR,ENTEROBACTER BACTERAEMIA,1
FR,EOSINOPHIL COUNT INCREASED,1
FR,ERYTHROSIS,1
FR,ESCHERICHIA TEST POSITIVE,1
FR,EUPHORIC MOOD,1
FR,EXOMPHALOS,1
FR,EXPOSED BONE IN JAW,1
FR,EYE DISORDER,1
FR,EYE HAEMORRHAGE,1
FR,EYE IRRITATION,1
FR,FAECAL INCONTINENCE,1
FR,FAECES DISCOLOURED,1
FR,FANCONI SYNDROME ACQUIRED,1
FR,FASCIITIS,1
FR,FEEDING DISORDER,1
FR,FINGER DEFORMITY,1
FR,FISTULA,1
FR,FLIGHT OF IDEAS,1
FR,FLUID RETENTION,1
FR,FOETAL ANTICONVULSANT SYNDROME,1
FR,FOETAL HEART RATE DISORDER,1
FR,FOETAL MALNUTRITION,1
FR,FOOD ALLERGY,1
FR,FOOD INTOLERANCE,1
FR,FOOT DEFORMITY,1
FR,FUNGAL SKIN INFECTION,1
FR,FURUNCLE,1
FR,GASTRIC HAEMORRHAGE,1
FR,GASTRODUODENAL ULCER,1
FR,GASTROENTERITIS,1
FR,GASTROINTESTINAL MOTILITY DISORDER,1
FR,GASTROINTESTINAL MUCOSA HYPERAEMIA,1
FR,GASTROINTESTINAL ULCER HAEMORRHAGE,1
FR,GINGIVAL DISORDER,1
FR,GLOMERULAR FILTRATION RATE DECREASED,1
FR,GRIP STRENGTH DECREASED,1
FR,GUILLAIN-BARRE SYNDROME,1
FR,HAEMANGIOMA,1
FR,HAEMATOMA EVACUATION,1
FR,HAEMOPTYSIS,1
FR,HALLUCINATIONS_ MIXED,1
FR,HAMARTOMA,1
FR,HEART DISEASE CONGENITAL,1
FR,HEART RATE DECREASED,1
FR,HEAT STROKE,1
FR,HEMIANOPIA HOMONYMOUS,1
FR,HEPATIC HAEMATOMA,1
FR,HEPATIC VEIN OCCLUSION,1
FR,HEPATOTOXICITY,1
FR,HERNIA,1
FR,HERPES ZOSTER,1
FR,HERPES ZOSTER MENINGOMYELITIS,1
FR,HISTIOCYTOSIS HAEMATOPHAGIC,1
FR,HOSTILITY,1
FR,HUMAN POLYOMAVIRUS INFECTION,1
FR,HYDRONEPHROSIS,1
FR,HYPERBILIRUBINAEMIA,1
FR,HYPERCAPNIC COMA,1
FR,HYPERKERATOSIS,1
FR,HYPERLACTACIDAEMIA,1
FR,HYPERSENSITIVITY,1
FR,HYPERSEXUALITY,1
FR,HYPERSOMNIA,1
FR,HYPERTELORISM OF ORBIT,1
FR,HYPERTENSIVE HEART DISEASE,1
FR,HYPERTHYROIDISM,1
FR,HYPERTONIA NEONATAL,1
FR,HYPERTRANSAMINASAEMIA,1
FR,HYPOCALCAEMIA,1
FR,HYPOKINESIA,1
FR,HYPOPERFUSION,1
FR,HYPOPROTHROMBINAEMIA,1
FR,HYPOREFLEXIA,1
FR,IIIRD NERVE PARALYSIS,1
FR,ILLUSION,1
FR,IMMUNE-MEDIATED ADVERSE REACTION,1
FR,IMMUNOSUPPRESSION,1
FR,IMPAIRED GASTRIC EMPTYING,1
FR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
FR,INCONTINENCE,1
FR,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
FR,INFANTILE ASTHMA,1
FR,INFARCTION,1
FR,INITIAL INSOMNIA,1
FR,INJECTION SITE DISCOLOURATION,1
FR,INJECTION SITE EXTRAVASATION,1
FR,INJECTION SITE INFLAMMATION,1
FR,INJECTION SITE NODULE,1
FR,INJECTION SITE REACTION,1
FR,INJECTION SITE SWELLING,1
FR,INNER EAR INFLAMMATION,1
FR,INTELLECTUAL DISABILITY,1
FR,INTENTIONAL PRODUCT USE ISSUE,1
FR,INTERSTITIAL LUNG DISEASE,1
FR,INTERVERTEBRAL DISC PROTRUSION,1
FR,INTESTINAL ISCHAEMIA,1
FR,INTESTINAL VILLI ATROPHY,1
FR,INTRA-ABDOMINAL HAEMATOMA,1
FR,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
FR,IRON OVERLOAD,1
FR,JAUNDICE,1
FR,JOINT LOCK,1
FR,JUDGEMENT IMPAIRED,1
FR,JUGULAR VEIN THROMBOSIS,1
FR,KERATITIS,1
FR,KIDNEY TRANSPLANT REJECTION,1
FR,KLEBSIELLA SEPSIS,1
FR,KNEE ARTHROPLASTY,1
FR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
FR,LACTOSE INTOLERANCE,1
FR,LACUNAR INFARCTION,1
FR,LANGUAGE DISORDER,1
FR,LARGE INTESTINE POLYP,1
FR,LARYNGEAL DYSPNOEA,1
FR,LARYNX IRRITATION,1
FR,LEFT VENTRICULAR HYPERTROPHY,1
FR,LIBIDO INCREASED,1
FR,LIP DISORDER,1
FR,LIP SWELLING,1
FR,LIVER DISORDER,1
FR,LIVER FUNCTION TEST ABNORMAL,1
FR,LOGORRHOEA,1
FR,LOOSE TOOTH,1
FR,LOSS OF PROPRIOCEPTION,1
FR,LOWER RESPIRATORY TRACT INFECTION VIRAL,1
FR,LUNG ADENOCARCINOMA,1
FR,LUNG NEOPLASM MALIGNANT,1
FR,LUNG SQUAMOUS CELL CARCINOMA METASTATIC,1
FR,LYMPHOMA,1
FR,MALABSORPTION,1
FR,MALIGNANT MELANOMA,1
FR,MASTICATION DISORDER,1
FR,MEDIASTINUM NEOPLASM,1
FR,MENINGITIS ASEPTIC,1
FR,MENORRHAGIA,1
FR,MENTAL IMPAIRMENT,1
FR,METABOLIC ACIDOSIS,1
FR,METABOLIC ENCEPHALOPATHY,1
FR,METASTASES TO BONE,1
FR,METASTATIC CARCINOMA OF THE BLADDER,1
FR,METRORRHAGIA,1
FR,MICROANGIOPATHY,1
FR,MICROCEPHALY,1
FR,MICROCYTIC ANAEMIA,1
FR,MICROGNATHIA,1
FR,MICTURITION DISORDER,1
FR,MIXED LIVER INJURY,1
FR,MONOCLONAL GAMMOPATHY,1
FR,MONOPLEGIA,1
FR,MORBID THOUGHTS,1
FR,MOUTH INJURY,1
FR,MOVEMENT DISORDER,1
FR,MULTIPLE INJURIES,1
FR,MUSCLE ATROPHY,1
FR,MUSCLE HAEMORRHAGE,1
FR,MUSCLE RIGIDITY,1
FR,MUSCLE TIGHTNESS,1
FR,MUSCULOSKELETAL CHEST PAIN,1
FR,MUSCULOSKELETAL PAIN,1
FR,MUSCULOSKELETAL STIFFNESS,1
FR,MUTISM,1
FR,MYELOPROLIFERATIVE NEOPLASM,1
FR,MYOCARDIAL NECROSIS,1
FR,MYOSITIS,1
FR,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,1
FR,NASOPHARYNGITIS,1
FR,NECROSIS,1
FR,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
FR,NEOPLASM MALIGNANT,1
FR,NEOPLASM PROGRESSION,1
FR,NEPHROLITHIASIS,1
FR,NEPHROPATHY TOXIC,1
FR,NEPHROTIC SYNDROME,1
FR,NERVE CONDUCTION STUDIES ABNORMAL,1
FR,NEURODEVELOPMENTAL DISORDER,1
FR,NEUROGENIC BLADDER,1
FR,NEUROSENSORY HYPOACUSIS,1
FR,NEUROTOXICITY,1
FR,NEUTROPHIL COUNT INCREASED,1
FR,NODAL RHYTHM,1
FR,NODULAR VASCULITIS,1
FR,NONINFECTIVE GINGIVITIS,1
FR,NOSOCOMIAL INFECTION,1
FR,OCULAR DISCOMFORT,1
FR,OESOPHAGEAL ADENOCARCINOMA STAGE III,1
FR,OESOPHAGEAL ATRESIA,1
FR,OESOPHAGITIS,1
FR,OPTIC ISCHAEMIC NEUROPATHY,1
FR,ORAL FUNGAL INFECTION,1
FR,ORAL MUCOSAL EXFOLIATION,1
FR,OROPHARYNGEAL PAIN,1
FR,OSTEITIS,1
FR,OSTEOPOROSIS,1
FR,OTITIS MEDIA ACUTE,1
FR,OVULATION DISORDER,1
FR,PALMOPLANTAR KERATODERMA,1
FR,PALPABLE PURPURA,1
FR,PANCREATIC CARCINOMA,1
FR,PANCREATIC CARCINOMA METASTATIC,1
FR,PANCREATIC DISORDER,1
FR,PANIC DISORDER,1
FR,PAPULE,1
FR,PARESIS,1
FR,PARKINSONISM,1
FR,PATHOGEN RESISTANCE,1
FR,PATHOLOGICAL FRACTURE,1
FR,PATHOLOGICAL GAMBLING,1
FR,PCO2 DECREASED,1
FR,PERFORMANCE STATUS DECREASED,1
FR,PERIODONTITIS,1
FR,PERIPHERAL MOTOR NEUROPATHY,1
FR,PERITONEAL HAEMATOMA,1
FR,PERNICIOUS ANAEMIA,1
FR,PHLEBITIS,1
FR,PHOBIA,1
FR,PHOTOPSIA,1
FR,PHRENIC NERVE PARALYSIS,1
FR,PHYSICAL DISABILITY,1
FR,PLACENTAL DISORDER,1
FR,PLATELET COUNT DECREASED,1
FR,PLATELET DISORDER,1
FR,PLATELET TRANSFUSION,1
FR,PNEUMOCOCCAL INFECTION,1
FR,PNEUMONIA KLEBSIELLA,1
FR,PNEUMONITIS,1
FR,PNEUMOTHORAX,1
FR,POLLAKIURIA,1
FR,POLYARTHRITIS,1
FR,POLYCYSTIC OVARIES,1
FR,POST LUMBAR PUNCTURE SYNDROME,1
FR,POST PROCEDURAL HAEMATURIA,1
FR,POST PROCEDURAL OEDEMA,1
FR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
FR,POSTMATURE BABY,1
FR,POSTOPERATIVE ABSCESS,1
FR,PREGNANCY,1
FR,PROCEDURAL HAEMORRHAGE,1
FR,PRODUCT PACKAGING CONFUSION,1
FR,PROSTATITIS,1
FR,PROTEIN TOTAL DECREASED,1
FR,PROTEINURIA,1
FR,PRURIGO,1
FR,PSEUDOMONAS INFECTION,1
FR,PSEUDOPORPHYRIA,1
FR,PSYCHIATRIC DECOMPENSATION,1
FR,PSYCHOLOGICAL TRAUMA,1
FR,PULMONARY ARTERIAL HYPERTENSION,1
FR,PULMONARY CONTUSION,1
FR,PULMONARY FIBROSIS,1
FR,PULMONARY MALFORMATION,1
FR,PURPURA NON-THROMBOCYTOPENIC,1
FR,PYLORIC STENOSIS,1
FR,RALES,1
FR,RASH GENERALISED,1
FR,RASH MORBILLIFORM,1
FR,RASH VESICULAR,1
FR,REACTION TO DRUG EXCIPIENTS,1
FR,READING DISORDER,1
FR,RECTAL CANCER,1
FR,RED BLOOD CELL COUNT DECREASED,1
FR,RENAL CYST,1
FR,RENAL DISORDER,1
FR,RENAL FAILURE CHRONIC,1
FR,RENAL IMPAIRMENT,1
FR,RESPIRATORY DEPRESSION,1
FR,RESTING TREMOR,1
FR,RETINAL ISCHAEMIA,1
FR,RETROPERITONEAL HAEMATOMA,1
FR,RHINITIS,1
FR,RIGHT VENTRICULAR FAILURE,1
FR,SALMONELLOSIS,1
FR,SCLERITIS,1
FR,SECOND PRIMARY MALIGNANCY,1
FR,SECONDARY ADRENOCORTICAL INSUFFICIENCY,1
FR,SENSE OF OPPRESSION,1
FR,SENSORIMOTOR DISORDER,1
FR,SEPTIC EMBOLUS,1
FR,SERUM FERRITIN DECREASED,1
FR,SINUS NODE DYSFUNCTION,1
FR,SINUS TACHYCARDIA,1
FR,SINUSITIS,1
FR,SKELETAL INJURY,1
FR,SKIN BURNING SENSATION,1
FR,SKIN CANDIDA,1
FR,SKIN EXFOLIATION,1
FR,SKIN FISSURES,1
FR,SKIN INJURY,1
FR,SKIN NECROSIS,1
FR,SKIN OPERATION,1
FR,SKIN PAPILLOMA,1
FR,SKULL MALFORMATION,1
FR,SLEEP DISORDER,1
FR,SOMNAMBULISM,1
FR,SPEECH DISORDER,1
FR,SPEECH DISORDER DEVELOPMENTAL,1
FR,SPHINCTER OF ODDI DYSFUNCTION,1
FR,SPINAL COMPRESSION FRACTURE,1
FR,SPINAL CORD COMPRESSION,1
FR,SPINAL DISORDER,1
FR,SPINAL FRACTURE,1
FR,SUBILEUS,1
FR,SUDDEN ONSET OF SLEEP,1
FR,SUICIDAL BEHAVIOUR,1
FR,SURGERY,1
FR,SWELLING,1
FR,SYSTEMIC LUPUS ERYTHEMATOSUS,1
FR,TENDON DISORDER,1
FR,TENDON RUPTURE,1
FR,TENDONITIS,1
FR,THEFT,1
FR,THERAPEUTIC EMBOLISATION,1
FR,THERAPEUTIC RESPONSE UNEXPECTED,1
FR,THERAPY NON-RESPONDER,1
FR,THINKING ABNORMAL,1
FR,THROMBOSIS IN DEVICE,1
FR,THYMOMA,1
FR,TINEA CRURIS,1
FR,TINNITUS,1
FR,TONGUE ULCERATION,1
FR,TONIC CONVULSION,1
FR,TONSILLAR HYPERTROPHY,1
FR,TOOTH ABSCESS,1
FR,TOOTH DISORDER,1
FR,TOOTH INJURY,1
FR,TOXIC ENCEPHALOPATHY,1
FR,TRACHEAL NEOPLASM,1
FR,TRACHEAL OBSTRUCTION,1
FR,TRANSFUSION,1
FR,TRANSIENT ISCHAEMIC ATTACK,1
FR,TRAUMATIC FRACTURE,1
FR,TREATMENT FAILURE,1
FR,TREATMENT NONCOMPLIANCE,1
FR,TUBULOINTERSTITIAL NEPHRITIS,1
FR,TUMOUR HAEMORRHAGE,1
FR,TYPE 2 DIABETES MELLITUS,1
FR,UMBILICAL HERNIA,1
FR,UNINTENDED PREGNANCY,1
FR,UPPER LIMB FRACTURE,1
FR,URETHRAL STENOSIS,1
FR,VANISHING BILE DUCT SYNDROME,1
FR,VARICOSE ULCERATION,1
FR,VASCULAR DEMENTIA,1
FR,VASCULAR INJURY,1
FR,VASCULAR PSEUDOANEURYSM,1
FR,VASCULITIS,1
FR,VASODILATATION,1
FR,VESSEL PUNCTURE SITE BRUISE,1
FR,VIRAL DIARRHOEA,1
FR,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
FR,VITAMIN B12 DEFICIENCY,1
FR,VITAMIN B12 INCREASED,1
FR,WEIGHT DECREASE NEONATAL,1
FR,WHEEZING,1
FR,WOUND HAEMORRHAGE,1
FR,WRONG PATIENT RECEIVED MEDICATION,1
DE,FATIGUE,43
DE,NAUSEA,42
DE,DYSPNOEA,38
DE,OVERDOSE,31
DE,ACUTE KIDNEY INJURY,29
DE,MULTIPLE SCLEROSIS RELAPSE,29
DE,TOXICITY TO VARIOUS AGENTS,29
DE,GENERAL PHYSICAL HEALTH DETERIORATION,26
DE,PNEUMONIA,26
DE,FALL,25
DE,PAIN,25
DE,HEADACHE,23
DE,ASTHENIA,22
DE,DIARRHOEA,22
DE,DIZZINESS,22
DE,EPILEPSY,22
DE,PAIN IN EXTREMITY,22
DE,SMALL FOR DATES BABY,21
DE,DECREASED APPETITE,20
DE,PARAESTHESIA,20
DE,GAIT DISTURBANCE,19
DE,LOSS OF CONSCIOUSNESS,19
DE,PYREXIA,19
DE,RENAL FAILURE,19
DE,ACTINIC KERATOSIS,18
DE,URINARY TRACT INFECTION,18
DE,WEIGHT DECREASED,18
DE,CONDITION AGGRAVATED,17
DE,DYSPHAGIA,17
DE,FEEDING DISORDER NEONATAL,17
DE,FOETAL EXPOSURE DURING PREGNANCY,17
DE,PRURITUS,17
DE,VOMITING,17
DE,ANAEMIA,16
DE,ARTHRALGIA,16
DE,CARDIAC FAILURE,16
DE,DRUG DEPENDENCE,16
DE,DRUG WITHDRAWAL SYNDROME,16
DE,PLEURAL EFFUSION,16
DE,BASAL CELL CARCINOMA,15
DE,BOWEN^S DISEASE,15
DE,CARDIAC ARREST,15
DE,SEPSIS,15
DE,ATRIAL SEPTAL DEFECT,14
DE,DRUG INEFFECTIVE,14
DE,INFECTION,14
DE,RESTLESSNESS,14
DE,TOOTH DISORDER,14
DE,TREMOR,14
DE,AGGRESSION,13
DE,HYPERTENSION,13
DE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,13
DE,SYNCOPE,13
DE,DISTURBANCE IN ATTENTION,12
DE,GASTROINTESTINAL HAEMORRHAGE,12
DE,HERPES ZOSTER,12
DE,SCIATICA,12
DE,SLEEP DISORDER,12
DE,SUICIDE ATTEMPT,12
DE,ABORTION SPONTANEOUS,11
DE,DEPRESSION,11
DE,METABOLIC ACIDOSIS,11
DE,MUSCULOSKELETAL STIFFNESS,11
DE,PANCREATITIS,11
DE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,11
DE,RASH,11
DE,BACK PAIN,10
DE,COMPLETED SUICIDE,10
DE,CONFUSIONAL STATE,10
DE,CONSTIPATION,10
DE,DISORIENTATION,10
DE,FEBRILE NEUTROPENIA,10
DE,HAEMOGLOBIN DECREASED,10
DE,HYPERHIDROSIS,10
DE,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,10
DE,INTENTIONAL OVERDOSE,10
DE,OROPHARYNGEAL PAIN,10
DE,SEIZURE,10
DE,TACHYCARDIA,10
DE,VERTIGO,10
DE,ABDOMINAL PAIN,9
DE,ABDOMINAL PAIN UPPER,9
DE,BLOOD CREATININE INCREASED,9
DE,C-REACTIVE PROTEIN INCREASED,9
DE,CHEST PAIN,9
DE,HYPERKINESIA,9
DE,HYPOSPADIAS,9
DE,MENTAL DISORDER,9
DE,MYALGIA,9
DE,NEONATAL RESPIRATORY DISTRESS SYNDROME,9
DE,PRECANCEROUS SKIN LESION,9
DE,VISUAL IMPAIRMENT,9
DE,ANXIETY,8
DE,BLOOD PRESSURE INCREASED,8
DE,CERVICOBRACHIAL SYNDROME,8
DE,DEATH,8
DE,DRUG ABUSE,8
DE,DYSARTHRIA,8
DE,FAECES SOFT,8
DE,GASTRIC ULCER,8
DE,HYPERTENSIVE CRISIS,8
DE,HYPOAESTHESIA,8
DE,INSOMNIA,8
DE,LEUKOPENIA,8
DE,MEMORY IMPAIRMENT,8
DE,MICROCEPHALY,8
DE,OPEN ANGLE GLAUCOMA,8
DE,ORAL PAIN,8
DE,POLYNEUROPATHY,8
DE,RESPIRATORY DISORDER NEONATAL,8
DE,TEMPERATURE REGULATION DISORDER,8
DE,THROMBOCYTOPENIA,8
DE,BLOOD GLUCOSE INCREASED,7
DE,BONE METABOLISM DISORDER,7
DE,CEREBROVASCULAR ACCIDENT,7
DE,CHILLS,7
DE,DELIRIUM,7
DE,ERYTHEMA,7
DE,EXPOSURE DURING PREGNANCY,7
DE,FOETAL GROWTH RESTRICTION,7
DE,GINGIVAL ATROPHY,7
DE,GINGIVAL DISORDER,7
DE,HYPONATRAEMIA,7
DE,HYPOTENSION,7
DE,INFLAMMATION,7
DE,JAW DISORDER,7
DE,MATERNAL EXPOSURE DURING PREGNANCY,7
DE,MUSCLE SPASMS,7
DE,OEDEMA PERIPHERAL,7
DE,PANCREATITIS ACUTE,7
DE,PULMONARY EMBOLISM,7
DE,ROAD TRAFFIC ACCIDENT,7
DE,SKIN CANCER,7
DE,SKIN ULCER,7
DE,VANISHING TWIN SYNDROME,7
DE,VISUAL FIELD DEFECT,7
DE,ACUTE RESPIRATORY FAILURE,6
DE,ANKLE FRACTURE,6
DE,ARTERIOSCLEROSIS,6
DE,ATAXIA,6
DE,BALANCE DISORDER,6
DE,BRADYCARDIA,6
DE,BREAST CANCER,6
DE,CHOLELITHIASIS,6
DE,CIRCULATORY COLLAPSE,6
DE,CONCOMITANT DISEASE AGGRAVATED,6
DE,CONTUSION,6
DE,DRUG INTOLERANCE,6
DE,DRUG PRESCRIBING ERROR,6
DE,DRY MOUTH,6
DE,EPISTAXIS,6
DE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,6
DE,GENERALISED TONIC-CLONIC SEIZURE,6
DE,HAEMORRHAGE,6
DE,HAEMORRHAGIC ANAEMIA,6
DE,HYPERVENTILATION,6
DE,HYPOKINESIA,6
DE,INTERVERTEBRAL DISC PROTRUSION,6
DE,MUSCULAR WEAKNESS,6
DE,OSTEOPENIA,6
DE,PERIPHERAL SWELLING,6
DE,PNEUMONIA ASPIRATION,6
DE,PRODUCT USE ISSUE,6
DE,SELF-MEDICATION,6
DE,SQUAMOUS CELL CARCINOMA,6
DE,SUICIDAL IDEATION,6
DE,TRANSAMINASES INCREASED,6
DE,WEIGHT INCREASED,6
DE,ACUTE MYOCARDIAL INFARCTION,5
DE,ALANINE AMINOTRANSFERASE INCREASED,5
DE,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,5
DE,ATRIAL FIBRILLATION,5
DE,BLOOD CREATINE PHOSPHOKINASE INCREASED,5
DE,CHRONIC KIDNEY DISEASE,5
DE,COGNITIVE DISORDER,5
DE,CONCUSSION,5
DE,CORONARY ARTERY DISEASE,5
DE,COUGH,5
DE,DRUG WITHDRAWAL SYNDROME NEONATAL,5
DE,DYSTONIA,5
DE,ELECTROCARDIOGRAM QT PROLONGED,5
DE,FEELING ABNORMAL,5
DE,FOOT FRACTURE,5
DE,GASTROINTESTINAL DISORDER,5
DE,GLOMERULAR FILTRATION RATE DECREASED,5
DE,HALLUCINATION_ AUDITORY,5
DE,HEPATIC FAILURE,5
DE,HOT FLUSH,5
DE,HYPOKALAEMIA,5
DE,HYPOTONIA,5
DE,LIVER FUNCTION TEST ABNORMAL,5
DE,LYMPHOCYTE COUNT DECREASED,5
DE,MALAISE,5
DE,MALIGNANT MELANOMA,5
DE,MOVEMENT DISORDER,5
DE,MUSCULOSKELETAL PAIN,5
DE,MYOCLONUS,5
DE,ORGANISING PNEUMONIA,5
DE,PANCYTOPENIA,5
DE,PERSECUTORY DELUSION,5
DE,PLACENTAL INSUFFICIENCY,5
DE,RENAL FAILURE ACUTE,5
DE,RESPIRATORY FAILURE,5
DE,RESPIRATORY TRACT INFECTION,5
DE,SOMNOLENCE,5
DE,TORSADE DE POINTES,5
DE,TYPE 2 DIABETES MELLITUS,5
DE,URINARY INCONTINENCE,5
DE,URINARY RETENTION,5
DE,VENTRICULAR SEPTAL DEFECT,5
DE,WHITE BLOOD CELL COUNT DECREASED,5
DE,ABDOMINAL DISCOMFORT,4
DE,ALOPECIA,4
DE,ATYPICAL PNEUMONIA,4
DE,BLADDER CANCER,4
DE,BRONCHITIS,4
DE,CEREBRAL INFARCTION,4
DE,CEREBRAL ISCHAEMIA,4
DE,CONVULSION NEONATAL,4
DE,DEHYDRATION,4
DE,DRUG-INDUCED LIVER INJURY,4
DE,EAR INFECTION,4
DE,ENTERITIS,4
DE,GOITRE,4
DE,HAEMATOMA,4
DE,HAEMATURIA,4
DE,HEMIPARESIS,4
DE,HYPERKALAEMIA,4
DE,HYPERSENSITIVITY,4
DE,HYPOTHYROIDISM,4
DE,IMPAIRED HEALING,4
DE,IMPAIRED QUALITY OF LIFE,4
DE,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,4
DE,INCORRECT DOSE ADMINISTERED,4
DE,INFLUENZA,4
DE,INFLUENZA LIKE ILLNESS,4
DE,LOWER LIMB FRACTURE,4
DE,MALIGNANT NEOPLASM PROGRESSION,4
DE,MULTI-ORGAN FAILURE,4
DE,MUSCLE TWITCHING,4
DE,NEUTROPENIA,4
DE,OSTEOARTHRITIS,4
DE,PALPITATIONS,4
DE,PARAESTHESIA ORAL,4
DE,PARKINSON^S DISEASE,4
DE,PAROTITIS,4
DE,PARTIAL SEIZURES,4
DE,PROCEDURAL PAIN,4
DE,PRODUCT USE IN UNAPPROVED INDICATION,4
DE,PSYCHOTIC DISORDER,4
DE,PULMONARY OEDEMA,4
DE,RESTLESS LEGS SYNDROME,4
DE,SEROTONIN SYNDROME,4
DE,SPEECH DISORDER,4
DE,STAPHYLOCOCCAL INFECTION,4
DE,TESTICULAR PAIN,4
DE,TETANY,4
DE,UTERINE LEIOMYOMA,4
DE,VISION BLURRED,4
DE,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,3
DE,AGITATION,3
DE,APHASIA,3
DE,APNOEA,3
DE,ARTHRITIS,3
DE,ARTHROPATHY,3
DE,ASPARTATE AMINOTRANSFERASE INCREASED,3
DE,AUTOIMMUNE HAEMOLYTIC ANAEMIA,3
DE,BLADDER DISORDER,3
DE,BLOOD BILIRUBIN INCREASED,3
DE,BURNING SENSATION,3
DE,CACHEXIA,3
DE,CARCINOMA IN SITU OF SKIN,3
DE,CARDIAC VALVE DISEASE,3
DE,CARDIOVASCULAR DISORDER,3
DE,CAROTID ARTERY STENOSIS,3
DE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
DE,COMA,3
DE,CONVULSION,3
DE,COORDINATION ABNORMAL,3
DE,CYSTITIS,3
DE,DEEP VEIN THROMBOSIS,3
DE,DEMENTIA,3
DE,DEPRESSED MOOD,3
DE,DIABETES MELLITUS,3
DE,DRUG ADMINISTRATION ERROR,3
DE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,3
DE,DYSKINESIA,3
DE,DYSPEPSIA,3
DE,EJECTION FRACTION DECREASED,3
DE,FEMORAL NECK FRACTURE,3
DE,FLATULENCE,3
DE,FLUSHING,3
DE,FOCAL NODULAR HYPERPLASIA,3
DE,FOOT DEFORMITY,3
DE,GASTRITIS,3
DE,GASTROENTERITIS,3
DE,GUILLAIN-BARRE SYNDROME,3
DE,HYPERAESTHESIA,3
DE,HYPERCALCAEMIA,3
DE,HYPERLIPIDAEMIA,3
DE,HYPOCALCAEMIA,3
DE,ILEUS,3
DE,INJECTION SITE ERYTHEMA,3
DE,IRRITABILITY,3
DE,KIDNEY TRANSPLANT REJECTION,3
DE,LIMB DISCOMFORT,3
DE,LIVER FUNCTION TEST INCREASED,3
DE,MELAENA,3
DE,MELANOCYTIC NAEVUS,3
DE,MENTAL IMPAIRMENT,3
DE,METASTASES TO PLEURA,3
DE,MITRAL VALVE INCOMPETENCE,3
DE,MULTIPLE SCLEROSIS,3
DE,MUSCLE DISORDER,3
DE,MUSCLE SPASTICITY,3
DE,MYOCARDIAL INFARCTION,3
DE,NASOPHARYNGITIS,3
DE,NEOPLASM MALIGNANT,3
DE,NEURALGIA,3
DE,OEDEMA,3
DE,OVARIAN CYST,3
DE,PARESIS,3
DE,PERITONITIS,3
DE,PLASMA CELL MYELOMA,3
DE,PLATELET COUNT INCREASED,3
DE,PRESCRIBED UNDERDOSE,3
DE,PRESYNCOPE,3
DE,PROTEINURIA,3
DE,RESPIRATORY DISTRESS,3
DE,RESPIRATORY SYNCYTIAL VIRUS INFECTION,3
DE,RETINOPATHY,3
DE,RHABDOMYOLYSIS,3
DE,RHEUMATOID ARTHRITIS,3
DE,SCAR,3
DE,SHOCK HAEMORRHAGIC,3
DE,SLEEP APNOEA SYNDROME,3
DE,SPINAL COLUMN STENOSIS,3
DE,SPINAL OSTEOARTHRITIS,3
DE,SURGERY,3
DE,THROMBOSIS,3
DE,THYROID DISORDER,3
DE,TORTICOLLIS,3
DE,UPPER GASTROINTESTINAL HAEMORRHAGE,3
DE,URTICARIA,3
DE,VASCULITIS,3
DE,VISUAL ACUITY REDUCED,3
DE,WHITE BLOOD CELL COUNT INCREASED,3
DE,WITHDRAWAL SYNDROME,3
DE,ABASIA,2
DE,ABSCESS LIMB,2
DE,ADVERSE DRUG REACTION,2
DE,AKINESIA,2
DE,AMYLASE INCREASED,2
DE,ANGINA PECTORIS,2
DE,APPLICATION SITE PRURITUS,2
DE,ARRHYTHMIA,2
DE,ASTHMA,2
DE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,2
DE,AUTOIMMUNE HEPATITIS,2
DE,BARRETT^S OESOPHAGUS,2
DE,BLISTER,2
DE,BLOOD CALCIUM DECREASED,2
DE,BLOOD COUNT ABNORMAL,2
DE,BLOOD LACTATE DEHYDROGENASE INCREASED,2
DE,BLOOD TRIGLYCERIDES INCREASED,2
DE,BODY TEMPERATURE INCREASED,2
DE,BONE MARROW INFILTRATION,2
DE,BONE PAIN,2
DE,BRADYARRHYTHMIA,2
DE,BRADYCARDIA NEONATAL,2
DE,BRAIN OEDEMA,2
DE,BRONCHIAL CARCINOMA,2
DE,BRONCHIAL OBSTRUCTION,2
DE,BUNDLE BRANCH BLOCK RIGHT,2
DE,CAESAREAN SECTION,2
DE,CARDIOPULMONARY FAILURE,2
DE,CELLULITIS,2
DE,CENTRAL NERVOUS SYSTEM INFLAMMATION,2
DE,CEREBRAL HAEMORRHAGE,2
DE,CHEST DISCOMFORT,2
DE,CHOLECYSTITIS,2
DE,CHOLECYSTITIS ACUTE,2
DE,CHRONIC FATIGUE SYNDROME,2
DE,CHRONIC GASTRITIS,2
DE,CONGESTIVE CARDIOMYOPATHY,2
DE,CRANIAL NERVE DISORDER,2
DE,CRANIOCEREBRAL INJURY,2
DE,CROHN^S DISEASE,2
DE,CYTOMEGALOVIRUS COLITIS,2
DE,DEAFNESS,2
DE,DERMATITIS ALLERGIC,2
DE,DEVICE RELATED INFECTION,2
DE,DIABETIC KETOACIDOSIS,2
DE,DISCOMFORT,2
DE,DISSEMINATED INTRAVASCULAR COAGULATION,2
DE,DIVERTICULITIS,2
DE,DRUG DOSE OMISSION,2
DE,DRY SKIN,2
DE,DYSAESTHESIA,2
DE,DYSGEUSIA,2
DE,DYSPHONIA,2
DE,ECZEMA,2
DE,ELECTROENCEPHALOGRAM ABNORMAL,2
DE,ENDOCARDITIS,2
DE,ENTEROCOCCAL INFECTION,2
DE,ENTEROCOCCAL SEPSIS,2
DE,EYE PAIN,2
DE,FAECALOMA,2
DE,FEELING COLD,2
DE,FREQUENT BOWEL MOVEMENTS,2
DE,GASTRIC VARICES,2
DE,GASTRITIS HAEMORRHAGIC,2
DE,GENERAL PHYSICAL CONDITION ABNORMAL,2
DE,GOUT,2
DE,GYNAECOMASTIA,2
DE,HAEMANGIOMA,2
DE,HAEMATOCRIT DECREASED,2
DE,HAEMODIALYSIS,2
DE,HAIR COLOUR CHANGES,2
DE,HALLUCINATION,2
DE,HEART RATE INCREASED,2
DE,HEART RATE IRREGULAR,2
DE,HEPATITIS,2
DE,HEPATOCELLULAR CARCINOMA,2
DE,HYPERBILIRUBINAEMIA NEONATAL,2
DE,HYPERGLYCAEMIA,2
DE,HYPOGLYCAEMIA,2
DE,HYPOPHAGIA,2
DE,IDIOPATHIC PULMONARY FIBROSIS,2
DE,IMMUNE THROMBOCYTOPENIC PURPURA,2
DE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
DE,INJECTION SITE INDURATION,2
DE,INJURY,2
DE,INTENTIONAL DRUG MISUSE,2
DE,ISCHAEMIC STROKE,2
DE,JOINT RANGE OF MOTION DECREASED,2
DE,LACTIC ACIDOSIS,2
DE,LEG AMPUTATION,2
DE,LHERMITTE^S SIGN,2
DE,LIPASE INCREASED,2
DE,LIVER DISORDER,2
DE,LOW BIRTH WEIGHT BABY,2
DE,LOWER GASTROINTESTINAL HAEMORRHAGE,2
DE,LUNG ADENOCARCINOMA,2
DE,LUNG DISORDER,2
DE,LYMPHADENOPATHY,2
DE,METASTASES TO BONE,2
DE,MIGRAINE,2
DE,MOBILITY DECREASED,2
DE,MONOCYTE COUNT INCREASED,2
DE,MOOD SWINGS,2
DE,MUSCLE ATROPHY,2
DE,MYOCARDIAL ISCHAEMIA,2
DE,NECK PAIN,2
DE,NECROSIS,2
DE,NERVE INJURY,2
DE,NERVOUS SYSTEM DISORDER,2
DE,NEUROLOGICAL DECOMPENSATION,2
DE,NEUROPATHY PERIPHERAL,2
DE,NIGHT SWEATS,2
DE,NO ADVERSE EVENT,2
DE,NOCTURIA,2
DE,NON-SMALL CELL LUNG CANCER,2
DE,NYSTAGMUS,2
DE,OPHTHALMIC HERPES ZOSTER,2
DE,OPTIC NEURITIS,2
DE,ORAL HERPES,2
DE,ORTHOPNOEA,2
DE,OSTEOPOROSIS,2
DE,OXYGEN SATURATION DECREASED,2
DE,PANCREATIC CARCINOMA,2
DE,PANIC ATTACK,2
DE,PANIC DISORDER,2
DE,PAPILLOMA,2
DE,PARANOIA,2
DE,PERFORMANCE STATUS DECREASED,2
DE,PERICARDIAL EFFUSION,2
DE,PERIPHERAL ISCHAEMIA,2
DE,PERSONALITY DISORDER,2
DE,PHARYNGEAL OEDEMA,2
DE,PHOTOSENSITIVITY REACTION,2
DE,PLATELET COUNT DECREASED,2
DE,POLLAKIURIA,2
DE,POLYARTHRITIS,2
DE,POLYURIA,2
DE,PREMATURE BABY,2
DE,PREMATURE LABOUR,2
DE,PROTHROMBIN TIME SHORTENED,2
DE,PSORIASIS,2
DE,PULSE ABSENT,2
DE,PYELONEPHRITIS,2
DE,PYODERMA GANGRENOSUM,2
DE,RED BLOOD CELL COUNT DECREASED,2
DE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
DE,RHEUMATIC DISORDER,2
DE,RHINORRHOEA,2
DE,RIGHT VENTRICULAR FAILURE,2
DE,SENSORY DISTURBANCE,2
DE,SEPTIC ENCEPHALOPATHY,2
DE,SEPTIC SHOCK,2
DE,SINOATRIAL BLOCK,2
DE,SINUSITIS,2
DE,SOFT TISSUE INFLAMMATION,2
DE,SPINAL DEFORMITY,2
DE,SPINAL DISORDER,2
DE,SPINAL PAIN,2
DE,SPLENIC INFARCTION,2
DE,STAPHYLOCOCCAL SEPSIS,2
DE,STATUS EPILEPTICUS,2
DE,STENOSIS,2
DE,STOMA SITE DISCHARGE,2
DE,STOMA SITE INFLAMMATION,2
DE,STOMA SITE PAIN,2
DE,SUBILEUS,2
DE,SWELLING,2
DE,SWELLING FACE,2
DE,THROMBOPHLEBITIS,2
DE,TINNITUS,2
DE,TOOTH INJURY,2
DE,TRANSPLANT DYSFUNCTION,2
DE,TRANSPLANT FAILURE,2
DE,TRANSPLANT REJECTION,2
DE,TREATMENT NONCOMPLIANCE,2
DE,TRIGEMINAL NEURALGIA,2
DE,UHTHOFF^S PHENOMENON,2
DE,URETEROLITHIASIS,2
DE,UTERINE CANCER,2
DE,VENTRICULAR EXTRASYSTOLES,2
DE,VENTRICULAR FIBRILLATION,2
DE,VENTRICULAR HYPOKINESIA,2
DE,WOUND INFECTION,2
DE,ABDOMINAL ABSCESS,1
DE,ABDOMINAL ADHESIONS,1
DE,ABDOMINAL DISTENSION,1
DE,ABDOMINAL HERNIA,1
DE,ABDOMINAL LYMPHADENOPATHY,1
DE,ABDOMINAL PAIN LOWER,1
DE,ABNORMAL DREAMS,1
DE,ABSCESS,1
DE,ACCIDENTAL EXPOSURE TO PRODUCT,1
DE,ACCIDENTAL OVERDOSE,1
DE,ACUTE ABDOMEN,1
DE,ACUTE CORONARY SYNDROME,1
DE,ACUTE HEPATIC FAILURE,1
DE,ACUTE PRERENAL FAILURE,1
DE,ADENOMA BENIGN,1
DE,ADJUSTMENT DISORDER,1
DE,ADVERSE EVENT,1
DE,AFFECTIVE DISORDER,1
DE,AGEUSIA,1
DE,AGRANULOCYTOSIS,1
DE,ALBUMINURIA,1
DE,ALTERED STATE OF CONSCIOUSNESS,1
DE,ALVEOLITIS ALLERGIC,1
DE,AMNESTIC DISORDER,1
DE,ANAL ABSCESS,1
DE,ANAL CANCER,1
DE,ANAL INCONTINENCE,1
DE,ANAPHYLACTIC REACTION,1
DE,ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES,1
DE,ANGIOEDEMA,1
DE,ANHEDONIA,1
DE,ANTICONVULSANT DRUG LEVEL DECREASED,1
DE,ANXIETY DISORDER,1
DE,AORTIC VALVE INCOMPETENCE,1
DE,AORTIC VALVE STENOSIS,1
DE,APATHY,1
DE,APPENDICITIS,1
DE,APPLICATION SITE ERYTHEMA,1
DE,APPLICATION SITE IRRITATION,1
DE,APPLICATION SITE REACTION,1
DE,ARTERIAL HAEMORRHAGE,1
DE,ARTERIAL OCCLUSIVE DISEASE,1
DE,ARTERIAL STENOSIS,1
DE,ARTERIOSPASM CORONARY,1
DE,ARTHRODESIS,1
DE,ASCITES,1
DE,ASPIRATION,1
DE,ASTHENOPIA,1
DE,ATRIAL THROMBOSIS,1
DE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
DE,ATROPHY,1
DE,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,1
DE,AURA,1
DE,AUTOIMMUNE THYROIDITIS,1
DE,BACTERIAL TEST POSITIVE,1
DE,BAND SENSATION,1
DE,BASILAR ARTERY THROMBOSIS,1
DE,BENIGN HEPATIC NEOPLASM,1
DE,BENIGN SALIVARY GLAND NEOPLASM,1
DE,BILIARY COLIC,1
DE,BIPOLAR DISORDER,1
DE,BLADDER DYSFUNCTION,1
DE,BLEPHAROSPASM,1
DE,BLINDNESS CORTICAL,1
DE,BLOOD CHROMOGRANIN A INCREASED,1
DE,BLOOD CREATININE ABNORMAL,1
DE,BLOOD CULTURE POSITIVE,1
DE,BLOOD HIV RNA INCREASED,1
DE,BLOOD IMMUNOGLOBULIN E INCREASED,1
DE,BLOOD LACTIC ACID INCREASED,1
DE,BLOOD MAGNESIUM DECREASED,1
DE,BLOOD POTASSIUM DECREASED,1
DE,BLOOD POTASSIUM INCREASED,1
DE,BLOOD PRESSURE DECREASED,1
DE,BLOOD PRESSURE FLUCTUATION,1
DE,BLOOD SODIUM DECREASED,1
DE,BLOOD TEST ABNORMAL,1
DE,BLOOD THYROID STIMULATING HORMONE INCREASED,1
DE,BLOOD UREA INCREASED,1
DE,BLOOD URIC ACID INCREASED,1
DE,BLOOD URINE,1
DE,BONE MARROW OEDEMA,1
DE,BONE MARROW TUMOUR CELL INFILTRATION,1
DE,BORDERLINE OVARIAN TUMOUR,1
DE,BRADYKINESIA,1
DE,BRAIN CONTUSION,1
DE,BRAIN INJURY,1
DE,BRAIN STEM HAEMORRHAGE,1
DE,BRAIN STEM INFARCTION,1
DE,BREAST CYST,1
DE,BRONCHITIS BACTERIAL,1
DE,BUNDLE BRANCH BLOCK LEFT,1
DE,BURNING FEET SYNDROME,1
DE,BURSITIS,1
DE,CALCULUS BLADDER,1
DE,CARDIAC FAILURE CHRONIC,1
DE,CARDIAC FIBRILLATION,1
DE,CARDIAC PACEMAKER INSERTION,1
DE,CARDIOMEGALY,1
DE,CARDIOVASCULAR INSUFFICIENCY,1
DE,CARPAL TUNNEL SYNDROME,1
DE,CEREBELLAR HAEMORRHAGE,1
DE,CEREBELLAR INFARCTION,1
DE,CEREBELLAR SYNDROME,1
DE,CEREBRAL ARTERY EMBOLISM,1
DE,CEREBRAL ARTERY OCCLUSION,1
DE,CEREBRAL MICROANGIOPATHY,1
DE,CEREBROVASCULAR INSUFFICIENCY,1
DE,CERVICAL DYSPLASIA,1
DE,CERVICAL SPINAL STENOSIS,1
DE,CERVICOGENIC HEADACHE,1
DE,CERVIX CARCINOMA STAGE 0,1
DE,CHAPPED LIPS,1
DE,CHOLANGIOCARCINOMA,1
DE,CHOLESTASIS,1
DE,CHOREA,1
DE,CHRONIC HEPATITIS C,1
DE,CLEAR CELL RENAL CELL CARCINOMA,1
DE,CLOSTRIDIUM DIFFICILE INFECTION,1
DE,CLUMSINESS,1
DE,COAGULATION TIME SHORTENED,1
DE,COLD SWEAT,1
DE,COLITIS ULCERATIVE,1
DE,COLON CANCER,1
DE,COLON CANCER METASTATIC,1
DE,COLONIC ABSCESS,1
DE,COLONIC FISTULA,1
DE,COMPARTMENT SYNDROME,1
DE,COMPLEX REGIONAL PAIN SYNDROME,1
DE,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
DE,CONGENITAL HYDRONEPHROSIS,1
DE,CONJUNCTIVAL HAEMORRHAGE,1
DE,CONJUNCTIVITIS INFECTIVE,1
DE,CONTRAINDICATED DRUG ADMINISTERED,1
DE,CONTRAINDICATED PRODUCT ADMINISTERED,1
DE,CORNEAL DISORDER,1
DE,CORONARY ARTERIAL STENT INSERTION,1
DE,CORONARY ARTERY OCCLUSION,1
DE,CORONARY ARTERY STENOSIS,1
DE,CORTISOL DEFICIENCY,1
DE,CREATININE RENAL CLEARANCE DECREASED,1
DE,CREATININE RENAL CLEARANCE INCREASED,1
DE,CYTOLOGY ABNORMAL,1
DE,DEAFNESS BILATERAL,1
DE,DECREASED ACTIVITY,1
DE,DECUBITUS ULCER,1
DE,DEFORMITY,1
DE,DELIRIUM FEBRILE,1
DE,DELUSION,1
DE,DELUSION OF GRANDEUR,1
DE,DERMATITIS BULLOUS,1
DE,DIABETIC FOOT,1
DE,DIARRHOEA INFECTIOUS,1
DE,DIASTOLIC DYSFUNCTION,1
DE,DILATATION VENTRICULAR,1
DE,DIPLOPIA,1
DE,DISEASE PROGRESSION,1
DE,DIVERTICULUM INTESTINAL,1
DE,DRUG EFFECT INCOMPLETE,1
DE,DRUG HYPERSENSITIVITY,1
DE,DRUG LEVEL FLUCTUATING,1
DE,DRUG LEVEL INCREASED,1
DE,DRY GANGRENE,1
DE,DUODENITIS,1
DE,DYSHIDROTIC ECZEMA,1
DE,DYSPLASTIC NAEVUS,1
DE,DYSPNOEA AT REST,1
DE,DYSPNOEA EXERTIONAL,1
DE,DYSSTASIA,1
DE,DYSURIA,1
DE,EAR PAIN,1
DE,ELECTROCARDIOGRAM ABNORMAL,1
DE,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,1
DE,ELECTROCARDIOGRAM T WAVE INVERSION,1
DE,EMBOLIC CEREBRAL INFARCTION,1
DE,EMBOLISM,1
DE,EMOTIONAL DISORDER,1
DE,EMPYEMA,1
DE,ENCEPHALOPATHY,1
DE,ENTEROCOLITIS,1
DE,ENTEROCOLITIS HAEMORRHAGIC,1
DE,EOSINOPHIL COUNT INCREASED,1
DE,EOSINOPHILIA,1
DE,EPSTEIN-BARR VIRUS INFECTION,1
DE,ERYSIPELAS,1
DE,ERYTHEMA NODOSUM,1
DE,ESCHERICHIA URINARY TRACT INFECTION,1
DE,EXECUTIVE DYSFUNCTION,1
DE,EXFOLIATIVE RASH,1
DE,EXOSTOSIS,1
DE,EXPOSURE VIA PARTNER,1
DE,EXTRAOCULAR MUSCLE DISORDER,1
DE,EXTRAPYRAMIDAL DISORDER,1
DE,EYE DISORDER,1
DE,EYE INFLAMMATION,1
DE,FACE OEDEMA,1
DE,FACET JOINT SYNDROME,1
DE,FACIAL BONES FRACTURE,1
DE,FACIAL PARALYSIS,1
DE,FAECAL INCONTINENCE,1
DE,FAECAL VOMITING,1
DE,FEAR OF FALLING,1
DE,FEBRILE INFECTION,1
DE,FEELING DRUNK,1
DE,FEELING HOT,1
DE,FEMORAL ARTERY DISSECTION,1
DE,FEMUR FRACTURE,1
DE,FIBRIN D DIMER INCREASED,1
DE,FLUID OVERLOAD,1
DE,FOETAL HEART RATE DECREASED,1
DE,FOLATE DEFICIENCY,1
DE,FORMICATION,1
DE,FREEZING PHENOMENON,1
DE,FUNGAL INFECTION,1
DE,FUNGAL TEST POSITIVE,1
DE,GANGRENE,1
DE,GASTRIC HAEMORRHAGE,1
DE,GASTROENTERITIS EOSINOPHILIC,1
DE,GASTROENTERITIS ESCHERICHIA COLI,1
DE,GASTROENTERITIS ROTAVIRUS,1
DE,GASTROINTESTINAL INFECTION,1
DE,GASTROINTESTINAL PAIN,1
DE,GASTROINTESTINAL SOUNDS ABNORMAL,1
DE,GASTROINTESTINAL TUBE INSERTION,1
DE,GAZE PALSY,1
DE,GENERAL SYMPTOM,1
DE,GENERALISED ERYTHEMA,1
DE,GENERALISED OEDEMA,1
DE,GINGIVAL BLEEDING,1
DE,GLIOBLASTOMA MULTIFORME,1
DE,GLOMERULAR FILTRATION RATE,1
DE,GLOMERULAR FILTRATION RATE ABNORMAL,1
DE,GLOMERULAR FILTRATION RATE INCREASED,1
DE,GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE,1
DE,GLYCOGEN STORAGE DISEASE TYPE II,1
DE,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
DE,GOUTY TOPHUS,1
DE,GRAND MAL CONVULSION,1
DE,GRANULOMATOSIS WITH POLYANGIITIS,1
DE,GRIP STRENGTH DECREASED,1
DE,HAEMANGIOMA OF LIVER,1
DE,HAEMATEMESIS,1
DE,HAEMATOCHEZIA,1
DE,HAEMOGLOBIN INCREASED,1
DE,HAEMORRHAGE INTRACRANIAL,1
DE,HAEMORRHAGIC DIATHESIS,1
DE,HALLUCINATION_ VISUAL,1
DE,HAMARTOMA,1
DE,HEART RATE DECREASED,1
DE,HEART SOUNDS ABNORMAL,1
DE,HEART VALVE INCOMPETENCE,1
DE,HELICOBACTER INFECTION,1
DE,HEPATIC CIRRHOSIS,1
DE,HEPATIC CYST,1
DE,HEPATIC ENCEPHALOPATHY,1
DE,HEPATIC ENZYME INCREASED,1
DE,HEPATIC LESION,1
DE,HEPATIC STEATOSIS,1
DE,HEPATITIS A,1
DE,HEPATITIS TOXIC,1
DE,HERPES VIRUS INFECTION,1
DE,HERPES ZOSTER OTICUS,1
DE,HIATUS HERNIA,1
DE,HIP FRACTURE,1
DE,HOSPITALISATION,1
DE,HYDRONEPHROSIS,1
DE,HYPERCHOLESTEROLAEMIA,1
DE,HYPERHOMOCYSTEINAEMIA,1
DE,HYPERLIPASAEMIA,1
DE,HYPERMETROPIA,1
DE,HYPERSENSITIVITY VASCULITIS,1
DE,HYPERSEXUALITY,1
DE,HYPERTENSIVE HEART DISEASE,1
DE,HYPERTRIGLYCERIDAEMIA,1
DE,HYPERURICAEMIA,1
DE,HYPERVIGILANCE,1
DE,HYPOCHROMIC ANAEMIA,1
DE,HYPOMAGNESAEMIA,1
DE,HYPOXIA,1
DE,ILL-DEFINED DISORDER,1
DE,IMMOBILE,1
DE,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
DE,INADEQUATE ANALGESIA,1
DE,INCONTINENCE,1
DE,INCORRECT DRUG ADMINISTRATION DURATION,1
DE,INCORRECT DRUG ADMINISTRATION RATE,1
DE,INDUCED LABOUR,1
DE,INFECTIOUS COLITIS,1
DE,INFLAMMATORY MARKER INCREASED,1
DE,INJECTION SITE HAEMATOMA,1
DE,INJECTION SITE HAEMORRHAGE,1
DE,INJECTION SITE PAIN,1
DE,INJECTION SITE REACTION,1
DE,INTENTIONAL PRODUCT MISUSE,1
DE,INTENTIONAL PRODUCT USE ISSUE,1
DE,INTERNAL HAEMORRHAGE,1
DE,INTERNATIONAL NORMALISED RATIO INCREASED,1
DE,INTERSTITIAL LUNG DISEASE,1
DE,INTERVERTEBRAL DISC DEGENERATION,1
DE,INTESTINAL ANASTOMOSIS COMPLICATION,1
DE,INTESTINAL PERFORATION,1
DE,INTESTINAL STENOSIS,1
DE,INTESTINAL ULCER,1
DE,INTRA-ABDOMINAL FLUID COLLECTION,1
DE,INTRACARDIAC THROMBUS,1
DE,INTRACRANIAL HAEMATOMA,1
DE,INTRACRANIAL VENOUS SINUS THROMBOSIS,1
DE,INVASIVE LOBULAR BREAST CARCINOMA,1
DE,INVESTIGATION,1
DE,IRON DEFICIENCY ANAEMIA,1
DE,IRRITABLE BOWEL SYNDROME,1
DE,ISCHAEMIA,1
DE,ISCHAEMIC CEREBRAL INFARCTION,1
DE,JAUNDICE,1
DE,JC VIRUS INFECTION,1
DE,JOINT DISLOCATION,1
DE,JOINT SWELLING,1
DE,KLEBSIELLA INFECTION,1
DE,KNEE ARTHROPLASTY,1
DE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
DE,LABORATORY TEST ABNORMAL,1
DE,LACERATION,1
DE,LACRIMATION INCREASED,1
DE,LACTOBACILLUS TEST POSITIVE,1
DE,LARGE INTESTINAL ULCER,1
DE,LARGE INTESTINE POLYP,1
DE,LARYNGEAL STENOSIS,1
DE,LEARNING DISABILITY,1
DE,LEFT VENTRICULAR FAILURE,1
DE,LEFT VENTRICULAR HYPERTROPHY,1
DE,LENTIGO MALIGNA,1
DE,LETHARGY,1
DE,LEUKOCYTOCLASTIC VASCULITIS,1
DE,LEUKOCYTOSIS,1
DE,LIGAMENT RUPTURE,1
DE,LIP SWELLING,1
DE,LISTERIA SEPSIS,1
DE,LIVER FUNCTION TEST,1
DE,LONG QT SYNDROME,1
DE,LOW DENSITY LIPOPROTEIN INCREASED,1
DE,LYMPHADENECTOMY,1
DE,LYMPHOCYTE PERCENTAGE DECREASED,1
DE,LYMPHOMA TRANSFORMATION,1
DE,LYMPHOPENIA,1
DE,MACULAR OEDEMA,1
DE,MACULAR SCAR,1
DE,MACULOPATHY,1
DE,MADAROSIS,1
DE,MAJOR DEPRESSION,1
DE,MALIGNANT HYPERTENSION,1
DE,MALIGNANT PLEURAL EFFUSION,1
DE,MEAN CELL VOLUME INCREASED,1
DE,MECHANICAL VENTILATION,1
DE,MEDIASTINAL DISORDER,1
DE,MEDICATION ERROR,1
DE,MENINGEAL DISORDER,1
DE,MENINGIOMA,1
DE,MENINGIOMA BENIGN,1
DE,MENINGOENCEPHALITIS HERPETIC,1
DE,MENISCUS INJURY,1
DE,METABOLIC ENCEPHALOPATHY,1
DE,METASTASES TO CENTRAL NERVOUS SYSTEM,1
DE,METASTASES TO LIVER,1
DE,METASTASES TO LYMPH NODES,1
DE,METASTASES TO MENINGES,1
DE,METASTATIC NEOPLASM,1
DE,METRORRHAGIA,1
DE,MICROANGIOPATHY,1
DE,MICTURITION DISORDER,1
DE,MICTURITION URGENCY,1
DE,MIDDLE INSOMNIA,1
DE,MONOCYTE PERCENTAGE INCREASED,1
DE,MOOD ALTERED,1
DE,MORTON^S NEURALGIA,1
DE,MOUTH HAEMORRHAGE,1
DE,MUCOUS MEMBRANE DISORDER,1
DE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
DE,MUSCLE CONTRACTIONS INVOLUNTARY,1
DE,MUSCLE TIGHTNESS,1
DE,MUSCULAR DYSTROPHY,1
DE,MUSCULOSKELETAL DISORDER,1
DE,MYELITIS,1
DE,MYOGLOBIN BLOOD INCREASED,1
DE,MYOPATHY,1
DE,MYOPIA,1
DE,MYOSITIS,1
DE,NAIL DISORDER,1
DE,NEOPLASM PROGRESSION,1
DE,NEPHROLITHIASIS,1
DE,NEPHROTIC SYNDROME,1
DE,NERVE COMPRESSION,1
DE,NERVE ROOT COMPRESSION,1
DE,NERVOUSNESS,1
DE,NEURITIS,1
DE,NEUROGENIC BOWEL,1
DE,NEUROTOXICITY,1
DE,NEUTROPHIL COUNT DECREASED,1
DE,NODAL RHYTHM,1
DE,NODULE,1
DE,NON-HODGKIN^S LYMPHOMA,1
DE,NON-SMALL CELL LUNG CANCER STAGE III,1
DE,NORMOCHROMIC ANAEMIA,1
DE,NOSOCOMIAL INFECTION,1
DE,OCULAR ICTERUS,1
DE,OEDEMATOUS PANCREATITIS,1
DE,OESOPHAGEAL CANDIDIASIS,1
DE,OPHTHALMOPLEGIA,1
DE,ORAL CANDIDIASIS,1
DE,OSTEOCHONDROSIS,1
DE,OSTEOLYSIS,1
DE,OSTEONECROSIS,1
DE,OSTEONECROSIS OF JAW,1
DE,OSTEOPOROTIC FRACTURE,1
DE,OSTEOSCLEROSIS,1
DE,OVARIAN ADENOMA,1
DE,OVARIAN ENLARGEMENT,1
DE,PAIN OF SKIN,1
DE,PALLOR,1
DE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
DE,PANCREATIC CARCINOMA METASTATIC,1
DE,PANNICULITIS,1
DE,PAPILLOMA VIRAL INFECTION,1
DE,PARALYSIS,1
DE,PARAPARESIS,1
DE,PARKINSONISM,1
DE,PAROSMIA,1
DE,PAROTID GLAND ENLARGEMENT,1
DE,PATELLA FRACTURE,1
DE,PATHOGEN RESISTANCE,1
DE,PELVIC PAIN,1
DE,PERIODONTAL DISEASE,1
DE,PERIODONTITIS,1
DE,PERIOSTITIS,1
DE,PERIPHERAL ARTERY OCCLUSION,1
DE,PERIPHERAL ARTERY THROMBOSIS,1
DE,PERIPHERAL COLDNESS,1
DE,PERIPHERAL EMBOLISM,1
DE,PERIRECTAL ABSCESS,1
DE,PERSONALITY CHANGE,1
DE,PERTUSSIS,1
DE,PETECHIAE,1
DE,PHIMOSIS,1
DE,PHOBIA,1
DE,PHOTOPHOBIA,1
DE,PINEAL GLAND CYST,1
DE,PITUITARY TUMOUR BENIGN,1
DE,PLACENTAL DISORDER,1
DE,PNEUMOCOCCAL SEPSIS,1
DE,POOR QUALITY SLEEP,1
DE,POST PROCEDURAL COMPLICATION,1
DE,POST PROCEDURAL HAEMATOMA,1
DE,POST PROCEDURAL HAEMORRHAGE,1
DE,POST PROCEDURAL INFECTION,1
DE,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,1
DE,POSTICTAL PARALYSIS,1
DE,POSTICTAL STATE,1
DE,POSTOPERATIVE WOUND INFECTION,1
DE,POSTRENAL FAILURE,1
DE,PREGNANCY,1
DE,PRERENAL FAILURE,1
DE,PRIAPISM,1
DE,PRODUCTIVE COUGH,1
DE,PROTEIN TOTAL DECREASED,1
DE,PROTEIN URINE PRESENT,1
DE,PROTHROMBIN TIME PROLONGED,1
DE,PRURIGO,1
DE,PSORIATIC ARTHROPATHY,1
GR,DRUG INEFFECTIVE,6
GR,PYREXIA,5
GR,DIZZINESS,4
GR,DYSPNOEA,4
GR,PLATELET COUNT DECREASED,4
GR,ANAEMIA,3
GR,ECCHYMOSIS,3
GR,FATIGUE,3
GR,OEDEMA PERIPHERAL,3
GR,PETECHIAE,3
GR,SOMNOLENCE,3
GR,ABNORMAL SLEEP-RELATED EVENT,2
GR,ALOPECIA,2
GR,ARTICULAR CALCIFICATION,2
GR,BLINDNESS,2
GR,CALCIUM PHOSPHATE PRODUCT INCREASED,2
GR,CHRONIC SPONTANEOUS URTICARIA,2
GR,CONSTIPATION,2
GR,DIARRHOEA,2
GR,DRY MOUTH,2
GR,DYSARTHRIA,2
GR,EPILEPSY,2
GR,HYPERPARATHYROIDISM SECONDARY,2
GR,HYPOAESTHESIA,2
GR,HYPOTENSION,2
GR,ILEUS,2
GR,NEOPLASM,2
GR,NEURALGIA,2
GR,PAIN IN EXTREMITY,2
GR,PAPULE,2
GR,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,2
GR,PRURITUS,2
GR,RESPIRATORY TRACT INFECTION,2
GR,SEPSIS,2
GR,SYNCOPE,2
GR,THROMBOTIC THROMBOCYTOPENIC PURPURA,2
GR,ABDOMINAL DISCOMFORT,1
GR,ABDOMINAL DISTENSION,1
GR,ABDOMINAL PAIN,1
GR,AGGRESSION,1
GR,ANGIOEDEMA,1
GR,ANXIETY,1
GR,ARTHRALGIA,1
GR,AUTOIMMUNE DISORDER,1
GR,BLOOD GLUCOSE DECREASED,1
GR,BLOOD PRESSURE INCREASED,1
GR,BRADYARRHYTHMIA,1
GR,CARDIO-RESPIRATORY ARREST,1
GR,CHEST PAIN,1
GR,CHOKING SENSATION,1
GR,CONDITION AGGRAVATED,1
GR,CONFUSIONAL STATE,1
GR,CONVULSION,1
GR,COORDINATION ABNORMAL,1
GR,COUGH,1
GR,DEAFNESS,1
GR,DECUBITUS ULCER,1
GR,DEHYDRATION,1
GR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
GR,DEPRESSION,1
GR,DISEASE PROGRESSION,1
GR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
GR,DRY SKIN,1
GR,DYSKINESIA,1
GR,DYSPHAGIA,1
GR,ERYTHEMA,1
GR,FALL,1
GR,FEAR,1
GR,FLATULENCE,1
GR,GAIT DISTURBANCE,1
GR,GASTROINTESTINAL HAEMORRHAGE,1
GR,GASTROINTESTINAL OEDEMA,1
GR,GASTROOESOPHAGEAL REFLUX DISEASE,1
GR,GRAND MAL CONVULSION,1
GR,HAEMATEMESIS,1
GR,HAEMODYNAMIC INSTABILITY,1
GR,HAEMOLYTIC ANAEMIA,1
GR,HAEMORRHAGE,1
GR,HAEMORRHAGIC STROKE,1
GR,HALLUCINATION_ AUDITORY,1
GR,HEAD TITUBATION,1
GR,HEADACHE,1
GR,INCORRECT DOSE ADMINISTERED,1
GR,INTESTINAL HAEMORRHAGE,1
GR,LIP SWELLING,1
GR,LOWER RESPIRATORY TRACT INFECTION,1
GR,MALIGNANT MELANOMA IN SITU,1
GR,MALIGNANT NEOPLASM PROGRESSION,1
GR,MULTI-ORGAN FAILURE,1
GR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
GR,MULTIPLE SCLEROSIS RELAPSE,1
GR,MUSCLE CONTRACTIONS INVOLUNTARY,1
GR,MUSCLE MASS,1
GR,MUSCLE TWITCHING,1
GR,MYALGIA,1
GR,MYOSITIS,1
GR,OBSESSIVE THOUGHTS,1
GR,OBSESSIVE-COMPULSIVE DISORDER,1
GR,OEDEMA,1
GR,OESOPHAGEAL SQUAMOUS CELL CARCINOMA,1
GR,OPTIC NEURITIS,1
GR,OVERDOSE,1
GR,PAIN,1
GR,PALLOR,1
GR,PARALYSIS,1
GR,PARKINSON^S DISEASE,1
GR,PERSECUTORY DELUSION,1
GR,PIGMENTATION DISORDER,1
GR,PRE-EXISTING CONDITION IMPROVED,1
GR,PRODUCT USE IN UNAPPROVED INDICATION,1
GR,PRODUCT USE ISSUE,1
GR,PULMONARY FIBROSIS,1
GR,PURULENT DISCHARGE,1
GR,QUADRIPARESIS,1
GR,RASH PAPULAR,1
GR,RENAL PAIN,1
GR,SEIZURE,1
GR,SELF-INJURIOUS IDEATION,1
GR,SEPTIC SHOCK,1
GR,SKIN EXFOLIATION,1
GR,SQUAMOUS CELL CARCINOMA OF THE CERVIX,1
GR,SQUAMOUS CELL CARCINOMA OF THE VAGINA,1
GR,STOMA SITE ERYTHEMA,1
GR,SUICIDAL IDEATION,1
GR,SUICIDE ATTEMPT,1
GR,SWELLING FACE,1
GR,THERAPEUTIC RESPONSE UNEXPECTED,1
GR,THROMBOCYTOPENIA,1
GR,THYROID CANCER,1
GR,TINNITUS,1
GR,TUBERCULOSIS,1
GR,VERTIGO,1
GR,VIRAL INFECTION,1
GR,VISION BLURRED,1
GR,VISUAL ACUITY REDUCED,1
GR,VISUAL FIELD DEFECT,1
GR,VOMITING,1
GT,CARDIAC TAMPONADE,1
GT,HERPES ZOSTER,1
HT,ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC,1
HT,DECREASED APPETITE,1
HT,DRUG DOSE OMISSION,1
HT,HERBAL INTERACTION,1
HT,INTERNATIONAL NORMALISED RATIO INCREASED,1
HK,CEREBROVASCULAR DISORDER,2
HK,SEIZURE,2
HK,TRANSIENT ISCHAEMIC ATTACK,2
HK,VISION BLURRED,2
HK,ALANINE AMINOTRANSFERASE INCREASED,1
HK,ANAEMIA,1
HK,BACK PAIN,1
HK,BILE DUCT OBSTRUCTION,1
HK,BLOOD FIBRINOGEN INCREASED,1
HK,CONDITION AGGRAVATED,1
HK,DISEASE PROGRESSION,1
HK,DYSARTHRIA,1
HK,DYSGRAPHIA,1
HK,DYSPNOEA,1
HK,ESCHERICHIA SEPSIS,1
HK,FIBRIN D DIMER INCREASED,1
HK,GENERAL PHYSICAL HEALTH DETERIORATION,1
HK,HYPERBILIRUBINAEMIA,1
HK,MALAISE,1
HK,METASTASES TO LUNG,1
HK,OESOPHAGEAL STENOSIS,1
HK,OVARIAN NEOPLASM,1
HK,PANCYTOPENIA,1
HK,PYREXIA,1
HK,RECTAL CANCER METASTATIC,1
HK,RESPIRATORY FAILURE,1
HK,SUBARACHNOID HAEMORRHAGE,1
HK,THROMBOCYTOPENIA,1
HK,TREMOR,1
HK,TRICHOSPORON INFECTION,1
HK,UROSEPSIS,1
HU,DRUG INEFFECTIVE,3
HU,DISSEMINATED TUBERCULOSIS,2
HU,GINGIVAL BLEEDING,2
HU,PANCYTOPENIA,2
HU,THROMBOCYTOPENIA,2
HU,ABSCESS,1
HU,ALANINE AMINOTRANSFERASE INCREASED,1
HU,ANTI-GAD ANTIBODY POSITIVE,1
HU,ASPARTATE AMINOTRANSFERASE INCREASED,1
HU,BLOOD ALKALINE PHOSPHATASE INCREASED,1
HU,BLOOD CREATININE INCREASED,1
HU,BLOOD GLUCOSE INCREASED,1
HU,BLOOD LACTATE DEHYDROGENASE INCREASED,1
HU,BLOOD UREA INCREASED,1
HU,BONE TUBERCULOSIS,1
HU,C-REACTIVE PROTEIN INCREASED,1
HU,CARDIAC FAILURE CONGESTIVE,1
HU,CARDIOPULMONARY FAILURE,1
HU,CONDITION AGGRAVATED,1
HU,CYSTITIS HAEMORRHAGIC,1
HU,DISSEMINATED INTRAVASCULAR COAGULATION,1
HU,DRUG INTOLERANCE,1
HU,DYSPNOEA,1
HU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
HU,GASTROINTESTINAL CANDIDIASIS,1
HU,GENERAL PHYSICAL HEALTH DETERIORATION,1
HU,GLOMERULAR FILTRATION RATE DECREASED,1
HU,HAEMATOCRIT DECREASED,1
HU,HEPATOSPLENOMEGALY,1
HU,LEUKOPENIA,1
HU,MENTAL DISORDER,1
HU,NEUTROPENIC INFECTION,1
HU,NEUTROPHIL COUNT INCREASED,1
HU,PSYCHOTIC DISORDER,1
HU,PYREXIA,1
HU,RED BLOOD CELL COUNT DECREASED,1
HU,SEIZURE,1
HU,SEPSIS,1
HU,SKIN ULCER,1
HU,SOFT TISSUE MASS,1
HU,STIFF PERSON SYNDROME,1
HU,SUICIDAL IDEATION,1
HU,WHITE BLOOD CELL COUNT INCREASED,1
IS,APPLICATION SITE HYPERSENSITIVITY,1
IS,APPLICATION SITE PAIN,1
IS,APPLICATION SITE VESICLES,1
IS,CEREBRAL HAEMORRHAGE,1
IS,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
IS,JOINT SWELLING,1
IS,MALIGNANT MELANOMA,1
IN,VENTRICULAR FIBRILLATION,8
IN,SUPRAVENTRICULAR TACHYCARDIA,7
IN,OVERDOSE,6
IN,IRRITABILITY,5
IN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,5
IN,SHOCK,5
IN,ACUTE KIDNEY INJURY,4
IN,AGITATION,4
IN,CARDIAC ARREST,4
IN,DRUG DEPENDENCE,4
IN,ISCHAEMIC HEPATITIS,4
IN,SEROTONIN SYNDROME,4
IN,DRUG ABUSE,3
IN,INSOMNIA,3
IN,CARDIOVASCULAR DISORDER,2
IN,COAGULOPATHY,2
IN,COORDINATION ABNORMAL,2
IN,DEPRESSED MOOD,2
IN,DRUG WITHDRAWAL SYNDROME,2
IN,PNEUMONIA,2
IN,VENTRICULAR TACHYCARDIA,2
IN,WITHDRAWAL SYNDROME,2
IN,ABDOMINAL PAIN,1
IN,ACTIVITIES OF DAILY LIVING IMPAIRED,1
IN,ANGIOEDEMA,1
IN,ANXIETY,1
IN,ASTHENIA,1
IN,BRADYKINESIA,1
IN,DEATH,1
IN,DEPENDENCE,1
IN,DISSEMINATED TUBERCULOSIS,1
IN,DISTURBANCE IN ATTENTION,1
IN,DIZZINESS,1
IN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
IN,DYSPHORIA,1
IN,FUNGAL SEPSIS,1
IN,GAIT DISTURBANCE,1
IN,HEPATIC VASCULAR THROMBOSIS,1
IN,HYPERTENSION,1
IN,HYPOPHAGIA,1
IN,LYMPHOCELE,1
IN,MASKED FACIES,1
IN,MENTAL DISORDER,1
IN,MUSCLE RIGIDITY,1
IN,MUSCLE SPASMS,1
IN,MYOCLONUS,1
IN,NEURALGIA,1
IN,PANCREATITIS ACUTE,1
IN,PERINEPHRIC COLLECTION,1
IN,PLEURAL EFFUSION,1
IN,PNEUMOTHORAX,1
IN,POLYP,1
IN,PORPHYRIA,1
IN,POST PROCEDURAL PERSISTENT DRAIN FLUID,1
IN,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
IN,PSYCHOMOTOR HYPERACTIVITY,1
IN,PYREXIA,1
IN,RESTLESS LEGS SYNDROME,1
IN,SEDATION,1
IN,SEIZURE,1
IN,SENSORY LOSS,1
IN,SLEEP DISORDER,1
IN,SOMNOLENCE,1
IN,THERAPEUTIC RESPONSE UNEXPECTED,1
IN,TREMOR,1
IN,VENTRICULAR EXTRASYSTOLES,1
ID,DEEP VEIN THROMBOSIS,2
ID,FIBRIN D DIMER INCREASED,2
ID,OEDEMA PERIPHERAL,2
ID,DEATH,1
ID,HEPATIC ENZYME INCREASED,1
ID,INTERNATIONAL NORMALISED RATIO INCREASED,1
ID,RENAL IMPAIRMENT,1
IR,MENINGITIS BACTERIAL,2
IR,NAUSEA,2
IR,OPTIC NEURITIS,2
IR,PRODUCT USE ISSUE,2
IR,VISION BLURRED,2
IR,VOMITING,2
IR,AUTOIMMUNE HEPATITIS,1
IR,BLISTER,1
IR,CAESAREAN SECTION,1
IR,CHILLS,1
IR,CONDITION AGGRAVATED,1
IR,DERMATITIS,1
IR,DIZZINESS,1
IR,FATIGUE,1
IR,HEADACHE,1
IR,HEPATIC ENCEPHALOPATHY,1
IR,HEPATIC ENZYME INCREASED,1
IR,HEPATIC FAILURE,1
IR,HYPERAESTHESIA,1
IR,INVASIVE PAPILLARY BREAST CARCINOMA,1
IR,LIVER DISORDER,1
IR,LOCALISED OEDEMA,1
IR,MATERNAL EXPOSURE DURING PREGNANCY,1
IR,NEURALGIA,1
IR,OEDEMA PERIPHERAL,1
IR,PALLOR,1
IR,PREMATURE DELIVERY,1
IR,PRODUCT SUBSTITUTION ISSUE,1
IR,PRURITUS,1
IR,PSYCHOTIC DISORDER,1
IR,SKIN EXFOLIATION,1
IR,SOMNOLENCE,1
IR,URINARY RETENTION,1
IE,RESPIRATORY FAILURE,11
IE,RESPIRATORY DEPRESSION,8
IE,SEDATION,6
IE,DEATH,4
IE,LOWER RESPIRATORY TRACT INFECTION,4
IE,PRODUCT USE IN UNAPPROVED INDICATION,4
IE,DYSPHAGIA,3
IE,DYSPNOEA,3
IE,FATIGUE,3
IE,PAIN,3
IE,PRODUCT USE ISSUE,3
IE,WEIGHT DECREASED,3
IE,BLOOD PRESSURE DECREASED,2
IE,CHOKING,2
IE,COGNITIVE DISORDER,2
IE,CONFUSIONAL STATE,2
IE,CONSTIPATION,2
IE,COUGH,2
IE,DIET NONCOMPLIANCE,2
IE,EAR INFECTION,2
IE,FALL,2
IE,HAEMOGLOBIN DECREASED,2
IE,HIATUS HERNIA,2
IE,HOSPITALISATION,2
IE,HYPOTENSION,2
IE,JAUNDICE,2
IE,LETHARGY,2
IE,LOSS OF CONSCIOUSNESS,2
IE,MALAISE,2
IE,MUSCULAR WEAKNESS,2
IE,NEUTROPENIC SEPSIS,2
IE,OESOPHAGEAL FOOD IMPACTION,2
IE,PARKINSON^S DISEASE,2
IE,PULMONARY OEDEMA,2
IE,PYREXIA,2
IE,WHITE BLOOD CELL COUNT INCREASED,2
IE,ACUTE RIGHT VENTRICULAR FAILURE,1
IE,AGGRESSION,1
IE,ALANINE AMINOTRANSFERASE INCREASED,1
IE,ANAEMIA,1
IE,ANGINA PECTORIS,1
IE,ARTERIOSCLEROSIS CORONARY ARTERY,1
IE,ASPARTATE AMINOTRANSFERASE INCREASED,1
IE,ASTHENIA,1
IE,ATAXIA,1
IE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
IE,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
IE,BACK PAIN,1
IE,BILE DUCT OBSTRUCTION,1
IE,BILIARY SEPSIS,1
IE,BONE CANCER,1
IE,BREAST ABSCESS,1
IE,BREAST PAIN,1
IE,BRONCHITIS,1
IE,C-REACTIVE PROTEIN INCREASED,1
IE,CELLULITIS,1
IE,CEREBROVASCULAR ACCIDENT,1
IE,CHEST DISCOMFORT,1
IE,CHILLS,1
IE,CHOLELITHIASIS,1
IE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
IE,CHRONIC SINUSITIS,1
IE,COLD TYPE HAEMOLYTIC ANAEMIA,1
IE,CORONAVIRUS TEST POSITIVE,1
IE,DECUBITUS ULCER,1
IE,DEPRESSED MOOD,1
IE,DIARRHOEA,1
IE,DISORIENTATION,1
IE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
IE,DYSKINESIA,1
IE,ELECTROCARDIOGRAM PR PROLONGATION,1
IE,ELECTROCARDIOGRAM QT PROLONGED,1
IE,ELECTROCARDIOGRAM T WAVE INVERSION,1
IE,EOSINOPHIL COUNT INCREASED,1
IE,ERYTHEMA,1
IE,EYE INFECTION,1
IE,FAECALOMA,1
IE,FEAR OF DEATH,1
IE,FEAR OF INJECTION,1
IE,FEBRILE NEUTROPENIA,1
IE,FEELING ABNORMAL,1
IE,FLUID RETENTION,1
IE,GAIT DISTURBANCE,1
IE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
IE,GASTRITIS,1
IE,GASTROINTESTINAL EROSION,1
IE,GASTROINTESTINAL HAEMORRHAGE,1
IE,GASTROOESOPHAGEAL REFLUX DISEASE,1
IE,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
IE,GOUT,1
IE,HAEMATOCRIT DECREASED,1
IE,HAEMATOMA INFECTION,1
IE,HAEMOGLOBIN ABNORMAL,1
IE,HAEMOLYTIC ANAEMIA,1
IE,HAEMORRHOIDS,1
IE,HALLUCINATION_ VISUAL,1
IE,HEART RATE INCREASED,1
IE,HIP ARTHROPLASTY,1
IE,HORDEOLUM,1
IE,HUMAN RHINOVIRUS TEST POSITIVE,1
IE,HYPERHIDROSIS,1
IE,IMMEDIATE POST-INJECTION REACTION,1
IE,INFECTION,1
IE,INTENTIONAL PRODUCT USE ISSUE,1
IE,INTERSTITIAL LUNG DISEASE,1
IE,INTERVERTEBRAL DISC DISPLACEMENT,1
IE,INTESTINAL OBSTRUCTION,1
IE,JOINT SWELLING,1
IE,KIDNEY CONGESTION,1
IE,KIDNEY INFECTION,1
IE,LEFT VENTRICULAR HYPERTROPHY,1
IE,LIMB INJURY,1
IE,LIVER INJURY,1
IE,LUMBAR VERTEBRAL FRACTURE,1
IE,LUNG ADENOCARCINOMA,1
IE,LUNG CONSOLIDATION,1
IE,LUNG NEOPLASM MALIGNANT,1
IE,LYMPHADENOPATHY,1
IE,LYMPHOCYTE COUNT INCREASED,1
IE,LYMPHOEDEMA,1
IE,MEAN CELL HAEMOGLOBIN INCREASED,1
IE,MEAN CELL VOLUME INCREASED,1
IE,MOBILITY DECREASED,1
IE,MONOCYTE COUNT DECREASED,1
IE,MOTOR NEURONE DISEASE,1
IE,MULTI-ORGAN DISORDER,1
IE,MUSCLE SPASTICITY,1
IE,MUSCULOSKELETAL PAIN,1
IE,MYALGIA,1
IE,NAUSEA,1
IE,NEOPLASM MALIGNANT,1
IE,NEUTROPHIL COUNT DECREASED,1
IE,NIGHT SWEATS,1
IE,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,1
IE,ODYNOPHAGIA,1
IE,OVERDOSE,1
IE,PALPITATIONS,1
IE,PANIC ATTACK,1
IE,PANIC REACTION,1
IE,PNEUMONIA ASPIRATION,1
IE,PNEUMONIA PARAINFLUENZAE VIRAL,1
IE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
IE,PROSTATE CANCER,1
IE,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
IE,PROSTATOMEGALY,1
IE,PRURITUS,1
IE,PULMONARY EMBOLISM,1
IE,RASH,1
IE,RENAL CYST,1
IE,RESPIRATORY RATE INCREASED,1
IE,RESPIRATORY SYMPTOM,1
IE,RESPIRATORY TRACT INFECTION,1
IE,RIB FRACTURE,1
IE,SERUM FERRITIN INCREASED,1
IE,SKIN ABRASION,1
IE,SKIN LESION,1
IE,STAPHYLOCOCCAL INFECTION,1
IE,SUICIDAL IDEATION,1
IE,SYNCOPE,1
IE,TEARFULNESS,1
IE,THROAT TIGHTNESS,1
IE,TINNITUS,1
IE,TREMOR,1
IE,TUBERCULOSIS,1
IE,TYPE 2 DIABETES MELLITUS,1
IE,UPPER LIMB FRACTURE,1
IE,URINARY TRACT INFECTION,1
IE,URTICARIA,1
IE,VOMITING,1
IE,WHITE BLOOD CELL COUNT DECREASED,1
IE,WOUND,1
IL,MALAISE,4
IL,ASTHENIA,2
IL,BACK PAIN,2
IL,CHILLS,2
IL,DIZZINESS,2
IL,DRUG INEFFECTIVE,2
IL,DRY MOUTH,2
IL,MUSCLE SPASMS,2
IL,NAUSEA,2
IL,PAIN IN EXTREMITY,2
IL,PIGMENTATION DISORDER,2
IL,PYREXIA,2
IL,ABSCESS NECK,1
IL,ARTHRITIS,1
IL,ARTHRITIS INFECTIVE,1
IL,ASCITES,1
IL,ASTERIXIS,1
IL,BLOOD ALBUMIN DECREASED,1
IL,BLOOD PRESSURE INCREASED,1
IL,BLOOD SODIUM DECREASED,1
IL,BRONCHITIS,1
IL,BURNING SENSATION,1
IL,CARDIAC DISORDER,1
IL,CHEST DISCOMFORT,1
IL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
IL,COGNITIVE DISORDER,1
IL,COMPLICATION OF DEVICE REMOVAL,1
IL,CONJUNCTIVAL DISCOLOURATION,1
IL,CONSTIPATION,1
IL,CONVULSION,1
IL,COUGH,1
IL,DECREASED APPETITE,1
IL,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IL,DEVICE RELATED INFECTION,1
IL,DIPLEGIA,1
IL,DIPLOPIA,1
IL,DISEASE PROGRESSION,1
IL,DISORIENTATION,1
IL,DYSURIA,1
IL,EPENDYMOMA MALIGNANT,1
IL,EXTRAOCULAR MUSCLE PARESIS,1
IL,EXTRAPYRAMIDAL DISORDER,1
IL,FACIAL PARESIS,1
IL,FATIGUE,1
IL,FEELING COLD,1
IL,FEELING HOT,1
IL,FEMORAL NECK FRACTURE,1
IL,FOOT FRACTURE,1
IL,FUNGAL SKIN INFECTION,1
IL,GALLBLADDER DISORDER,1
IL,GENERAL PHYSICAL HEALTH DETERIORATION,1
IL,HEADACHE,1
IL,HEART RATE IRREGULAR,1
IL,HEPATIC FUNCTION ABNORMAL,1
IL,HEPATIC STEATOSIS,1
IL,HEPATITIS,1
IL,HOT FLUSH,1
IL,JAUNDICE,1
IL,LIP DRY,1
IL,MACULE,1
IL,MASTICATION DISORDER,1
IL,MUSCLE SPASTICITY,1
IL,MUSCULAR WEAKNESS,1
IL,MUSCULOSKELETAL DISORDER,1
IL,MYASTHENIA GRAVIS,1
IL,MYELITIS,1
IL,NAIL DISCOLOURATION,1
IL,NEUTROPENIA,1
IL,OBSTRUCTION GASTRIC,1
IL,ORAL FUNGAL INFECTION,1
IL,PAIN,1
IL,PARAESTHESIA,1
IL,PERIPHERAL SWELLING,1
IL,PIGMENTATION BUCCAL,1
IL,PLANTAR FASCIITIS,1
IL,POLLAKIURIA,1
IL,POLYNEUROPATHY,1
IL,PROSTATIC DISORDER,1
IL,PSORIASIS,1
IL,PSORIATIC ARTHROPATHY,1
IL,RENAL CELL CARCINOMA,1
IL,RENAL FAILURE ACUTE,1
IL,SENSORY DISTURBANCE,1
IL,SKIN DISCOLOURATION,1
IL,SKIN EXFOLIATION,1
IL,SKIN HYPERPIGMENTATION,1
IL,SOMNOLENCE,1
IL,STAPHYLOCOCCAL INFECTION,1
IL,STUPOR,1
IL,SYNCOPE,1
IL,URINARY RETENTION,1
IL,URINARY TRACT INFECTION,1
IT,DRUG ABUSE,235
IT,SOPOR,132
IT,INTENTIONAL SELF-INJURY,110
IT,CONFUSIONAL STATE,78
IT,COMA,63
IT,ASTHENIA,55
IT,TOXICITY TO VARIOUS AGENTS,52
IT,TREMOR,45
IT,INTENTIONAL OVERDOSE,43
IT,FALL,42
IT,HEAD INJURY,40
IT,HYPOTENSION,35
IT,SOMNOLENCE,35
IT,HEADACHE,34
IT,BRADYPHRENIA,33
IT,LOSS OF CONSCIOUSNESS,33
IT,SUICIDE ATTEMPT,33
IT,VERTIGO,28
IT,ANAEMIA,27
IT,PYREXIA,27
IT,NAUSEA,26
IT,OVERDOSE,26
IT,PSYCHOMOTOR HYPERACTIVITY,25
IT,ALCOHOL INTERACTION,22
IT,INJURY,21
IT,SUICIDAL IDEATION,20
IT,BRADYKINESIA,19
IT,MALAISE,19
IT,VOMITING,19
IT,AGITATION,18
IT,BALANCE DISORDER,18
IT,WOUND,18
IT,ABDOMINAL PAIN,17
IT,HYPONATRAEMIA,17
IT,SLOW SPEECH,16
IT,ABDOMINAL PAIN UPPER,15
IT,ACUTE KIDNEY INJURY,15
IT,HALLUCINATION,15
IT,HYPERKALAEMIA,15
IT,HYPOXIA,15
IT,PRESYNCOPE,15
IT,PRODUCT USE ISSUE,15
IT,RHABDOMYOLYSIS,15
IT,SYNCOPE,15
IT,INTENTIONAL PRODUCT MISUSE,14
IT,ANGIOEDEMA,13
IT,DIARRHOEA,13
IT,DRUG INEFFECTIVE,13
IT,DYSPHAGIA,13
IT,ALCOHOL ABUSE,12
IT,BRADYPNOEA,12
IT,DYSARTHRIA,12
IT,ERYTHEMA,12
IT,GAIT DISTURBANCE,12
IT,MYDRIASIS,12
IT,PHOTOPHOBIA,12
IT,PSYCHOMOTOR SKILLS IMPAIRED,12
IT,ATAXIA,11
IT,DISORIENTATION,11
IT,DYSPNOEA,11
IT,ELECTROCARDIOGRAM QT PROLONGED,11
IT,FATIGUE,11
IT,INSOMNIA,11
IT,PARAESTHESIA,11
IT,SPEECH DISORDER,11
IT,APHASIA,10
IT,CONDITION AGGRAVATED,10
IT,CONSTIPATION,10
IT,DECREASED APPETITE,10
IT,DIZZINESS,10
IT,DRUG USE DISORDER,10
IT,HYPOGLYCAEMIA,10
IT,HYPOKINESIA,10
IT,RENAL IMPAIRMENT,10
IT,SELF INJURIOUS BEHAVIOUR,10
IT,SELF-INJURIOUS IDEATION,10
IT,CONTUSION,9
IT,DEATH,9
IT,DISORGANISED SPEECH,9
IT,FRACTURE,9
IT,HYPERCREATININAEMIA,9
IT,HYPERHIDROSIS,9
IT,HYPERPYREXIA,9
IT,MALIGNANT NEOPLASM PROGRESSION,9
IT,SEDATION,9
IT,SLUGGISHNESS,9
IT,STEREOTYPY,9
IT,TACHYPNOEA,9
IT,URINARY RETENTION,9
IT,GENERAL PHYSICAL HEALTH DETERIORATION,8
IT,HALLUCINATION_ VISUAL,8
IT,LEUKOENCEPHALOPATHY,8
IT,MEMORY IMPAIRMENT,8
IT,MUSCULAR WEAKNESS,8
IT,NERVOUS SYSTEM DISORDER,8
IT,RESPIRATORY ACIDOSIS,8
IT,RESPIRATORY DEPRESSION,8
IT,RESPIRATORY FAILURE,8
IT,SEROTONIN SYNDROME,8
IT,SINUS TACHYCARDIA,8
IT,ACCIDENTAL OVERDOSE,7
IT,ASPARTATE AMINOTRANSFERASE INCREASED,7
IT,CATATONIA,7
IT,CHEST PAIN,7
IT,CHOLESTASIS,7
IT,DEPRESSED LEVEL OF CONSCIOUSNESS,7
IT,DYSGEUSIA,7
IT,EXTRAPYRAMIDAL DISORDER,7
IT,HEPATOCELLULAR INJURY,7
IT,HEPATOTOXICITY,7
IT,HYPERCAPNIA,7
IT,HYPONATRAEMIC SYNDROME,7
IT,ILEUS PARALYTIC,7
IT,LEUKOPENIA,7
IT,MUCOSAL INFLAMMATION,7
IT,MUSCLE SPASMS,7
IT,OXYGEN SATURATION DECREASED,7
IT,PANCYTOPENIA,7
IT,RESTLESSNESS,7
IT,SKIN ULCER,7
IT,TRANSAMINASES INCREASED,7
IT,TRANSIENT ISCHAEMIC ATTACK,7
IT,URINARY TRACT INFECTION,7
IT,WEIGHT DECREASED,7
IT,AGGRESSION,6
IT,ALTERED STATE OF CONSCIOUSNESS,6
IT,ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC,6
IT,BLOOD LACTATE DEHYDROGENASE INCREASED,6
IT,DELIRIUM,6
IT,DEPRESSION,6
IT,DEREALISATION,6
IT,DRUG DEPENDENCE,6
IT,EOSINOPHILIA,6
IT,EPILEPSY,6
IT,EXCORIATION,6
IT,MOVEMENT DISORDER,6
IT,NEUROLEPTIC MALIGNANT SYNDROME,6
IT,PAROSMIA,6
IT,RETCHING,6
IT,SEPSIS,6
IT,STRESS CARDIOMYOPATHY,6
IT,WITHDRAWAL SYNDROME,6
IT,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,5
IT,ACUTE MYOCARDIAL INFARCTION,5
IT,ADVERSE REACTION,5
IT,BLOOD CREATINE PHOSPHOKINASE INCREASED,5
IT,BRADYCARDIA,5
IT,BREATH SOUNDS ABNORMAL,5
IT,CARDIOGENIC SHOCK,5
IT,CEREBRAL ISCHAEMIA,5
IT,FORMICATION,5
IT,HYPERTENSION,5
IT,HYPOGLYCAEMIC COMA,5
IT,HYPOREFLEXIA,5
IT,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,5
IT,LUNG NEOPLASM MALIGNANT,5
IT,MEDICATION ERROR,5
IT,MIOSIS,5
IT,PNEUMONIA,5
IT,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,5
IT,PSYCHOGENIC SEIZURE,5
IT,RENAL FAILURE,5
IT,TACHYCARDIA,5
IT,TONGUE OEDEMA,5
IT,ABASIA,4
IT,ABNORMAL WEIGHT GAIN,4
IT,ACUTE RESPIRATORY FAILURE,4
IT,ALANINE AMINOTRANSFERASE INCREASED,4
IT,ANXIETY,4
IT,ARTHRALGIA,4
IT,ATRIOVENTRICULAR BLOCK FIRST DEGREE,4
IT,BLOOD POTASSIUM INCREASED,4
IT,CARDIAC ARREST,4
IT,CHOREA,4
IT,COUGH,4
IT,DYSPHONIA,4
IT,EROSIVE OESOPHAGITIS,4
IT,FEMORAL NECK FRACTURE,4
IT,FLATULENCE,4
IT,HALLUCINATION_ AUDITORY,4
IT,HYPERTRANSAMINASAEMIA,4
IT,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,4
IT,INCORRECT DOSE ADMINISTERED,4
IT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,4
IT,MUSCLE RIGIDITY,4
IT,MYALGIA,4
IT,NEUTROPENIA,4
IT,OESOPHAGITIS HAEMORRHAGIC,4
IT,OLIGURIA,4
IT,OROMANDIBULAR DYSTONIA,4
IT,PAIN,4
IT,PRURITUS,4
IT,RECTAL HAEMORRHAGE,4
IT,TROPONIN INCREASED,4
IT,URTICARIA,4
IT,VASOPLEGIA SYNDROME,4
IT,VISUAL FIELD DEFECT,4
IT,ACIDOSIS,3
IT,APRAXIA,3
IT,ARTERIOSPASM CORONARY,3
IT,BIPOLAR DISORDER,3
IT,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,3
IT,BLOOD CREATININE INCREASED,3
IT,BRAIN NATRIURETIC PEPTIDE INCREASED,3
IT,DISEASE PROGRESSION,3
IT,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,3
IT,DRUG-INDUCED LIVER INJURY,3
IT,DYSKINESIA,3
IT,DYSSTASIA,3
IT,FAECALOMA,3
IT,FOETAL EXPOSURE DURING PREGNANCY,3
IT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
IT,HEART RATE INCREASED,3
IT,HYPERCREATINAEMIA,3
IT,INTERNATIONAL NORMALISED RATIO INCREASED,3
IT,LACTIC ACIDOSIS,3
IT,METABOLIC ACIDOSIS,3
IT,MUSCLE NECROSIS,3
IT,MYOGLOBIN URINE PRESENT,3
IT,NEUROLOGICAL SYMPTOM,3
IT,NORMOCYTIC ANAEMIA,3
IT,OEDEMA PERIPHERAL,3
IT,PULMONARY OEDEMA,3
IT,TENDERNESS,3
IT,THROMBOCYTOPENIA,3
IT,TONGUE DISCOLOURATION,3
IT,ABNORMAL BEHAVIOUR,2
IT,AMYLASE INCREASED,2
IT,ANGINA PECTORIS,2
IT,ANTINUCLEAR ANTIBODY POSITIVE,2
IT,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,2
IT,ANURIA,2
IT,AUTOIMMUNE HEPATITIS,2
IT,BASAL CELL CARCINOMA,2
IT,BLOOD BILIRUBIN INCREASED,2
IT,BLOOD CALCIUM DECREASED,2
IT,BLOOD LACTIC ACID INCREASED,2
IT,BLOOD POTASSIUM DECREASED,2
IT,BLOOD PRESSURE INCREASED,2
IT,CATARACT,2
IT,CEREBRAL HAEMORRHAGE,2
IT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
IT,CONVULSION,2
IT,DEHYDRATION,2
IT,DEVICE RELATED INFECTION,2
IT,DRUG WITHDRAWAL CONVULSIONS,2
IT,DRY MOUTH,2
IT,DYSTONIA,2
IT,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,2
IT,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,2
IT,EPIGASTRIC DISCOMFORT,2
IT,EYE PAIN,2
IT,FEEDING DISORDER,2
IT,FEELING ABNORMAL,2
IT,FEMUR FRACTURE,2
IT,FLUID INTAKE REDUCED,2
IT,GASTROINTESTINAL DISORDER,2
IT,H1N1 INFLUENZA,2
IT,HAEMATURIA,2
IT,HAEMORRHAGIC STROKE,2
IT,HEMIPARESIS,2
IT,HYPERGLYCAEMIA,2
IT,HYPOAESTHESIA,2
IT,INFECTION PARASITIC,2
IT,INTERNATIONAL NORMALISED RATIO ABNORMAL,2
IT,IRON DEFICIENCY ANAEMIA,2
IT,IRRITABILITY,2
IT,LEUKOCYTOSIS,2
IT,LIVER DISORDER,2
IT,LYMPHOPENIA,2
IT,MALNUTRITION,2
IT,MATERNAL EXPOSURE DURING PREGNANCY,2
IT,METABOLIC ENCEPHALOPATHY,2
IT,MULTI-ORGAN FAILURE,2
IT,MULTIPLE SCLEROSIS RELAPSE,2
IT,MYOCARDIAL INFARCTION,2
IT,MYOCARDIAL OEDEMA,2
IT,NEUTROPHILIA,2
IT,NO THERAPEUTIC RESPONSE,2
IT,NORMOCHROMIC NORMOCYTIC ANAEMIA,2
IT,OBSTRUCTIVE AIRWAYS DISORDER,2
IT,ORAL INFECTION,2
IT,PARAESTHESIA ORAL,2
IT,PETIT MAL EPILEPSY,2
IT,POISONING,2
IT,POSTURE ABNORMAL,2
IT,PRODUCT USE IN UNAPPROVED INDICATION,2
IT,PRURITUS GENERALISED,2
IT,PSYCHIATRIC SYMPTOM,2
IT,PSYCHOTIC DISORDER,2
IT,RASH,2
IT,RESPIRATORY RATE INCREASED,2
IT,SINUS BRADYCARDIA,2
IT,SLOW RESPONSE TO STIMULI,2
IT,SPINA BIFIDA,2
IT,SPINAL CORD INJURY,2
IT,STUPOR,2
IT,THERAPEUTIC RESPONSE DECREASED,2
IT,THERAPEUTIC RESPONSE UNEXPECTED,2
IT,THROMBOCYTOSIS,2
IT,VENTRICULAR FIBRILLATION,2
IT,VENTRICULAR HYPOKINESIA,2
IT,VENTRICULAR SEPTAL DEFECT,2
IT,VISION BLURRED,2
IT,WHITE BLOOD CELL COUNT DECREASED,2
IT,ABDOMINAL DISCOMFORT,1
IT,ABDOMINAL SEPSIS,1
IT,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
IT,ACUTE LYMPHOCYTIC LEUKAEMIA,1
IT,AFFECTIVE DISORDER,1
IT,AMNESIA,1
IT,ANTICHOLINERGIC SYNDROME,1
IT,ATRIAL FIBRILLATION,1
IT,AZOTAEMIA,1
IT,BACK PAIN,1
IT,BIPOLAR II DISORDER,1
IT,BLOOD ALKALINE PHOSPHATASE INCREASED,1
IT,BLOOD CHOLINESTERASE DECREASED,1
IT,BLOOD CREATINE INCREASED,1
IT,BLOOD PRESSURE DECREASED,1
IT,BODY TEMPERATURE INCREASED,1
IT,BONE CYST,1
IT,BREAKTHROUGH PAIN,1
IT,BREAST CALCIFICATIONS,1
IT,BRONCHOPNEUMONIA,1
IT,C-REACTIVE PROTEIN INCREASED,1
IT,CARDIAC FAILURE,1
IT,CARDIAC FAILURE ACUTE,1
IT,CARDIO-RESPIRATORY ARREST,1
IT,CARDIOPULMONARY FAILURE,1
IT,CARDIOVASCULAR DISORDER,1
IT,CEREBRAL ATROPHY,1
IT,CEREBRAL DISORDER,1
IT,CHOLECYSTITIS ACUTE,1
IT,CHRONIC GASTRITIS,1
IT,CIRCULATORY COLLAPSE,1
IT,CLEFT PALATE,1
IT,COGNITIVE DISORDER,1
IT,COMPULSIVE HOARDING,1
IT,CONGENITAL ANOMALY,1
IT,DERMO-HYPODERMITIS,1
IT,DIABETES MELLITUS INADEQUATE CONTROL,1
IT,DIALYSIS,1
IT,DIPLOPIA,1
IT,DISCOMFORT,1
IT,DISTURBANCE IN ATTENTION,1
IT,DIZZINESS POSTURAL,1
IT,DRUG LEVEL INCREASED,1
IT,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
IT,DRUG WITHDRAWAL SYNDROME,1
IT,DRY SKIN,1
IT,DYSENTERY,1
IT,DYSPEPSIA,1
IT,DYSPNOEA AT REST,1
IT,EATING DISORDER,1
IT,EJECTION FRACTION DECREASED,1
IT,ENCEPHALITIS VIRAL,1
IT,ENTERITIS,1
IT,ENTEROCOLITIS,1
IT,EOSINOPHILIC PNEUMONIA,1
IT,ESCHERICHIA SEPSIS,1
IT,EWING^S SARCOMA,1
IT,EXFOLIATIVE RASH,1
IT,EXOPHTHALMOS,1
IT,EXTRASYSTOLES,1
IT,EYE INFLAMMATION,1
IT,EYE OEDEMA,1
IT,FACIAL BONES FRACTURE,1
IT,FAECES DISCOLOURED,1
IT,FALLOT^S TETRALOGY,1
IT,FLUSHING,1
IT,FOOT FRACTURE,1
IT,GASTRIC HAEMORRHAGE,1
IT,GASTROENTERITIS,1
IT,GENERAL SYMPTOM,1
IT,GINGIVAL BLEEDING,1
IT,GRAFT VERSUS HOST DISEASE IN SKIN,1
IT,HAEMATOMA,1
IT,HAEMORRHAGE,1
IT,HAEMORRHAGE INTRACRANIAL,1
IT,HAEMORRHAGE SUBCUTANEOUS,1
IT,HEPATIC FUNCTION ABNORMAL,1
IT,HEPATITIS,1
IT,HEPATITIS ACUTE,1
IT,HEPATITIS INFECTIOUS,1
IT,HERPES ZOSTER,1
IT,HICCUPS,1
IT,HYPERCALCAEMIA,1
IT,HYPERPROLACTINAEMIA,1
IT,HYPERREFLEXIA,1
IT,HYPERSENSITIVITY,1
IT,HYPERTONIA,1
IT,HYPERTRIGLYCERIDAEMIA,1
IT,HYPOACUSIS,1
IT,HYPOKALAEMIA,1
IT,HYPOTONIA,1
IT,ILL-DEFINED DISORDER,1
IT,IMPAIRED WORK ABILITY,1
IT,IMPULSE-CONTROL DISORDER,1
IT,INCOHERENT,1
IT,INFECTION,1
IT,INFLUENZA LIKE ILLNESS,1
IT,INJECTION SITE PAIN,1
IT,INTENTIONAL PRODUCT USE ISSUE,1
IT,INTESTINAL ISCHAEMIA,1
IT,INTESTINAL PERFORATION,1
IT,ISCHAEMIC STROKE,1
IT,JAUNDICE,1
IT,JOINT INJURY,1
IT,KLEBSIELLA INFECTION,1
IT,LACERATION,1
IT,LARYNGEAL OEDEMA,1
IT,LARYNGOSPASM,1
IT,LICHENOID KERATOSIS,1
IT,LIPASE INCREASED,1
IT,LOCALISED OEDEMA,1
IT,LOGORRHOEA,1
IT,LUNG DISORDER,1
IT,LUNG INFECTION,1
IT,MACULAR DEGENERATION,1
IT,MAJOR DEPRESSION,1
IT,MALLORY-WEISS SYNDROME,1
IT,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
IT,MELAENA,1
IT,MENORRHAGIA,1
IT,MENSTRUATION IRREGULAR,1
IT,METASTASES TO KIDNEY,1
IT,METASTASES TO LIVER,1
IT,METASTASES TO PERITONEUM,1
IT,MIGRAINE,1
IT,MITRAL VALVE INCOMPETENCE,1
IT,MONONUCLEOSIS SYNDROME,1
IT,MOTOR DYSFUNCTION,1
IT,MUCOSAL ULCERATION,1
IT,MULTIPLE SCLEROSIS,1
IT,MUSCULOSKELETAL STIFFNESS,1
IT,MYOCLONUS,1
IT,MYOGLOBIN BLOOD INCREASED,1
IT,MYOPIA,1
IT,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,1
IT,NASAL INJURY,1
IT,NEURALGIA,1
IT,NEUROTOXICITY,1
IT,NOCTURIA,1
IT,NON-SMALL CELL LUNG CANCER STAGE IV,1
IT,NONINFECTIVE ENCEPHALITIS,1
IT,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,1
IT,NYSTAGMUS,1
IT,OBSESSIVE-COMPULSIVE DISORDER,1
IT,OEDEMA MOUTH,1
IT,OESOPHAGEAL CANDIDIASIS,1
IT,OPHTHALMIC HERPES ZOSTER,1
IT,OPTIC NERVE DISORDER,1
IT,ORAL CANDIDIASIS,1
IT,ORTHOSTATIC HYPOTENSION,1
IT,PAIN IN EXTREMITY,1
IT,PALATAL OEDEMA,1
IT,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
IT,PALPITATIONS,1
IT,PANCREATIC CARCINOMA STAGE IV,1
IT,PANIC DISORDER,1
IT,PELVIC HAEMATOMA,1
IT,PENILE OEDEMA,1
IT,PERIPHERAL ISCHAEMIA,1
IT,PHOTOSENSITIVITY REACTION,1
IT,PLEURAL EFFUSION,1
IT,PNEUMOCOCCAL SEPSIS,1
IT,POISONING DELIBERATE,1
IT,POSTURAL TREMOR,1
IT,POVERTY OF SPEECH,1
IT,PROCTALGIA,1
IT,PROSTATIC ADENOMA,1
IT,PSYCHOMOTOR RETARDATION,1
IT,PULMONARY TUBERCULOSIS,1
IT,PUSTULAR PSORIASIS,1
IT,Q FEVER,1
IT,RASH ERYTHEMATOUS,1
IT,RENAL COLIC,1
IT,RENAL FAILURE ACUTE,1
IT,RENAL FAILURE CHRONIC,1
IT,RESPIRATORY DISTRESS,1
IT,RESPIRATORY TRACT INFECTION,1
IT,SACCADIC EYE MOVEMENT,1
IT,SEIZURE,1
IT,SEXUAL DYSFUNCTION,1
IT,SHOCK,1
IT,SKIN PAPILLOMA,1
IT,SMALL FOR DATES BABY,1
IT,SOFT TISSUE HAEMORRHAGE,1
IT,STATUS EPILEPTICUS,1
IT,SUBARACHNOID HAEMORRHAGE,1
IT,SUBDURAL HAEMATOMA,1
IT,SUBSTANCE ABUSE,1
IT,SUDDEN DEATH,1
IT,SUICIDAL BEHAVIOUR,1
IT,SUPERFICIAL SPREADING MELANOMA STAGE IV,1
IT,SUPRAVENTRICULAR EXTRASYSTOLES,1
IT,SWOLLEN TONGUE,1
IT,TONGUE MOVEMENT DISTURBANCE,1
IT,TRACHEOBRONCHITIS,1
IT,TRANSFUSION,1
IT,TRAUMATIC AMPUTATION,1
IT,TRICUSPID VALVE PROLAPSE,1
IT,TUBULOINTERSTITIAL NEPHRITIS,1
IT,TYPE 2 DIABETES MELLITUS,1
IT,UNDERDOSE,1
IT,URINARY INCONTINENCE,1
IT,VASCULAR ENCEPHALOPATHY,1
IT,VENTRICULAR DYSKINESIA,1
IT,VENTRICULAR HYPERKINESIA,1
IT,VERTIGO CNS ORIGIN,1
IT,VERTIGO POSITIONAL,1
IT,VIOLENCE-RELATED SYMPTOM,1
IT,VULVOVAGINAL HUMAN PAPILLOMA VIRUS INFECTION,1
IT,WHEEZING,1
IT,WHITE MATTER LESION,1
IT,WRONG DRUG ADMINISTERED,1
JP,DRUG INEFFECTIVE,13
JP,PYREXIA,8
JP,DECREASED APPETITE,7
JP,RASH,7
JP,ALTERED STATE OF CONSCIOUSNESS,6
JP,SOMNOLENCE,6
JP,ARRHYTHMIA,5
JP,BLOOD PRESSURE DECREASED,5
JP,INTERSTITIAL LUNG DISEASE,5
JP,NAUSEA,5
JP,OVERDOSE,5
JP,PLATELET COUNT DECREASED,5
JP,STATUS EPILEPTICUS,5
JP,HAEMATOTOXICITY,4
JP,HEPATIC FUNCTION ABNORMAL,4
JP,HYPOTENSION,4
JP,LEUKOPENIA,4
JP,SEPSIS,4
JP,ATONIC SEIZURES,3
JP,CONVULSION,3
JP,DELIRIUM,3
JP,DISSEMINATED INTRAVASCULAR COAGULATION,3
JP,DRUG ERUPTION,3
JP,DRUG LEVEL INCREASED,3
JP,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,3
JP,DRUG-INDUCED LIVER INJURY,3
JP,DYSPNOEA,3
JP,FEBRILE NEUTROPENIA,3
JP,GAIT DISTURBANCE,3
JP,HYPOCALCAEMIA,3
JP,INFECTION,3
JP,MALAISE,3
JP,MALIGNANT NEOPLASM PROGRESSION,3
JP,MUSCULAR WEAKNESS,3
JP,NEUTROPHIL COUNT DECREASED,3
JP,PRODUCT USE ISSUE,3
JP,RESPIRATORY FAILURE,3
JP,RESTLESSNESS,3
JP,THERAPEUTIC RESPONSE UNEXPECTED,3
JP,TOXIC EPIDERMAL NECROLYSIS,3
JP,TOXICITY TO VARIOUS AGENTS,3
JP,VOMITING,3
JP,ABDOMINAL DISTENSION,2
JP,ACUTE MYOCARDIAL INFARCTION,2
JP,ANAEMIA,2
JP,ASTHMA,2
JP,BLAST CELLS PRESENT,2
JP,BONE MARROW FAILURE,2
JP,BRONCHOPULMONARY ASPERGILLOSIS,2
JP,CHEST DISCOMFORT,2
JP,DEHYDRATION,2
JP,DERMATITIS BULLOUS,2
JP,DIZZINESS,2
JP,DYSKINESIA,2
JP,DYSPHAGIA,2
JP,FALL,2
JP,GENERALISED OEDEMA,2
JP,HEADACHE,2
JP,HYPERKALAEMIA,2
JP,HYPOALBUMINAEMIA,2
JP,HYPOPHAGIA,2
JP,HYPOXIA,2
JP,ILEUS,2
JP,ILEUS PARALYTIC,2
JP,INSOMNIA,2
JP,LOSS OF CONSCIOUSNESS,2
JP,NEUROPATHY PERIPHERAL,2
JP,ORGANISING PNEUMONIA,2
JP,PANCREATITIS ACUTE,2
JP,PLEURAL EFFUSION,2
JP,PNEUMOCYSTIS JIROVECII PNEUMONIA,2
JP,PNEUMONIA,2
JP,PNEUMONIA INFLUENZAL,2
JP,PROTEINURIA,2
JP,RENAL FAILURE ACUTE,2
JP,RESPIRATORY DISORDER,2
JP,RESPIRATORY DISTRESS,2
JP,SEPTIC SHOCK,2
JP,STEVENS-JOHNSON SYNDROME,2
JP,STOMATITIS,2
JP,THERAPEUTIC RESPONSE DECREASED,2
JP,VENTRICULAR FIBRILLATION,2
JP,WEIGHT DECREASED,2
JP,WHITE BLOOD CELL COUNT DECREASED,2
JP,WHITE BLOOD CELL COUNT INCREASED,2
JP,ABDOMINAL PAIN,1
JP,ABDOMINAL REBOUND TENDERNESS,1
JP,ABDOMINAL RIGIDITY,1
JP,ABNORMAL BEHAVIOUR,1
JP,ABORTION,1
JP,ABULIA,1
JP,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
JP,ACUTE RESPIRATORY FAILURE,1
JP,ADRENAL ATROPHY,1
JP,ADRENAL INSUFFICIENCY,1
JP,AGITATION,1
JP,ALANINE AMINOTRANSFERASE INCREASED,1
JP,ALOPECIA,1
JP,ANHIDROSIS,1
JP,ANTICONVULSANT DRUG LEVEL INCREASED,1
JP,ANTINUCLEAR ANTIBODY INCREASED,1
JP,APPARENT DEATH,1
JP,ARTHRALGIA,1
JP,ASCITES,1
JP,ASPARTATE AMINOTRANSFERASE INCREASED,1
JP,ASTHENIA,1
JP,BACK PAIN,1
JP,BLOOD BETA-D-GLUCAN INCREASED,1
JP,BLOOD CREATININE INCREASED,1
JP,BLOOD GLUCOSE DECREASED,1
JP,BLOOD GLUCOSE INCREASED,1
JP,BLOOD LACTATE DEHYDROGENASE INCREASED,1
JP,BLOOD POTASSIUM DECREASED,1
JP,BLOOD PYRUVIC ACID INCREASED,1
JP,BONE MARROW DISORDER,1
JP,BREAST CANCER,1
JP,BROMODERMA,1
JP,BRONCHITIS,1
JP,CANCER PAIN,1
JP,CARDIAC ARREST,1
JP,CARDIAC ENZYMES INCREASED,1
JP,CARDIAC FAILURE,1
JP,CARDIAC FAILURE CHRONIC,1
JP,CARDIOGENIC SHOCK,1
JP,CARDIOMEGALY,1
JP,CERVIX CARCINOMA,1
JP,COGNITIVE DISORDER,1
JP,COMPLETED SUICIDE,1
JP,COMPLEX PARTIAL SEIZURES,1
JP,CONJUNCTIVITIS,1
JP,CONSTIPATION,1
JP,CORONARY ARTERY STENOSIS,1
JP,COUGH,1
JP,DEATH,1
JP,DECREASED ACTIVITY,1
JP,DEPRESSED LEVEL OF CONSCIOUSNESS,1
JP,DERMATOMYOSITIS,1
JP,DIARRHOEA,1
JP,DISEASE PROGRESSION,1
JP,DIVERTICULUM INTESTINAL,1
JP,DRUG EFFECT INCOMPLETE,1
JP,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
JP,DRUG LEVEL DECREASED,1
JP,DRUG WITHDRAWAL SYNDROME,1
JP,DYSLALIA,1
JP,DYSPNOEA EXERTIONAL,1
JP,ECZEMA ASTEATOTIC,1
JP,EJECTION FRACTION DECREASED,1
JP,EMOTIONAL DISORDER,1
JP,EPILEPSY,1
JP,ERYTHEMA,1
JP,FLASHBACK,1
JP,FLUSHING,1
JP,FOETAL EXPOSURE DURING PREGNANCY,1
JP,GASTROENTERITIS EOSINOPHILIC,1
JP,GASTROINTESTINAL DISORDER,1
JP,GASTROINTESTINAL HAEMORRHAGE,1
JP,GASTROINTESTINAL HYPOMOTILITY,1
JP,GASTROINTESTINAL PERFORATION,1
JP,GENERAL PHYSICAL HEALTH DETERIORATION,1
JP,GENERALISED TONIC-CLONIC SEIZURE,1
JP,GINGIVAL HYPERTROPHY,1
JP,GRAND MAL CONVULSION,1
JP,GRANULOCYTOPENIA,1
JP,HAEMOGLOBIN DECREASED,1
JP,HALLUCINATION_ AUDITORY,1
JP,HEAD INJURY,1
JP,HEART RATE DECREASED,1
JP,HEMIPARESIS,1
JP,HEPATITIS B,1
JP,HETEROTAXIA,1
JP,HICCUPS,1
JP,HUMAN HERPESVIRUS 6 INFECTION,1
JP,HYPERGLYCAEMIA,1
JP,HYPERSOMNIA,1
JP,HYPOCOMPLEMENTAEMIA,1
JP,HYPOGLYCAEMIA,1
JP,HYPOPROTEINAEMIA,1
JP,HYPORESPONSIVE TO STIMULI,1
JP,HYPOTHYROIDISM,1
JP,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
JP,INDURATION,1
JP,INTENTIONAL OVERDOSE,1
JP,INTENTIONAL UNDERDOSE,1
JP,INTESTINAL PERFORATION,1
JP,LACTIC ACIDOSIS,1
JP,LACUNAR INFARCTION,1
JP,LARGE INTESTINAL ULCER PERFORATION,1
JP,LEUKAEMIA RECURRENT,1
JP,LEUKOENCEPHALOPATHY,1
JP,LIP EROSION,1
JP,LIVER DISORDER,1
JP,LUNG DISORDER,1
JP,LUPUS-LIKE SYNDROME,1
JP,LYMPHADENOPATHY,1
JP,LYMPHOCYTE COUNT DECREASED,1
JP,LYMPHOPENIA,1
JP,MACULAR OEDEMA,1
JP,MELAENA,1
JP,MENTAL STATUS CHANGES,1
JP,METASTASES TO LUNG,1
JP,MYOCARDITIS,1
JP,MYOCLONIC EPILEPSY,1
JP,NASOPHARYNGITIS,1
JP,NEAR DROWNING,1
JP,NEOPLASM PROGRESSION,1
JP,NEPHROTIC SYNDROME,1
JP,NEURALGIA,1
JP,NEUROLEPTIC MALIGNANT SYNDROME,1
JP,NEUROTOXICITY,1
JP,NIGHTMARE,1
JP,NIKOLSKY^S SIGN,1
JP,NON-SMALL CELL LUNG CANCER,1
JP,OEDEMA,1
JP,OPTIC ISCHAEMIC NEUROPATHY,1
JP,PAIN,1
JP,PAIN IN EXTREMITY,1
JP,PALLOR,1
JP,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
JP,PANCREATIC ATROPHY,1
JP,PANCYTOPENIA,1
JP,PARALYSIS,1
JP,PARANOIA,1
JP,PARASOMNIA,1
JP,PERICARDIAL EFFUSION,1
JP,PERITONITIS,1
JP,PHARYNGEAL ERYTHEMA,1
JP,PNEUMONIA ASPIRATION,1
JP,PNEUMONIA BACTERIAL,1
JP,PNEUMONIA FUNGAL,1
JP,PREGNANCY,1
JP,PRESCRIBED OVERDOSE,1
JP,PULMONARY CONGESTION,1
JP,PULMONARY EMBOLISM,1
JP,PULMONARY HAEMORRHAGE,1
JP,PUTAMEN HAEMORRHAGE,1
JP,RASH ERYTHEMATOUS,1
JP,RASH PRURITIC,1
JP,RED BLOOD CELL COUNT DECREASED,1
JP,RENAL IMPAIRMENT,1
JP,RESPIRATORY RATE DECREASED,1
JP,RESPIRATORY RATE INCREASED,1
JP,RIGHT VENTRICULAR HYPERTROPHY,1
JP,SALIVARY HYPERSECRETION,1
JP,SECONDARY HYPOGONADISM,1
JP,SEDATION,1
JP,SEIZURE,1
JP,SEROTONIN SYNDROME,1
JP,SLEEP DISORDER,1
JP,STEM CELL TRANSPLANT,1
JP,STUPOR,1
JP,SUICIDE ATTEMPT,1
JP,SULPHAEMOGLOBIN INCREASED,1
JP,SUNCT SYNDROME,1
JP,SYSTEMIC LUPUS ERYTHEMATOSUS,1
JP,THERAPEUTIC PRODUCT INEFFECTIVE,1
JP,THERMAL BURN,1
JP,THYROID ATROPHY,1
JP,TREMOR,1
JP,UPPER RESPIRATORY TRACT INFLAMMATION,1
JP,URINARY RETENTION,1
JP,URINARY TRACT INFECTION,1
JP,UROGENITAL ATROPHY,1
JP,VASCULITIS GASTROINTESTINAL,1
JP,VENTRICULAR TACHYCARDIA,1
JP,VISION BLURRED,1
JP,WHEEZING,1
JP,WITHDRAWAL SYNDROME,1
JO,BILIRUBIN CONJUGATED INCREASED,1
JO,BLOOD ALBUMIN DECREASED,1
JO,BLOOD BILIRUBIN INCREASED,1
JO,DYSARTHRIA,1
JO,HEMIPARESIS,1
JO,INTERNATIONAL NORMALISED RATIO INCREASED,1
JO,LIVER INJURY,1
JO,OEDEMA,1
JO,OEDEMA PERIPHERAL,1
JO,TUMOUR HAEMORRHAGE,1
JO,VIITH NERVE PARALYSIS,1
KR,MYOCLONUS,26
KR,NEUTROPENIA,16
KR,PNEUMONIA,16
KR,PRODUCT USE IN UNAPPROVED INDICATION,12
KR,DELIRIUM,11
KR,DIARRHOEA,11
KR,ASTHENIA,9
KR,FEBRILE NEUTROPENIA,9
KR,NAUSEA,9
KR,PYREXIA,8
KR,ABDOMINAL PAIN,7
KR,DECREASED APPETITE,7
KR,INSOMNIA,6
KR,NEUTROPHIL COUNT DECREASED,6
KR,DEATH,5
KR,DIZZINESS,5
KR,DRUG INEFFECTIVE,5
KR,DRUG-INDUCED LIVER INJURY,5
KR,VOMITING,5
KR,ACUTE KIDNEY INJURY,4
KR,ALANINE AMINOTRANSFERASE INCREASED,4
KR,ANAEMIA,4
KR,BACK PAIN,4
KR,EXTRADURAL HAEMATOMA,4
KR,FATIGUE,4
KR,MALIGNANT NEOPLASM PROGRESSION,4
KR,SEPSIS,4
KR,URINARY TRACT INFECTION,4
KR,ASPARTATE AMINOTRANSFERASE INCREASED,3
KR,CONSTIPATION,3
KR,HAEMOGLOBIN DECREASED,3
KR,HEADACHE,3
KR,HEPATOCELLULAR INJURY,3
KR,HYPOAESTHESIA,3
KR,HYPOKALAEMIA,3
KR,PANCYTOPENIA,3
KR,PARAESTHESIA,3
KR,PERIPHERAL SENSORY NEUROPATHY,3
KR,RHABDOMYOLYSIS,3
KR,SEPTIC SHOCK,3
KR,TREMOR,3
KR,ABDOMINAL DISTENSION,2
KR,AGITATION,2
KR,ARTHRALGIA,2
KR,CONDITION AGGRAVATED,2
KR,DISORIENTATION,2
KR,ELECTROCARDIOGRAM QT PROLONGED,2
KR,GENERALISED OEDEMA,2
KR,HAEMORRHAGE,2
KR,HERPES ZOSTER,2
KR,HYPONATRAEMIA,2
KR,INTERSTITIAL LUNG DISEASE,2
KR,MACULAR OEDEMA,2
KR,MYALGIA,2
KR,NEUROPATHY PERIPHERAL,2
KR,PAIN,2
KR,PAIN IN EXTREMITY,2
KR,PLASMA CELL MYELOMA,2
KR,PLATELET COUNT DECREASED,2
KR,PULMONARY EMBOLISM,2
KR,RASH MACULO-PAPULAR,2
KR,SOMNOLENCE,2
KR,THROMBOCYTOPENIA,2
KR,ABSCESS,1
KR,ADRENAL INSUFFICIENCY,1
KR,AGGRESSION,1
KR,APHASIA,1
KR,APLASIA PURE RED CELL,1
KR,ARTHRITIS BACTERIAL,1
KR,ATELECTASIS,1
KR,ATRIAL FIBRILLATION,1
KR,BACTERAEMIA,1
KR,BLINDNESS,1
KR,BLOOD ALBUMIN DECREASED,1
KR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
KR,BLOOD CALCIUM DECREASED,1
KR,BLOOD CREATININE INCREASED,1
KR,BLOOD OSMOLARITY DECREASED,1
KR,BLOOD PHOSPHORUS DECREASED,1
KR,BLOOD PRESSURE DECREASED,1
KR,BLOOD UREA INCREASED,1
KR,CAROTID ARTERY OCCLUSION,1
KR,CELLULITIS,1
KR,CERVICAL VERTEBRAL FRACTURE,1
KR,CHEST PAIN,1
KR,COLITIS,1
KR,COUGH,1
KR,CYSTITIS,1
KR,DEAFNESS,1
KR,DEHYDRATION,1
KR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
KR,DEPRESSION,1
KR,DERMATITIS ALLERGIC,1
KR,DERMATITIS CONTACT,1
KR,DEVICE RELATED INFECTION,1
KR,DIABETIC COMPLICATION,1
KR,DRUG CROSS-REACTIVITY,1
KR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
KR,DRY MOUTH,1
KR,DYSPNOEA,1
KR,ENCEPHALOPATHY,1
KR,ENURESIS,1
KR,EOSINOPHIL COUNT INCREASED,1
KR,EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,1
KR,EPIGLOTTITIS,1
KR,ERYTHEMA,1
KR,ERYTHROLEUKAEMIA,1
KR,EYE PAIN,1
KR,FACIAL BONES FRACTURE,1
KR,FACIAL PAIN,1
KR,FACIAL PARALYSIS,1
KR,FALL,1
KR,FEELING HOT,1
KR,FUNGAL INFECTION,1
KR,GAIT DISTURBANCE,1
KR,GASTRIC ULCER,1
KR,GASTROINTESTINAL DISORDER,1
KR,GASTROINTESTINAL HAEMORRHAGE,1
KR,GASTROOESOPHAGEAL REFLUX DISEASE,1
KR,GROIN ABSCESS,1
KR,HAEMATURIA,1
KR,HALLUCINATION,1
KR,HALLUCINATION_ AUDITORY,1
KR,HEPATITIS,1
KR,HOT FLUSH,1
KR,HYPERGLYCAEMIA,1
KR,HYPERSENSITIVITY,1
KR,HYPERTROPHIC CARDIOMYOPATHY,1
KR,HYPOALBUMINAEMIA,1
KR,HYPOPHOSPHATAEMIA,1
KR,HYPOTENSION,1
KR,ILEUS,1
KR,INCORRECT DOSE ADMINISTERED,1
KR,INFLAMMATORY MARKER INCREASED,1
KR,INFUSION SITE INFECTION,1
KR,INJURY,1
KR,INTENTIONAL PRODUCT MISUSE,1
KR,INTERVERTEBRAL DISC DISORDER,1
KR,INTERVERTEBRAL DISC PROTRUSION,1
KR,LACUNAR INFARCTION,1
KR,LARGE INTESTINE POLYP,1
KR,LIGAMENT SPRAIN,1
KR,LIVER FUNCTION TEST INCREASED,1
KR,LOCALISED OEDEMA,1
KR,MALIGNANT PLEURAL EFFUSION,1
KR,METASTASES TO BONE,1
KR,METASTATIC GASTRIC CANCER,1
KR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
KR,MUSCULAR WEAKNESS,1
KR,MUSCULOSKELETAL PAIN,1
KR,MYOSITIS,1
KR,NAIL DISORDER,1
KR,NEOPLASM,1
KR,NO THERAPEUTIC RESPONSE,1
KR,OBSTRUCTION GASTRIC,1
KR,OEDEMA PERIPHERAL,1
KR,ONYCHOMADESIS,1
KR,OPHTHALMIC HERPES ZOSTER,1
KR,OSTEONECROSIS,1
KR,PANCREATIC CARCINOMA,1
KR,PARALYSIS,1
KR,PARKINSONISM,1
KR,PAROSMIA,1
KR,PAROTITIS,1
KR,PERITONITIS,1
KR,PLEURAL EFFUSION,1
KR,PNEUMONIA KLEBSIELLA,1
KR,PNEUMONIA STREPTOCOCCAL,1
KR,PNEUMONITIS,1
KR,PRESCRIBED OVERDOSE,1
KR,PRODUCT USE ISSUE,1
KR,PRODUCTIVE COUGH,1
KR,PSEUDOMEMBRANOUS COLITIS,1
KR,PSEUDOMONAS INFECTION,1
KR,PUBIS FRACTURE,1
KR,PULMONARY FIBROSIS,1
KR,PYELONEPHRITIS ACUTE,1
KR,RASH,1
KR,RASH GENERALISED,1
KR,RENAL DISORDER,1
KR,RENAL FAILURE,1
KR,RENAL IMPAIRMENT,1
KR,RENAL TUBULAR ACIDOSIS,1
KR,RESTLESS LEGS SYNDROME,1
KR,RETINAL DETACHMENT,1
KR,RHEUMATOID ARTHRITIS,1
KR,ROAD TRAFFIC ACCIDENT,1
KR,SEDATION,1
KR,SEIZURE,1
KR,SHOCK,1
KR,SMALL INTESTINAL HAEMORRHAGE,1
KR,SPEECH DISORDER,1
KR,SPINAL COLUMN STENOSIS,1
KR,SPINAL FRACTURE,1
KR,STENT MALFUNCTION,1
KR,SUICIDAL IDEATION,1
KR,SWELLING,1
KR,THECAL SAC COMPRESSION,1
KR,THERAPEUTIC RESPONSE DECREASED,1
KR,TOXIC EPIDERMAL NECROLYSIS,1
KR,TYPE 2 DIABETES MELLITUS,1
KR,UPPER RESPIRATORY TRACT INFECTION,1
KR,URINARY RETENTION,1
KR,URINE OUTPUT DECREASED,1
KR,VASCULAR PARKINSONISM,1
KR,VASCULITIS,1
KR,VISUAL ACUITY REDUCED,1
KR,WEIGHT INCREASED,1
KR,WHITE BLOOD CELL COUNT INCREASED,1
KR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
KW,DRUG EFFECT DECREASED,1
LV,ASTHENIA,2
LV,BLOOD PRESSURE INCREASED,1
LV,CHRONIC HEPATITIS C,1
LV,CRYOGLOBULINAEMIA,1
LV,DECREASED APPETITE,1
LV,DIARRHOEA,1
LV,DRUG INEFFECTIVE,1
LV,DRUG-INDUCED LIVER INJURY,1
LV,DYSPNOEA,1
LV,HEPATIC ENCEPHALOPATHY,1
LV,HEPATOMEGALY,1
LV,HOSPITALISATION,1
LV,HYPERTENSION,1
LV,JAUNDICE,1
LV,LIMB INJURY,1
LV,NAUSEA,1
LV,NEUTROPENIA,1
LV,OEDEMA PERIPHERAL,1
LV,PAIN,1
LV,PETECHIAE,1
LV,POLYNEUROPATHY,1
LV,PULMONARY OEDEMA,1
LV,PYREXIA,1
LV,SYNCOPE,1
LV,THROMBOCYTOPENIA,1
LV,VASCULITIS,1
LV,VOMITING,1
LB,MYOCARDIAL INFARCTION,3
LB,DYSPNOEA,2
LB,GANGRENE,2
LB,NAUSEA,2
LB,OEDEMA,2
LB,OSTEOMYELITIS,2
LB,ARTHRALGIA,1
LB,ASTHENIA,1
LB,BLOOD PRESSURE MEASUREMENT,1
LB,CARDIAC DISORDER,1
LB,CHEST INJURY,1
LB,CHEST PAIN,1
LB,DEATH,1
LB,DIZZINESS,1
LB,DRUG INEFFECTIVE,1
LB,DRUG RESISTANCE,1
LB,EPISTAXIS,1
LB,FALL,1
LB,HEADACHE,1
LB,HYPOGLYCAEMIA,1
LB,MYALGIA,1
LB,NECROSIS,1
LB,NEUROPATHY PERIPHERAL,1
LB,PAIN,1
LB,PRURITUS,1
LB,PYREXIA,1
LB,RASH,1
LB,RETINAL IMPLANT,1
LB,RIB FRACTURE,1
LB,SPEECH DISORDER,1
LB,TACHYCARDIA,1
LT,DRUG INEFFECTIVE,1
LT,OSTEOMYELITIS,1
LT,RASH PAPULAR,1
MY,DIABETES MELLITUS INADEQUATE CONTROL,2
MY,ABNORMAL BEHAVIOUR,1
MY,ABSCESS,1
MY,AGGRESSION,1
MY,ASTHMA,1
MY,CEREBROVASCULAR ACCIDENT,1
MY,CHOKING SENSATION,1
MY,CONFUSIONAL STATE,1
MY,CONTUSION,1
MY,DRUG INEFFECTIVE,1
MY,DYSPNOEA,1
MY,HALLUCINATION,1
MY,HEPATIC ENZYME INCREASED,1
MY,HEPATITIS ACUTE,1
MY,HUNGER,1
MY,IMPAIRED REASONING,1
MY,MEMORY IMPAIRMENT,1
MY,MENTAL DISORDER,1
MY,MOOD ALTERED,1
MY,OROPHARYNGEAL PAIN,1
MY,PERIPHERAL VASCULAR DISORDER,1
MY,PRURITUS,1
MY,PYREXIA,1
MY,RASH MACULAR,1
MY,SEPTIC SHOCK,1
MY,SPINAL DISORDER,1
MY,SWELLING FACE,1
MY,SWOLLEN TONGUE,1
MY,TREMOR,1
MT,PULMONARY EMBOLISM,1
MX,PAIN IN EXTREMITY,10
MX,FATIGUE,9
MX,HEADACHE,9
MX,ASTHENIA,7
MX,DIZZINESS,7
MX,GAIT DISTURBANCE,7
MX,ANXIETY,6
MX,ARTHRALGIA,6
MX,GENERAL PHYSICAL HEALTH DETERIORATION,6
MX,MUCOSAL INFLAMMATION,6
MX,CEREBROVASCULAR ACCIDENT,5
MX,MALAISE,5
MX,MUSCULAR WEAKNESS,5
MX,PAIN,5
MX,SOMNOLENCE,5
MX,ABDOMINAL PAIN UPPER,4
MX,DIARRHOEA,4
MX,DRUG INEFFECTIVE,4
MX,DYSPNOEA,4
MX,FALL,4
MX,HYPERTENSION,4
MX,MULTIPLE SCLEROSIS RELAPSE,4
MX,ORAL CANDIDIASIS,4
MX,THROMBOSIS,4
MX,URINARY TRACT INFECTION,4
MX,ABDOMINAL PAIN,3
MX,ACTIVITIES OF DAILY LIVING IMPAIRED,3
MX,AMNESIA,3
MX,ANAEMIA,3
MX,ARTHROPATHY,3
MX,BACK PAIN,3
MX,BLOOD CHOLESTEROL INCREASED,3
MX,CATARACT,3
MX,CHEILITIS,3
MX,DECREASED APPETITE,3
MX,DYSPEPSIA,3
MX,HYPERGLYCAEMIA,3
MX,INSOMNIA,3
MX,LYMPHOCYTE COUNT DECREASED,3
MX,MEDICATION ERROR,3
MX,MUCOSAL ATROPHY,3
MX,NAUSEA,3
MX,PALLOR,3
MX,PLATELET COUNT DECREASED,3
MX,POST INFLAMMATORY PIGMENTATION CHANGE,3
MX,PRODUCT USE ISSUE,3
MX,RASH,3
MX,SKIN DISCOLOURATION,3
MX,VISION BLURRED,3
MX,WEIGHT INCREASED,3
MX,WRONG TECHNIQUE IN DRUG USAGE PROCESS,3
MX,ABDOMINAL DISTENSION,2
MX,ANGER,2
MX,ARTHRITIS,2
MX,ASPHYXIA,2
MX,BALANCE DISORDER,2
MX,BLOOD GLUCOSE INCREASED,2
MX,BLOOD PRESSURE DECREASED,2
MX,BLOOD TRIGLYCERIDES INCREASED,2
MX,BONE PAIN,2
MX,BURNING SENSATION,2
MX,CEREBRAL ATROPHY,2
MX,CHEST DISCOMFORT,2
MX,CRYING,2
MX,DEATH,2
MX,DEPRESSED MOOD,2
MX,DEPRESSION,2
MX,DIABETES MELLITUS,2
MX,DYSPHEMIA,2
MX,DYSURIA,2
MX,EYE PAIN,2
MX,FEELING HOT,2
MX,GALLBLADDER DISORDER,2
MX,GASTRIC DISORDER,2
MX,GENERALISED OEDEMA,2
MX,HAEMORRHOIDS,2
MX,HEPATIC FAILURE,2
MX,HYPERSOMNIA,2
MX,HYPOAESTHESIA,2
MX,JOINT RANGE OF MOTION DECREASED,2
MX,MOBILITY DECREASED,2
MX,MULTI-ORGAN FAILURE,2
MX,MUSCULOSKELETAL DISORDER,2
MX,NAIL DISORDER,2
MX,PAIN IN JAW,2
MX,PNEUMONIA,2
MX,POISONING,2
MX,POLLAKIURIA,2
MX,RENAL FAILURE,2
MX,RESPIRATORY FAILURE,2
MX,RHEUMATIC DISORDER,2
MX,SPEECH DISORDER,2
MX,STEROID THERAPY,2
MX,WEIGHT DECREASED,2
MX,ABASIA,1
MX,ABDOMINAL DISCOMFORT,1
MX,ABSCESS LIMB,1
MX,ACUTE KIDNEY INJURY,1
MX,ACUTE PULMONARY OEDEMA,1
MX,ALOPECIA,1
MX,ANAL PARAESTHESIA,1
MX,APPLICATION SITE IRRITATION,1
MX,ARRHYTHMIA,1
MX,ARTHROFIBROSIS,1
MX,BILE DUCT STONE,1
MX,BLADDER DISORDER,1
MX,BLINDNESS,1
MX,BLINDNESS UNILATERAL,1
MX,BLOOD ALBUMIN ABNORMAL,1
MX,BLOOD BILIRUBIN INCREASED,1
MX,BLOOD DISORDER,1
MX,BLOOD GLUCOSE DECREASED,1
MX,BLOOD PRESSURE ABNORMAL,1
MX,BLOOD PRESSURE DIASTOLIC INCREASED,1
MX,BLOOD PRESSURE INCREASED,1
MX,BLOOD TEST ABNORMAL,1
MX,BONE MARROW DISORDER,1
MX,BRAIN HYPOXIA,1
MX,BRAIN INJURY,1
MX,BREAST CANCER,1
MX,BRONCHITIS,1
MX,CAPILLARY NAIL REFILL TEST ABNORMAL,1
MX,CARDIAC FAILURE,1
MX,CARDIAC FAILURE CONGESTIVE,1
MX,CARDIOMEGALY,1
MX,CAROTID ARTERY OCCLUSION,1
MX,CERVICAL MYELOPATHY,1
MX,CERVIX DISORDER,1
MX,CHEST PAIN,1
MX,CHEST WALL TUMOUR,1
MX,CHOLELITHIASIS,1
MX,CHONDROPATHY,1
MX,COAGULOPATHY,1
MX,COGNITIVE DISORDER,1
MX,COLITIS,1
MX,CONSTIPATION,1
MX,CONTUSION,1
MX,COORDINATION ABNORMAL,1
MX,CYANOSIS,1
MX,DEHYDRATION,1
MX,DELIRIUM,1
MX,DEMENTIA ALZHEIMER^S TYPE,1
MX,DERMATITIS ALLERGIC,1
MX,DIET REFUSAL,1
MX,DISCOMFORT,1
MX,DISEASE PROGRESSION,1
MX,DISSEMINATED TUBERCULOSIS,1
MX,DISTURBANCE IN ATTENTION,1
MX,DROOLING,1
MX,DRUG DEPENDENCE,1
MX,DRUG INTOLERANCE,1
MX,DRUG PRESCRIBING ERROR,1
MX,DRY MOUTH,1
MX,DRY SKIN,1
MX,DYSGEUSIA,1
MX,DYSGRAPHIA,1
MX,DYSPHONIA,1
MX,DYSSTASIA,1
MX,EATING DISORDER,1
MX,ECZEMA,1
MX,ELECTROLYTE IMBALANCE,1
MX,EMBOLISM,1
MX,EMOTIONAL DISORDER,1
MX,EMPHYSEMA,1
MX,ENCEPHALOPATHY,1
MX,EPISTAXIS,1
MX,ERECTILE DYSFUNCTION,1
MX,EYE INJURY,1
MX,FAECES DISCOLOURED,1
MX,FEAR,1
MX,FEEDING DISORDER,1
MX,FEELING ABNORMAL,1
MX,FEELING DRUNK,1
MX,FEELING OF BODY TEMPERATURE CHANGE,1
MX,FEELING OF DESPAIR,1
MX,FEMUR FRACTURE,1
MX,FIBROSIS,1
MX,FINGERPRINT LOSS,1
MX,FLUID RETENTION,1
MX,GALLBLADDER NEOPLASM,1
MX,GANGRENE,1
MX,GASTRITIS,1
MX,GASTRITIS EROSIVE,1
MX,GASTROENTERITIS,1
MX,GASTROINTESTINAL HAEMORRHAGE,1
MX,GASTROOESOPHAGEAL REFLUX DISEASE,1
MX,GENITAL BURNING SENSATION,1
MX,GLOSSITIS,1
MX,HAEMOTHORAX,1
MX,HALLUCINATION,1
MX,HEAD DISCOMFORT,1
MX,HEAD INJURY,1
MX,HEARING IMPAIRED,1
MX,HELICOBACTER INFECTION,1
MX,HEPATIC PAIN,1
MX,HEPATITIS,1
MX,HERPES ZOSTER,1
MX,HODGKIN^S DISEASE,1
MX,HYPERKALAEMIA,1
MX,HYPEROSMOLAR STATE,1
MX,HYPOACUSIS,1
MX,HYPOTHYROIDISM,1
MX,HYPOVOLAEMIC SHOCK,1
MX,IMPAIRED REASONING,1
MX,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
MX,INFLAMMATION,1
MX,INFUSION RELATED REACTION,1
MX,INTENTIONAL PRODUCT USE ISSUE,1
MX,INTERVERTEBRAL DISCITIS,1
MX,INTESTINAL PERFORATION,1
MX,INVESTIGATION,1
MX,IRRITABILITY,1
MX,JAW DISORDER,1
MX,KETOACIDOSIS,1
MX,LIMB DISCOMFORT,1
MX,LOSS OF CONTROL OF LEGS,1
MX,LYMPHADENOPATHY,1
MX,MAJOR DEPRESSION,1
MX,MALIGNANT NEOPLASM PROGRESSION,1
MX,MEMORY IMPAIRMENT,1
MX,METASTASIS,1
MX,METRORRHAGIA,1
MX,MICTURITION URGENCY,1
MX,MOUTH INJURY,1
MX,MOUTH ULCERATION,1
MX,MOVEMENT DISORDER,1
MX,MUSCLE SPASMS,1
MX,MUSCULOSKELETAL PAIN,1
MX,MYELITIS,1
MX,MYOCARDIAL INFARCTION,1
MX,MYXOID LIPOSARCOMA,1
MX,NASAL INJURY,1
MX,NEOPLASM MALIGNANT,1
MX,NEOPLASM PROGRESSION,1
MX,NERVE INJURY,1
MX,NERVE ROOT INJURY,1
MX,NERVOUS SYSTEM DISORDER,1
MX,NEUROLOGICAL DECOMPENSATION,1
MX,NEUROPATHY PERIPHERAL,1
MX,NEUTROPENIA,1
MX,NIGHTMARE,1
MX,ODYNOPHAGIA,1
MX,OEDEMA PERIPHERAL,1
MX,OESOPHAGITIS,1
MX,ONYCHOMADESIS,1
MX,ONYCHOMYCOSIS,1
MX,OPTIC NERVE INJURY,1
MX,ORAL DISCOMFORT,1
MX,OSTEOARTHRITIS,1
MX,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
MX,PALPITATIONS,1
MX,PANIC ATTACK,1
MX,PARAESTHESIA,1
MX,PARALYSIS,1
MX,PARATHYROID TUMOUR BENIGN,1
MX,PELVIC INFLAMMATORY DISEASE,1
MX,PERIPHERAL SWELLING,1
MX,POOR QUALITY SLEEP,1
MX,PROCTALGIA,1
MX,PRODUCT USE IN UNAPPROVED INDICATION,1
MX,PULMONARY CONGESTION,1
MX,PURPURA,1
MX,PYREXIA,1
MX,RASH GENERALISED,1
MX,RASH MACULO-PAPULAR,1
MX,RENAL DISORDER,1
MX,RETINAL DISORDER,1
MX,RETINAL THICKENING,1
MX,ROAD TRAFFIC ACCIDENT,1
MX,SCIATIC NERVE INJURY,1
MX,SCIATICA,1
MX,SHOCK,1
MX,SKIN BURNING SENSATION,1
MX,SKIN HYPERPIGMENTATION,1
MX,SPINAL COLUMN INJURY,1
MX,SPINAL COMPRESSION FRACTURE,1
MX,SPINAL CORD DISORDER,1
MX,STRESS,1
MX,SUICIDAL IDEATION,1
MX,SWELLING,1
MX,SYNCOPE,1
MX,TACHYCARDIA,1
MX,TEARFULNESS,1
MX,THIRST,1
MX,THROAT TIGHTNESS,1
MX,TOOTH ABSCESS,1
MX,TRANSAMINASES INCREASED,1
MX,TREMOR,1
MX,TRISMUS,1
MX,TUMOUR NECROSIS,1
MX,ULCER,1
MX,UMBILICAL HERNIA,1
MX,UPPER AIRWAY OBSTRUCTION,1
MX,UPPER GASTROINTESTINAL HAEMORRHAGE,1
MX,URETHRAL PAIN,1
MX,URETHRITIS NONINFECTIVE,1
MX,URTICARIA,1
MX,VISUAL IMPAIRMENT,1
MX,VOMITING,1
MX,VULVOVAGINAL DRYNESS,1
MX,WHITE BLOOD CELL COUNT INCREASED,1
MX,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
NL,HYPOGLYCAEMIA,20
NL,LOSS OF CONSCIOUSNESS,10
NL,SHOCK,10
NL,TOXICITY TO VARIOUS AGENTS,10
NL,TREMOR,7
NL,BRADYCARDIA,6
NL,COMA,6
NL,HYPERTENSION,6
NL,ATRIOVENTRICULAR BLOCK COMPLETE,5
NL,FALL,5
NL,HYPOTENSION,5
NL,OLIGURIA,5
NL,PARKINSONISM,5
NL,CONDITION AGGRAVATED,4
NL,DIARRHOEA,4
NL,PYREXIA,4
NL,CEREBRAL HAEMORRHAGE,3
NL,CONFUSIONAL STATE,3
NL,LACERATION,3
NL,MUSCLE SPASMS,3
NL,NAUSEA,3
NL,PAIN IN EXTREMITY,3
NL,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,3
NL,SOMNOLENCE,3
NL,SYNCOPE,3
NL,TRISMUS,3
NL,VISUAL IMPAIRMENT,3
NL,ABORTION SPONTANEOUS,2
NL,ADVERSE DRUG REACTION,2
NL,AFFECT LABILITY,2
NL,ANXIETY,2
NL,APATHY,2
NL,ARTHRALGIA,2
NL,ASPIRATION,2
NL,ATRIOVENTRICULAR BLOCK,2
NL,COGNITIVE DISORDER,2
NL,CONSTIPATION,2
NL,CONVULSION,2
NL,COORDINATION ABNORMAL,2
NL,DEATH,2
NL,DEHYDRATION,2
NL,DIZZINESS,2
NL,DRUG INEFFECTIVE,2
NL,DYSARTHRIA,2
NL,EPILEPSY,2
NL,FATIGUE,2
NL,FEBRILE NEUTROPENIA,2
NL,HALLUCINATION,2
NL,INSOMNIA,2
NL,MALAISE,2
NL,MUSCLE TWITCHING,2
NL,MUSCULOSKELETAL PAIN,2
NL,MUSCULOSKELETAL STIFFNESS,2
NL,NEURALGIA,2
NL,NYSTAGMUS,2
NL,PAIN,2
NL,PRODUCT USE IN UNAPPROVED INDICATION,2
NL,REDUCED FACIAL EXPRESSION,2
NL,SENSORY DISTURBANCE,2
NL,TARDIVE DYSKINESIA,2
NL,ABASIA,1
NL,ABDOMINAL PAIN LOWER,1
NL,ABNORMAL BEHAVIOUR,1
NL,AGITATION,1
NL,AMAUROSIS FUGAX,1
NL,AMBLYOPIA,1
NL,APHASIA,1
NL,ARRHYTHMIA,1
NL,ARTHROPATHY,1
NL,ASTHENIA,1
NL,ATRIAL FIBRILLATION,1
NL,BLOOD LACTIC ACID INCREASED,1
NL,BURSITIS,1
NL,CARDIOVASCULAR DISORDER,1
NL,CEREBROVASCULAR ACCIDENT,1
NL,CHEST DISCOMFORT,1
NL,CHILLS,1
NL,CHOLECYSTITIS ACUTE,1
NL,CHOLELITHIASIS,1
NL,COGWHEEL RIGIDITY,1
NL,COMMINUTED FRACTURE,1
NL,COUGH,1
NL,CYTOPENIA,1
NL,DEFAECATION URGENCY,1
NL,DELUSION,1
NL,DEPENDENCE,1
NL,DEPRESSED MOOD,1
NL,DEPRESSION,1
NL,DIPLOPIA,1
NL,DISORIENTATION,1
NL,DISTURBANCE IN ATTENTION,1
NL,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
NL,DRUG EFFECT INCOMPLETE,1
NL,DRUG EFFECT VARIABLE,1
NL,DRUG LEVEL INCREASED,1
NL,DRUG WITHDRAWAL SYNDROME,1
NL,DYSKINESIA,1
NL,DYSPEPSIA,1
NL,DYSPHAGIA,1
NL,DYSPHONIA,1
NL,DYSPNOEA,1
NL,DYSSTASIA,1
NL,EAR INFECTION,1
NL,ECCHYMOSIS,1
NL,EMOTIONAL DISORDER,1
NL,ENDOMETRIOSIS,1
NL,ENTERITIS INFECTIOUS,1
NL,ERYTHEMA MULTIFORME,1
NL,EXPOSURE DURING PREGNANCY,1
NL,EYE MOVEMENT DISORDER,1
NL,FACIAL BONES FRACTURE,1
NL,FEAR,1
NL,FEEDING DISORDER,1
NL,FIBROMA,1
NL,FISTULA,1
NL,FLAT AFFECT,1
NL,FRACTURE,1
NL,GAIT DISTURBANCE,1
NL,GASTRITIS EROSIVE,1
NL,GASTROINTESTINAL DISORDER,1
NL,GROIN PAIN,1
NL,HAEMATEMESIS,1
NL,HEADACHE,1
NL,HEMIPARESIS,1
NL,HEPATITIS,1
NL,HERPES SIMPLEX ENCEPHALITIS,1
NL,HERPES ZOSTER,1
NL,HYPERHIDROSIS,1
NL,HYPERKINESIA,1
NL,HYPERSENSITIVITY,1
NL,HYPOACUSIS,1
NL,HYPOAESTHESIA,1
NL,HYPOALBUMINAEMIA,1
NL,HYPONATRAEMIA,1
NL,HYSTEROSALPINGO-OOPHORECTOMY,1
NL,INCREASED TENDENCY TO BRUISE,1
NL,INFLAMMATION,1
NL,INFLUENZA LIKE ILLNESS,1
NL,INJECTION SITE DISCOLOURATION,1
NL,JOINT STIFFNESS,1
NL,LARYNGITIS,1
NL,LIP SWELLING,1
NL,LIVER FUNCTION TEST ABNORMAL,1
NL,LUPUS-LIKE SYNDROME,1
NL,MATERNAL EXPOSURE BEFORE PREGNANCY,1
NL,MEMORY IMPAIRMENT,1
NL,METASTASES TO PELVIS,1
NL,MOBILITY DECREASED,1
NL,MUCOSAL INFLAMMATION,1
NL,MULTIPLE SCLEROSIS RELAPSE,1
NL,MUSCLE RIGIDITY,1
NL,MUSCULAR WEAKNESS,1
NL,MUSCULOSKELETAL DISCOMFORT,1
NL,MYASTHENIA GRAVIS,1
NL,MYOCARDIAL INFARCTION,1
NL,NEPHROLITHIASIS,1
NL,NEUROPATHY PERIPHERAL,1
NL,NEUTROPENIA,1
NL,OBSESSIVE THOUGHTS,1
NL,OBSESSIVE-COMPULSIVE DISORDER,1
NL,OBSTRUCTIVE AIRWAYS DISORDER,1
NL,OEDEMA PERIPHERAL,1
NL,ON AND OFF PHENOMENON,1
NL,OSTEOARTHRITIS,1
NL,OVERDOSE,1
NL,PARAESTHESIA,1
NL,PELVIC PAIN,1
NL,PERIPHERAL SWELLING,1
NL,PITUITARY TUMOUR BENIGN,1
NL,PNEUMONIA,1
NL,POOR QUALITY SLEEP,1
NL,PRODUCT USE ISSUE,1
NL,PURPURA,1
NL,RENAL IMPAIRMENT,1
NL,RESPIRATORY TRACT INFECTION,1
NL,RESTLESS LEGS SYNDROME,1
NL,RESTLESSNESS,1
NL,RHABDOMYOLYSIS,1
NL,SLEEP DISORDER,1
NL,SLUGGISHNESS,1
NL,SPEECH DISORDER,1
NL,STEVENS-JOHNSON SYNDROME,1
NL,STOMA SITE DISCHARGE,1
NL,STOMA SITE ERYTHEMA,1
NL,SUDDEN DEATH,1
NL,SWOLLEN TONGUE,1
NL,TENSION HEADACHE,1
NL,THIRST,1
NL,TRAUMATIC HAEMATOMA,1
NL,TRIGEMINAL NEURALGIA,1
NL,UNEVALUABLE EVENT,1
NL,URINARY TRACT INFECTION,1
NL,VERTIGO,1
NL,VESTIBULAR NYSTAGMUS,1
NL,VOMITING,1
NL,WOUND COMPLICATION,1
NZ,VOMITING,6
NZ,DYSPNOEA,5
NZ,AMNESIA,4
NZ,MALAISE,4
NZ,NAUSEA,4
NZ,ANAEMIA,3
NZ,ANXIETY,3
NZ,CONFUSIONAL STATE,3
NZ,DEPRESSED LEVEL OF CONSCIOUSNESS,3
NZ,DEPRESSION,3
NZ,FATIGUE,3
NZ,HEADACHE,3
NZ,HYPOMANIA,3
NZ,MEDICATION ERROR,3
NZ,NEPHROPATHY TOXIC,3
NZ,PAIN,3
NZ,SPINAL FUSION SURGERY,3
NZ,TOXICITY TO VARIOUS AGENTS,3
NZ,ACUTE MYOCARDIAL INFARCTION,2
NZ,CEREBROVASCULAR ACCIDENT,2
NZ,DISEASE PROGRESSION,2
NZ,DIZZINESS,2
NZ,DYSARTHRIA,2
NZ,DYSPHAGIA,2
NZ,HEPATIC ENCEPHALOPATHY,2
NZ,HEPATIC FAILURE,2
NZ,HEPATIC FUNCTION ABNORMAL,2
NZ,HYPERBILIRUBINAEMIA,2
NZ,HYPERHIDROSIS,2
NZ,HYPOGAMMAGLOBULINAEMIA,2
NZ,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,2
NZ,INTERSTITIAL LUNG DISEASE,2
NZ,MELAENA,2
NZ,PAIN IN EXTREMITY,2
NZ,PARAESTHESIA,2
NZ,RASH,2
NZ,RENAL FAILURE ACUTE,2
NZ,SEDATION,2
NZ,SLEEP APNOEA SYNDROME,2
NZ,SYNCOPE,2
NZ,URINARY TRACT INFECTION,2
NZ,ABDOMINAL DISTENSION,1
NZ,ABDOMINAL PAIN,1
NZ,ABNORMAL DREAMS,1
NZ,ALOPECIA,1
NZ,ANGINA PECTORIS,1
NZ,ARTHRODESIS,1
NZ,ASTHMA,1
NZ,ATAXIA,1
NZ,ATELECTASIS,1
NZ,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
NZ,BACK PAIN,1
NZ,BREAST CELLULITIS,1
NZ,BURNING SENSATION,1
NZ,CANDIDA INFECTION,1
NZ,CANDIDA SEPSIS,1
NZ,CARDIAC DISCOMFORT,1
NZ,CARDIAC FAILURE,1
NZ,CELLULITIS,1
NZ,CENTRAL NERVOUS SYSTEM LESION,1
NZ,CEREBELLAR INFARCTION,1
NZ,CHEST DISCOMFORT,1
NZ,CHILLS,1
NZ,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
NZ,CLOSTRIDIUM DIFFICILE INFECTION,1
NZ,COMPLEX REGIONAL PAIN SYNDROME,1
NZ,COUGH,1
NZ,CREPITATIONS,1
NZ,CYANOSIS,1
NZ,DEAFNESS,1
NZ,DEATH,1
NZ,DECREASED APPETITE,1
NZ,DELIRIUM,1
NZ,DEMENTIA,1
NZ,DEPENDENCE,1
NZ,DISEASE SUSCEPTIBILITY,1
NZ,DISTURBANCE IN ATTENTION,1
NZ,DIVERTICULITIS,1
NZ,DRUG DOSE OMISSION,1
NZ,DRUG EFFECT INCOMPLETE,1
NZ,DRUG INEFFECTIVE,1
NZ,DRUG WITHDRAWAL SYNDROME NEONATAL,1
NZ,DRY SKIN,1
NZ,DYSPEPSIA,1
NZ,EMOTIONAL DISORDER,1
NZ,EMOTIONAL DISTRESS,1
NZ,EMPHYSEMA,1
NZ,EXPOSURE DURING PREGNANCY,1
NZ,EYELID OEDEMA,1
NZ,EYELID PTOSIS,1
NZ,FALL,1
NZ,GAIT DISTURBANCE,1
NZ,GASTRIC HAEMORRHAGE,1
NZ,GASTROENTERITIS,1
NZ,HEART RATE INCREASED,1
NZ,HEMIPARESIS,1
NZ,HEMIPLEGIA,1
NZ,HEPATIC STEATOSIS,1
NZ,HEPATITIS CHOLESTATIC,1
NZ,HOSPITALISATION,1
NZ,HYPERTHYROIDISM,1
NZ,HYPERTONIA,1
NZ,HYPOAESTHESIA,1
NZ,INFECTION,1
NZ,INFLAMMATION,1
NZ,INFLAMMATORY MARKER INCREASED,1
NZ,INFREQUENT BOWEL MOVEMENTS,1
NZ,INTENTIONAL DRUG MISUSE,1
NZ,INTENTIONAL SELF-INJURY,1
NZ,JOINT ARTHROPLASTY,1
NZ,LOWER RESPIRATORY TRACT INFECTION,1
NZ,MANTLE CELL LYMPHOMA,1
NZ,MASTITIS,1
NZ,MATERNAL EXPOSURE DURING PREGNANCY,1
NZ,MENORRHAGIA,1
NZ,METASTASES TO CENTRAL NERVOUS SYSTEM,1
NZ,MIDDLE INSOMNIA,1
NZ,MIGRAINE,1
NZ,MOBILITY DECREASED,1
NZ,MUSCLE RIGIDITY,1
NZ,MYOCARDIAL INFARCTION,1
NZ,MYOCARDIAL ISCHAEMIA,1
NZ,NEURALGIA,1
NZ,NIGHTMARE,1
NZ,NON-CARDIAC CHEST PAIN,1
NZ,NON-SMALL CELL LUNG CANCER,1
NZ,NYSTAGMUS,1
NZ,OPTIC ATROPHY,1
NZ,ORTHOSTATIC HYPOTENSION,1
NZ,OSTEOPOROSIS,1
NZ,PALPITATIONS,1
NZ,PERIORBITAL OEDEMA,1
NZ,PHOTOPHOBIA,1
NZ,PNEUMONIA,1
NZ,PNEUMONIA ASPIRATION,1
NZ,POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME,1
NZ,PREMENSTRUAL SYNDROME,1
NZ,PRURITUS,1
NZ,PSYCHOTIC DISORDER,1
NZ,PULMONARY EMBOLISM,1
NZ,PULMONARY HYPERTENSION,1
NZ,PYREXIA,1
NZ,RASH MACULAR,1
NZ,RENAL IMPAIRMENT,1
NZ,RESPIRATORY FAILURE,1
NZ,RESPIRATORY MONILIASIS,1
NZ,RHABDOMYOLYSIS,1
NZ,RHINORRHOEA,1
NZ,SELF-MEDICATION,1
NZ,SENSORY LOSS,1
NZ,SEPSIS,1
NZ,SOFT TISSUE INJURY,1
NZ,SPUTUM CULTURE POSITIVE,1
NZ,SUICIDAL IDEATION,1
NZ,SUICIDE ATTEMPT,1
NZ,SWOLLEN TONGUE,1
NZ,TENDON RUPTURE,1
NZ,TINNITUS,1
NZ,TONGUE DRY,1
NZ,TONGUE MOVEMENT DISTURBANCE,1
NZ,TYPE 2 DIABETES MELLITUS,1
NZ,UROSEPSIS,1
NZ,VERTIGO,1
NZ,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
NZ,VISION BLURRED,1
NZ,WEIGHT BEARING DIFFICULTY,1
NZ,WEIGHT DECREASED,1
NZ,WHEEZING,1
NZ,WITHDRAWAL SYNDROME,1
NI,BLOOD PRESSURE INCREASED,1
NI,MULTIPLE SCLEROSIS RELAPSE,1
NI,SEIZURE,1
NI,STRESS AT WORK,1
NO,DYSARTHRIA,21
NO,FATIGUE,21
NO,DIZZINESS,19
NO,DRUG DEPENDENCE,16
NO,DRUG ABUSE,14
NO,ACUTE KIDNEY INJURY,13
NO,DRUG DIVERSION,13
NO,MYOCLONUS,12
NO,CONFUSIONAL STATE,11
NO,ALANINE AMINOTRANSFERASE INCREASED,10
NO,INTERCEPTED MEDICATION ERROR,10
NO,PAIN IN EXTREMITY,10
NO,WALKING DISABILITY,9
NO,AMNESIA,8
NO,ASPARTATE AMINOTRANSFERASE INCREASED,8
NO,ATAXIA,8
NO,FACIAL PARESIS,8
NO,NEUROPATHY PERIPHERAL,8
NO,WRONG DRUG ADMINISTERED,8
NO,HEADACHE,7
NO,MALAISE,7
NO,MYOCARDIAL INFARCTION,7
NO,REBOUND EFFECT,7
NO,RENAL FAILURE,7
NO,NAUSEA,6
NO,DRUG INEFFECTIVE,5
NO,DYSPNOEA,5
NO,GAMMA-GLUTAMYLTRANSFERASE INCREASED,5
NO,HYPERKALAEMIA,5
NO,HYPOGLYCAEMIA,5
NO,HYPOTENSION,5
NO,HYPOTHERMIA,5
NO,LACTIC ACIDOSIS,5
NO,SEDATION,5
NO,SINUS BRADYCARDIA,5
NO,ABORTION SPONTANEOUS,4
NO,ACUTE HEPATIC FAILURE,4
NO,ASTHENIA,4
NO,BALANCE DISORDER,4
NO,CIRCULATORY COLLAPSE,4
NO,DEPRESSION,4
NO,DIABETIC KETOACIDOSIS,4
NO,DIARRHOEA,4
NO,FEMUR FRACTURE,4
NO,GENERAL PHYSICAL HEALTH DETERIORATION,4
NO,HALLUCINATION,4
NO,HOSTILITY,4
NO,MOOD ALTERED,4
NO,MYALGIA,4
NO,PARAESTHESIA,4
NO,PNEUMONIA,4
NO,POLYNEUROPATHY,4
NO,PSYCHOTIC DISORDER,4
NO,SWEAT GLAND DISORDER,4
NO,ABDOMINAL PAIN,3
NO,BLOOD PRESSURE FLUCTUATION,3
NO,DIPLOPIA,3
NO,EYELID PTOSIS,3
NO,HYPOKINESIA,3
NO,INSOMNIA,3
NO,INTERMITTENT CLAUDICATION,3
NO,LOSS OF CONSCIOUSNESS,3
NO,MUSCLE ATROPHY,3
NO,MUSCULAR WEAKNESS,3
NO,MYASTHENIA GRAVIS,3
NO,MYELOPATHY,3
NO,OSTEONECROSIS OF JAW,3
NO,PAIN,3
NO,PSYCHOTIC BEHAVIOUR,3
NO,SOMNOLENCE,3
NO,SUICIDAL IDEATION,3
NO,SUSPICIOUSNESS,3
NO,THINKING ABNORMAL,3
NO,TREMOR,3
NO,WITHDRAWAL SYNDROME,3
NO,ACTIVITIES OF DAILY LIVING IMPAIRED,2
NO,ALOPECIA,2
NO,ANXIETY,2
NO,APATHY,2
NO,ARTERIOSCLEROSIS,2
NO,BURNING SENSATION,2
NO,CHEST PAIN,2
NO,CHILLS,2
NO,COMMUNICATION DISORDER,2
NO,CONDITION AGGRAVATED,2
NO,CRYING,2
NO,DELUSION,2
NO,DIPLEGIA,2
NO,DRUG CLEARANCE DECREASED,2
NO,DRUG EFFECT INCOMPLETE,2
NO,DRY MOUTH,2
NO,EMBOLISM ARTERIAL,2
NO,EOSINOPHILIA,2
NO,EPILEPSY,2
NO,FAECAL INCONTINENCE,2
NO,FEELING ABNORMAL,2
NO,FEELING OF DESPAIR,2
NO,FRUSTRATION,2
NO,HAEMOGLOBIN DECREASED,2
NO,HYPERSENSITIVITY,2
NO,HYPOACUSIS,2
NO,INFECTION,2
NO,IRRITABILITY,2
NO,MATERNAL EXPOSURE DURING PREGNANCY,2
NO,MEDICATION ERROR,2
NO,MIGRAINE,2
NO,NECK PAIN,2
NO,OSTEITIS,2
NO,PERIPHERAL ISCHAEMIA,2
NO,PERSONALITY CHANGE,2
NO,PLATELET COUNT INCREASED,2
NO,PRODUCT USE IN UNAPPROVED INDICATION,2
NO,PYREXIA,2
NO,SJOGREN^S SYNDROME,2
NO,SUICIDE ATTEMPT,2
NO,TINNITUS,2
NO,URINARY INCONTINENCE,2
NO,VISUAL IMPAIRMENT,2
NO,VOMITING,2
NO,ABDOMINAL DISCOMFORT,1
NO,ABNORMAL BEHAVIOUR,1
NO,ACUTE MYOCARDIAL INFARCTION,1
NO,AFFECT LABILITY,1
NO,AGGRESSION,1
NO,ANGER,1
NO,ANTIDEPRESSANT DRUG LEVEL,1
NO,AORTIC THROMBOSIS,1
NO,APPENDICITIS,1
NO,APPLICATION SITE PAIN,1
NO,APPLICATION SITE WARMTH,1
NO,ARTERIAL DISORDER,1
NO,ARTERIAL THROMBOSIS,1
NO,ARTHRALGIA,1
NO,ASTHMA,1
NO,ATRIAL FLUTTER,1
NO,AUDITORY DISORDER,1
NO,BACK PAIN,1
NO,BLOOD BILIRUBIN INCREASED,1
NO,BLOOD LACTATE DEHYDROGENASE INCREASED,1
NO,BONE MARROW FAILURE,1
NO,CAESAREAN SECTION,1
NO,CARDIAC ARREST,1
NO,CARDIAC VENTRICULAR THROMBOSIS,1
NO,CARDIOMYOPATHY,1
NO,CARDIOVASCULAR DISORDER,1
NO,CEREBRAL ARTERY OCCLUSION,1
NO,CEREBRAL ARTERY STENOSIS,1
NO,CEREBRAL DISORDER,1
NO,CEREBRAL HAEMORRHAGE,1
NO,CEREBRAL INFARCTION,1
NO,CEREBROVASCULAR DISORDER,1
NO,CHOKING,1
NO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
NO,CONGENITAL ANOMALY,1
NO,CONGENITAL CYSTIC KIDNEY DISEASE,1
NO,CONNECTIVE TISSUE DISORDER,1
NO,CONSTIPATION,1
NO,CONTUSION,1
NO,CORONARY ARTERY OCCLUSION,1
NO,DEAFNESS,1
NO,DECREASED APPETITE,1
NO,DELIRIUM,1
NO,DEMENTIA,1
NO,DEPRESSED LEVEL OF CONSCIOUSNESS,1
NO,DEPRESSIVE SYMPTOM,1
NO,DEREALISATION,1
NO,DERMATITIS,1
NO,DISEASE PROGRESSION,1
NO,DISSOCIATION,1
NO,DISTURBANCE IN SOCIAL BEHAVIOUR,1
NO,DRUG DISPENSED TO WRONG PATIENT,1
NO,DRUG EFFECT DECREASED,1
NO,DRUG EFFECT DELAYED,1
NO,DRUG ERUPTION,1
NO,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
NO,DRUG SCREEN POSITIVE,1
NO,DRUG WITHDRAWAL SYNDROME,1
NO,DRY EYE,1
NO,DYSGEUSIA,1
NO,EATING DISORDER,1
NO,ELECTROLYTE IMBALANCE,1
NO,EMOTIONAL POVERTY,1
NO,EMPHYSEMA,1
NO,ENCEPHALITIS,1
NO,ENTERITIS,1
NO,ERYSIPELAS,1
NO,ERYTHEMA,1
NO,EXTRADURAL HAEMATOMA,1
NO,EYE SWELLING,1
NO,FEELING HOT,1
NO,FOETAL EXPOSURE DURING PREGNANCY,1
NO,FOETAL GROWTH RESTRICTION,1
NO,FOLLICLE CENTRE LYMPHOMA_ FOLLICULAR GRADE I_ II_ III STAGE III,1
NO,GAIT DISTURBANCE,1
NO,GENERALISED ANXIETY DISORDER,1
NO,GINGIVITIS,1
NO,HAEMATOMA,1
NO,HAEMORRHAGE,1
NO,HAEMORRHOIDS,1
NO,HANGOVER,1
NO,HEPATIC STEATOSIS,1
NO,HEPATITIS,1
NO,HYPERCHLORHYDRIA,1
NO,HYPERGLYCAEMIA,1
NO,HYPERHIDROSIS,1
NO,HYPOAESTHESIA,1
NO,HYPOKALAEMIA,1
NO,INCORRECT DOSE ADMINISTERED,1
NO,INDIFFERENCE,1
NO,INFARCTION,1
NO,INTENTIONAL DRUG MISUSE,1
NO,IRRITABLE BOWEL SYNDROME,1
NO,KLINEFELTER^S SYNDROME,1
NO,LARGE INTESTINAL STENOSIS,1
NO,LARGE INTESTINE POLYP,1
NO,LETHARGY,1
NO,LIMB DISCOMFORT,1
NO,LIMB REDUCTION DEFECT,1
NO,LISTLESS,1
NO,LIVER TRANSPLANT,1
NO,LOSS OF LIBIDO,1
NO,LOW BIRTH WEIGHT BABY,1
NO,LYMPHADENOPATHY,1
NO,LYMPHOCYTE COUNT DECREASED,1
NO,MALIGNANT MELANOMA,1
NO,MALIGNANT NEOPLASM PROGRESSION,1
NO,MENOPAUSE,1
NO,METABOLIC ACIDOSIS,1
NO,METASTASES TO LUNG,1
NO,METASTASES TO LYMPH NODES,1
NO,METASTATIC NEOPLASM,1
NO,MICROENCEPHALY,1
NO,MULTI-ORGAN FAILURE,1
NO,MULTIPLE CONGENITAL ABNORMALITIES,1
NO,MUSCLE TWITCHING,1
NO,MUSCULOSKELETAL PAIN,1
NO,NASOPHARYNGITIS,1
NO,NERVOUSNESS,1
NO,NEURALGIC AMYOTROPHY,1
NO,OCULAR HYPERAEMIA,1
NO,ODYNOPHAGIA,1
NO,OROPHARYNGEAL PAIN,1
NO,PALLOR,1
NO,PARANOIA,1
NO,PCO2 INCREASED,1
NO,PHARYNGEAL OEDEMA,1
NO,PHARYNGITIS,1
NO,PNEUMONIA HERPES VIRAL,1
NO,PNEUMOTHORAX,1
NO,POISONING,1
NO,PRE-EXISTING CONDITION IMPROVED,1
NO,PRODUCT USE ISSUE,1
NO,PROSTATE CANCER,1
NO,PULMONARY EMBOLISM,1
NO,QUADRIPLEGIA,1
NO,RASH,1
NO,REACTION TO DRUG EXCIPIENTS,1
NO,RENAL ARTERY THROMBOSIS,1
NO,RESPIRATORY ARREST,1
NO,RESTLESSNESS,1
NO,RHYTHM IDIOVENTRICULAR,1
NO,SCIATICA,1
NO,SCREAMING,1
NO,SEPSIS,1
NO,SLEEP DISORDER,1
NO,SPINA BIFIDA,1
NO,SPINAL FRACTURE,1
NO,STOMATITIS,1
NO,STUPOR,1
NO,SUBCUTANEOUS ABSCESS,1
NO,SUICIDAL BEHAVIOUR,1
NO,SWELLING FACE,1
NO,SWOLLEN TONGUE,1
NO,SYNCOPE,1
NO,THERAPEUTIC RESPONSE UNEXPECTED,1
NO,THYMOMA,1
NO,THYMUS ENLARGEMENT,1
NO,TOXICITY TO VARIOUS AGENTS,1
NO,TRISOMY 21,1
NO,TUMOUR LYSIS SYNDROME,1
NO,ULTRASOUND ANTENATAL SCREEN,1
NO,VARICELLA,1
NO,VISUAL ACUITY REDUCED,1
NO,VON WILLEBRAND^S FACTOR ANTIGEN DECREASED,1
NO,WAIST CIRCUMFERENCE INCREASED,1
NO,WEIGHT DECREASED,1
NO,YELLOW SKIN,1
PK,CENTRAL NERVOUS SYSTEM DERMOID TUMOUR,1
PK,DEATH,1
PK,DEPRESSION,1
PK,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
PK,EPILEPSY,1
PK,HAEMOGLOBIN DECREASED,1
PK,MEMORY IMPAIRMENT,1
PK,PLATELET COUNT DECREASED,1
PK,SEIZURE,1
PA,ANAEMIA,1
PA,ASTIGMATISM,1
PA,BALANCE DISORDER,1
PA,BRADYCARDIA,1
PA,BRAIN OEDEMA,1
PA,CENTRAL NERVOUS SYSTEM LESION,1
PA,CHEST PAIN,1
PA,CHILLS,1
PA,COUGH,1
PA,DECREASED IMMUNE RESPONSIVENESS,1
PA,DEPRESSION,1
PA,DIZZINESS,1
PA,EYE SWELLING,1
PA,FATIGUE,1
PA,FIBROMYALGIA,1
PA,HEADACHE,1
PA,HYPERTENSION,1
PA,HYPOAESTHESIA,1
PA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PA,INFLUENZA,1
PA,IRRITABLE BOWEL SYNDROME,1
PA,LIMB DISCOMFORT,1
PA,MALAISE,1
PA,MELANOCYTIC NAEVUS,1
PA,MENINGIOMA,1
PA,MIGRAINE,1
PA,MULTIPLE SCLEROSIS,1
PA,MULTIPLE SCLEROSIS RELAPSE,1
PA,MUSCULAR WEAKNESS,1
PA,MYOPIA,1
PA,NASOPHARYNGITIS,1
PA,OEDEMA,1
PA,OPTIC NEURITIS,1
PA,PAIN,1
PA,PAIN IN EXTREMITY,1
PA,PERIPHERAL VENOUS DISEASE,1
PA,PRESCRIBED UNDERDOSE,1
PA,PYREXIA,1
PA,SKIN ULCER,1
PA,STRESS,1
PA,VIRAL PHARYNGITIS,1
PA,VISUAL IMPAIRMENT,1
PE,DEATH,21
PE,PNEUMONIA,4
PE,CEREBROVASCULAR ACCIDENT,2
PE,CONDITION AGGRAVATED,2
PE,DRUG EFFECT INCOMPLETE,2
PE,DRUG INEFFECTIVE,2
PE,GASTRITIS,2
PE,HEADACHE,2
PE,HYPERTENSION,2
PE,HYPOGLYCAEMIA,2
PE,INFECTION,2
PE,LIMB DISCOMFORT,2
PE,MALAISE,2
PE,URINARY TRACT INFECTION,2
PE,ABASIA,1
PE,ABDOMINAL PAIN UPPER,1
PE,ABNORMAL FAECES,1
PE,ACUTE MYOCARDIAL INFARCTION,1
PE,ARRHYTHMIA,1
PE,ASTHENIA,1
PE,ATRIAL FIBRILLATION,1
PE,BEDRIDDEN,1
PE,BIPOLAR DISORDER,1
PE,BLOOD CHOLESTEROL ABNORMAL,1
PE,BLOOD PHOSPHORUS INCREASED,1
PE,BONE DISORDER,1
PE,BONE PAIN,1
PE,BREAST CANCER,1
PE,BRUCELLOSIS,1
PE,BURSITIS,1
PE,CARDIAC ARREST,1
PE,CARDIAC PSEUDOANEURYSM,1
PE,CARDIOMYOPATHY,1
PE,CEREBRAL INFARCTION,1
PE,CONTUSION,1
PE,CORONARY ARTERY DISEASE,1
PE,DEAFNESS,1
PE,DECREASED APPETITE,1
PE,DEEP VEIN THROMBOSIS,1
PE,DEPRESSION,1
PE,DIABETES MELLITUS,1
PE,DIABETIC COMA,1
PE,DISCOMFORT,1
PE,DISEASE RECURRENCE,1
PE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
PE,DYSPNOEA,1
PE,DYSSTASIA,1
PE,EMOTIONAL DISORDER,1
PE,FALL,1
PE,FEELING ABNORMAL,1
PE,FLUID RETENTION,1
PE,GAIT DISTURBANCE,1
PE,GASTROINTESTINAL DISORDER,1
PE,GASTROOESOPHAGEAL REFLUX DISEASE,1
PE,HAEMOGLOBIN DECREASED,1
PE,HEAD DEFORMITY,1
PE,HEART ALTERNATION,1
PE,HIATUS HERNIA,1
PE,HYPERKALAEMIA,1
PE,IMMUNODEFICIENCY,1
PE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PE,INFLAMMATION,1
PE,INTENTIONAL PRODUCT MISUSE,1
PE,LOWER LIMB FRACTURE,1
PE,LUNG INFECTION,1
PE,MACULAR HOLE,1
PE,MENOPAUSE,1
PE,MUSCULAR WEAKNESS,1
PE,MYOCARDIAL INFARCTION,1
PE,NAUSEA,1
PE,NEURALGIA,1
PE,NEUROPATHY PERIPHERAL,1
PE,OSTEOARTHRITIS,1
PE,OVERDOSE,1
PE,PAIN,1
PE,PAIN IN EXTREMITY,1
PE,PERIPHERAL SWELLING,1
PE,PHARYNGITIS,1
PE,PNEUMONIA BACTERIAL,1
PE,PSYCHIATRIC SYMPTOM,1
PE,PULMONARY THROMBOSIS,1
PE,PYREXIA,1
PE,RASH PRURITIC,1
PE,RENAL DISORDER,1
PE,RENAL FAILURE,1
PE,SEIZURE,1
PE,SKIN DISCOLOURATION,1
PE,SKIN DISORDER,1
PE,SKIN ULCER,1
PE,SLEEP APNOEA SYNDROME,1
PE,SOFT TISSUE INJURY,1
PE,SOMNOLENCE,1
PE,SWELLING,1
PE,TACHYCARDIA,1
PE,THROMBOSIS,1
PE,UNDERWEIGHT,1
PE,VISUAL ACUITY REDUCED,1
PE,WEIGHT DECREASED,1
PE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
PH,DYSPHAGIA,2
PH,ABDOMINAL DISCOMFORT,1
PH,ABDOMINAL PAIN UPPER,1
PH,BREAST CANCER FEMALE,1
PH,DIARRHOEA,1
PH,DYSPNOEA,1
PH,HEADACHE,1
PH,HYPERSENSITIVITY,1
PH,LUNG INFECTION,1
PH,MYALGIA,1
PH,WHEEZING,1
PL,DRUG INEFFECTIVE,10
PL,CONFUSIONAL STATE,7
PL,DIZZINESS,7
PL,BALANCE DISORDER,6
PL,DYSPNOEA,6
PL,ASPARTATE AMINOTRANSFERASE INCREASED,5
PL,PNEUMONIA,5
PL,ALANINE AMINOTRANSFERASE INCREASED,4
PL,ANGIOEDEMA,4
PL,DRUG ERUPTION,4
PL,EOSINOPHILIA,4
PL,LEUKOCYTOSIS,4
PL,NEUTROPHILIA,4
PL,PLASMA CELL MYELOMA,4
PL,SOMNOLENCE,4
PL,VOMITING,4
PL,ALOPECIA,3
PL,ANAEMIA,3
PL,CONDITION AGGRAVATED,3
PL,CONSTIPATION,3
PL,CORONARY ARTERY DISEASE,3
PL,DELIRIUM,3
PL,DIARRHOEA,3
PL,HYPOAESTHESIA,3
PL,NEURALGIA,3
PL,PAIN IN EXTREMITY,3
PL,PATHOLOGICAL FRACTURE,3
PL,RENAL IMPAIRMENT,3
PL,TACHYCARDIA,3
PL,THROMBOCYTOPENIA,3
PL,ABDOMINAL DISCOMFORT,2
PL,ADENOCARCINOMA GASTRIC,2
PL,ARTHRALGIA,2
PL,ARTHROPOD BITE,2
PL,BLOOD PRESSURE DECREASED,2
PL,BLOOD PRESSURE INCREASED,2
PL,CANDIDIASIS,2
PL,DRY MOUTH,2
PL,DYSPEPSIA,2
PL,GASTRIC MUCOSA ERYTHEMA,2
PL,GASTRIC MUCOSAL HYPERTROPHY,2
PL,GASTRITIS EROSIVE,2
PL,GASTRITIS HAEMORRHAGIC,2
PL,GASTROINTESTINAL OEDEMA,2
PL,GENERAL PHYSICAL HEALTH DETERIORATION,2
PL,HAEMORRHOIDS,2
PL,HELICOBACTER INFECTION,2
PL,HYPOTENSION,2
PL,LIVER INJURY,2
PL,LOSS OF CONSCIOUSNESS,2
PL,NAUSEA,2
PL,OVERDOSE,2
PL,PAIN,2
PL,RASH,2
PL,RENAL INJURY,2
PL,RESTLESS LEGS SYNDROME,2
PL,SEIZURE,2
PL,SPINAL OSTEOARTHRITIS,2
PL,VERTIGO,2
PL,VISION BLURRED,2
PL,VISUAL ACUITY REDUCED,2
PL,WEIGHT INCREASED,2
PL,ABASIA,1
PL,ABDOMINAL DISTENSION,1
PL,ACTIVITIES OF DAILY LIVING IMPAIRED,1
PL,AFFECT LABILITY,1
PL,AMBLYOPIA,1
PL,ANXIETY,1
PL,ARRHYTHMIA,1
PL,ASTHENIA,1
PL,AXONAL NEUROPATHY,1
PL,BEDRIDDEN,1
PL,BLINDNESS UNILATERAL,1
PL,BLOOD CREATININE INCREASED,1
PL,BLOOD PRESSURE ABNORMAL,1
PL,BLOOD THYROID STIMULATING HORMONE INCREASED,1
PL,BODY TEMPERATURE DECREASED,1
PL,BONE MARROW FAILURE,1
PL,BRADYCARDIA,1
PL,BREAST FEEDING,1
PL,CAESAREAN SECTION,1
PL,CAROTID ARTERY OCCLUSION,1
PL,CHEST PAIN,1
PL,CHRONIC KIDNEY DISEASE,1
PL,COGNITIVE DISORDER,1
PL,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
PL,COMPRESSION FRACTURE,1
PL,CONTUSION,1
PL,CONVULSION,1
PL,DEATH,1
PL,DECREASED APPETITE,1
PL,DEPENDENT PERSONALITY DISORDER,1
PL,DEPRESSED MOOD,1
PL,DEPRESSION,1
PL,DEPRESSIVE SYMPTOM,1
PL,DRUG EFFECT INCOMPLETE,1
PL,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
PL,DRUG INTOLERANCE,1
PL,DRY SKIN,1
PL,DYSKINESIA,1
PL,DYSSTASIA,1
PL,ELECTROCARDIOGRAM QT PROLONGED,1
PL,EMBOLISM,1
PL,ENTEROBACTER INFECTION,1
PL,EOSINOPHIL COUNT DECREASED,1
PL,EPISTAXIS,1
PL,ERYTHEMA,1
PL,EYE SWELLING,1
PL,FATIGUE,1
PL,FLATULENCE,1
PL,FLUID OVERLOAD,1
PL,FREQUENT BOWEL MOVEMENTS,1
PL,GASTRIC POLYPS,1
PL,GASTRITIS,1
PL,GENERAL PHYSICAL CONDITION ABNORMAL,1
PL,HAEMATOCRIT DECREASED,1
PL,HAEMATURIA,1
PL,HAEMOGLOBIN DECREASED,1
PL,HEAD BANGING,1
PL,HEADACHE,1
PL,HEART RATE INCREASED,1
PL,HERPES ZOSTER,1
PL,HOSPITALISATION,1
PL,HYDRONEPHROSIS,1
PL,HYPERSOMNIA,1
PL,HYPOREFLEXIA,1
PL,HYPOTHYROIDISM,1
PL,ILEUS PARALYTIC,1
PL,ILLOGICAL THINKING,1
PL,IMMUNODEFICIENCY,1
PL,INTERNATIONAL NORMALISED RATIO INCREASED,1
PL,INTERVERTEBRAL DISC SPACE NARROWING,1
PL,KYPHOSIS,1
PL,LEFT ATRIAL ENLARGEMENT,1
PL,LEFT VENTRICULAR HYPERTROPHY,1
PL,LEUKOPENIA,1
PL,LOWER RESPIRATORY TRACT INFECTION,1
PL,LYMPHOCYTE COUNT INCREASED,1
PL,MEAN PLATELET VOLUME INCREASED,1
PL,MEDICATION ERROR,1
PL,MEMORY IMPAIRMENT,1
PL,MENSTRUATION IRREGULAR,1
PL,MENTAL DISORDER,1
PL,METASTASES TO LUNG,1
PL,METASTASES TO LYMPH NODES,1
PL,MOBILITY DECREASED,1
PL,MONOCYTE COUNT INCREASED,1
PL,MUSCLE SPASMS,1
PL,MUSCULAR WEAKNESS,1
PL,MYALGIA,1
PL,NEPHROPATHY TOXIC,1
PL,NEPHROSCLEROSIS,1
PL,NEUROPATHY PERIPHERAL,1
PL,NEUTROPENIA,1
PL,NEUTROPHIL COUNT INCREASED,1
PL,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
PL,OSTEITIS,1
PL,OSTEONECROSIS OF JAW,1
PL,OSTEOPENIA,1
PL,PALLOR,1
PL,PARAPARESIS,1
PL,PELVIC VENOUS THROMBOSIS,1
PL,PERICARDIAL DISEASE,1
PL,PERIPHERAL SWELLING,1
PL,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
PL,PNEUMONIA BACTERIAL,1
PL,POLYDIPSIA,1
PL,POLYNEUROPATHY,1
PL,POLYP,1
PL,POSTPERICARDIOTOMY SYNDROME,1
PL,PREGNANCY,1
PL,PRODUCT SUBSTITUTION ISSUE,1
PL,PRODUCT USE IN UNAPPROVED INDICATION,1
PL,PRODUCT USE ISSUE,1
PL,PSEUDOMONAS INFECTION,1
PL,PSYCHOTIC DISORDER,1
PL,PYREXIA,1
PL,RASH ERYTHEMATOUS,1
PL,RASH PRURITIC,1
PL,RED BLOOD CELL COUNT DECREASED,1
PL,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
PL,RED CELL DISTRIBUTION WIDTH INCREASED,1
PL,RENAL CYST,1
PL,RESPIRATORY FAILURE,1
PL,RESPIRATORY TRACT INFECTION,1
PL,RETCHING,1
PL,RHINITIS ATROPHIC,1
PL,RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED,1
PL,SALIVARY GLAND NEOPLASM,1
PL,SENSORY DISTURBANCE,1
PL,SPINAL FLATTENING,1
PL,STATUS EPILEPTICUS,1
PL,SUBILEUS,1
PL,SUDDEN DEATH,1
PL,SWELLING FACE,1
PL,SWOLLEN TONGUE,1
PL,TEMPERATURE INTOLERANCE,1
PL,TEMPORAL ARTERITIS,1
PL,THERAPY RESPONDER,1
PL,TOXICITY TO VARIOUS AGENTS,1
PL,TREMOR,1
PL,TRIGEMINAL NEURALGIA,1
PL,TUMOUR HAEMORRHAGE,1
PL,URETERAL NECROSIS,1
PL,URINARY FISTULA,1
PL,URINARY TRACT INFECTION,1
PL,VENA CAVA THROMBOSIS,1
PL,VENTRICULAR ARRHYTHMIA,1
PL,VISUAL FIELD DEFECT,1
PL,VISUAL IMPAIRMENT,1
PL,WHITE BLOOD CELL COUNT INCREASED,1
PT,FATIGUE,4
PT,PAIN IN EXTREMITY,4
PT,ASTHENIA,3
PT,DECREASED APPETITE,3
PT,DIARRHOEA,3
PT,HAEMOGLOBIN DECREASED,3
PT,PYREXIA,3
PT,SOMNOLENCE,3
PT,THROMBOCYTOPENIA,3
PT,AUTOIMMUNE HAEMOLYTIC ANAEMIA,2
PT,BLOOD LACTATE DEHYDROGENASE INCREASED,2
PT,BRONCHOSPASM,2
PT,CHILLS,2
PT,DEATH,2
PT,EYELID OEDEMA,2
PT,FAECAL INCONTINENCE,2
PT,GAIT DISTURBANCE,2
PT,GENERAL PHYSICAL HEALTH DETERIORATION,2
PT,HERPES ZOSTER,2
PT,HYPERTENSION,2
PT,HYPOTENSION,2
PT,HYPOXIA,2
PT,INJECTION SITE INFLAMMATION,2
PT,INTENTIONAL PRODUCT MISUSE,2
PT,LEUKOCYTOSIS,2
PT,LIVEDO RETICULARIS,2
PT,MEMORY IMPAIRMENT,2
PT,MUSCULAR WEAKNESS,2
PT,NAUSEA,2
PT,NEUROPATHY PERIPHERAL,2
PT,NEUTROPENIA,2
PT,OEDEMA PERIPHERAL,2
PT,OLIGURIA,2
PT,PAIN,2
PT,PANCREATIC CARCINOMA,2
PT,PNEUMONIA,2
PT,PRODUCT USE IN UNAPPROVED INDICATION,2
PT,PRURITUS,2
PT,TACHYCARDIA,2
PT,VISUAL IMPAIRMENT,2
PT,WEIGHT DECREASED,2
PT,WEIGHT INCREASED,2
PT,ABDOMINAL PAIN,1
PT,ACNE,1
PT,ACUTE HEPATIC FAILURE,1
PT,ACUTE KIDNEY INJURY,1
PT,ADENOCARCINOMA,1
PT,AGGRESSION,1
PT,AGITATION,1
PT,ALANINE AMINOTRANSFERASE INCREASED,1
PT,ANAEMIA,1
PT,ASPARTATE AMINOTRANSFERASE INCREASED,1
PT,ATAXIA,1
PT,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
PT,BACK PAIN,1
PT,BALANCE DISORDER,1
PT,BENIGN PROSTATIC HYPERPLASIA,1
PT,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
PT,BLOOD PRESSURE INCREASED,1
PT,BODY TEMPERATURE INCREASED,1
PT,BONE MARROW FAILURE,1
PT,BRONCHITIS,1
PT,CACHEXIA,1
PT,CARCINOID SYNDROME,1
PT,CARDIAC FAILURE CONGESTIVE,1
PT,COGNITIVE DISORDER,1
PT,COMA,1
PT,CONDITION AGGRAVATED,1
PT,CONTUSION,1
PT,DEPERSONALISATION,1
PT,DEPRESSION,1
PT,DIPLOPIA,1
PT,DISTURBANCE IN ATTENTION,1
PT,DRUG INEFFECTIVE,1
PT,DYSPHONIA,1
PT,DYSPNOEA,1
PT,DYSURIA,1
PT,EOSINOPHILIA,1
PT,EPISTAXIS,1
PT,ERYTHEMA,1
PT,EXPOSURE DURING PREGNANCY,1
PT,EYE PAIN,1
PT,FEBRILE NEUTROPENIA,1
PT,FLUSHING,1
PT,FRONTOTEMPORAL DEMENTIA,1
PT,GINGIVAL BLEEDING,1
PT,HAEMATOTOXICITY,1
PT,HAEMATURIA,1
PT,HAEMORRHAGE INTRACRANIAL,1
PT,HAPTOGLOBIN DECREASED,1
PT,HEADACHE,1
PT,HEMIPARESIS,1
PT,HYPERCAPNIA,1
PT,HYPERPHAGIA,1
PT,HYPOAESTHESIA,1
PT,HYPOGLYCAEMIA,1
PT,INFECTION,1
PT,INFLUENZA,1
PT,INFLUENZA LIKE ILLNESS,1
PT,ISCHAEMIC STROKE,1
PT,LEUKOCYTURIA,1
PT,LEUKOENCEPHALOPATHY,1
PT,MALAISE,1
PT,MATERNAL EXPOSURE DURING PREGNANCY,1
PT,METABOLIC ACIDOSIS,1
PT,METASTASES TO BONE,1
PT,METASTASES TO LIVER,1
PT,MULTI-ORGAN FAILURE,1
PT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
PT,MULTIPLE SCLEROSIS,1
PT,MULTIPLE SCLEROSIS RELAPSE,1
PT,MYALGIA,1
PT,NEPHRITIS ALLERGIC,1
PT,NEUTROPHILIA,1
PT,OXYGEN SATURATION DECREASED,1
PT,PANCYTOPENIA,1
PT,PARAESTHESIA,1
PT,PNEUMONIA MYCOPLASMAL,1
PT,PRODUCTIVE COUGH,1
PT,PROTEINURIA,1
PT,RASH GENERALISED,1
PT,RASH MACULO-PAPULAR,1
PT,RASH MORBILLIFORM,1
PT,RASH PRURITIC,1
PT,RENAL IMPAIRMENT,1
PT,RESPIRATORY ACIDOSIS,1
PT,RESPIRATORY FATIGUE,1
PT,SEPSIS,1
PT,SEPTIC SHOCK,1
PT,SKIN EXFOLIATION,1
PT,SKIN LESION,1
PT,STRONGYLOIDIASIS,1
PT,SUICIDE ATTEMPT,1
PT,THERAPEUTIC RESPONSE UNEXPECTED,1
PT,TOXICITY TO VARIOUS AGENTS,1
PT,TREATMENT FAILURE,1
PT,TUBULOINTERSTITIAL NEPHRITIS,1
PT,URINARY INCONTINENCE,1
PT,URINARY RETENTION,1
PT,URINARY TRACT INFECTION,1
PT,URINE OUTPUT DECREASED,1
PT,UTERINE CANCER,1
PT,VISION BLURRED,1
PT,VISUAL FIELD DEFECT,1
PR,INJECTION SITE PAIN,123
PR,PAIN,80
PR,NASOPHARYNGITIS,65
PR,ARTHRALGIA,55
PR,DRUG INEFFECTIVE,47
PR,HEADACHE,45
PR,FATIGUE,44
PR,INFLAMMATION,36
PR,PAIN IN EXTREMITY,36
PR,NAUSEA,31
PR,DIARRHOEA,30
PR,DIZZINESS,28
PR,INJECTION SITE ERYTHEMA,28
PR,ASTHENIA,24
PR,FALL,24
PR,MALAISE,24
PR,PYREXIA,24
PR,VOMITING,24
PR,PSORIASIS,22
PR,BRONCHITIS,21
PR,COUGH,21
PR,INJECTION SITE PRURITUS,21
PR,ASTHMA,20
PR,URINARY TRACT INFECTION,19
PR,BURNING SENSATION,18
PR,ABDOMINAL PAIN,17
PR,HYPERSENSITIVITY,17
PR,HYPERTENSION,17
PR,PRURITUS,17
PR,ARTHRITIS,16
PR,DYSPNOEA,15
PR,HAEMOGLOBIN DECREASED,15
PR,DEPRESSION,14
PR,WEIGHT DECREASED,14
PR,BACK PAIN,13
PR,CELLULITIS,13
PR,CHIKUNGUNYA VIRUS INFECTION,13
PR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,13
PR,PHARYNGITIS,13
PR,RASH,13
PR,BLOOD GLUCOSE INCREASED,12
PR,GAIT DISTURBANCE,12
PR,URTICARIA,12
PR,CATARACT,11
PR,INJECTION SITE INFLAMMATION,11
PR,NASAL CONGESTION,11
PR,PERIPHERAL SWELLING,11
PR,PNEUMONIA,11
PR,RHEUMATOID ARTHRITIS,11
PR,CHEST PAIN,10
PR,DYSPHONIA,10
PR,INJECTION SITE HAEMATOMA,10
PR,ABDOMINAL PAIN UPPER,9
PR,DRUG HYPERSENSITIVITY,9
PR,ERYTHEMA,9
PR,GASTROINTESTINAL INFLAMMATION,9
PR,INSOMNIA,9
PR,PRODUCTIVE COUGH,9
PR,RASH MACULAR,9
PR,SOMNOLENCE,9
PR,ABDOMINAL DISCOMFORT,8
PR,DECREASED APPETITE,8
PR,DIABETES MELLITUS,8
PR,DIVERTICULITIS,8
PR,FIBROMYALGIA,8
PR,HYPOAESTHESIA,8
PR,INCORRECT DOSE ADMINISTERED,8
PR,LOSS OF CONSCIOUSNESS,8
PR,MENISCUS INJURY,8
PR,MYALGIA,8
PR,OROPHARYNGEAL PAIN,8
PR,OSTEOARTHRITIS,8
PR,ARTHROPATHY,7
PR,BONE PAIN,7
PR,HAEMATOMA,7
PR,HYPERCHOLESTEROLAEMIA,7
PR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,7
PR,MEMORY IMPAIRMENT,7
PR,MUSCLE SPASMS,7
PR,ANXIETY,6
PR,CHOLELITHIASIS,6
PR,CONTUSION,6
PR,EAR INFECTION,6
PR,FEELING ABNORMAL,6
PR,HERPES ZOSTER,6
PR,IMMUNODEFICIENCY,6
PR,INFLUENZA,6
PR,INJECTION SITE REACTION,6
PR,INJECTION SITE SWELLING,6
PR,INJECTION SITE WARMTH,6
PR,JOINT SWELLING,6
PR,MOBILITY DECREASED,6
PR,MUSCULAR WEAKNESS,6
PR,NECK PAIN,6
PR,PHLEBITIS,6
PR,PRURITUS GENERALISED,6
PR,SINUSITIS,6
PR,SKIN DISCOLOURATION,6
PR,VIRAL INFECTION,6
PR,WEIGHT INCREASED,6
PR,ABSCESS,5
PR,AMNESIA,5
PR,BACTERIAL INFECTION,5
PR,BLOOD CHOLESTEROL INCREASED,5
PR,BLOOD GLUCOSE DECREASED,5
PR,CARDIAC ARREST,5
PR,CARPAL TUNNEL SYNDROME,5
PR,CHILLS,5
PR,DISCOMFORT,5
PR,DISORIENTATION,5
PR,DRUG PRESCRIBING ERROR,5
PR,EYE INFLAMMATION,5
PR,FEELING HOT,5
PR,GASTRITIS,5
PR,HEART RATE DECREASED,5
PR,HEPATIC ENZYME INCREASED,5
PR,HYPERHIDROSIS,5
PR,INJECTION SITE HAEMORRHAGE,5
PR,INJECTION SITE INDURATION,5
PR,INTERVERTEBRAL DISC PROTRUSION,5
PR,LOCALISED INFECTION,5
PR,MUSCULOSKELETAL PAIN,5
PR,RECTAL HAEMORRHAGE,5
PR,ANAEMIA,4
PR,APPENDICITIS,4
PR,ASPHYXIA,4
PR,BLOOD GLUCOSE ABNORMAL,4
PR,CARDIAC FAILURE,4
PR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
PR,CONSTIPATION,4
PR,DEHYDRATION,4
PR,DERMATITIS ALLERGIC,4
PR,DRUG EFFECT INCOMPLETE,4
PR,DRY SKIN,4
PR,EXOSTOSIS,4
PR,EYE DISORDER,4
PR,HYPERTRIGLYCERIDAEMIA,4
PR,INJECTION SITE DISCOMFORT,4
PR,INTERVERTEBRAL DISC DISORDER,4
PR,KNEE ARTHROPLASTY,4
PR,MYOCARDIAL INFARCTION,4
PR,NEPHROLITHIASIS,4
PR,NEUROPATHY PERIPHERAL,4
PR,OSTEOPOROSIS,4
PR,PULMONARY MASS,4
PR,PULMONARY OEDEMA,4
PR,RASH GENERALISED,4
PR,RESPIRATORY TRACT CONGESTION,4
PR,SEPSIS,4
PR,SKIN ULCER,4
PR,TOOTH EXTRACTION,4
PR,UNEVALUABLE EVENT,4
PR,VIRAL UPPER RESPIRATORY TRACT INFECTION,4
PR,VISION BLURRED,4
PR,VITAMIN D DEFICIENCY,4
PR,ABNORMAL BEHAVIOUR,3
PR,ABSCESS LIMB,3
PR,ADVERSE DRUG REACTION,3
PR,ALOPECIA,3
PR,ANKYLOSING SPONDYLITIS,3
PR,BLOOD POTASSIUM DECREASED,3
PR,BLOOD POTASSIUM INCREASED,3
PR,BLOOD TRIGLYCERIDES ABNORMAL,3
PR,BREAST MASS,3
PR,CARDIAC DISORDER,3
PR,CHEST DISCOMFORT,3
PR,CONDITION AGGRAVATED,3
PR,CONVULSION,3
PR,DEPRESSED MOOD,3
PR,DEVICE ISSUE,3
PR,DIPLOPIA,3
PR,DYSGEUSIA,3
PR,EPISTAXIS,3
PR,FLUID RETENTION,3
PR,FUNGAL SKIN INFECTION,3
PR,GOITRE,3
PR,HEAD INJURY,3
PR,HYPOTENSION,3
PR,HYPOTHYROIDISM,3
PR,INFARCTION,3
PR,INFECTION,3
PR,INJECTION SITE RASH,3
PR,INJECTION SITE URTICARIA,3
PR,INTESTINAL POLYP,3
PR,IRRITABLE BOWEL SYNDROME,3
PR,JOINT INJURY,3
PR,LIMB DISCOMFORT,3
PR,LIMB INJURY,3
PR,LUNG DISORDER,3
PR,MUSCULOSKELETAL DISORDER,3
PR,MUSCULOSKELETAL STIFFNESS,3
PR,NERVE COMPRESSION,3
PR,NODULE,3
PR,OEDEMA,3
PR,OROPHARYNGEAL DISCOMFORT,3
PR,PLATELET COUNT DECREASED,3
PR,PROCEDURAL PAIN,3
PR,PRODUCT USE IN UNAPPROVED INDICATION,3
PR,RHINORRHOEA,3
PR,SCIATICA,3
PR,SKIN CANCER,3
PR,SOMNAMBULISM,3
PR,SPINAL PAIN,3
PR,SYNCOPE,3
PR,TACHYCARDIA,3
PR,THERAPEUTIC RESPONSE UNEXPECTED,3
PR,THROMBOPHLEBITIS,3
PR,THROMBOSIS,3
PR,THYROID DISORDER,3
PR,TINNITUS,3
PR,VAGINAL HAEMORRHAGE,3
PR,WHITE BLOOD CELL COUNT DECREASED,3
PR,WOUND,3
PR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,3
PR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,3
PR,ABASIA,2
PR,ABDOMINAL DISTENSION,2
PR,ANAL ABSCESS,2
PR,ANKLE FRACTURE,2
PR,AORTIC ARTERIOSCLEROSIS,2
PR,ARRHYTHMIA,2
PR,ARTHROPOD BITE,2
PR,BACTERAEMIA,2
PR,BALANCE DISORDER,2
PR,BLINDNESS UNILATERAL,2
PR,BLOOD PRESSURE INCREASED,2
PR,BREAST ABSCESS,2
PR,BREAST CANCER,2
PR,BREAST CANCER FEMALE,2
PR,BREAST DISORDER,2
PR,CARDIAC FAILURE CONGESTIVE,2
PR,COLITIS,2
PR,CROHN^S DISEASE,2
PR,DEATH,2
PR,DENGUE FEVER,2
PR,DEVICE MALFUNCTION,2
PR,DRUG DOSE OMISSION,2
PR,DRUG EFFECT DECREASED,2
PR,DYSSTASIA,2
PR,DYSURIA,2
PR,EYE HAEMORRHAGE,2
PR,EYE IRRITATION,2
PR,EYE SWELLING,2
PR,FINGER DEFORMITY,2
PR,FOOD INTOLERANCE,2
PR,FOOT DEFORMITY,2
PR,FOOT FRACTURE,2
PR,FUNGAL INFECTION,2
PR,GASTROINTESTINAL DISORDER,2
PR,GASTROINTESTINAL HAEMORRHAGE,2
PR,GASTROINTESTINAL HYPOMOTILITY,2
PR,HAEMORRHAGE,2
PR,HAEMORRHAGIC STROKE,2
PR,HOSPITALISATION,2
PR,HOT FLUSH,2
PR,INFLAMMATORY MARKER INCREASED,2
PR,INGROWING NAIL,2
PR,INJECTION SITE DISCOLOURATION,2
PR,INJECTION SITE HYPERSENSITIVITY,2
PR,INJECTION SITE OEDEMA,2
PR,INJURY ASSOCIATED WITH DEVICE,2
PR,INTERVERTEBRAL DISC DEGENERATION,2
PR,INTRACRANIAL ANEURYSM,2
PR,INTRADUCTAL PAPILLOMA OF BREAST,2
PR,LABORATORY TEST ABNORMAL,2
PR,LOWER RESPIRATORY TRACT INFECTION BACTERIAL,2
PR,MASS,2
PR,MEDICATION ERROR,2
PR,MELANOCYTIC NAEVUS,2
PR,MENORRHAGIA,2
PR,MIGRAINE,2
PR,NEOPLASM PROGRESSION,2
PR,OCULAR HYPERAEMIA,2
PR,OEDEMA PERIPHERAL,2
PR,ONYCHOMADESIS,2
PR,OPHTHALMOPLEGIA,2
PR,OSTEOPENIA,2
PR,OVARIAN CYST,2
PR,PALPITATIONS,2
PR,PARAESTHESIA,2
PR,PAROSMIA,2
PR,POST PROCEDURAL INFECTION,2
PR,POSTOPERATIVE WOUND INFECTION,2
PR,PRURITUS ALLERGIC,2
PR,PULMONARY FIBROSIS,2
PR,RASH PAPULAR,2
PR,RASH PUSTULAR,2
PR,RESPIRATORY DISTRESS,2
PR,RETINAL DETACHMENT,2
PR,SEIZURE,2
PR,SLEEP APNOEA SYNDROME,2
PR,SPINAL DISORDER,2
PR,SPINAL OSTEOARTHRITIS,2
PR,STAPHYLOCOCCAL INFECTION,2
PR,SYNOVIAL CYST,2
PR,SYSTEMIC LUPUS ERYTHEMATOSUS,2
PR,TENDON INJURY,2
PR,TENDON RUPTURE,2
PR,THYROID CANCER,2
PR,TYPE 2 DIABETES MELLITUS,2
PR,UMBILICAL HERNIA,2
PR,UTERINE HAEMORRHAGE,2
PR,UTERINE LEIOMYOMA,2
PR,VAGINAL INFECTION,2
PR,VISUAL IMPAIRMENT,2
PR,ABDOMINAL ABSCESS,1
PR,ABDOMINAL ADHESIONS,1
PR,ABDOMINAL INJURY,1
PR,ABDOMINAL NEOPLASM,1
PR,ABSCESS INTESTINAL,1
PR,ABSCESS NECK,1
PR,ACCIDENTAL OVERDOSE,1
PR,ACNE,1
PR,ACTIVITIES OF DAILY LIVING IMPAIRED,1
PR,ADMINISTRATION SITE REACTION,1
PR,ADVERSE REACTION,1
PR,AGGRESSION,1
PR,ALANINE AMINOTRANSFERASE INCREASED,1
PR,ALLERGIC SINUSITIS,1
PR,ANAL FISTULA,1
PR,ANAL HAEMORRHAGE,1
PR,ANAL ULCER,1
PR,ANAPHYLACTIC REACTION,1
PR,ANGIOPLASTY,1
PR,APHASIA,1
PR,APHTHOUS ULCER,1
PR,ARTERIAL OCCLUSIVE DISEASE,1
PR,ARTERIAL STENOSIS,1
PR,ASPARTATE AMINOTRANSFERASE INCREASED,1
PR,ATELECTASIS,1
PR,BACK INJURY,1
PR,BACTERIAL DIARRHOEA,1
PR,BEDRIDDEN,1
PR,BLADDER PROLAPSE,1
PR,BLINDNESS,1
PR,BLOOD CALCIUM INCREASED,1
PR,BLOOD CHOLESTEROL ABNORMAL,1
PR,BLOOD CREATININE DECREASED,1
PR,BLOOD GLUCOSE FLUCTUATION,1
PR,BLOOD IRON DECREASED,1
PR,BLOOD OESTROGEN DECREASED,1
PR,BLOOD PRESSURE DECREASED,1
PR,BLOOD URINE PRESENT,1
PR,BREAST HAEMATOMA,1
PR,BREAST OPERATION,1
PR,BREAST PAIN,1
PR,BREAST RECONSTRUCTION,1
PR,C-REACTIVE PROTEIN INCREASED,1
PR,CALCINOSIS,1
PR,CALCULUS URINARY,1
PR,CANDIDA INFECTION,1
PR,CARDIAC MURMUR,1
PR,CARDIOVASCULAR DISORDER,1
PR,CAROTID ARTERY DISEASE,1
PR,CAROTID ARTERY OCCLUSION,1
PR,CARTILAGE INJURY,1
PR,CATHETER SITE INFECTION,1
PR,CEREBRAL HAEMORRHAGE,1
PR,CEREBROVASCULAR ACCIDENT,1
PR,CERUMEN IMPACTION,1
PR,CERVICITIS,1
PR,CHEMICAL BURN OF SKIN,1
PR,CHEST X-RAY ABNORMAL,1
PR,CHOKING,1
PR,CHOLECYSTITIS,1
PR,CHOLECYSTITIS ACUTE,1
PR,CHOLECYSTITIS INFECTIVE,1
PR,COAGULOPATHY,1
PR,COLD SWEAT,1
PR,COLITIS ULCERATIVE,1
PR,COORDINATION ABNORMAL,1
PR,CORONARY VEIN STENOSIS,1
PR,CYST,1
PR,DERMAL CYST,1
PR,DERMATITIS,1
PR,DEVICE RELATED INFECTION,1
PR,DIABETES MELLITUS INADEQUATE CONTROL,1
PR,DIABETIC NEUROPATHY,1
PR,DISLOCATION OF VERTEBRA,1
PR,DISTURBANCE IN ATTENTION,1
PR,DIVERTICULUM,1
PR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,1
PR,DRUG ADMINISTRATION ERROR,1
PR,DRUG INTOLERANCE,1
PR,DRY EYE,1
PR,DRY MOUTH,1
PR,DRY THROAT,1
PR,DYSARTHRIA,1
PR,DYSMENORRHOEA,1
PR,DYSPEPSIA,1
PR,DYSPHAGIA,1
PR,DYSPLASIA,1
PR,EAR CANAL STENOSIS,1
PR,EAR DISCOMFORT,1
PR,EAR DISORDER,1
PR,EAR PAIN,1
PR,EMBOLISM,1
PR,EMPHYSEMA,1
PR,ENDODONTIC PROCEDURE,1
PR,ENDOTRACHEAL INTUBATION COMPLICATION,1
PR,ERECTILE DYSFUNCTION,1
PR,EYE MOVEMENT DISORDER,1
PR,EYE PAIN,1
PR,EYE PRURITUS,1
PR,EYELID OEDEMA,1
PR,EYELID PTOSIS,1
PR,FAECES SOFT,1
PR,FEAR OF INJECTION,1
PR,FEEDING DISORDER,1
PR,FEELING OF DESPAIR,1
PR,FEMUR FRACTURE,1
PR,FOOD POISONING,1
PR,FOREIGN BODY,1
PR,FRACTURE,1
PR,FREQUENT BOWEL MOVEMENTS,1
PR,FURUNCLE,1
PR,GALLBLADDER DISORDER,1
PR,GALLBLADDER NON-FUNCTIONING,1
PR,GANGRENE,1
PR,GASTRIC DISORDER,1
PR,GASTRIC INFECTION,1
PR,GASTRIC ULCER,1
PR,GASTROENTERITIS VIRAL,1
PR,GASTROINTESTINAL COMPLICATION ASSOCIATED WITH DEVICE,1
PR,GASTROINTESTINAL FUNGAL INFECTION,1
PR,GASTROOESOPHAGEAL REFLUX DISEASE,1
PR,GINGIVAL BLEEDING,1
PR,GINGIVITIS,1
PR,GLAUCOMA,1
PR,GOUT,1
PR,GROIN ABSCESS,1
PR,HAEMATEMESIS,1
PR,HAEMATOCHEZIA,1
PR,HAEMOGLOBIN ABNORMAL,1
PR,HAEMORRHOIDS,1
PR,HAND DEFORMITY,1
PR,HAND FRACTURE,1
PR,HEAD DISCOMFORT,1
PR,HEARING IMPAIRED,1
PR,HEPATIC PAIN,1
PR,HEPATIC STEATOSIS,1
PR,HEREDITARY ANGIOEDEMA,1
PR,HERNIA,1
PR,HIATUS HERNIA,1
PR,HIP ARTHROPLASTY,1
PR,HIP FRACTURE,1
PR,HYPERKERATOSIS,1
PR,HYPERTENSIVE CRISIS,1
PR,HYPOKALAEMIA,1
PR,HYPOPHAGIA,1
PR,HYPOXIA,1
PR,HYSTERECTOMY,1
PR,IMMUNOSUPPRESSION,1
PR,IMPETIGO,1
PR,INCOHERENT,1
PR,INCORRECT PRODUCT STORAGE,1
PR,INCREASED APPETITE,1
PR,INFECTED SKIN ULCER,1
PR,INJECTION SITE CELLULITIS,1
PR,INJECTION SITE PUSTULE,1
PR,INJECTION SITE ULCER,1
PR,INTERVERTEBRAL DISC DISPLACEMENT,1
PR,INTESTINAL INFARCTION,1
PR,INTESTINAL OBSTRUCTION,1
PR,INTESTINAL PERFORATION,1
PR,INTESTINAL STENOSIS,1
PR,INTESTINAL ULCER,1
PR,JAUNDICE CHOLESTATIC,1
PR,JAW DISORDER,1
PR,JOINT ABSCESS,1
PR,JOINT DISLOCATION,1
PR,JOINT EFFUSION,1
PR,JOINT RANGE OF MOTION DECREASED,1
PR,JOINT STIFFNESS,1
PR,KERATITIS,1
PR,KNEE OPERATION,1
PR,LACERATION,1
PR,LAPAROSCOPY,1
PR,LARGE INTESTINE POLYP,1
PR,LARYNGITIS,1
PR,LIGAMENT RUPTURE,1
PR,LIGAMENT SPRAIN,1
PR,LIMB DEFORMITY,1
PR,LIVER DISORDER,1
PR,LOCAL SWELLING,1
PR,LOWER EXTREMITY MASS,1
PR,LUMBAR SPINAL STENOSIS,1
PR,LUNG NEOPLASM,1
PR,LYMPHADENOPATHY,1
PR,MACULAR DEGENERATION,1
PR,MAJOR DEPRESSION,1
PR,MENISCUS OPERATION,1
PR,MENSTRUAL DISORDER,1
PR,MENSTRUATION IRREGULAR,1
PR,MENTAL STATUS CHANGES,1
PR,MIDDLE EAR EFFUSION,1
PR,MITE ALLERGY,1
PR,MITRAL VALVE PROLAPSE,1
PR,MONOPLEGIA,1
PR,MOUTH HAEMORRHAGE,1
PR,MOUTH SWELLING,1
PR,MUSCLE FATIGUE,1
PR,MUSCLE STRAIN,1
PR,MUSCULOSKELETAL CHEST PAIN,1
PR,MYOSITIS,1
PR,NAIL DISCOLOURATION,1
PR,NAIL DISORDER,1
PR,NAIL INFECTION,1
PR,NASAL ABSCESS,1
PR,NEOPLASM,1
PR,NEOPLASM MALIGNANT,1
PR,NERVOUSNESS,1
PR,NEURITIS,1
PR,NIGHT SWEATS,1
PR,NONINFECTIVE GINGIVITIS,1
PR,NONINFECTIVE OOPHORITIS,1
PR,ODYNOPHAGIA,1
PR,OESOPHAGEAL PAIN,1
PR,ONYCHOCLASIS,1
PR,OPTIC NEURITIS,1
PR,ORAL HERPES,1
PR,ORAL INFECTION,1
PR,OROPHARYNGEAL PLAQUE,1
PR,OTORRHOEA,1
PR,OVARIAN DISORDER,1
PR,OVERDOSE,1
PR,OXYGEN SATURATION ABNORMAL,1
PR,PAIN OF SKIN,1
PR,PANCREATIC DISORDER,1
PR,PANCREATITIS,1
PR,PANIC ATTACK,1
PR,PARALYSIS,1
PR,PATELLA FRACTURE,1
PR,PATHOGEN RESISTANCE,1
PR,PEAU D^ORANGE,1
PR,PELVIC PAIN,1
PR,PERIPROSTHETIC FRACTURE,1
PR,PHARYNGEAL INFLAMMATION,1
PR,PHARYNGEAL NEOPLASM,1
PR,PLATELET COUNT INCREASED,1
PR,PLATELET DISORDER,1
PR,PLEURAL EFFUSION,1
PR,PLEURITIC PAIN,1
PR,PNEUMOTHORAX,1
PR,POLYP,1
PR,POST HERPETIC NEURALGIA,1
PR,POST PROCEDURAL COMPLICATION,1
PR,PRE-EXISTING CONDITION IMPROVED,1
PR,PROCTALGIA,1
PR,PRODUCT QUALITY ISSUE,1
PR,PRODUCT USE ISSUE,1
PR,PROTEIN TOTAL INCREASED,1
PR,PSORIATIC ARTHROPATHY,1
PR,PULMONARY GRANULOMA,1
PR,PULMONARY HYPERTENSION,1
PR,PULMONARY PAIN,1
PR,PURULENT DISCHARGE,1
PR,RASH PRURITIC,1
PR,RECTAL TENESMUS,1
PR,RED BLOOD CELL COUNT DECREASED,1
PR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
PR,RENAL DISORDER,1
PR,RENAL FAILURE,1
PR,RENAL NEOPLASM,1
PR,RENAL PAIN,1
PR,RESPIRATORY ARREST,1
PR,RESPIRATORY DEPRESSION,1
PR,RESPIRATORY DISORDER,1
PR,RESPIRATORY RATE DECREASED,1
PR,RESPIRATORY TRACT INFECTION,1
PR,RESTLESSNESS,1
PR,RETINOPATHY,1
PR,ROTATOR CUFF SYNDROME,1
PR,SCAR,1
PR,SCIATIC NERVE INJURY,1
PR,SCRATCH,1
PR,SENSORY DISTURBANCE,1
PR,SERUM FERRITIN DECREASED,1
PR,SHOULDER OPERATION,1
PR,SKELETAL INJURY,1
PR,SKIN BURNING SENSATION,1
PR,SKIN DISORDER,1
PR,SKIN EXFOLIATION,1
PR,SKIN FISSURES,1
PR,SKIN HYPERPLASIA,1
PR,SKIN INDURATION,1
PR,SKIN IRRITATION,1
PR,SLEEP DISORDER,1
PR,SMALL INTESTINAL OBSTRUCTION,1
PR,SNEEZING,1
PR,SPINAL COLUMN STENOSIS,1
PR,SPINAL OPERATION,1
PR,SPONDYLITIS,1
PR,STOMA SITE ABSCESS,1
PR,STOMA SITE CELLULITIS,1
PR,STOMA SITE INFLAMMATION,1
PR,STRESS,1
PR,SUBCUTANEOUS ABSCESS,1
PR,SURGERY,1
PR,SWELLING,1
PR,SWELLING FACE,1
PR,SWOLLEN TONGUE,1
PR,TENDONITIS,1
PR,TESTICULAR HAEMORRHAGE,1
PR,THERAPEUTIC RESPONSE SHORTENED,1
PR,THERMAL BURN,1
PR,THIRST,1
PR,THROAT IRRITATION,1
PR,THYROID FUNCTION TEST ABNORMAL,1
PR,THYROID MASS,1
PR,THYROID NEOPLASM,1
PR,THYROID PAIN,1
PR,TONGUE DISORDER,1
PR,TONSILLITIS,1
PR,TOOTH FRACTURE,1
PR,TOOTH INFECTION,1
PR,TOOTHACHE,1
PR,TRACHEAL INFLAMMATION,1
PR,TRACHEAL OEDEMA,1
PR,TREATMENT NONCOMPLIANCE,1
PR,TREMOR,1
PR,TUBERCULIN TEST POSITIVE,1
PR,TYMPANIC MEMBRANE PERFORATION,1
PR,ULCER,1
PR,UPPER RESPIRATORY TRACT CONGESTION,1
PR,URINARY RETENTION,1
PR,UTERINE ADHESIONS,1
PR,UTERINE DISORDER,1
PR,VARICOSE VEIN,1
PR,VASCULAR INSUFFICIENCY,1
PR,VENOUS OCCLUSION,1
PR,VERTIGO,1
PR,VITAMIN D DECREASED,1
PR,VOCAL CORD DISORDER,1
PR,VULVOVAGINAL MYCOTIC INFECTION,1
PR,WHITE BLOOD CELL COUNT ABNORMAL,1
PR,WHITE BLOOD CELL COUNT INCREASED,1
PR,WRIST FRACTURE,1
QA,RHABDOMYOLYSIS,7
QA,UROSEPSIS,4
QA,ESCHERICHIA INFECTION,3
QA,DYSPNOEA,2
QA,LETHARGY,2
QA,MUSCULAR WEAKNESS,2
QA,MYALGIA,2
QA,BLOOD BILIRUBIN INCREASED,1
QA,DEATH,1
QA,HEPATITIS B,1
QA,LIVER FUNCTION TEST ABNORMAL,1
RO,CARDIO-RESPIRATORY ARREST,2
RO,ACUTE RESPIRATORY DISTRESS SYNDROME,1
RO,ACUTE RESPIRATORY FAILURE,1
RO,AKATHISIA,1
RO,APATHY,1
RO,ARTERIOSCLEROSIS,1
RO,ASTHENIA,1
RO,ATRIOVENTRICULAR BLOCK,1
RO,BLINDNESS TRANSIENT,1
RO,BLOOD GLUCOSE INCREASED,1
RO,CARDIAC ARREST,1
RO,CEREBRAL ATROPHY,1
RO,COLON CANCER,1
RO,DECREASED APPETITE,1
RO,DERMAL CYST,1
RO,DRUG INEFFECTIVE,1
RO,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
RO,FATIGUE,1
RO,GASTRITIS,1
RO,GENERAL PHYSICAL HEALTH DETERIORATION,1
RO,HAEMOGLOBIN DECREASED,1
RO,HEART RATE INCREASED,1
RO,HELICOBACTER INFECTION,1
RO,HEMIANAESTHESIA,1
RO,HYPERTENSION,1
RO,HYPERTONIA,1
RO,INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION,1
RO,JAUNDICE,1
RO,LACUNAR STROKE,1
RO,METASTASES TO LIVER,1
RO,MUSCLE SPASMS,1
RO,NEPHROLITHIASIS,1
RO,NEUROLEPTIC MALIGNANT SYNDROME,1
RO,PALMOMENTAL REFLEX,1
RO,PLATELET COUNT DECREASED,1
RO,SOMNOLENCE,1
RO,THERAPEUTIC RESPONSE DECREASED,1
RO,VIRAEMIA,1
RO,WEIGHT DECREASED,1
RU,GAIT DISTURBANCE,1
RU,HYPOKINESIA,1
SA,BRADYCARDIA,1
SA,ECG SIGNS OF MYOCARDIAL ISCHAEMIA,1
RS,ASTHENIA,1
RS,FACIAL PAIN,1
RS,FEELING ABNORMAL,1
RS,LACRIMATION INCREASED,1
RS,OCULAR HYPERAEMIA,1
RS,VERTIGO,1
SG,DIZZINESS,3
SG,FANCONI SYNDROME,2
SG,HYPONATRAEMIA,2
SG,PAIN,2
SG,PERIORBITAL OEDEMA,2
SG,RASH,2
SG,SEPSIS,2
SG,TOXICITY TO VARIOUS AGENTS,2
SG,ANAEMIA,1
SG,ASTHENIA,1
SG,BLOOD CREATININE INCREASED,1
SG,BLOOD DISORDER,1
SG,BLOOD URIC ACID DECREASED,1
SG,CARDIAC DISORDER,1
SG,CARDIAC FAILURE CONGESTIVE,1
SG,COMA SCALE ABNORMAL,1
SG,DERMATITIS EXFOLIATIVE,1
SG,DRUG INTOLERANCE,1
SG,DYSPNOEA,1
SG,ELECTROLYTE IMBALANCE,1
SG,ENTEROCUTANEOUS FISTULA,1
SG,FALL,1
SG,FATIGUE,1
SG,FEBRILE NEUTROPENIA,1
SG,FISTULA DISCHARGE,1
SG,FUNGAL INFECTION,1
SG,HEPATOCELLULAR CARCINOMA,1
SG,HUNGER,1
SG,HYPERCALCAEMIA,1
SG,HYPERGLYCAEMIA,1
SG,HYPOCALCAEMIA,1
SG,HYPOKALAEMIA,1
SG,HYPOPHOSPHATAEMIA,1
SG,HYPOVOLAEMIC SHOCK,1
SG,LETHARGY,1
SG,MENTAL STATUS CHANGES,1
SG,MYOCARDIAL ISCHAEMIA,1
SG,NEOPLASM RECURRENCE,1
SG,NEURALGIA,1
SG,PANCREATIC CARCINOMA,1
SG,PELVIC MASS,1
SG,PERICARDIAL EFFUSION,1
SG,PROTEINURIA,1
SG,PULMONARY OEDEMA,1
SG,RASH ERYTHEMATOUS,1
SG,ROAD TRAFFIC ACCIDENT,1
SG,SOMNOLENCE,1
SG,STEVENS-JOHNSON SYNDROME,1
SG,SWELLING FACE,1
SG,TOXIC EPIDERMAL NECROLYSIS,1
SG,URINARY TRACT INFECTION,1
SG,VITAMIN D DEFICIENCY,1
SG,WEIGHT INCREASED,1
SK,CONDITION AGGRAVATED,1
SK,DIABETIC METABOLIC DECOMPENSATION,1
SK,DISTURBANCE IN ATTENTION,1
SK,HYPERGLYCAEMIA,1
SK,MALAISE,1
SK,MOTOR DYSFUNCTION,1
SK,NEUROPATHY PERIPHERAL,1
SK,PNEUMONIA,1
SK,RESPIRATORY TRACT INFECTION,1
SK,SEIZURE,1
SK,TREATMENT NONCOMPLIANCE,1
SK,TREMOR,1
SK,WEIGHT DECREASED,1
SI,ABDOMINAL PAIN,1
SI,CHEST PAIN,1
SI,CHOKING,1
SI,DIARRHOEA,1
SI,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
SI,DYSPNOEA,1
SI,PAIN,1
SI,PULMONARY EMBOLISM,1
ZA,ARTHRALGIA,2
ZA,FALL,2
ZA,HYPOAESTHESIA,2
ZA,LOSS OF CONSCIOUSNESS,2
ZA,PAIN,2
ZA,ABASIA,1
ZA,ADDISON^S DISEASE,1
ZA,AKATHISIA,1
ZA,ATAXIA,1
ZA,CEREBELLAR SYNDROME,1
ZA,CERVICAL RADICULOPATHY,1
ZA,CONVULSION,1
ZA,DEBRIDEMENT,1
ZA,DEPRESSION,1
ZA,DRUG DEPENDENCE,1
ZA,DRUG INEFFECTIVE,1
ZA,EXPOSURE DURING PREGNANCY,1
ZA,FATIGUE,1
ZA,HEADACHE,1
ZA,HIP FRACTURE,1
ZA,HYPERTENSION,1
ZA,INFECTIVE MYOSITIS,1
ZA,LYMPHADENOPATHY,1
ZA,MULTIPLE SCLEROSIS RELAPSE,1
ZA,MUSCLE SPASMS,1
ZA,MYALGIA,1
ZA,OEDEMA PERIPHERAL,1
ZA,PAROTID GLAND ENLARGEMENT,1
ZA,PAROTID LIPOMATOSIS,1
ZA,PRURITUS,1
ZA,PRURITUS GENERALISED,1
ZA,PYREXIA,1
ZA,RASH ERYTHEMATOUS,1
ZA,RETINAL DEGENERATION,1
ZA,RETINAL DEPIGMENTATION,1
ZA,RETINOPATHY,1
ZA,RHEUMATOID ARTHRITIS,1
ZA,SALIVARY GLAND ENLARGEMENT,1
ZA,SHOULDER ARTHROPLASTY,1
ZA,SPEECH DISORDER,1
ZA,SWELLING FACE,1
ZA,SWOLLEN TONGUE,1
ZA,SYSTEMIC LUPUS ERYTHEMATOSUS,1
ZA,TREMOR,1
ZA,UNEVALUABLE EVENT,1
ZA,UPPER LIMB FRACTURE,1
ES,CONSTIPATION,23
ES,INTESTINAL OBSTRUCTION,19
ES,CONJUNCTIVITIS,18
ES,PSORIASIS,18
ES,HYPERTENSION,17
ES,MENTAL DISORDER,17
ES,VISION BLURRED,17
ES,HALLUCINATION_ VISUAL,16
ES,ACUTE KIDNEY INJURY,15
ES,PSYCHOTIC DISORDER DUE TO A GENERAL MEDICAL CONDITION,15
ES,SOMNOLENCE,15
ES,WRONG PATIENT RECEIVED MEDICATION,14
ES,PSYCHOTIC DISORDER,13
ES,AGRANULOCYTOSIS,12
ES,DRY EYE,12
ES,FALL,12
ES,HYPOTENSION,12
ES,PAIN,12
ES,PRODUCT USE IN UNAPPROVED INDICATION,12
ES,DECREASED APPETITE,11
ES,DEPRESSED LEVEL OF CONSCIOUSNESS,11
ES,EYE IRRITATION,11
ES,HYPERKALAEMIA,11
ES,CONFUSIONAL STATE,10
ES,RASH,10
ES,RASH PRURITIC,10
ES,VISUAL IMPAIRMENT,10
ES,VOMITING,10
ES,ANAEMIA,9
ES,RENAL FAILURE ACUTE,9
ES,ASTHENIA,7
ES,DISORIENTATION,7
ES,METABOLIC ACIDOSIS,7
ES,PRURITUS,7
ES,DELUSION,6
ES,DIARRHOEA,6
ES,DIZZINESS,6
ES,DRUG INEFFECTIVE,6
ES,DRUG INTOLERANCE,6
ES,DYSKINESIA,6
ES,FATIGUE,6
ES,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,6
ES,INTENTIONAL OVERDOSE,6
ES,NEUTROPENIA,6
ES,PYREXIA,6
ES,DRUG DEPENDENCE,5
ES,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,5
ES,PARAESTHESIA,5
ES,PNEUMONIA,5
ES,PRODUCT USE ISSUE,5
ES,RASH GENERALISED,5
ES,RHABDOMYOLYSIS,5
ES,THROMBOCYTOPENIA,5
ES,URINARY TRACT INFECTION,5
ES,ACUTE RESPIRATORY FAILURE,4
ES,ADVERSE EVENT,4
ES,ANAEMIA MEGALOBLASTIC,4
ES,ANXIETY,4
ES,COMPLETED SUICIDE,4
ES,DEPRESSION,4
ES,ENCEPHALITIS VIRAL,4
ES,FEBRILE NEUTROPENIA,4
ES,HEPATITIS,4
ES,HYPONATRAEMIA,4
ES,METABOLIC ENCEPHALOPATHY,4
ES,NAUSEA,4
ES,NERVOUS SYSTEM DISORDER,4
ES,PLATELET COUNT DECREASED,4
ES,RESPIRATORY FAILURE,4
ES,UNEVALUABLE EVENT,4
ES,ABDOMINAL PAIN,3
ES,ADENOVIRUS INFECTION,3
ES,AGITATION,3
ES,ARTHRALGIA,3
ES,BACK PAIN,3
ES,BACTERAEMIA,3
ES,BLOOD PRESSURE DECREASED,3
ES,BRONCHIAL OEDEMA,3
ES,CARDIAC FAILURE,3
ES,CARDIAC FAILURE CONGESTIVE,3
ES,CARDIOTOXICITY,3
ES,DEATH,3
ES,ENCEPHALOPATHY,3
ES,FEELING ABNORMAL,3
ES,GASTROINTESTINAL HAEMORRHAGE,3
ES,HAEMOGLOBIN DECREASED,3
ES,HEADACHE,3
ES,HEPATOCELLULAR CARCINOMA,3
ES,HYPOGAMMAGLOBULINAEMIA,3
ES,INFLUENZA,3
ES,INTENTIONAL DRUG MISUSE,3
ES,MALAISE,3
ES,MALNUTRITION,3
ES,MUCOSAL INFLAMMATION,3
ES,MYALGIA,3
ES,NEUROTOXICITY,3
ES,NON-CARDIAC CHEST PAIN,3
ES,OVERDOSE,3
ES,PARANOIA,3
ES,RENAL FAILURE,3
ES,SCIATICA,3
ES,SEPTIC SHOCK,3
ES,SUBARACHNOID HAEMORRHAGE,3
ES,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,3
ES,TREMOR,3
ES,UPPER GASTROINTESTINAL HAEMORRHAGE,3
ES,URINARY INCONTINENCE,3
ES,URINARY RETENTION,3
ES,ACUTE CORONARY SYNDROME,2
ES,ACUTE LYMPHOCYTIC LEUKAEMIA,2
ES,AGGRESSION,2
ES,APPENDICITIS,2
ES,BLOOD CREATININE INCREASED,2
ES,BRADYPHRENIA,2
ES,CARDIOGENIC SHOCK,2
ES,CLOSTRIDIUM DIFFICILE COLITIS,2
ES,CONDITION AGGRAVATED,2
ES,CRANIOCEREBRAL INJURY,2
ES,CUSHING^S SYNDROME,2
ES,DELIRIUM,2
ES,DIABETES WITH HYPEROSMOLARITY,2
ES,DISEASE PROGRESSION,2
ES,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
ES,DRUG WITHDRAWAL SYNDROME,2
ES,DYSPNOEA,2
ES,EJACULATION DELAYED,2
ES,ELECTROCARDIOGRAM QT PROLONGED,2
ES,ERECTILE DYSFUNCTION,2
ES,FOETAL EXPOSURE DURING PREGNANCY,2
ES,HALLUCINATION,2
ES,HEART RATE INCREASED,2
ES,HEPATOTOXICITY,2
ES,HUMAN HERPESVIRUS 6 INFECTION,2
ES,HYPOAESTHESIA,2
ES,HYPOCALCAEMIA,2
ES,HYPOGLYCAEMIA,2
ES,HYPOVOLAEMIC SHOCK,2
ES,INJECTION SITE ERYTHEMA,2
ES,INSOMNIA,2
ES,INTENTIONAL PRODUCT USE ISSUE,2
ES,ISCHAEMIC HEPATITIS,2
ES,MALIGNANT NEOPLASM PROGRESSION,2
ES,MITRAL VALVE INCOMPETENCE,2
ES,NERVOUSNESS,2
ES,NEUROPATHY PERIPHERAL,2
ES,OSTEOARTHRITIS,2
ES,OSTEONECROSIS OF JAW,2
ES,PAIN IN EXTREMITY,2
ES,PARALYSIS,2
ES,PLEURAL EFFUSION,2
ES,PNEUMONIA STAPHYLOCOCCAL,2
ES,PULMONARY EMBOLISM,2
ES,PULMONARY OEDEMA,2
ES,RESPIRATORY TRACT INFECTION,2
ES,RHEUMATOID ARTHRITIS,2
ES,SELF-MEDICATION,2
ES,SLEEP APNOEA SYNDROME,2
ES,SOFT TISSUE INFECTION,2
ES,SUBCUTANEOUS ABSCESS,2
ES,SUICIDE ATTEMPT,2
ES,THROMBOCYTOSIS,2
ES,TOXICITY TO VARIOUS AGENTS,2
ES,UNRESPONSIVE TO STIMULI,2
ES,WEIGHT DECREASED,2
ES,ABASIA,1
ES,ABDOMINAL DISCOMFORT,1
ES,ABDOMINAL DISTENSION,1
ES,ABDOMINAL PAIN UPPER,1
ES,ABNORMAL BEHAVIOUR,1
ES,ACUTE INTERSTITIAL PNEUMONITIS,1
ES,ADRENAL INSUFFICIENCY,1
ES,AFFECT LABILITY,1
ES,ALANINE AMINOTRANSFERASE INCREASED,1
ES,ALOPECIA,1
ES,AMYLASE INCREASED,1
ES,ANGINA PECTORIS,1
ES,ANGIOMYOLIPOMA,1
ES,ANKYLOSING SPONDYLITIS,1
ES,ANTICIPATORY ANXIETY,1
ES,ANURIA,1
ES,AORTIC VALVE SCLEROSIS,1
ES,APHTHOUS STOMATITIS,1
ES,APPLICATION SITE ERYTHEMA,1
ES,APPLICATION SITE PRURITUS,1
ES,ATRIAL FIBRILLATION,1
ES,ATRIAL FLUTTER,1
ES,AUTOIMMUNE HEPATITIS,1
ES,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
ES,BALANCE DISORDER,1
ES,BLINDNESS,1
ES,BLOOD ALKALINE PHOSPHATASE INCREASED,1
ES,BLOOD CREATININE DECREASED,1
ES,BLOOD SODIUM DECREASED,1
ES,BONE PAIN,1
ES,BREAKTHROUGH PAIN,1
ES,BREAST NEOPLASM,1
ES,CAPILLARY LEAK SYNDROME,1
ES,CARDIAC ARREST,1
ES,CARDIAC FAILURE ACUTE,1
ES,CARDIAC MURMUR,1
ES,CARDIOMEGALY,1
ES,CAUDA EQUINA SYNDROME,1
ES,CELLULITIS,1
ES,CEREBROVASCULAR ACCIDENT,1
ES,CERVICAL VERTEBRAL FRACTURE,1
ES,CHEST PAIN,1
ES,CHOKING SENSATION,1
ES,CHOLELITHIASIS,1
ES,CHOLESTASIS,1
ES,CHRONIC HEPATITIS,1
ES,CONGESTIVE CARDIOMYOPATHY,1
ES,CONTRAINDICATION TO MEDICAL TREATMENT,1
ES,CONTUSION,1
ES,COORDINATION ABNORMAL,1
ES,COUGH,1
ES,CYSTITIS,1
ES,CYTOMEGALOVIRUS INFECTION,1
ES,DEEP VEIN THROMBOSIS,1
ES,DEHYDRATION,1
ES,DEMENTIA,1
ES,DEPRESSED MOOD,1
ES,DERMATITIS ACNEIFORM,1
ES,DERMATITIS BULLOUS,1
ES,DEVICE DISLOCATION,1
ES,DEVICE RELATED INFECTION,1
ES,DIABETES MELLITUS,1
ES,DILATATION VENTRICULAR,1
ES,DIPLOPIA,1
ES,DISINHIBITION,1
ES,DIVERTICULITIS,1
ES,DRUG ABUSE,1
ES,DRUG DISPENSING ERROR,1
ES,DRY MOUTH,1
ES,DYSARTHRIA,1
ES,DYSPHAGIA,1
ES,DYSPNOEA EXERTIONAL,1
ES,DYSTHYMIC DISORDER,1
ES,EJECTION FRACTION DECREASED,1
ES,ELECTROCARDIOGRAM T WAVE INVERSION,1
ES,ENTEROCOLITIS INFECTIOUS,1
ES,EOSINOPHILIA,1
ES,EOSINOPHILIC FASCIITIS,1
ES,ERYSIPELAS,1
ES,ERYTHEMA,1
ES,ERYTHEMA MULTIFORME,1
ES,ESCHERICHIA URINARY TRACT INFECTION,1
ES,EUPHORIC MOOD,1
ES,EXTRA DOSE ADMINISTERED,1
ES,EYE PRURITUS,1
ES,FAECAL VOMITING,1
ES,FEELING COLD,1
ES,GASTRIC ULCER HAEMORRHAGE,1
ES,GENERAL PHYSICAL CONDITION ABNORMAL,1
ES,GENERAL PHYSICAL HEALTH DETERIORATION,1
ES,GLOMERULAR FILTRATION RATE DECREASED,1
ES,GLOSSITIS,1
ES,HAEMORRHAGIC STROKE,1
ES,HALLUCINATION_ TACTILE,1
ES,HALLUCINATIONS_ MIXED,1
ES,HEART RATE DECREASED,1
ES,HELICOBACTER GASTRITIS,1
ES,HEPATIC ENCEPHALOPATHY,1
ES,HEPATIC ENZYME INCREASED,1
ES,HEPATIC FAILURE,1
ES,HEPATIC FUNCTION ABNORMAL,1
ES,HEPATIC NEOPLASM,1
ES,HEPATITIS ACUTE,1
ES,HEPATITIS CHOLESTATIC,1
ES,HEPATITIS TOXIC,1
ES,HEPATITIS VIRAL,1
ES,HEPATOMEGALY,1
ES,HERPES ZOSTER,1
ES,HYPERBILIRUBINAEMIA,1
ES,HYPERPARATHYROIDISM,1
ES,HYPERTRANSAMINASAEMIA,1
ES,HYPOALBUMINAEMIA,1
ES,HYPOKALAEMIA,1
ES,HYPOMANIA,1
ES,HYPOTHERMIA,1
ES,IMPAIRED DRIVING ABILITY,1
ES,INCORRECT DOSE ADMINISTERED,1
ES,INCORRECT DRUG ADMINISTRATION DURATION,1
ES,INFREQUENT BOWEL MOVEMENTS,1
ES,INJECTION SITE BRUISING,1
ES,INJECTION SITE PHLEBITIS,1
ES,INJECTION SITE SWELLING,1
ES,INTENTIONAL PRODUCT MISUSE,1
ES,INTERNATIONAL NORMALISED RATIO INCREASED,1
ES,INTERSTITIAL LUNG DISEASE,1
ES,INTERVERTEBRAL DISC DEGENERATION,1
ES,INTERVERTEBRAL DISC PROTRUSION,1
ES,INTESTINAL ISCHAEMIA,1
ES,IRRITABILITY,1
ES,JAUNDICE,1
ES,JOINT DISLOCATION,1
ES,JOINT RANGE OF MOTION DECREASED,1
ES,KAPOSI^S SARCOMA,1
ES,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
ES,LACTIC ACIDOSIS,1
ES,LACUNAR INFARCTION,1
ES,LARYNGEAL POLYP,1
ES,LEUKOCYTOSIS,1
ES,LEUKOPENIA,1
ES,LIPASE INCREASED,1
ES,LIVER DISORDER,1
ES,LOSS OF CONSCIOUSNESS,1
ES,LOW CARDIAC OUTPUT SYNDROME,1
ES,LUNG ADENOCARCINOMA,1
ES,LUNG INFECTION,1
ES,LUNG INFILTRATION,1
ES,LYMPHADENITIS,1
ES,LYMPHOPENIA,1
ES,MACULAR OEDEMA,1
ES,MACULOPATHY,1
ES,MANIA,1
ES,MENTAL IMPAIRMENT,1
ES,METASTASES TO BONE,1
ES,METASTASES TO PERITONEUM,1
ES,MICTURITION FREQUENCY DECREASED,1
ES,MOOD ALTERED,1
ES,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
ES,MULTIPLE SCLEROSIS RELAPSE,1
ES,MUSCLE ENZYME INCREASED,1
ES,MUSCLE HAEMORRHAGE,1
ES,MUSCLE RIGIDITY,1
ES,MUSCLE SPASMS,1
ES,MYOCARDIAL INFARCTION,1
ES,MYOCARDIAL ISCHAEMIA,1
ES,MYOCLONUS,1
ES,NECK PAIN,1
ES,NEOPLASM PROGRESSION,1
ES,NEUTROPHIL COUNT DECREASED,1
ES,NO ADVERSE EVENT,1
ES,ODYNOPHAGIA,1
ES,OESOPHAGEAL SQUAMOUS CELL CARCINOMA,1
ES,OPTIC NEURITIS,1
ES,OPTIC NEUROPATHY,1
ES,OROPHARYNGEAL CANDIDIASIS,1
ES,ORTHOPNOEA,1
ES,OSTEONECROSIS,1
ES,PALPITATIONS,1
ES,PANCREATIC CARCINOMA,1
ES,PANCYTOPENIA,1
ES,PANNICULITIS,1
ES,PARAPARESIS,1
ES,PELVIC VENOUS THROMBOSIS,1
ES,PERICARDIAL HAEMORRHAGE,1
ES,PERIPHERAL VENOUS DISEASE,1
ES,PETECHIAE,1
ES,PHLEBITIS,1
ES,PHOTOSENSITIVITY REACTION,1
ES,PLATELET COUNT ABNORMAL,1
ES,PLEURAL FIBROSIS,1
ES,PNEUMONIA FUNGAL,1
ES,POISONING,1
ES,POLLAKIURIA,1
ES,PREMATURE BABY,1
ES,PRODUCT QUALITY ISSUE,1
ES,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
ES,PROTEINURIA,1
ES,PSEUDOMEMBRANOUS COLITIS,1
ES,PSYCHOGENIC SEIZURE,1
ES,PSYCHOMOTOR HYPERACTIVITY,1
ES,PUBIS FRACTURE,1
ES,PULMONARY HYPERTENSION,1
ES,PULMONARY TOXICITY,1
ES,PURPURA,1
ES,PYELONEPHRITIS,1
ES,RECTAL PROLAPSE,1
ES,RENAL CYST,1
ES,RENAL IMPAIRMENT,1
ES,RENAL ONCOCYTOMA,1
ES,RESPIRATORY RATE DECREASED,1
ES,RESTLESSNESS,1
ES,RHINORRHOEA,1
ES,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,1
ES,SEIZURE,1
ES,SELF-INJURIOUS IDEATION,1
ES,SEPSIS,1
ES,SEROTONIN SYNDROME,1
ES,SHOCK HAEMORRHAGIC,1
ES,SKIN EXFOLIATION,1
ES,SKIN ULCER,1
ES,SNORING,1
ES,SPINAL PAIN,1
ES,SPUTUM DISCOLOURED,1
ES,SUDDEN DEATH,1
ES,SUICIDAL IDEATION,1
ES,SWELLING FACE,1
ES,TEMPERATURE INTOLERANCE,1
ES,TERMINAL STATE,1
ES,THERAPEUTIC RESPONSE UNEXPECTED,1
ES,TONGUE OEDEMA,1
ES,TOXIC SKIN ERUPTION,1
ES,TRANSAMINASES INCREASED,1
ES,TUMOUR INVASION,1
ES,URINARY SEDIMENT PRESENT,1
ES,VARICES OESOPHAGEAL,1
ES,VENA CAVA THROMBOSIS,1
ES,VENTRICULAR DYSFUNCTION,1
ES,VENTRICULAR HYPOKINESIA,1
ES,VERTIGO,1
ES,VITAMIN D DEFICIENCY,1
ES,WHITE BLOOD CELL COUNT DECREASED,1
ES,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
ES,XXXY SYNDROME,1
LK,HYPOTHERMIA,1
SE,TOXICITY TO VARIOUS AGENTS,40
SE,HEADACHE,25
SE,NAUSEA,24
SE,FATIGUE,20
SE,DIZZINESS,18
SE,VOMITING,17
SE,DYSPNOEA,13
SE,MUSCULAR WEAKNESS,11
SE,CONFUSIONAL STATE,10
SE,DIPLOPIA,10
SE,WEIGHT DECREASED,10
SE,APHASIA,9
SE,HEART RATE INCREASED,9
SE,MUSCLE TWITCHING,9
SE,SOMNOLENCE,9
SE,ABDOMINAL PAIN,8
SE,ALOPECIA,8
SE,DEPRESSED LEVEL OF CONSCIOUSNESS,8
SE,DIARRHOEA,8
SE,INTENTIONAL SELF-INJURY,8
SE,PHARYNGEAL OEDEMA,8
SE,SWOLLEN TONGUE,8
SE,ABNORMAL FAECES,7
SE,BALANCE DISORDER,7
SE,CHILLS,7
SE,HALLUCINATION_ VISUAL,7
SE,MUSCLE SPASMS,7
SE,PAIN IN EXTREMITY,7
SE,RED BLOOD CELL COUNT DECREASED,7
SE,AMNESIA,6
SE,BLOOD CREATININE INCREASED,6
SE,CHROMATURIA,6
SE,DRY MOUTH,6
SE,EAR INFECTION,6
SE,FLUSHING,6
SE,GASTROINTESTINAL MOTILITY DISORDER,6
SE,LIP SWELLING,6
SE,MUSCULOSKELETAL DISCOMFORT,6
SE,MUSCULOSKELETAL STIFFNESS,6
SE,ORAL DISCOMFORT,6
SE,OVERDOSE,6
SE,PYREXIA,6
SE,SOMATIC DELUSION,6
SE,SUICIDAL IDEATION,6
SE,TINNITUS,6
SE,URINE ODOUR ABNORMAL,6
SE,WHITE BLOOD CELL COUNT DECREASED,6
SE,ANALGESIC DRUG LEVEL INCREASED,5
SE,COORDINATION ABNORMAL,5
SE,DEHYDRATION,5
SE,DYSPHAGIA,5
SE,DYSSTASIA,5
SE,GAIT DISTURBANCE,5
SE,HALLUCINATION,5
SE,MALAISE,5
SE,PARAESTHESIA,5
SE,PSYCHOTIC DISORDER,5
SE,RENAL IMPAIRMENT,5
SE,SUICIDE ATTEMPT,5
SE,VISION BLURRED,5
SE,ACCIDENTAL OVERDOSE,4
SE,DISTURBANCE IN ATTENTION,4
SE,DRUG ABUSE,4
SE,DRUG ERUPTION,4
SE,GENERAL PHYSICAL HEALTH DETERIORATION,4
SE,HYPERHIDROSIS,4
SE,HYPERSENSITIVITY,4
SE,JAUNDICE,4
SE,MYOCLONUS,4
SE,NIGHTMARE,4
SE,OEDEMA,4
SE,ORAL MUCOSAL BLISTERING,4
SE,PNEUMONIA,4
SE,URINARY TRACT INFECTION,4
SE,WEIGHT INCREASED,4
SE,AFFECT LABILITY,3
SE,AGEUSIA,3
SE,ANAEMIA,3
SE,ANORGASMIA,3
SE,ANOSMIA,3
SE,ANXIETY,3
SE,DECREASED APPETITE,3
SE,DEPRESSION,3
SE,DISORGANISED SPEECH,3
SE,DUODENAL ULCER HAEMORRHAGE,3
SE,DYSARTHRIA,3
SE,DYSGRAPHIA,3
SE,GINGIVAL BLEEDING,3
SE,HEPATIC FAILURE,3
SE,HYPERKALAEMIA,3
SE,HYPERTENSION,3
SE,HYPOHIDROSIS,3
SE,HYPOTENSION,3
SE,INCREASED APPETITE,3
SE,MOUTH SWELLING,3
SE,MUSCLE ATROPHY,3
SE,NEUROPSYCHIATRIC SYNDROME,3
SE,NEUTROPENIA,3
SE,OCULAR ICTERUS,3
SE,OEDEMA PERIPHERAL,3
SE,PALPITATIONS,3
SE,PRODUCT USE ISSUE,3
SE,RASH,3
SE,SKIN ODOUR ABNORMAL,3
SE,SPEECH DISORDER,3
SE,STRABISMUS,3
SE,TONGUE FUNGAL INFECTION,3
SE,TREMOR,3
SE,URINARY RETENTION,3
SE,VERTIGO,3
SE,ABDOMINAL PAIN UPPER,2
SE,AGGRESSION,2
SE,ANAPHYLACTIC SHOCK,2
SE,ANTIVIRAL DRUG LEVEL ABOVE THERAPEUTIC,2
SE,ASTHENIA,2
SE,ATAXIA,2
SE,ATRIAL FIBRILLATION,2
SE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,2
SE,BACK PAIN,2
SE,BLADDER DYSFUNCTION,2
SE,BONE PAIN,2
SE,C-REACTIVE PROTEIN INCREASED,2
SE,CONDITION AGGRAVATED,2
SE,CONSTIPATION,2
SE,DEPRESSED MOOD,2
SE,DEREALISATION,2
SE,DISORIENTATION,2
SE,DRUG INEFFECTIVE,2
SE,DRUG WITHDRAWAL SYNDROME,2
SE,ELECTROCARDIOGRAM QT PROLONGED,2
SE,EPIGLOTTIC OEDEMA,2
SE,FACE OEDEMA,2
SE,FALL,2
SE,FEBRILE NEUTROPENIA,2
SE,FEELING ABNORMAL,2
SE,HEART RATE DECREASED,2
SE,HYPOAESTHESIA,2
SE,INTERSTITIAL LUNG DISEASE,2
SE,MATERNAL EXPOSURE DURING PREGNANCY,2
SE,MUSCULOSKELETAL PAIN,2
SE,PANCREATITIS ACUTE,2
SE,POLYNEUROPATHY,2
SE,RENAL FAILURE,2
SE,RENAL FAILURE ACUTE,2
SE,SEROTONIN SYNDROME,2
SE,SKIN ULCER,2
SE,SYNCOPE,2
SE,VISUAL IMPAIRMENT,2
SE,ABNORMAL DREAMS,1
SE,ABORTION SPONTANEOUS,1
SE,ACIDOSIS,1
SE,ACUTE KIDNEY INJURY,1
SE,ACUTE MYOCARDIAL INFARCTION,1
SE,ALANINE AMINOTRANSFERASE INCREASED,1
SE,ALKALOSIS,1
SE,ALVEOLITIS,1
SE,ANAEMIA MACROCYTIC,1
SE,ANAPHYLACTIC REACTION,1
SE,ANGER,1
SE,APHTHOUS ULCER,1
SE,ARRHYTHMIA,1
SE,ARTERIOSPASM CORONARY,1
SE,B-CELL LYMPHOMA,1
SE,BLOOD GLUCOSE INCREASED,1
SE,BLOOD IMMUNOGLOBULIN M DECREASED,1
SE,BLOOD PRESSURE DECREASED,1
SE,BRADYCARDIA,1
SE,BRAIN OEDEMA,1
SE,CARDIAC ARREST,1
SE,CARDIAC FAILURE,1
SE,CEREBRAL HAEMORRHAGE,1
SE,CHEST DISCOMFORT,1
SE,CHEST PAIN,1
SE,CHRONIC MYELOMONOCYTIC LEUKAEMIA,1
SE,CIRCULATORY COLLAPSE,1
SE,COMA SCALE ABNORMAL,1
SE,CORONARY ARTERY DISSECTION,1
SE,CYANOSIS,1
SE,DEATH,1
SE,DELUSION,1
SE,DEPRESSIVE SYMPTOM,1
SE,DIABETES MELLITUS,1
SE,DISCOMFORT,1
SE,DISEASE PROGRESSION,1
SE,DISSOCIATION,1
SE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
SE,DRUG DEPENDENCE,1
SE,DRUG USE DISORDER,1
SE,DYSLOGIA,1
SE,DYSPHONIA,1
SE,EMBOLISM,1
SE,ENCEPHALOPATHY,1
SE,EPILEPSY,1
SE,EPISTAXIS,1
SE,ERYSIPELAS,1
SE,EXTRAPYRAMIDAL DISORDER,1
SE,EYE OEDEMA,1
SE,FEELING DRUNK,1
SE,FLATULENCE,1
SE,FLUID RETENTION,1
SE,FUMBLING,1
SE,GINGIVITIS,1
SE,HAEMATOMA,1
SE,HAEMOGLOBIN DECREASED,1
SE,HAEMOGLOBIN INCREASED,1
SE,HAEMOLYSIS,1
SE,HAEMOPHILIA,1
SE,HEARING IMPAIRED,1
SE,HEART RATE IRREGULAR,1
SE,HEPATITIS B,1
SE,HERPES ZOSTER,1
SE,HYPERVENTILATION,1
SE,HYPOALBUMINAEMIA,1
SE,HYPOKALAEMIA,1
SE,HYPONATRAEMIA,1
SE,HYPOPHAGIA,1
SE,HYPOTHYROIDISM,1
SE,HYPOXIA,1
SE,IMPRISONMENT,1
SE,INTENTIONAL PRODUCT USE ISSUE,1
SE,IRRITABILITY,1
SE,JOINT STIFFNESS,1
SE,LARGE INTESTINE PERFORATION,1
SE,LETHARGY,1
SE,LEUKOCYTOSIS,1
SE,LEUKOPENIA,1
SE,LOSS OF CONSCIOUSNESS,1
SE,LUNG INFECTION,1
SE,LUNG NEOPLASM MALIGNANT,1
SE,MENTAL IMPAIRMENT,1
SE,MICTURITION FREQUENCY DECREASED,1
SE,MIXED LIVER INJURY,1
SE,MUSCLE CONTRACTIONS INVOLUNTARY,1
SE,MYOCARDIAL INFARCTION,1
SE,NASOPHARYNGITIS,1
SE,NEURALGIA,1
SE,NEUROGENIC BLADDER,1
SE,NEUROLOGICAL SYMPTOM,1
SE,NEUTROPHIL COUNT DECREASED,1
SE,NON-CARDIAC CHEST PAIN,1
SE,NYSTAGMUS,1
SE,OBSTRUCTIVE AIRWAYS DISORDER,1
SE,OEDEMA MOUTH,1
SE,ONYCHOCLASIS,1
SE,OROPHARYNGEAL PAIN,1
SE,OSTEONECROSIS,1
SE,OSTEONECROSIS OF JAW,1
SE,PAIN,1
SE,PERIPHERAL SWELLING,1
SE,PERSONALITY CHANGE,1
SE,PHOTOSENSITIVITY REACTION,1
SE,PHYSICAL ASSAULT,1
SE,PNEUMONIA ASPIRATION,1
SE,POISONING,1
SE,POLYCYTHAEMIA,1
SE,PORPHYRIA NON-ACUTE,1
SE,POST VIRAL FATIGUE SYNDROME,1
SE,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
SE,PRESCRIBED OVERDOSE,1
SE,PRODUCT SUBSTITUTION,1
SE,PRURITUS,1
SE,PSORIASIS,1
SE,PSORIATIC ARTHROPATHY,1
SE,PSYCHOMOTOR HYPERACTIVITY,1
SE,PULMONARY OEDEMA,1
SE,RASH GENERALISED,1
SE,RECTAL DISCHARGE,1
SE,RESPIRATORY ACIDOSIS,1
SE,RESPIRATORY DISTRESS,1
SE,RESPIRATORY TRACT INFECTION,1
SE,RESPIRATORY TRACT OEDEMA,1
SE,RESTLESS LEGS SYNDROME,1
SE,RESTLESSNESS,1
SE,RHABDOMYOLYSIS,1
SE,RHINITIS,1
SE,SEDATION,1
SE,SEIZURE,1
SE,SERUM FERRITIN INCREASED,1
SE,SHOCK,1
SE,SINUS ARREST,1
SE,SKIN HAEMORRHAGE,1
SE,SKIN REACTION,1
SE,SOMNAMBULISM,1
SE,STILLBIRTH,1
SE,SUBARACHNOID HAEMORRHAGE,1
SE,SUBDURAL HAEMATOMA,1
SE,SUDDEN CARDIAC DEATH,1
SE,SWELLING FACE,1
SE,TACHYCARDIA,1
SE,TEETH BRITTLE,1
SE,TIC,1
SE,TOXIC SKIN ERUPTION,1
SE,URTICARIA,1
SE,VENOUS THROMBOSIS,1
SE,VENTRICULAR FIBRILLATION,1
SE,VENTRICULAR TACHYCARDIA,1
SE,VISUAL ACUITY REDUCED,1
SE,WITHDRAWAL SYNDROME,1
SE,WOUND,1
CH,CONFUSIONAL STATE,7
CH,DIZZINESS,7
CH,ATRIOVENTRICULAR BLOCK COMPLETE,6
CH,NAUSEA,6
CH,COGNITIVE DISORDER,5
CH,ACUTE KIDNEY INJURY,4
CH,CARDIOGENIC SHOCK,4
CH,DEATH,4
CH,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,4
CH,DYSPNOEA,4
CH,FALL,4
CH,HYPOTENSION,4
CH,PNEUMONIA,4
CH,PSYCHOMOTOR SKILLS IMPAIRED,4
CH,SUICIDE ATTEMPT,4
CH,AGRANULOCYTOSIS,3
CH,ALTERED STATE OF CONSCIOUSNESS,3
CH,APHASIA,3
CH,ASTHENIA,3
CH,COMA,3
CH,CONTRAINDICATED PRODUCT ADMINISTERED,3
CH,DISORIENTATION,3
CH,FOETAL GROWTH RESTRICTION,3
CH,HAEMATEMESIS,3
CH,ORTHOSTATIC HYPOTENSION,3
CH,PANCYTOPENIA,3
CH,RENAL FAILURE CHRONIC,3
CH,TOXICITY TO VARIOUS AGENTS,3
CH,URINARY TRACT INFECTION,3
CH,ABDOMINAL PAIN UPPER,2
CH,ACCIDENTAL OVERDOSE,2
CH,BALANCE DISORDER,2
CH,BLOOD ALKALINE PHOSPHATASE INCREASED,2
CH,BRADYCARDIA,2
CH,CARDIAC PACEMAKER INSERTION,2
CH,COLITIS,2
CH,CONDITION AGGRAVATED,2
CH,CONSTIPATION,2
CH,DECREASED APPETITE,2
CH,DEEP VEIN THROMBOSIS,2
CH,DELIRIUM,2
CH,DRUG PRESCRIBING ERROR,2
CH,ENDOTRACHEAL INTUBATION,2
CH,FATIGUE,2
CH,GAIT DISTURBANCE,2
CH,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
CH,GENERAL PHYSICAL HEALTH DETERIORATION,2
CH,HAEMOGLOBIN DECREASED,2
CH,HEAD INJURY,2
CH,HEPATIC ENZYME INCREASED,2
CH,HYPERKALAEMIA,2
CH,INCORRECT DOSE ADMINISTERED,2
CH,INTESTINAL ULCER,2
CH,LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR,2
CH,LIVER INJURY,2
CH,LOSS OF CONSCIOUSNESS,2
CH,MALAISE,2
CH,MUSCLE HAEMORRHAGE,2
CH,OVERDOSE,2
CH,PARAESTHESIA,2
CH,PRURITUS,2
CH,PULMONARY SEPSIS,2
CH,PYREXIA,2
CH,RASH MACULO-PAPULAR,2
CH,RENAL FAILURE ACUTE,2
CH,SOMNOLENCE,2
CH,SPINAL OSTEOARTHRITIS,2
CH,SPONTANEOUS HAEMATOMA,2
CH,VAGINAL HAEMORRHAGE,2
CH,ACIDOSIS,1
CH,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
CH,ADJUSTMENT DISORDER,1
CH,ALANINE AMINOTRANSFERASE INCREASED,1
CH,AMNESIA,1
CH,ANTIDEPRESSANT DRUG LEVEL INCREASED,1
CH,APPLICATION SITE REACTION,1
CH,ASPARTATE AMINOTRANSFERASE INCREASED,1
CH,ATYPICAL FEMUR FRACTURE,1
CH,BACTERIAL INFECTION,1
CH,BACTERIAL SEPSIS,1
CH,BIOPSY SKIN ABNORMAL,1
CH,BLOOD CREATININE INCREASED,1
CH,BLOOD URINE PRESENT,1
CH,BRONCHITIS,1
CH,BURSITIS,1
CH,CHRONIC MYELOID LEUKAEMIA,1
CH,CONCOMITANT DISEASE AGGRAVATED,1
CH,DEPRESSED MOOD,1
CH,DERMATITIS EXFOLIATIVE,1
CH,DIARRHOEA,1
CH,DRUG ADMINISTRATION ERROR,1
CH,DRUG EFFECT INCOMPLETE,1
CH,DRY MOUTH,1
CH,DYSARTHRIA,1
CH,DYSHIDROTIC ECZEMA,1
CH,DYSPHAGIA,1
CH,ELECTROCARDIOGRAM ABNORMAL,1
CH,EPILEPSY,1
CH,EXPOSURE DURING PREGNANCY,1
CH,FANCONI SYNDROME,1
CH,FOETAL EXPOSURE DURING PREGNANCY,1
CH,FRUSTRATION,1
CH,GASTROINTESTINAL HAEMORRHAGE,1
CH,GASTROOESOPHAGEAL REFLUX DISEASE,1
CH,GLOMERULAR FILTRATION RATE DECREASED,1
CH,HAEMORRHAGIC ANAEMIA,1
CH,HALLUCINATION_ VISUAL,1
CH,HEADACHE,1
CH,HEMIANAESTHESIA,1
CH,HEMIPARESIS,1
CH,HEPATOCELLULAR INJURY,1
CH,HIATUS HERNIA,1
CH,HLA MARKER STUDY POSITIVE,1
CH,HUMERUS FRACTURE,1
CH,HYPERCALCAEMIA,1
CH,HYPERGLYCAEMIA,1
CH,HYPOCALCAEMIA,1
CH,HYPOCHROMIC ANAEMIA,1
CH,INSOMNIA,1
CH,INTERSTITIAL LUNG DISEASE,1
CH,JAUNDICE,1
CH,KERATORHEXIS,1
CH,LANGUAGE DISORDER,1
CH,LIVER DISORDER,1
CH,LYMPHADENOPATHY,1
CH,MATERNAL EXPOSURE DURING PREGNANCY,1
CH,MELAENA,1
CH,MOTOR DYSFUNCTION,1
CH,MUCOSAL EROSION,1
CH,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
CH,MULTIPLE SCLEROSIS,1
CH,MUSCLE SPASTICITY,1
CH,NEUROTOXICITY,1
CH,NEUTROPENIA,1
CH,NODAL ARRHYTHMIA,1
CH,PAIN,1
CH,PANCREATITIS,1
CH,PARESIS,1
CH,PNEUMONITIS,1
CH,POLYURIA,1
CH,PRESCRIBED OVERDOSE,1
CH,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,1
CH,PRODUCT USE ISSUE,1
CH,PURPURA,1
CH,RESPIRATORY FAILURE,1
CH,SCIATICA,1
CH,SEPSIS,1
CH,SQUAMOUS CELL CARCINOMA OF THE HYPOPHARYNX,1
CH,SUDDEN CARDIAC DEATH,1
CH,SYNCOPE,1
CH,THROMBOCYTOPENIA,1
CH,TREMOR,1
CH,VERTIGO,1
CH,VISION BLURRED,1
CH,VISUAL IMPAIRMENT,1
CH,VOMITING,1
TW,DIZZINESS,3
TW,ERECTILE DYSFUNCTION,3
TW,PREMATURE EJACULATION,3
TW,AGRANULOCYTOSIS,2
TW,ALTERED STATE OF CONSCIOUSNESS,2
TW,ASTHENIA,2
TW,CONFUSIONAL STATE,2
TW,CONSTIPATION,2
TW,DRUG INEFFECTIVE,2
TW,DRY MOUTH,2
TW,HAEMOGLOBIN DECREASED,2
TW,HALLUCINATION,2
TW,LETHARGY,2
TW,MUSCLE SPASMS,2
TW,NAUSEA,2
TW,TOXICITY TO VARIOUS AGENTS,2
TW,BLOOD GLUCOSE INCREASED,1
TW,BLOOD PRESSURE INCREASED,1
TW,CELLULITIS,1
TW,CEREBROVASCULAR ACCIDENT,1
TW,DEMENTIA WITH LEWY BODIES,1
TW,DERMATITIS ALLERGIC,1
TW,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
TW,EPILEPSY,1
TW,FEELING COLD,1
TW,GASTRITIS EROSIVE,1
TW,HAEMATOCRIT DECREASED,1
TW,HEADACHE,1
TW,HERPES ZOSTER,1
TW,HYPERTENSION,1
TW,HYPOAESTHESIA,1
TW,INJECTION SITE ULCER,1
TW,LUNG INFILTRATION,1
TW,LYMPHOCYTE COUNT DECREASED,1
TW,MOUTH ULCERATION,1
TW,MUSCLE TIGHTNESS,1
TW,NEUROLEPTIC MALIGNANT SYNDROME,1
TW,NEUTROPHIL COUNT INCREASED,1
TW,ORAL DISCOMFORT,1
TW,PAIN,1
TW,PARAESTHESIA,1
TW,PLATELET COUNT DECREASED,1
TW,PNEUMONIA,1
TW,POLLAKIURIA,1
TW,PROSTATITIS,1
TW,PYREXIA,1
TW,RESPIRATORY FAILURE,1
TW,SEPSIS,1
TW,SOMNOLENCE,1
TW,SYNCOPE,1
TW,THERAPEUTIC RESPONSE UNEXPECTED,1
TW,VERTIGO,1
TW,VOMITING,1
TW,WHITE BLOOD CELL COUNT INCREASED,1
TH,HYPOAESTHESIA,3
TH,BACK PAIN,2
TH,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
TH,ABDOMINAL DISCOMFORT,1
TH,ABDOMINAL PAIN,1
TH,AMNESIA,1
TH,ARTHRALGIA,1
TH,BALANCE DISORDER,1
TH,CONSTIPATION,1
TH,DEATH,1
TH,DERMATITIS EXFOLIATIVE,1
TH,DIZZINESS,1
TH,DYSURIA,1
TH,ENERGY INCREASED,1
TH,ENTEROCOLITIS,1
TH,ERYTHEMA,1
TH,ERYTHEMA MULTIFORME,1
TH,FALL,1
TH,FATIGUE,1
TH,FEELING DRUNK,1
TH,GAIT DISTURBANCE,1
TH,HEPATITIS,1
TH,HYPOGLYCAEMIA,1
TH,INJECTION SITE PAIN,1
TH,MENTAL IMPAIRMENT,1
TH,MUSCLE SPASMS,1
TH,MUSCLE TWITCHING,1
TH,MUSCULAR WEAKNESS,1
TH,OVERDOSE,1
TH,PAIN,1
TH,PAIN IN EXTREMITY,1
TH,PANCREATIC CARCINOMA,1
TH,PARAESTHESIA,1
TH,PLASMA CELL MYELOMA,1
TH,PRODUCT USE IN UNAPPROVED INDICATION,1
TH,PYREXIA,1
TH,RASH MACULO-PAPULAR,1
TH,RESPIRATORY FAILURE,1
TH,SEDATION,1
TH,SOMNOLENCE,1
TH,UPPER GASTROINTESTINAL HAEMORRHAGE,1
TH,URETERIC STENOSIS,1
TH,URINARY TRACT INFECTION,1
TN,HYPERSENSITIVITY VASCULITIS,3
TN,NECROSIS,1
TN,PETECHIAE,1
TN,SKIN LESION,1
TN,VASCULAR PURPURA,1
TR,NEUROLEPTIC MALIGNANT SYNDROME,16
TR,MAJOR DEPRESSION,9
TR,SEPSIS,9
TR,THROMBOCYTOPENIA,9
TR,ABORTION SPONTANEOUS,7
TR,PNEUMONIA,7
TR,WITHDRAWAL SYNDROME,7
TR,ALTERED STATE OF CONSCIOUSNESS,6
TR,CARDIAC ARREST,6
TR,GINGIVAL BLEEDING,6
TR,MATERNAL EXPOSURE DURING PREGNANCY,6
TR,MULTIPLE SCLEROSIS RELAPSE,6
TR,TREMOR,6
TR,ASTHENIA,5
TR,DRUG INEFFECTIVE,5
TR,INTRAOCULAR PRESSURE INCREASED,5
TR,PSYCHOTIC DISORDER,5
TR,SEPTIC SHOCK,5
TR,AMYLASE INCREASED,4
TR,DYSKINESIA,4
TR,LACTIC ACIDOSIS,4
TR,MYOCARDIAL INFARCTION,4
TR,PAIN IN EXTREMITY,4
TR,PANCYTOPENIA,4
TR,TOXICITY TO VARIOUS AGENTS,4
TR,VERTIGO,4
TR,VOMITING,4
TR,DEATH,3
TR,DECREASED APPETITE,3
TR,DIZZINESS,3
TR,DRUG DEPENDENCE,3
TR,DYSPNOEA,3
TR,FATIGUE,3
TR,HYPOAESTHESIA,3
TR,INSOMNIA,3
TR,LIPASE INCREASED,3
TR,MEMORY IMPAIRMENT,3
TR,NAUSEA,3
TR,PALPITATIONS,3
TR,PANCREATITIS,3
TR,PRODUCT USE IN UNAPPROVED INDICATION,3
TR,SOMNOLENCE,3
TR,ABDOMINAL PAIN UPPER,2
TR,ACUTE KIDNEY INJURY,2
TR,BACK PAIN,2
TR,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
TR,BLOOD GLUCOSE INCREASED,2
TR,BREAST CANCER,2
TR,BRUXISM,2
TR,DEPRESSED MOOD,2
TR,DIARRHOEA,2
TR,DIPLOPIA,2
TR,DISSEMINATED TUBERCULOSIS,2
TR,DRUG WITHDRAWAL SYNDROME,2
TR,GAIT DISTURBANCE,2
TR,GENERAL PHYSICAL HEALTH DETERIORATION,2
TR,HAEMATURIA,2
TR,HALLUCINATION,2
TR,HYPERHIDROSIS,2
TR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
TR,INCREASED APPETITE,2
TR,INJECTION SITE PAIN,2
TR,MENSTRUATION IRREGULAR,2
TR,MUSCLE RIGIDITY,2
TR,MUSCLE SPASMS,2
TR,MUTISM,2
TR,MYOCLONUS,2
TR,OEDEMA PERIPHERAL,2
TR,PAIN,2
TR,PNEUMONITIS,2
TR,PYREXIA,2
TR,RESTLESS LEGS SYNDROME,2
TR,SCIATIC NERVE NEUROPATHY,2
TR,SCOLIOSIS,2
TR,SUICIDAL IDEATION,2
TR,THERAPEUTIC RESPONSE UNEXPECTED,2
TR,TRANSAMINASES INCREASED,2
TR,WEIGHT DECREASED,2
TR,ABASIA,1
TR,ABDOMINAL DISTENSION,1
TR,ABDOMINAL PAIN,1
TR,ABNORMAL BEHAVIOUR,1
TR,ABSCESS,1
TR,ABSCESS LIMB,1
TR,ADENOCARCINOMA OF COLON,1
TR,AGITATION,1
TR,AMNESIA,1
TR,ANAEMIA,1
TR,ANTERIOR CHAMBER DISORDER,1
TR,ANXIETY,1
TR,APHAGIA,1
TR,APHTHOUS ULCER,1
TR,AQUAGENIC WRINKLING OF PALMS,1
TR,ARRHYTHMIA,1
TR,ARTHRALGIA,1
TR,ASCITES,1
TR,ATAXIA,1
TR,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,1
TR,BALANCE DISORDER,1
TR,BEZOAR,1
TR,BLIGHTED OVUM,1
TR,BLINDNESS,1
TR,BLOOD BILIRUBIN INCREASED,1
TR,BLOOD CREATINE INCREASED,1
TR,BLOOD CREATININE INCREASED,1
TR,BLOOD IRON DECREASED,1
TR,BLOOD PRESSURE INCREASED,1
TR,BLOOD UREA INCREASED,1
TR,BRADYCARDIA,1
TR,BREAST CYST,1
TR,CALCULUS URINARY,1
TR,CHEST PAIN,1
TR,CHILLS,1
TR,CHOLECYSTITIS,1
TR,CHOLELITHIASIS,1
TR,COMA,1
TR,COMPARTMENT SYNDROME,1
TR,COUGH,1
TR,CRYING,1
TR,DEAFNESS,1
TR,DEEP VEIN THROMBOSIS,1
TR,DISCOMFORT,1
TR,DIVERTICULITIS,1
TR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,1
TR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
TR,DRUG LEVEL ABOVE THERAPEUTIC,1
TR,EAR HAEMORRHAGE,1
TR,EJACULATION FAILURE,1
TR,ENCEPHALOPATHY,1
TR,EOSINOPHILIC PNEUMONIA,1
TR,EPILEPSY,1
TR,ERYTHEMA,1
TR,ESSENTIAL TREMOR,1
TR,EUPHORIC MOOD,1
TR,EXPOSURE DURING PREGNANCY,1
TR,EYE SWELLING,1
TR,FALL,1
TR,FEAR,1
TR,FEAR OF INJECTION,1
TR,FEELING ABNORMAL,1
TR,FEELING DRUNK,1
TR,FOOT FRACTURE,1
TR,GAIT INABILITY,1
TR,GALLBLADDER DISORDER,1
TR,GENERAL PHYSICAL CONDITION ABNORMAL,1
TR,HAEMATURIA TRAUMATIC,1
TR,HAEMORRHOIDS,1
TR,HAIR GROWTH ABNORMAL,1
TR,HALLUCINATIONS_ MIXED,1
TR,HEADACHE,1
TR,HEPATITIS B,1
TR,HEPATOSPLENOMEGALY,1
TR,HYPERGLYCAEMIA,1
TR,HYPERSENSITIVITY,1
TR,HYPERSENSITIVITY VASCULITIS,1
TR,HYPOGLYCAEMIA,1
TR,HYPOKINESIA,1
TR,HYPONATRAEMIA,1
TR,ILLUSION,1
TR,INFECTION,1
TR,INFLUENZA,1
TR,INJECTION SITE BRUISING,1
TR,INJECTION SITE ERYTHEMA,1
TR,INJECTION SITE MASS,1
TR,INJECTION SITE REACTION,1
TR,IRON DEFICIENCY,1
TR,IRRITABLE BOWEL SYNDROME,1
TR,LARGE INTESTINAL OBSTRUCTION,1
TR,LIMB IMMOBILISATION,1
TR,LOCAL SWELLING,1
TR,LYMPHOCYTE COUNT DECREASED,1
TR,LYMPHOMA,1
TR,MALIGNANT PLEURAL EFFUSION,1
TR,MENTAL RETARDATION,1
TR,MOVEMENT DISORDER,1
TR,MUSCLE CONTRACTIONS INVOLUNTARY,1
TR,MUSCLE CONTRACTURE,1
TR,MUSCULAR WEAKNESS,1
TR,MUSCULOSKELETAL PAIN,1
TR,MYDRIASIS,1
TR,MYOSITIS,1
TR,NERVOUSNESS,1
TR,NEUTROPENIA,1
TR,OPEN ANGLE GLAUCOMA,1
TR,OROPHARYNGEAL PAIN,1
TR,OVERDOSE,1
TR,PAIN IN JAW,1
TR,PANCREATITIS ACUTE,1
TR,PARAESTHESIA,1
TR,PARKINSONISM,1
TR,PARKINSON^S DISEASE,1
TR,PERICARDITIS,1
TR,PERIPHERAL SWELLING,1
TR,PLATELET COUNT INCREASED,1
TR,POISONING,1
TR,PRE-EXISTING CONDITION IMPROVED,1
TR,PROCTALGIA,1
TR,PRODUCT QUALITY ISSUE,1
TR,PRODUCT USE ISSUE,1
TR,PRURITUS,1
TR,PSYCHOTIC BEHAVIOUR,1
TR,PULSE ABNORMAL,1
TR,RECALL PHENOMENON,1
TR,RENAL PAIN,1
TR,RESPIRATORY DISTRESS,1
TR,RETINAL ARTERY OCCLUSION,1
TR,RHABDOMYOLYSIS,1
TR,SCIATICA,1
TR,SERUM FERRITIN DECREASED,1
TR,SHOCK,1
TR,SKIN DISCOLOURATION,1
TR,SOLILOQUY,1
TR,SPEECH DISORDER,1
TR,STRESS,1
TR,SWELLING FACE,1
TR,SYNCOPE,1
TR,TENDERNESS,1
TR,THERAPY CHANGE,1
TR,THINKING ABNORMAL,1
TR,THYROXINE FREE DECREASED,1
TR,URINARY TRACT INFECTION,1
TR,UTERINE CANCER,1
TR,UTERINE LEIOMYOMA,1
TR,VENOUS THROMBOSIS,1
TR,VISION BLURRED,1
TR,VISUAL IMPAIRMENT,1
TR,VITAMIN D INCREASED,1
TR,WHITE BLOOD CELLS URINE,1
TR,WOLFF-PARKINSON-WHITE SYNDROME,1
TR,WOUND INFECTION,1
TR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
GB,MALAISE,258
GB,CONFUSIONAL STATE,247
GB,DIZZINESS,239
GB,DYSPNOEA,226
GB,HEADACHE,205
GB,NAUSEA,200
GB,FEELING ABNORMAL,160
GB,DIARRHOEA,158
GB,PAIN,158
GB,VOMITING,148
GB,PAIN IN EXTREMITY,138
GB,DEPRESSION,135
GB,FALL,135
GB,SOMNOLENCE,133
GB,FATIGUE,131
GB,PARAESTHESIA,130
GB,ANXIETY,126
GB,RASH,118
GB,HALLUCINATION,115
GB,TREMOR,105
GB,TOXICITY TO VARIOUS AGENTS,102
GB,LOSS OF CONSCIOUSNESS,101
GB,MUSCLE SPASMS,101
GB,MUSCULAR WEAKNESS,98
GB,PYREXIA,96
GB,INSOMNIA,95
GB,VISION BLURRED,95
GB,ARTHRALGIA,93
GB,DRUG INEFFECTIVE,91
GB,ACUTE KIDNEY INJURY,90
GB,CONDITION AGGRAVATED,89
GB,AMNESIA,87
GB,AGGRESSION,86
GB,LETHARGY,86
GB,MYALGIA,84
GB,DRY MOUTH,83
GB,SUICIDAL IDEATION,82
GB,HYPERHIDROSIS,77
GB,GAIT DISTURBANCE,73
GB,PALPITATIONS,73
GB,NIGHTMARE,72
GB,LOWER RESPIRATORY TRACT INFECTION,71
GB,WITHDRAWAL SYNDROME,71
GB,ABDOMINAL PAIN UPPER,70
GB,CHEST PAIN,70
GB,HYPOAESTHESIA,69
GB,PERIPHERAL SWELLING,69
GB,ABDOMINAL PAIN,68
GB,BACK PAIN,68
GB,HYPOTENSION,68
GB,MEMORY IMPAIRMENT,67
GB,SPEECH DISORDER,67
GB,MUSCULOSKELETAL STIFFNESS,65
GB,SWELLING FACE,65
GB,BALANCE DISORDER,64
GB,MUSCLE TWITCHING,64
GB,PNEUMONIA,63
GB,VISUAL IMPAIRMENT,63
GB,DYSARTHRIA,62
GB,OROPHARYNGEAL PAIN,62
GB,PRURITUS,62
GB,CONSTIPATION,61
GB,PRODUCT USE ISSUE,59
GB,DYSKINESIA,57
GB,OVERDOSE,56
GB,COUGH,55
GB,INFECTION,55
GB,LIVER FUNCTION TEST ABNORMAL,55
GB,ASTHENIA,54
GB,INTENTIONAL OVERDOSE,53
GB,SEPSIS,53
GB,MENTAL IMPAIRMENT,51
GB,DECREASED APPETITE,49
GB,SEROTONIN SYNDROME,49
GB,DISORIENTATION,48
GB,HAEMATEMESIS,48
GB,DEATH,47
GB,SEIZURE,47
GB,DISTURBANCE IN ATTENTION,46
GB,AGITATION,45
GB,ALOPECIA,45
GB,ANAPHYLACTIC REACTION,45
GB,RENAL IMPAIRMENT,45
GB,WEIGHT DECREASED,45
GB,HYPONATRAEMIA,44
GB,LIP SWELLING,44
GB,SKIN EXFOLIATION,44
GB,HYPERKALAEMIA,43
GB,ABDOMINAL DISTENSION,42
GB,HYPERTENSION,42
GB,SLEEP DISORDER,42
GB,DYSGEUSIA,41
GB,DYSPEPSIA,41
GB,INFLUENZA LIKE ILLNESS,41
GB,SWOLLEN TONGUE,41
GB,ABNORMAL BEHAVIOUR,40
GB,TINNITUS,40
GB,BRADYCARDIA,39
GB,DEPRESSED MOOD,39
GB,PULMONARY EMBOLISM,39
GB,CIRCULATORY COLLAPSE,38
GB,IRRITABILITY,38
GB,DYSPHAGIA,37
GB,ERYTHEMA,37
GB,LIMB DISCOMFORT,36
GB,MOOD ALTERED,36
GB,RENAL FAILURE ACUTE,36
GB,THROMBOCYTOPENIA,36
GB,COGNITIVE DISORDER,35
GB,DEPRESSED LEVEL OF CONSCIOUSNESS,35
GB,NEURALGIA,35
GB,THINKING ABNORMAL,35
GB,WHEEZING,35
GB,CARDIAC ARREST,34
GB,CHEST DISCOMFORT,34
GB,CONTUSION,34
GB,CRYING,34
GB,DRUG WITHDRAWAL SYNDROME,34
GB,SEDATION,34
GB,SYNCOPE,34
GB,URINARY TRACT INFECTION,34
GB,DYSPHONIA,33
GB,MENTAL DISORDER,33
GB,PRODUCT USE IN UNAPPROVED INDICATION,33
GB,PSORIASIS,33
GB,ANGER,32
GB,DRUG DEPENDENCE,32
GB,URINARY RETENTION,32
GB,ABNORMAL WEIGHT GAIN,31
GB,ANGIOEDEMA,31
GB,FEBRILE NEUTROPENIA,31
GB,FOETAL EXPOSURE DURING PREGNANCY,31
GB,RASH PRURITIC,31
GB,TEARFULNESS,31
GB,UPPER GASTROINTESTINAL HAEMORRHAGE,31
GB,CEREBRAL INFARCTION,30
GB,CHILLS,30
GB,COORDINATION ABNORMAL,30
GB,DEHYDRATION,30
GB,HYPERSENSITIVITY,30
GB,MOOD SWINGS,30
GB,PANCYTOPENIA,30
GB,SUICIDE ATTEMPT,30
GB,ABDOMINAL DISCOMFORT,29
GB,NEUROPATHY PERIPHERAL,29
GB,UNRESPONSIVE TO STIMULI,29
GB,VERTIGO,29
GB,EPILEPSY,28
GB,MOUTH ULCERATION,28
GB,PHARYNGEAL OEDEMA,28
GB,MOBILITY DECREASED,27
GB,NECK PAIN,27
GB,INTERNATIONAL NORMALISED RATIO INCREASED,26
GB,BLISTER,25
GB,ELECTROCARDIOGRAM QT PROLONGED,25
GB,GASTROINTESTINAL HAEMORRHAGE,25
GB,MYOCLONUS,25
GB,RESPIRATORY DEPRESSION,25
GB,URTICARIA,25
GB,ANAEMIA,24
GB,APHASIA,24
GB,ERECTILE DYSFUNCTION,24
GB,HALLUCINATION_ VISUAL,24
GB,JOINT SWELLING,24
GB,MIGRAINE,24
GB,MYOCARDIAL INFARCTION,24
GB,PARALYSIS,24
GB,WEIGHT INCREASED,24
GB,CEREBROVASCULAR ACCIDENT,23
GB,HYPERAESTHESIA,23
GB,MUSCULOSKELETAL PAIN,23
GB,NEUTROPENIA,23
GB,NIGHT SWEATS,23
GB,PANIC ATTACK,23
GB,RESPIRATORY FAILURE,23
GB,ARRHYTHMIA,22
GB,CELLULITIS,22
GB,DRUG ABUSE,22
GB,FEELING DRUNK,22
GB,JOINT STIFFNESS,22
GB,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,22
GB,AGEUSIA,21
GB,ANGINA PECTORIS,21
GB,ASTHMA,21
GB,DRY SKIN,21
GB,EYE SWELLING,21
GB,GASTRITIS,21
GB,MYOCARDIAL ISCHAEMIA,21
GB,OEDEMA PERIPHERAL,21
GB,PERSONALITY CHANGE,21
GB,RASH GENERALISED,21
GB,ABNORMAL LOSS OF WEIGHT,20
GB,ALCOHOL INTERACTION,20
GB,ARTERIOSCLEROSIS CORONARY ARTERY,20
GB,CONVULSION,20
GB,DELIRIUM,20
GB,DYSTONIA,20
GB,EPISTAXIS,20
GB,HEART RATE INCREASED,20
GB,HEMIPARESIS,20
GB,HYPERSOMNIA,20
GB,HYPOAESTHESIA ORAL,20
GB,HYPOGLYCAEMIA,20
GB,MELAENA,20
GB,PRESYNCOPE,20
GB,URINARY INCONTINENCE,20
GB,C-REACTIVE PROTEIN INCREASED,19
GB,DELUSION,19
GB,DRY EYE,19
GB,GASTROINTESTINAL DISORDER,19
GB,GENERAL PHYSICAL HEALTH DETERIORATION,19
GB,INTENTIONAL PRODUCT MISUSE,19
GB,NEGATIVE THOUGHTS,19
GB,NEUTROPENIC SEPSIS,19
GB,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,19
GB,RESTLESS LEGS SYNDROME,19
GB,ABNORMAL DREAMS,18
GB,ATRIAL FIBRILLATION,18
GB,FEMORAL NECK FRACTURE,18
GB,INFLUENZA,18
GB,LYMPHOEDEMA,18
GB,MOUTH SWELLING,18
GB,MUSCLE RIGIDITY,18
GB,PRURITUS GENERALISED,18
GB,RECTAL HAEMORRHAGE,18
GB,ABDOMINAL TENDERNESS,17
GB,DERMATITIS ALLERGIC,17
GB,DRUG HYPERSENSITIVITY,17
GB,EYE PAIN,17
GB,HYPOCALCAEMIA,17
GB,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,17
GB,PANCREATITIS ACUTE,17
GB,RASH ERYTHEMATOUS,17
GB,RASH PAPULAR,17
GB,SOCIAL AVOIDANT BEHAVIOUR,17
GB,THROAT TIGHTNESS,17
GB,VISUAL ACUITY REDUCED,17
GB,AUTONOMIC NERVOUS SYSTEM IMBALANCE,16
GB,DRUG PRESCRIBING ERROR,16
GB,FEELING HOT,16
GB,FEELING OF BODY TEMPERATURE CHANGE,16
GB,GASTRIC ULCER,16
GB,NASOPHARYNGITIS,16
GB,SPUTUM DISCOLOURED,16
GB,WHITE BLOOD CELL COUNT INCREASED,16
GB,BLADDER DISORDER,15
GB,COMA SCALE ABNORMAL,15
GB,DISCOMFORT,15
GB,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,15
GB,HIATUS HERNIA,15
GB,HYPERGLYCAEMIA,15
GB,HYPOXIA,15
GB,JAUNDICE,15
GB,MEDICATION ERROR,15
GB,OCULAR HYPERAEMIA,15
GB,PANCREATITIS,15
GB,PLATELET COUNT DECREASED,15
GB,PSYCHOTIC DISORDER,15
GB,PULMONARY OEDEMA,15
GB,WHITE BLOOD CELL COUNT DECREASED,15
GB,BRADYPHRENIA,14
GB,COMA,14
GB,DIPLOPIA,14
GB,FAECES DISCOLOURED,14
GB,FLATULENCE,14
GB,GASTROOESOPHAGEAL REFLUX DISEASE,14
GB,MOVEMENT DISORDER,14
GB,PHOTOSENSITIVITY REACTION,14
GB,RHABDOMYOLYSIS,14
GB,SURGERY,14
GB,SWELLING,14
GB,ACCIDENTAL OVERDOSE,13
GB,AFFECTIVE DISORDER,13
GB,ALANINE AMINOTRANSFERASE INCREASED,13
GB,BLOOD CREATINE PHOSPHOKINASE INCREASED,13
GB,CONGENITAL CARDIOVASCULAR ANOMALY,13
GB,CONGENITAL THROMBOCYTOPENIA,13
GB,ECZEMA,13
GB,EMOTIONAL DISORDER,13
GB,EUPHORIC MOOD,13
GB,FACIAL PARALYSIS,13
GB,GENERALISED TONIC-CLONIC SEIZURE,13
GB,GINGIVAL PAIN,13
GB,GINGIVITIS,13
GB,INTENTIONAL PRODUCT USE ISSUE,13
GB,LOCAL SWELLING,13
GB,MATERNAL EXPOSURE DURING PREGNANCY,13
GB,MUSCULOSKELETAL DISORDER,13
GB,NERVE INJURY,13
GB,PARANOIA,13
GB,PAROSMIA,13
GB,ABASIA,12
GB,ABDOMINAL TRANSPOSITION,12
GB,ACUTE LEFT VENTRICULAR FAILURE,12
GB,ARTHRITIS,12
GB,BEDRIDDEN,12
GB,BLOOD GLUCOSE INCREASED,12
GB,BONE PAIN,12
GB,CATATONIA,12
GB,CLUMSINESS,12
GB,DEEP VEIN THROMBOSIS,12
GB,DIABETIC KETOACIDOSIS,12
GB,GRIP STRENGTH DECREASED,12
GB,HEPATITIS,12
GB,INCOHERENT,12
GB,INCORRECT DOSE ADMINISTERED,12
GB,METABOLIC ACIDOSIS,12
GB,MOTOR DYSFUNCTION,12
GB,MUSCLE DISORDER,12
GB,NEUTROPHIL COUNT DECREASED,12
GB,OEDEMA,12
GB,ORAL CANDIDIASIS,12
GB,OSTEOMYELITIS,12
GB,OXYGEN SATURATION DECREASED,12
GB,PALLOR,12
GB,PNEUMONITIS,12
GB,POLLAKIURIA,12
GB,PRODUCTIVE COUGH,12
GB,PSORIATIC ARTHROPATHY,12
GB,TALIPES,12
GB,TENDONITIS,12
GB,WOUND,12
GB,ABULIA,11
GB,APPETITE DISORDER,11
GB,APRAXIA,11
GB,ATYPICAL FEMUR FRACTURE,11
GB,BLOOD BILIRUBIN INCREASED,11
GB,BLOOD POTASSIUM INCREASED,11
GB,COMPLETED SUICIDE,11
GB,DRUG ADMINISTRATION ERROR,11
GB,ENURESIS,11
GB,EXTRAPYRAMIDAL DISORDER,11
GB,INTERVERTEBRAL DISC PROTRUSION,11
GB,MUCOSAL INFLAMMATION,11
GB,MUSCLE TIGHTNESS,11
GB,NAIL DISORDER,11
GB,NERVOUS SYSTEM DISORDER,11
GB,NOCTURIA,11
GB,OBSESSIVE THOUGHTS,11
GB,ORTHOSTATIC HYPOTENSION,11
GB,PNEUMONIA ASPIRATION,11
GB,POTENTIATING DRUG INTERACTION,11
GB,TACHYCARDIA,11
GB,THERAPEUTIC RESPONSE UNEXPECTED,11
GB,TOE OPERATION,11
GB,AFFECT LABILITY,10
GB,AXONAL NEUROPATHY,10
GB,BASAL CELL CARCINOMA,10
GB,DUODENAL ULCER HAEMORRHAGE,10
GB,DYSPHEMIA,10
GB,EMOTIONAL DISTRESS,10
GB,EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS,10
GB,EXPOSURE DURING PREGNANCY,10
GB,FOOD CRAVING,10
GB,FOOD INTERACTION,10
GB,GOUT,10
GB,GROIN PAIN,10
GB,HYPOMAGNESAEMIA,10
GB,INCREASED APPETITE,10
GB,INTERNATIONAL NORMALISED RATIO DECREASED,10
GB,INTESTINAL PERFORATION,10
GB,LEUKOPENIA,10
GB,MANIA,10
GB,MENORRHAGIA,10
GB,NEUROLEPTIC MALIGNANT SYNDROME,10
GB,PLEURITIC PAIN,10
GB,RESTLESSNESS,10
GB,SINUS TACHYCARDIA,10
GB,SKIN DISCOLOURATION,10
GB,SUICIDAL BEHAVIOUR,10
GB,ABORTION SPONTANEOUS,9
GB,ARTERIOSPASM CORONARY,9
GB,ATRIOVENTRICULAR BLOCK COMPLETE,9
GB,BRAIN INJURY,9
GB,BURNING SENSATION,9
GB,CHROMATURIA,9
GB,COLITIS ISCHAEMIC,9
GB,DECREASED INTEREST,9
GB,DISORGANISED SPEECH,9
GB,DRUG DOSE OMISSION,9
GB,DYSPNOEA EXERTIONAL,9
GB,EYE DISORDER,9
GB,EYE MOVEMENT DISORDER,9
GB,EYE PRURITUS,9
GB,FACIAL PARESIS,9
GB,GASTROINTESTINAL PAIN,9
GB,HAEMOGLOBIN DECREASED,9
GB,HAEMORRHAGE,9
GB,HEMIPLEGIA,9
GB,HERPES ZOSTER,9
GB,HOT FLUSH,9
GB,IMPAIRED DRIVING ABILITY,9
GB,INFECTED SKIN ULCER,9
GB,LOSS OF LIBIDO,9
GB,MACROGLOSSIA,9
GB,MIOSIS,9
GB,NASAL CONGESTION,9
GB,NERVOUSNESS,9
GB,OESOPHAGITIS,9
GB,ORAL DISCOMFORT,9
GB,PANIC REACTION,9
GB,PLEURAL EFFUSION,9
GB,POSTURE ABNORMAL,9
GB,PSYCHOMOTOR HYPERACTIVITY,9
GB,RASH MACULO-PAPULAR,9
GB,RESPIRATORY TRACT INFECTION,9
GB,SENSORY DISTURBANCE,9
GB,SKIN ULCER,9
GB,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,9
GB,THYROID DISORDER,9
GB,TOXIC EPIDERMAL NECROLYSIS,9
GB,TRANSIENT ISCHAEMIC ATTACK,9
GB,VIRAL INFECTION,9
GB,ABNORMAL SENSATION IN EYE,8
GB,BLOOD CREATININE INCREASED,8
GB,BURSITIS,8
GB,CARDIAC FAILURE CONGESTIVE,8
GB,CHOLESTASIS,8
GB,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,8
GB,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,8
GB,COLITIS MICROSCOPIC,8
GB,CONGENITAL ANOMALY,8
GB,CONTRAINDICATED PRODUCT ADMINISTERED,8
GB,CONVULSIVE THRESHOLD LOWERED,8
GB,DISSOCIATION,8
GB,DRUG ERUPTION,8
GB,DYSGRAPHIA,8
GB,EJACULATION DELAYED,8
GB,GAIT INABILITY,8
GB,HEPATIC CIRRHOSIS,8
GB,HYPOTONIA,8
GB,IMPAIRED HEALING,8
GB,INHIBITORY DRUG INTERACTION,8
GB,INJURY,8
GB,ISCHAEMIC STROKE,8
GB,LEFT VENTRICULAR DYSFUNCTION,8
GB,LUNG CANCER METASTATIC,8
GB,LYMPHADENOPATHY,8
GB,NEOPLASM MALIGNANT,8
GB,PAIN OF SKIN,8
GB,PENILE SIZE REDUCED,8
GB,PERIORBITAL OEDEMA,8
GB,PERSONALITY DISORDER,8
GB,PLASMA CELL MYELOMA,8
GB,POLYARTHRITIS,8
GB,PRESCRIBED OVERDOSE,8
GB,PULSELESS ELECTRICAL ACTIVITY,8
GB,RENAL FAILURE,8
GB,SALIVARY HYPERSECRETION,8
GB,SINGLE UMBILICAL ARTERY,8
GB,SKIN REACTION,8
GB,SLOW SPEECH,8
GB,SNEEZING,8
GB,TENDON RUPTURE,8
GB,TOOTH DISORDER,8
GB,VENTRICULAR FIBRILLATION,8
GB,ACTIVITIES OF DAILY LIVING IMPAIRED,7
GB,ACUTE HEPATIC FAILURE,7
GB,ANAPHYLACTIC SHOCK,7
GB,ARTERIOVENOUS MALFORMATION,7
GB,BLOOD SODIUM ABNORMAL,7
GB,CEREBELLAR HAEMORRHAGE,7
GB,CHRONIC LYMPHOCYTIC LEUKAEMIA,7
GB,CONGENITAL BLADDER ANOMALY,7
GB,CONGENITAL HYDRONEPHROSIS,7
GB,DEPRESSION SUICIDAL,7
GB,DEREALISATION,7
GB,DIABETES MELLITUS,7
GB,DISEASE PROGRESSION,7
GB,DISSOCIATIVE AMNESIA,7
GB,DRUG INTOLERANCE,7
GB,DRUG LEVEL INCREASED,7
GB,DYSMENORRHOEA,7
GB,DYSURIA,7
GB,ELECTROLYTE IMBALANCE,7
GB,EYE IRRITATION,7
GB,EYELID PAIN,7
GB,FIBROMYALGIA,7
GB,FOETAL CARDIAC DISORDER,7
GB,FOETAL GROWTH RESTRICTION,7
GB,FOETAL PLACENTAL THROMBOSIS,7
GB,FURUNCLE,7
GB,GASTRIC HAEMORRHAGE,7
GB,GENITAL ULCERATION,7
GB,GLOMERULAR FILTRATION RATE DECREASED,7
GB,GLOSSODYNIA,7
GB,HAEMARTHROSIS,7
GB,HALLUCINATIONS_ MIXED,7
GB,HOMICIDAL IDEATION,7
GB,HYPOKINESIA,7
GB,HYPOVITAMINOSIS,7
GB,INJECTION SITE ERYTHEMA,7
GB,INTENTIONAL DRUG MISUSE,7
GB,INTENTIONAL SELF-INJURY,7
GB,INTERSTITIAL LUNG DISEASE,7
GB,IRRITABLE BOWEL SYNDROME,7
GB,LARYNGOSPASM,7
GB,LUNG DISORDER,7
GB,LUNG INFILTRATION,7
GB,MALIGNANT NEOPLASM PROGRESSION,7
GB,MINERAL DEFICIENCY,7
GB,MUSCLE INJURY,7
GB,MUSCLE SPASTICITY,7
GB,MYDRIASIS,7
GB,NASAL DRYNESS,7
GB,NASAL ODOUR,7
GB,NYSTAGMUS,7
GB,OESOPHAGEAL CARCINOMA,7
GB,OPISTHOTONUS,7
GB,OSTEOARTHRITIS,7
GB,PAPULE,7
GB,PARKINSON^S DISEASE,7
GB,PARVOVIRUS B19 INFECTION,7
GB,PERIPHERAL COLDNESS,7
GB,PHARYNGITIS,7
GB,PLACENTAL INFARCTION,7
GB,PLACENTAL INSUFFICIENCY,7
GB,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,7
GB,POSTMENOPAUSAL HAEMORRHAGE,7
GB,PYELOCALIECTASIS,7
GB,RENAL CYST,7
GB,SENSORY LOSS,7
GB,SKIN ATROPHY,7
GB,SKIN NECROSIS,7
GB,SKIN WARM,7
GB,STEVENS-JOHNSON SYNDROME,7
GB,STOMATITIS,7
GB,SUBDURAL HAEMATOMA,7
GB,TEETH BRITTLE,7
GB,TENSION HEADACHE,7
GB,THERMAL BURN,7
GB,THIRST,7
GB,TOOTH ABSCESS,7
GB,TOOTH INFECTION,7
GB,TREATMENT FAILURE,7
GB,URGE INCONTINENCE,7
GB,VASCULITIC RASH,7
GB,VENTRICULAR SEPTAL DEFECT,7
GB,VIITH NERVE PARALYSIS,7
GB,WEIGHT BEARING DIFFICULTY,7
GB,ABORTION INDUCED,6
GB,ACUTE RESPIRATORY DISTRESS SYNDROME,6
GB,ADVERSE DRUG REACTION,6
GB,ANOSMIA,6
GB,APALLIC SYNDROME,6
GB,APHONIA,6
GB,APLASIA PURE RED CELL,6
GB,ARTERIOSCLEROSIS,6
GB,ASPARTATE AMINOTRANSFERASE INCREASED,6
GB,BIPOLAR I DISORDER,6
GB,BLOOD PRESSURE DECREASED,6
GB,BLOOD URINE PRESENT,6
GB,BODY TEMPERATURE FLUCTUATION,6
GB,BODY TEMPERATURE INCREASED,6
GB,BONE DISORDER,6
GB,CARDIAC FAILURE,6
GB,CARDIAC FAILURE ACUTE,6
GB,CAUDAL REGRESSION SYNDROME,6
GB,COLD SWEAT,6
GB,COMMUNICATION DISORDER,6
GB,CONTRAINDICATED DRUG ADMINISTERED,6
GB,CYANOSIS,6
GB,DENTAL CARIES,6
GB,DEPENDENCE,6
GB,DIABETES MELLITUS INADEQUATE CONTROL,6
GB,DIVERTICULITIS,6
GB,DUODENAL ULCER,6
GB,EROSIVE DUODENITIS,6
GB,FEAR,6
GB,FEELING COLD,6
GB,FEELING OF DESPAIR,6
GB,FUNGAL INFECTION,6
GB,GASTRIC DISORDER,6
GB,GENITAL HAEMORRHAGE,6
GB,HALLUCINATION_ AUDITORY,6
GB,HEPATOTOXICITY,6
GB,HYDRONEPHROSIS,6
GB,HYPERACUSIS,6
GB,HYPOGAMMAGLOBULINAEMIA,6
GB,IMPAIRED QUALITY OF LIFE,6
GB,KERATITIS,6
GB,LIBIDO DECREASED,6
GB,LIVER INJURY,6
GB,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,6
GB,LOWER LIMB FRACTURE,6
GB,MENSTRUATION DELAYED,6
GB,MORBID THOUGHTS,6
GB,MULTIPLE SCLEROSIS RELAPSE,6
GB,MUSCLE CONTRACTIONS INVOLUNTARY,6
GB,NECROSIS,6
GB,OCULAR ICTERUS,6
GB,OEDEMA MOUTH,6
GB,OESOPHAGEAL CANDIDIASIS,6
GB,ONYCHOCLASIS,6
GB,ORAL MUCOSAL BLISTERING,6
GB,PANCREATIC INSUFFICIENCY,6
GB,PARAESTHESIA ORAL,6
GB,PARKINSONISM,6
GB,PARTIAL SEIZURES,6
GB,PHARYNGEAL HYPOAESTHESIA,6
GB,PHOTOPHOBIA,6
GB,PRODUCT QUALITY ISSUE,6
GB,PURPURA,6
GB,RASH MACULAR,6
GB,RENAL PAIN,6
GB,SOMNAMBULISM,6
GB,SPINAL COMPRESSION FRACTURE,6
GB,STILLBIRTH,6
GB,SUPERFICIAL SPREADING MELANOMA STAGE UNSPECIFIED,6
GB,TONIC CONVULSION,6
GB,TOOTH INJURY,6
GB,TOOTH LOSS,6
GB,ULTRASOUND ANTENATAL SCREEN,6
GB,UPPER RESPIRATORY TRACT INFECTION,6
GB,URINE ODOUR ABNORMAL,6
GB,UROSEPSIS,6
GB,VAGINAL HAEMORRHAGE,6
GB,VASCULAR DEMENTIA,6
GB,VICTIM OF CRIME,6
GB,VULVOVAGINAL CANDIDIASIS,6
GB,ABDOMINAL SYMPTOM,5
GB,ACUTE MYOCARDIAL INFARCTION,5
GB,ACUTE PSYCHOSIS,5
GB,ANKLE FRACTURE,5
GB,ANORGASMIA,5
GB,ATAXIA,5
GB,BLISTER RUPTURE,5
GB,BRAIN MALFORMATION,5
GB,BRAIN MIDLINE SHIFT,5
GB,BREAST CANCER,5
GB,CALCIPHYLAXIS,5
GB,CEREBRAL ARTERY OCCLUSION,5
GB,CHOLECYSTITIS,5
GB,CHOLINERGIC SYNDROME,5
GB,CHOREA,5
GB,COMPLEX PARTIAL SEIZURES,5
GB,COMPULSIONS,5
GB,DECUBITUS ULCER,5
GB,DIABETIC FOOT,5
GB,DIAPHRAGMATIC PARALYSIS,5
GB,DREAMY STATE,5
GB,DRUG-INDUCED LIVER INJURY,5
GB,DYSSTASIA,5
GB,EAR CONGESTION,5
GB,ENCEPHALOPATHY,5
GB,EXTREMITY CONTRACTURE,5
GB,FAECES SOFT,5
GB,FLUSHING,5
GB,FRACTURE,5
GB,GASTRIC ULCER PERFORATION,5
GB,GASTROENTERITIS,5
GB,GENITAL TRACT INFLAMMATION,5
GB,HAEMORRHAGIC STROKE,5
GB,HALLUCINATION_ SYNAESTHETIC,5
GB,HAND DEFORMITY,5
GB,HEAD DISCOMFORT,5
GB,HEAD INJURY,5
GB,HEART RATE DECREASED,5
GB,HEPATITIS CHOLESTATIC,5
GB,HYPERPYREXIA,5
GB,HYPOKALAEMIA,5
GB,HYPOMANIA,5
GB,HYPOPHAGIA,5
GB,IDIOPATHIC PULMONARY FIBROSIS,5
GB,IMPAIRED WORK ABILITY,5
GB,INJECTION SITE PRURITUS,5
GB,JAUNDICE CHOLESTATIC,5
GB,LIMB DEFORMITY,5
GB,LIVER DISORDER,5
GB,MALIGNANT MELANOMA,5
GB,MENTAL STATUS CHANGES,5
GB,MUSCULOSKELETAL CHEST PAIN,5
GB,MYASTHENIA GRAVIS,5
GB,MYELODYSPLASTIC SYNDROME,5
GB,NEOPLASM,5
GB,NITRITE URINE PRESENT,5
GB,PANCREATIC PSEUDOCYST,5
GB,PELVIC INFLAMMATORY DISEASE,5
GB,PENILE BLISTER,5
GB,PHARYNGEAL DISORDER,5
GB,PLATELET COUNT INCREASED,5
GB,PRIMARY COUGH HEADACHE,5
GB,PROCTALGIA,5
GB,PRODUCT SUBSTITUTION ISSUE,5
GB,RENAL DISORDER,5
GB,RESPIRATORY ARREST,5
GB,RHEUMATOID ARTHRITIS,5
GB,SINUSITIS,5
GB,SKIN INFECTION,5
GB,SLE ARTHRITIS,5
GB,SLEEP ATTACKS,5
GB,SLEEP TALKING,5
GB,STATUS EPILEPTICUS,5
GB,SUPERINFECTION,5
GB,TARDIVE DYSKINESIA,5
GB,TONGUE MOVEMENT DISTURBANCE,5
GB,TONSILLAR ULCER,5
GB,TRANCE,5
GB,WRONG DRUG ADMINISTERED,5
GB,YELLOW SKIN,5
GB,ADVERSE EVENT,4
GB,ALCOHOL INTOLERANCE,4
GB,ALTERED STATE OF CONSCIOUSNESS,4
GB,AMENORRHOEA,4
GB,ANAL INCONTINENCE,4
GB,BLOOD CHOLESTEROL INCREASED,4
GB,BLOOD TESTOSTERONE DECREASED,4
GB,BLOOD VISCOSITY INCREASED,4
GB,BODY TEMPERATURE ABNORMAL,4
GB,BONE CANCER,4
GB,BREAST MASS,4
GB,BREAST PAIN,4
GB,CARDIAC DEATH,4
GB,CATHETER SITE CELLULITIS,4
GB,CLAUSTROPHOBIA,4
GB,CLUSTER HEADACHE,4
GB,COLITIS,4
GB,DERMATITIS,4
GB,DEVICE RELATED INFECTION,4
GB,DISEASE COMPLICATION,4
GB,DROOLING,4
GB,DYSLEXIA,4
GB,ENDOMETRIOSIS,4
GB,ENLARGED UVULA,4
GB,EOSINOPHILIA,4
GB,ERYTHEMA MULTIFORME,4
GB,EYELID OEDEMA,4
GB,FINE MOTOR SKILL DYSFUNCTION,4
GB,GASTROINTESTINAL ULCER,4
GB,GINGIVAL ULCERATION,4
GB,HAEMORRHAGE INTRACRANIAL,4
GB,HEARING IMPAIRED,4
GB,HEPATIC PAIN,4
GB,HYPERNATRAEMIA,4
GB,HYPERREFLEXIA,4
GB,HYPOPHOSPHATAEMIA,4
GB,INJECTION SITE PAIN,4
GB,LEFT VENTRICULAR FAILURE,4
GB,LEUKOENCEPHALOPATHY,4
GB,LIGAMENT INJURY,4
GB,LOOSE TOOTH,4
GB,MALNUTRITION,4
GB,METAMORPHOPSIA,4
GB,METASTASES TO LIVER,4
GB,MILIARIA,4
GB,MULTI-ORGAN FAILURE,4
GB,MULTIPLE SCLEROSIS,4
GB,NEPHROLITHIASIS,4
GB,OESOPHAGEAL ULCER,4
GB,OLIGURIA,4
GB,OSTEONECROSIS OF JAW,4
GB,OSTEOPENIA,4
GB,OSTEOPOROSIS,4
GB,OVERWEIGHT,4
GB,PARESIS,4
GB,PENILE SWELLING,4
GB,PERICARDIAL EFFUSION,4
GB,PERITONITIS,4
GB,PERONEAL NERVE PALSY,4
GB,POSTOPERATIVE WOUND INFECTION,4
GB,PROCEDURAL PAIN,4
GB,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,4
GB,PSYCHIATRIC DECOMPENSATION,4
GB,PULMONARY FIBROSIS,4
GB,QUADRIPLEGIA,4
GB,RASH MORBILLIFORM,4
GB,REACTION TO DRUG EXCIPIENTS,4
GB,SCIATICA,4
GB,SKIN HAEMORRHAGE,4
GB,SLEEP APNOEA SYNDROME,4
GB,SMALL INTESTINAL HAEMORRHAGE,4
GB,STAPHYLOCOCCAL INFECTION,4
GB,TENSION,4
GB,TRANSAMINASES INCREASED,4
GB,VOMITING IN PREGNANCY,4
GB,WHEELCHAIR USER,4
GB,ABDOMINAL PAIN LOWER,3
GB,ABDOMINAL RIGIDITY,3
GB,AGITATED DEPRESSION,3
GB,ANGIOPATHY,3
GB,ANTICONVULSANT DRUG LEVEL INCREASED,3
GB,AORTIC VALVE DISEASE MIXED,3
GB,ARTHROPATHY,3
GB,ASTHENOPIA,3
GB,ATELECTASIS,3
GB,ATHETOSIS,3
GB,BLEPHARITIS,3
GB,BLOOD DISORDER,3
GB,BLOOD PRESSURE ABNORMAL,3
GB,BLOOD PRESSURE FLUCTUATION,3
GB,BLOOD SODIUM DECREASED,3
GB,BRAIN NEOPLASM,3
GB,BREAST DISCHARGE,3
GB,BREAST SWELLING,3
GB,BREAST TENDERNESS,3
GB,BURSA DISORDER,3
GB,CANDIDA INFECTION,3
GB,CARDIAC DISORDER,3
GB,CARPAL TUNNEL SYNDROME,3
GB,CATHETER SITE RASH,3
GB,CHOLELITHIASIS,3
GB,CLEAR CELL RENAL CELL CARCINOMA,3
GB,COAGULATION TIME PROLONGED,3
GB,CREPITATIONS,3
GB,CROHN^S DISEASE,3
GB,DEAFNESS,3
GB,DERMATITIS BULLOUS,3
GB,DRUG EFFECT VARIABLE,3
GB,DRY THROAT,3
GB,ENTERITIS,3
GB,EYELID PTOSIS,3
GB,FACE OEDEMA,3
GB,FACIAL SPASM,3
GB,FLUID RETENTION,3
GB,FULL BLOOD COUNT ABNORMAL,3
GB,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
GB,GASTROINTESTINAL STOMA COMPLICATION,3
GB,GASTROINTESTINAL TUBE INSERTION,3
GB,GRAND MAL CONVULSION,3
GB,GYNAECOMASTIA,3
GB,HAEMATOCHEZIA,3
GB,HAEMOPTYSIS,3
GB,HALO VISION,3
GB,HEART RATE IRREGULAR,3
GB,HEMIPLEGIC MIGRAINE,3
GB,HICCUPS,3
GB,ILL-DEFINED DISORDER,3
GB,IMPATIENCE,3
GB,INCORRECT ROUTE OF DRUG ADMINISTRATION,3
GB,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,3
GB,INFLAMMATION,3
GB,INJECTION SITE REACTION,3
GB,INTESTINAL POLYP,3
GB,INTESTINAL ULCER,3
GB,INTESTINAL VILLI ATROPHY,3
GB,IRON DEFICIENCY ANAEMIA,3
GB,LABORATORY TEST ABNORMAL,3
GB,LARYNGECTOMY,3
GB,LIP DISCOLOURATION,3
GB,LOWER GASTROINTESTINAL HAEMORRHAGE,3
GB,LUNG CONSOLIDATION,3
GB,LUNG INFECTION,3
GB,LYMPHOCYTE COUNT DECREASED,3
GB,METASTASES TO BONE,3
GB,METASTASES TO PANCREAS,3
GB,MICTURITION URGENCY,3
GB,NO ADVERSE EVENT,3
GB,NON-SMALL CELL LUNG CANCER,3
GB,OCULOGYRIC CRISIS,3
GB,OPTIC ISCHAEMIC NEUROPATHY,3
GB,PANCREATIC CARCINOMA,3
GB,PANIC DISORDER,3
GB,PELVIC PAIN,3
GB,PERIPHERAL ISCHAEMIA,3
GB,POSTPRANDIAL HYPOGLYCAEMIA,3
GB,PROSTATE CANCER,3
GB,PYODERMA GANGRENOSUM,3
GB,RENAL COLIC,3
GB,RENAL FAILURE CHRONIC,3
GB,RESPIRATORY RATE INCREASED,3
GB,RHINITIS,3
GB,SEXUAL DYSFUNCTION,3
GB,SINUS BRADYCARDIA,3
GB,SKIN BURNING SENSATION,3
GB,SPINAL CORD COMPRESSION,3
GB,STRESS,3
GB,STRIDOR,3
GB,SUDDEN DEATH,3
GB,TENDON PAIN,3
GB,THROMBOSIS,3
GB,THYROIDITIS ACUTE,3
GB,TONGUE COATED,3
GB,TOXIC ENCEPHALOPATHY,3
GB,TROPONIN T INCREASED,3
GB,WOUND HAEMORRHAGE,3
GB,WOUND INFECTION,3
GB,ABDOMINAL HERNIA,2
GB,ACCIDENT,2
GB,ACUTE INTERSTITIAL PNEUMONITIS,2
GB,ALCOHOL USE,2
GB,ANAL ULCER HAEMORRHAGE,2
GB,ANURIA,2
GB,APHTHOUS STOMATITIS,2
GB,APPLICATION SITE RASH,2
GB,AREFLEXIA,2
GB,ASCITES,2
GB,BACTERIAL INFECTION,2
GB,BINGE EATING,2
GB,BLADDER DYSFUNCTION,2
GB,BLADDER PAIN,2
GB,BLINDNESS,2
GB,BLINDNESS TRANSIENT,2
GB,BLOOD ALKALINE PHOSPHATASE INCREASED,2
GB,BLOOD LACTIC ACID INCREASED,2
GB,BLOOD UREA INCREASED,2
GB,BREAST CELLULITIS,2
GB,BRONCHOPNEUMONIA,2
GB,BRONCHOSPASM,2
GB,CARDIAC MURMUR,2
GB,CEREBRAL HAEMORRHAGE,2
GB,CEREBRAL VENTRICLE DILATATION,2
GB,CHANGE OF BOWEL HABIT,2
GB,CHEST WALL HAEMATOMA,2
GB,CHOLECYSTITIS INFECTIVE,2
GB,CHRONIC FATIGUE SYNDROME,2
GB,CHRONIC KIDNEY DISEASE,2
GB,CLOSTRIDIUM DIFFICILE COLITIS,2
GB,CLOSTRIDIUM DIFFICILE INFECTION,2
GB,COMPULSIVE SHOPPING,2
GB,CONJUNCTIVAL HAEMORRHAGE,2
GB,CORONARY ARTERY OCCLUSION,2
GB,CREATININE RENAL CLEARANCE DECREASED,2
GB,DECREASED ACTIVITY,2
GB,DERMATITIS EXFOLIATIVE,2
GB,DEVICE MALFUNCTION,2
GB,DIABETIC FOETOPATHY,2
GB,DISCOLOURED VOMIT,2
GB,DISEASE RECURRENCE,2
GB,DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED,2
GB,DRUG SCREEN POSITIVE,2
GB,DRUG USE DISORDER,2
GB,DUODENITIS,2
GB,DYSPNOEA PAROXYSMAL NOCTURNAL,2
GB,EAR PAIN,2
GB,EATING DISORDER,2
GB,EMOTIONAL POVERTY,2
GB,ERUCTATION,2
GB,ERYTHRODERMIC PSORIASIS,2
GB,ESCHERICHIA SEPSIS,2
GB,EXCORIATION,2
GB,EXPOSED BONE IN JAW,2
GB,EXTRAVASATION,2
GB,EYE HAEMORRHAGE,2
GB,FACIAL NEURALGIA,2
GB,FACIAL PAIN,2
GB,FAECAL VOLUME INCREASED,2
GB,FEEDING DISORDER,2
GB,FLUID INTAKE REDUCED,2
GB,FOOT FRACTURE,2
GB,FORMICATION,2
GB,FUNCTIONAL GASTROINTESTINAL DISORDER,2
GB,GASTRIC PERFORATION,2
GB,GASTROINTESTINAL MOTILITY DISORDER,2
GB,GASTROINTESTINAL PERFORATION,2
GB,GLASSY EYES,2
GB,GLOMERULAR FILTRATION RATE INCREASED,2
GB,GLOSSITIS,2
GB,HAEMATURIA,2
GB,HAEMODYNAMIC INSTABILITY,2
GB,HALLUCINATION_ OLFACTORY,2
GB,HEPATIC FUNCTION ABNORMAL,2
GB,HEPATOCELLULAR CARCINOMA,2
GB,HEPATOMEGALY,2
GB,HERNIA,2
GB,HIP ARTHROPLASTY,2
GB,HIP SURGERY,2
GB,HORNER^S SYNDROME,2
GB,HUMERUS FRACTURE,2
GB,HYPERCHLORHYDRIA,2
GB,HYPERTHERMIA,2
GB,HYPERTONIC BLADDER,2
GB,HYPOVENTILATION,2
GB,HYPOVOLAEMIC SHOCK,2
GB,IMMUNE SYSTEM DISORDER,2
GB,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
GB,INCREASED BRONCHIAL SECRETION,2
GB,INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION,2
GB,INFLAMMATORY BOWEL DISEASE,2
GB,INJECTION SITE INFECTION,2
GB,INTERVERTEBRAL DISC COMPRESSION,2
GB,INTERVERTEBRAL DISC DEGENERATION,2
GB,INTESTINAL DILATATION,2
GB,INTESTINAL RESECTION,2
GB,ISCHAEMIA,2
GB,ISCHAEMIC CARDIOMYOPATHY,2
GB,KIDNEY INFECTION,2
GB,LEUKOCYTOSIS,2
GB,LIP ULCERATION,2
GB,LOCALISED INFECTION,2
GB,LOSS OF CONTROL OF LEGS,2
GB,MALE GENITAL ATROPHY,2
GB,MALE SEXUAL DYSFUNCTION,2
GB,MALIGNANT HYPERTENSION,2
GB,MEDICATION RESIDUE PRESENT,2
GB,METASTASES TO CENTRAL NERVOUS SYSTEM,2
GB,METASTASES TO LUNG,2
GB,METASTATIC GASTRIC CANCER,2
GB,MICTURITION DISORDER,2
GB,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
GB,MYELOPATHY,2
GB,MYOCARDIAL FIBROSIS,2
GB,NERVE COMPRESSION,2
GB,NEUROLOGICAL SYMPTOM,2
GB,NEUTROPHIL COUNT INCREASED,2
GB,NON-CARDIAC CHEST PAIN,2
GB,OBSESSIVE-COMPULSIVE DISORDER,2
GB,OCULAR DISCOMFORT,2
GB,ORAL HERPES,2
US,DRUG INEFFECTIVE,9385
US,FATIGUE,6010
US,PAIN,5381
US,NAUSEA,5232
US,DIARRHOEA,4406
US,DRUG HYPERSENSITIVITY,4300
US,HEADACHE,4164
US,DIZZINESS,4162
US,FALL,4123
US,DYSPNOEA,3389
US,PAIN IN EXTREMITY,3158
US,MALAISE,3157
US,ASTHENIA,2933
US,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2865
US,INSOMNIA,2688
US,DRUG DOSE OMISSION,2662
US,VOMITING,2659
US,PNEUMONIA,2592
US,ARTHRALGIA,2586
US,FEELING ABNORMAL,2577
US,GAIT DISTURBANCE,2483
US,DEPRESSION,2473
US,BACK PAIN,2444
US,SOMNOLENCE,2364
US,DEATH,2234
US,WEIGHT DECREASED,2182
US,ANXIETY,2124
US,RASH,2072
US,PRODUCT USE ISSUE,2027
US,HYPOAESTHESIA,1961
US,WEIGHT INCREASED,1948
US,MUSCLE SPASMS,1905
US,CONDITION AGGRAVATED,1829
US,PRURITUS,1722
US,MEMORY IMPAIRMENT,1710
US,CONSTIPATION,1706
US,PARAESTHESIA,1683
US,NEUROPATHY PERIPHERAL,1681
US,TREMOR,1618
US,PERIPHERAL SWELLING,1571
US,URINARY TRACT INFECTION,1559
US,DECREASED APPETITE,1555
US,PYREXIA,1546
US,COUGH,1536
US,CHEST PAIN,1392
US,HYPERTENSION,1372
US,COMPLETED SUICIDE,1366
US,BALANCE DISORDER,1365
US,ABDOMINAL PAIN UPPER,1317
US,INJECTION SITE PAIN,1298
US,MUSCULAR WEAKNESS,1270
US,ABDOMINAL DISCOMFORT,1257
US,ABDOMINAL PAIN,1244
US,TOXICITY TO VARIOUS AGENTS,1236
US,CONFUSIONAL STATE,1227
US,VISION BLURRED,1213
US,ANAEMIA,1196
US,MULTIPLE SCLEROSIS RELAPSE,1168
US,ALOPECIA,1125
US,DEHYDRATION,1122
US,NASOPHARYNGITIS,1105
US,HYPOTENSION,1028
US,PRODUCT USE IN UNAPPROVED INDICATION,984
US,GASTROINTESTINAL HAEMORRHAGE,977
US,MYALGIA,954
US,BURNING SENSATION,950
US,CEREBROVASCULAR ACCIDENT,944
US,HYPERHIDROSIS,937
US,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,925
US,OEDEMA PERIPHERAL,925
US,BLOOD GLUCOSE INCREASED,919
US,CONTUSION,912
US,SEIZURE,897
US,PRODUCT QUALITY ISSUE,893
US,SINUSITIS,890
US,MYOCARDIAL INFARCTION,873
US,BLOOD PRESSURE INCREASED,871
US,BRONCHITIS,855
US,MIGRAINE,853
US,LOSS OF CONSCIOUSNESS,849
US,HYPERSENSITIVITY,835
US,FLUSHING,820
US,ARTHRITIS,813
US,INFLUENZA,795
US,THERAPEUTIC RESPONSE UNEXPECTED,787
US,VISUAL IMPAIRMENT,780
US,JOINT SWELLING,777
US,WHITE BLOOD CELL COUNT DECREASED,774
US,GASTROOESOPHAGEAL REFLUX DISEASE,769
US,DRY MOUTH,765
US,INTENTIONAL PRODUCT MISUSE,762
US,AMNESIA,758
US,DRUG INTOLERANCE,741
US,DRUG EFFECT INCOMPLETE,739
US,SWELLING,733
US,ERYTHEMA,720
US,SUICIDAL IDEATION,720
US,URTICARIA,714
US,INFLUENZA LIKE ILLNESS,710
US,INFECTION,709
US,OVERDOSE,700
US,SEPSIS,696
US,INCORRECT DOSE ADMINISTERED,694
US,DYSPHAGIA,691
US,ACUTE KIDNEY INJURY,686
US,DYSPEPSIA,679
US,HERPES ZOSTER,679
US,MUSCULOSKELETAL PAIN,672
US,CARDIAC FAILURE CONGESTIVE,665
US,CHILLS,655
US,NECK PAIN,643
US,OROPHARYNGEAL PAIN,642
US,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,637
US,RENAL FAILURE,636
US,RHEUMATOID ARTHRITIS,632
US,NEURALGIA,628
US,DIABETES MELLITUS,619
US,SYNCOPE,617
US,MUSCULOSKELETAL STIFFNESS,615
US,THROMBOSIS,604
US,UNEVALUABLE EVENT,601
US,ABDOMINAL DISTENSION,596
US,OSTEOARTHRITIS,594
US,PLATELET COUNT DECREASED,581
US,CELLULITIS,577
US,CHEST DISCOMFORT,577
US,INTERVERTEBRAL DISC PROTRUSION,563
US,DEEP VEIN THROMBOSIS,560
US,INJECTION SITE ERYTHEMA,559
US,MOBILITY DECREASED,556
US,FIBROMYALGIA,555
US,ATRIAL FIBRILLATION,544
US,DRUG WITHDRAWAL SYNDROME,542
US,PALPITATIONS,542
US,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,542
US,PULMONARY EMBOLISM,540
US,HAEMOGLOBIN DECREASED,538
US,DRUG EFFECT DECREASED,534
US,DYSGEUSIA,531
US,HEART RATE INCREASED,529
US,PSORIASIS,524
US,ASTHMA,522
US,HALLUCINATION,520
US,THERAPY CESSATION,514
US,HOT FLUSH,513
US,STRESS,511
US,CATARACT,499
US,MULTIPLE SCLEROSIS,496
US,ARTHROPATHY,495
US,DISEASE PROGRESSION,494
US,FLUID RETENTION,489
US,EPISTAXIS,485
US,INJECTION SITE BRUISING,484
US,LETHARGY,481
US,SPEECH DISORDER,479
US,CARDIAC ARREST,474
US,OSTEOPOROSIS,469
US,RESPIRATORY FAILURE,466
US,AGITATION,465
US,DYSPHONIA,464
US,IRRITABILITY,462
US,CARDIAC DISORDER,453
US,SLEEP DISORDER,448
US,OEDEMA,437
US,ROAD TRAFFIC ACCIDENT,436
US,NERVOUSNESS,432
US,UPPER RESPIRATORY TRACT INFECTION,432
US,CARDIO-RESPIRATORY ARREST,431
US,STOMATITIS,430
US,ADVERSE DRUG REACTION,429
US,ABASIA,426
US,HAEMORRHAGE,425
US,LIMB DISCOMFORT,425
US,DISTURBANCE IN ATTENTION,423
US,PLASMA CELL MYELOMA,423
US,BONE PAIN,421
US,ACTIVITIES OF DAILY LIVING IMPAIRED,415
US,HOSPITALISATION,413
US,SLEEP APNOEA SYNDROME,413
US,VERTIGO,412
US,ADVERSE EVENT,409
US,FEELING HOT,409
US,INJURY,407
US,DRY SKIN,406
US,MENTAL STATUS CHANGES,405
US,RHINORRHOEA,403
US,INTENTIONAL PRODUCT USE ISSUE,397
US,DYSKINESIA,394
US,CRYING,392
US,INJECTION SITE REACTION,388
US,PRE-EXISTING CONDITION IMPROVED,385
US,BLISTER,384
US,POLLAKIURIA,379
US,BLOOD CHOLESTEROL INCREASED,377
US,GASTROINTESTINAL DISORDER,376
US,URINARY INCONTINENCE,376
US,COGNITIVE DISORDER,374
US,SWELLING FACE,371
US,STAPHYLOCOCCAL INFECTION,365
US,DYSSTASIA,361
US,INTERVERTEBRAL DISC DEGENERATION,360
US,LOCAL SWELLING,359
US,BACK DISORDER,357
US,HEAD INJURY,354
US,NEPHROLITHIASIS,353
US,DEPRESSED MOOD,352
US,NASAL CONGESTION,350
US,NEUTROPENIA,349
US,PLEURAL EFFUSION,349
US,DRUG ABUSE,348
US,FLATULENCE,344
US,CYSTITIS,343
US,HYPERSOMNIA,341
US,RECTAL HAEMORRHAGE,337
US,WRONG TECHNIQUE IN DRUG USAGE PROCESS,333
US,THROMBOCYTOPENIA,328
US,PANIC ATTACK,326
US,DYSURIA,325
US,HEPATIC ENZYME INCREASED,325
US,RESTLESS LEGS SYNDROME,324
US,TACHYCARDIA,324
US,SKIN DISCOLOURATION,323
US,BLOOD POTASSIUM DECREASED,322
US,DYSARTHRIA,321
US,FOOT FRACTURE,319
US,CONVULSION,315
US,INJECTION SITE PRURITUS,315
US,WITHDRAWAL SYNDROME,315
US,MALIGNANT NEOPLASM PROGRESSION,314
US,EMOTIONAL DISTRESS,312
US,BONE DISORDER,310
US,WHEEZING,309
US,BLOOD GLUCOSE DECREASED,308
US,TINNITUS,308
US,DISORIENTATION,303
US,BLOOD PRESSURE DECREASED,295
US,RASH PRURITIC,294
US,UNDERDOSE,293
US,TRANSIENT ISCHAEMIC ATTACK,292
US,DIPLOPIA,291
US,HIP FRACTURE,289
US,LIMB INJURY,285
US,BLOOD CREATININE INCREASED,284
US,SURGERY,284
US,NIGHT SWEATS,282
US,OSTEOMYELITIS,282
US,PRODUCTIVE COUGH,282
US,DISCOMFORT,281
US,ANGER,279
US,INJECTION SITE HAEMORRHAGE,277
US,SEDATION,277
US,IMPAIRED HEALING,276
US,ORAL PAIN,274
US,RENAL DISORDER,273
US,VISUAL ACUITY REDUCED,273
US,GENERAL PHYSICAL HEALTH DETERIORATION,272
US,CROHN^S DISEASE,271
US,RESPIRATORY ARREST,269
US,NERVE INJURY,268
US,SKIN EXFOLIATION,268
US,HYPOXIA,267
US,RIB FRACTURE,267
US,PANCREATITIS,266
US,PANCYTOPENIA,266
US,MENTAL DISORDER,264
US,RENAL IMPAIRMENT,263
US,SPINAL OSTEOARTHRITIS,263
US,GASTRIC DISORDER,262
US,JOINT INJURY,262
US,MUSCLE TWITCHING,262
US,PAIN IN JAW,262
US,URINARY RETENTION,262
US,LOCALISED INFECTION,261
US,PRODUCT ADHESION ISSUE,260
US,SCIATICA,260
US,DRUG ADMINISTRATION ERROR,252
US,OXYGEN SATURATION DECREASED,250
US,INJECTION SITE SWELLING,249
US,DRY EYE,248
US,DYSPNOEA EXERTIONAL,248
US,APHASIA,247
US,HAEMATOCHEZIA,247
US,BODY HEIGHT DECREASED,245
US,RESTLESSNESS,245
US,EYE PAIN,244
US,TYPE 2 DIABETES MELLITUS,244
US,UPPER LIMB FRACTURE,243
US,INCORRECT DRUG ADMINISTRATION DURATION,241
US,ANKLE FRACTURE,238
US,MOVEMENT DISORDER,237
US,CENTRAL NERVOUS SYSTEM LESION,235
US,COORDINATION ABNORMAL,235
US,FULL BLOOD COUNT DECREASED,235
US,NIGHTMARE,235
US,SKIN ULCER,235
US,TREATMENT NONCOMPLIANCE,235
US,FUNGAL INFECTION,233
US,MENTAL IMPAIRMENT,233
US,DEVICE MALFUNCTION,232
US,THERAPEUTIC RESPONSE DECREASED,232
US,WHITE BLOOD CELL COUNT INCREASED,232
US,CORONARY ARTERY DISEASE,230
US,MOOD SWINGS,230
US,ABNORMAL BEHAVIOUR,229
US,HYPOKALAEMIA,228
US,LUNG DISORDER,227
US,THINKING ABNORMAL,227
US,CARPAL TUNNEL SYNDROME,223
US,HAEMATURIA,223
US,NO ADVERSE EVENT,223
US,RED BLOOD CELL COUNT DECREASED,222
US,THROAT IRRITATION,222
US,INJECTION SITE MASS,220
US,OSTEOPENIA,220
US,RENAL FAILURE ACUTE,220
US,HYPOTHYROIDISM,218
US,DEVICE ISSUE,217
US,PULMONARY OEDEMA,215
US,SPINAL COLUMN STENOSIS,214
US,VIRAL INFECTION,214
US,CLOSTRIDIUM DIFFICILE INFECTION,212
US,SUICIDE ATTEMPT,212
US,PRODUCT SUBSTITUTION ISSUE,211
US,PRURITUS GENERALISED,211
US,CHOLELITHIASIS,209
US,DIABETIC NEUROPATHY,209
US,ROTATOR CUFF SYNDROME,209
US,ACUTE RESPIRATORY FAILURE,208
US,BREAST CANCER,208
US,LYMPHADENOPATHY,208
US,AGGRESSION,207
US,FEELING COLD,206
US,OSTEONECROSIS OF JAW,206
US,VITAMIN D DEFICIENCY,205
US,LABORATORY TEST ABNORMAL,204
US,MOOD ALTERED,204
US,CARDIAC FAILURE,203
US,HEART RATE DECREASED,203
US,POOR QUALITY SLEEP,202
US,EYE DISORDER,201
US,MUSCLE SPASTICITY,201
US,RASH GENERALISED,201
US,HYPOACUSIS,200
US,SKIN LESION,200
US,EAR PAIN,199
US,TOOTHACHE,199
US,HYPONATRAEMIA,198
US,LOWER LIMB FRACTURE,198
US,CHRONIC KIDNEY DISEASE,197
US,EXOSTOSIS,197
US,HAEMOPTYSIS,197
US,WOUND,197
US,BLINDNESS,196
US,SPINAL FRACTURE,196
US,SINUS DISORDER,195
US,EYE SWELLING,193
US,HYPOPHAGIA,193
US,JOINT STIFFNESS,193
US,BRADYCARDIA,192
US,ABNORMAL DREAMS,191
US,PULMONARY MASS,191
US,IMPAIRED WORK ABILITY,190
US,COMA,189
US,NERVOUS SYSTEM DISORDER,189
US,HIATUS HERNIA,188
US,TOOTH DISORDER,188
US,INFLAMMATION,187
US,HYPOGLYCAEMIA,186
US,INTENTIONAL DRUG MISUSE,186
US,UNRESPONSIVE TO STIMULI,186
US,MUSCULOSKELETAL DISORDER,185
US,SEPTIC SHOCK,184
US,DRUG DEPENDENCE,183
US,DIVERTICULITIS,182
US,IMPAIRED DRIVING ABILITY,182
US,HAEMORRHOIDS,181
US,INTESTINAL OBSTRUCTION,181
US,GASTRITIS,180
US,MUSCULOSKELETAL DISCOMFORT,180
US,EXPIRED PRODUCT ADMINISTERED,179
US,FEELING DRUNK,179
US,LACERATION,179
US,MUSCLE TIGHTNESS,179
US,MYOCLONUS,179
US,SKIN DISORDER,178
US,ACNE,177
US,EATING DISORDER,177
US,DELIRIUM,176
US,GASTROENTERITIS VIRAL,176
US,EMOTIONAL DISORDER,175
US,FEAR,174
US,PRESCRIBED OVERDOSE,174
US,PULMONARY HYPERTENSION,174
US,FLUID OVERLOAD,172
US,HEMIPARESIS,172
US,NERVE COMPRESSION,171
US,IRRITABLE BOWEL SYNDROME,170
US,FEBRILE NEUTROPENIA,169
US,COLITIS,168
US,RASH MACULAR,167
US,GOUT,166
US,HYPERGLYCAEMIA,166
US,HYPERLIPIDAEMIA,166
US,MEDICATION ERROR,166
US,EYE IRRITATION,165
US,MUSCULOSKELETAL CHEST PAIN,165
US,RASH ERYTHEMATOUS,165
US,ARRHYTHMIA,164
US,BACK INJURY,164
US,ALANINE AMINOTRANSFERASE INCREASED,163
US,GLYCOSYLATED HAEMOGLOBIN INCREASED,163
US,KIDNEY INFECTION,163
US,BLOOD COUNT ABNORMAL,161
US,ASPARTATE AMINOTRANSFERASE INCREASED,160
US,DRUG PRESCRIBING ERROR,160
US,KNEE ARTHROPLASTY,160
US,ATAXIA,158
US,GLAUCOMA,158
US,LIVER DISORDER,158
US,PSORIATIC ARTHROPATHY,158
US,PHARYNGEAL OEDEMA,157
US,UPPER GASTROINTESTINAL HAEMORRHAGE,157
US,BURSITIS,155
US,DRUG TITRATION ERROR,154
US,FEELING JITTERY,154
US,GALLBLADDER DISORDER,154
US,NEOPLASM MALIGNANT,154
US,ATELECTASIS,153
US,HEPATIC STEATOSIS,153
US,EAR INFECTION,152
US,FEMUR FRACTURE,152
US,HAEMATOMA,152
US,SKIN BURNING SENSATION,152
US,VAGINAL HAEMORRHAGE,152
US,DENTAL CARIES,151
US,LIP SWELLING,151
US,CANDIDA INFECTION,150
US,SWOLLEN TONGUE,150
US,HERNIA,149
US,SENSORY DISTURBANCE,149
US,APPLICATION SITE ERYTHEMA,148
US,DIABETIC KETOACIDOSIS,148
US,HAEMATOCRIT DECREASED,148
US,RETCHING,148
US,WALKING AID USER,148
US,BLOOD URINE PRESENT,147
US,ANGINA PECTORIS,146
US,LEUKOPENIA,146
US,SYSTEMIC LUPUS ERYTHEMATOSUS,146
US,LACRIMATION INCREASED,145
US,BEDRIDDEN,144
US,CHROMATURIA,144
US,ENCEPHALOPATHY,144
US,LUNG NEOPLASM MALIGNANT,144
US,INTENTIONAL OVERDOSE,143
US,LIGAMENT SPRAIN,143
US,MICTURITION URGENCY,143
US,MULTIPLE FRACTURES,143
US,SINUS CONGESTION,142
US,FAECES DISCOLOURED,141
US,GLOSSODYNIA,141
US,SCOLIOSIS,141
US,CARDIOMEGALY,140
US,DECREASED INTEREST,140
US,PERONEAL NERVE PALSY,140
US,HYPERKALAEMIA,139
US,PERICARDIAL EFFUSION,139
US,ANAPHYLACTIC REACTION,138
US,HAEMATEMESIS,137
US,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,137
US,LUNG INFECTION,137
US,MASS,137
US,DISABILITY,136
US,FOETAL EXPOSURE DURING PREGNANCY,136
US,INCORRECT ROUTE OF DRUG ADMINISTRATION,136
US,PNEUMONIA ASPIRATION,136
US,WRIST FRACTURE,136
US,COAGULOPATHY,135
US,OCULAR HYPERAEMIA,135
US,PRESYNCOPE,135
US,SPINAL DISORDER,135
US,BIPOLAR DISORDER,134
US,BLADDER DISORDER,134
US,NEOPLASM PROGRESSION,134
US,APPLICATION SITE PAIN,133
US,FOOT DEFORMITY,132
US,HYPOKINESIA,132
US,PRODUCT PHYSICAL ISSUE,132
US,BASAL CELL CARCINOMA,130
US,CHOKING,130
US,DEAFNESS,130
US,DIVERTICULUM,130
US,HEART RATE IRREGULAR,130
US,TENDERNESS,130
US,ACCIDENTAL OVERDOSE,129
US,LEUKOCYTOSIS,129
US,PROCEDURAL PAIN,129
US,PSYCHOTIC DISORDER,129
US,SEASONAL ALLERGY,129
US,EUPHORIC MOOD,128
US,EXTRA DOSE ADMINISTERED,128
US,RESPIRATORY TRACT CONGESTION,128
US,BLOOD POTASSIUM INCREASED,127
US,BLOOD TRIGLYCERIDES INCREASED,127
US,HAEMORRHAGIC ANAEMIA,127
US,HYPERAESTHESIA,127
US,ORTHOSTATIC HYPOTENSION,127
US,THROAT TIGHTNESS,127
US,DECUBITUS ULCER,126
US,RESPIRATORY DISORDER,126
US,TOOTH FRACTURE,126
US,INTERNAL HAEMORRHAGE,125
US,JOINT RANGE OF MOTION DECREASED,125
US,LIVER FUNCTION TEST ABNORMAL,125
US,SCAR,124
US,SENSORY LOSS,124
US,THYROID DISORDER,124
US,CONCUSSION,123
US,HEAD DISCOMFORT,123
US,ILL-DEFINED DISORDER,123
US,RESPIRATORY DISTRESS,123
US,LYMPHOCYTE COUNT DECREASED,122
US,CORONARY ARTERY OCCLUSION,121
US,DEPRESSED LEVEL OF CONSCIOUSNESS,121
US,INCONTINENCE,121
US,POST PROCEDURAL COMPLICATION,121
US,ACUTE MYOCARDIAL INFARCTION,120
US,COLD SWEAT,120
US,GASTRIC ULCER,120
US,GENERALISED TONIC-CLONIC SEIZURE,120
US,JOINT DISLOCATION,120
US,METASTASES TO BONE,120
US,VITAMIN D DECREASED,120
US,DRUG WITHDRAWAL SYNDROME NEONATAL,119
US,INFUSION RELATED REACTION,119
US,INTERNATIONAL NORMALISED RATIO INCREASED,119
US,PRESCRIBED UNDERDOSE,119
US,RHABDOMYOLYSIS,119
US,SPINAL OPERATION,119
US,ULCER,119
US,AGEUSIA,118
US,BLOOD PRESSURE ABNORMAL,118
US,FACIAL PAIN,118
US,LOWER GASTROINTESTINAL HAEMORRHAGE,118
US,DEMENTIA,117
US,MALABSORPTION,117
US,CEREBRAL HAEMORRHAGE,116
US,INJECTION SITE RASH,116
US,PAIN OF SKIN,116
US,SKIN CANCER,116
US,ERECTILE DYSFUNCTION,115
US,INCREASED APPETITE,115
US,BLOOD SODIUM DECREASED,114
US,MENISCUS INJURY,114
US,RASH PAPULAR,114
US,EMPHYSEMA,113
US,HYPOAESTHESIA ORAL,113
US,IMPAIRED GASTRIC EMPTYING,113
US,PERIPHERAL COLDNESS,113
US,ELECTROCARDIOGRAM QT PROLONGED,112
US,TOOTH INFECTION,112
US,DRUG DISPENSING ERROR,111
US,PHOTOPHOBIA,111
US,FREQUENT BOWEL MOVEMENTS,110
US,IMMUNE SYSTEM DISORDER,110
US,IRON DEFICIENCY ANAEMIA,110
US,LUMBAR SPINAL STENOSIS,110
US,MIDDLE INSOMNIA,110
US,PARANOIA,109
US,WEIGHT FLUCTUATION,109
US,APPLICATION SITE PRURITUS,108
US,INJECTION SITE URTICARIA,108
US,NODULE,108
US,RESPIRATORY TRACT INFECTION,108
US,TOOTH LOSS,108
US,DEVICE RELATED INFECTION,106
US,OBESITY,106
US,BONE LESION,105
US,CLOSTRIDIUM DIFFICILE COLITIS,105
US,NEUTROPHIL COUNT DECREASED,105
US,THIRST,105
US,HEPATIC CIRRHOSIS,104
US,SNEEZING,104
US,SPINAL PAIN,104
US,TENDONITIS,104
US,TRIGEMINAL NEURALGIA,104
US,HALLUCINATION_ VISUAL,103
US,ABDOMINAL PAIN LOWER,102
US,PSYCHOMOTOR HYPERACTIVITY,102
US,RENAL FAILURE CHRONIC,102
US,CARDIOMYOPATHY,101
US,INJECTION SITE WARMTH,101
US,ABSCESS,100
US,APHONIA,100
US,BLOOD PRESSURE FLUCTUATION,100
US,DEVICE DISLOCATION,100
US,MANIA,100
US,MITRAL VALVE INCOMPETENCE,100
US,MOUTH ULCERATION,100
US,ORAL CANDIDIASIS,100
US,SEROTONIN SYNDROME,100
US,SMALL INTESTINAL OBSTRUCTION,100
US,TOOTH ABSCESS,100
US,FEEDING DISORDER,99
US,HIP ARTHROPLASTY,99
US,DIZZINESS POSTURAL,98
US,INTERVERTEBRAL DISC DISORDER,98
US,PARALYSIS,98
US,SOMNAMBULISM,98
US,SPINAL COMPRESSION FRACTURE,98
US,NOCTURIA,97
US,PULMONARY ARTERIAL HYPERTENSION,97
US,ARTERIOSCLEROSIS,96
US,INCORRECT PRODUCT STORAGE,96
US,INCREASED TENDENCY TO BRUISE,96
US,MOTOR DYSFUNCTION,96
US,OESOPHAGITIS,96
US,BLINDNESS UNILATERAL,95
US,BLOOD ALKALINE PHOSPHATASE INCREASED,95
US,BLOOD GLUCOSE ABNORMAL,95
US,ANHEDONIA,94
US,FLANK PAIN,94
US,INITIAL INSOMNIA,94
US,BLOOD UREA INCREASED,93
US,EYE PRURITUS,93
US,GAIT INABILITY,93
US,TEMPERATURE INTOLERANCE,93
US,CYST,92
US,DRUG SCREEN POSITIVE,92
US,EXPOSURE DURING PREGNANCY,92
US,LYMPHOEDEMA,92
US,PALLOR,92
US,ACCIDENTAL EXPOSURE TO PRODUCT,91
US,HAIR TEXTURE ABNORMAL,91
US,HUNGER,91
US,PHOTOSENSITIVITY REACTION,91
US,ASCITES,90
US,BODY TEMPERATURE INCREASED,90
US,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,90
US,PELVIC FRACTURE,90
US,PULMONARY FIBROSIS,90
US,RENAL CYST,90
US,AFFECT LABILITY,89
US,PRODUCT TASTE ABNORMAL,89
US,PULMONARY CONGESTION,89
US,SUBDURAL HAEMATOMA,89
US,BLOOD MAGNESIUM DECREASED,88
US,CARDIOVASCULAR DISORDER,88
US,COMPRESSION FRACTURE,88
US,DEFORMITY,88
US,LUNG INFILTRATION,88
US,ORAL DISCOMFORT,88
US,ORAL DISORDER,88
US,PULMONARY THROMBOSIS,88
US,ANGIOEDEMA,87
US,DYSGRAPHIA,87
US,HAND FRACTURE,87
US,TREATMENT FAILURE,87
US,ABNORMAL LOSS OF WEIGHT,86
US,BLOOD BILIRUBIN INCREASED,86
US,HYPERCALCAEMIA,86
US,PERIPHERAL VASCULAR DISORDER,86
US,PNEUMOTHORAX,86
US,POST-TRAUMATIC STRESS DISORDER,86
US,OPTIC NEURITIS,85
US,PARKINSON^S DISEASE,85
US,PNEUMONITIS,85
US,DRUG ADMINISTERED AT INAPPROPRIATE SITE,84
US,GROIN PAIN,84
US,LARYNGITIS,84
US,MATERNAL EXPOSURE DURING PREGNANCY,84
US,METASTASES TO LIVER,84
US,PELVIC PAIN,84
US,BLOOD CALCIUM DECREASED,83
US,ERUCTATION,83
US,JOINT EFFUSION,83
US,WOUND COMPLICATION,83
US,FRACTURE,82
US,MUCOSAL INFLAMMATION,82
US,SPLENOMEGALY,82
US,COLITIS ULCERATIVE,81
US,ECCHYMOSIS,81
US,HEARING IMPAIRED,81
US,PATHOLOGICAL FRACTURE,81
US,UROSEPSIS,81
US,CHOLECYSTECTOMY,80
US,ECZEMA,80
US,FORMICATION,80
US,GINGIVAL BLEEDING,80
US,INJECTION SITE NODULE,80
US,MEDICATION RESIDUE PRESENT,80
US,MUSCLE ATROPHY,80
US,OSTEOLYSIS,80
US,BLOOD IRON DECREASED,79
US,BRAIN INJURY,79
US,DEVICE FAILURE,79
US,FAECAL INCONTINENCE,79
US,INJECTION SITE INDURATION,79
US,METABOLIC ACIDOSIS,79
US,OSTEOSCLEROSIS,79
US,POOR QUALITY DRUG ADMINISTERED,79
US,ACCIDENT,78
US,MUSCLE STRAIN,78
US,BACTERIAL INFECTION,77
US,BLOOD TEST ABNORMAL,77
US,MALIGNANT MELANOMA,77
US,ORAL MUCOSAL BLISTERING,77
US,PARAESTHESIA ORAL,77
US,HAIR COLOUR CHANGES,76
US,LARGE INTESTINE POLYP,76
US,MALNUTRITION,76
US,PROSTATE CANCER,76
US,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,75
US,DIABETES MELLITUS INADEQUATE CONTROL,75
US,LOWER RESPIRATORY TRACT INFECTION,75
US,SLUGGISHNESS,75
US,TRICUSPID VALVE INCOMPETENCE,75
US,CARDIAC MURMUR,74
US,GASTROINTESTINAL PAIN,74
US,HYPERKERATOSIS,74
US,MAJOR DEPRESSION,74
US,SCAB,74
US,SKIN FISSURES,74
US,VITREOUS FLOATERS,74
US,WOUND INFECTION,74
US,DISEASE RECURRENCE,73
US,HALLUCINATION_ AUDITORY,73
US,HEPATIC FAILURE,73
US,RADICULOPATHY,73
US,WHEELCHAIR USER,73
US,DRUG TOLERANCE,72
US,EYE INFECTION,72
US,HYSTERECTOMY,72
US,ORAL HERPES,72
US,PHARYNGITIS STREPTOCOCCAL,72
US,PROSTATIC SPECIFIC ANTIGEN INCREASED,72
US,RENAL PAIN,72
US,TOOTH EXTRACTION,72
US,ANAL INCONTINENCE,71
US,BACTERAEMIA,71
US,BREAST PAIN,71
US,COLON CANCER,71
US,DRY THROAT,71
US,ESSENTIAL HYPERTENSION,71
US,EYE HAEMORRHAGE,71
US,EYE MOVEMENT DISORDER,71
US,LACTIC ACIDOSIS,71
US,MENORRHAGIA,71
US,BLOOD TESTOSTERONE DECREASED,70
US,DERMATITIS,70
US,DYSPHEMIA,70
US,LIVER FUNCTION TEST INCREASED,70
US,SKIN IRRITATION,70
US,TONGUE DISORDER,70
US,APATHY,69
US,HEPATITIS C,69
US,SYNOVIAL CYST,69
US,ASPIRATION,68
US,DELUSION,68
US,EAR DISCOMFORT,68
US,OSTEONECROSIS,68
US,PERSONALITY CHANGE,68
US,TENDON RUPTURE,68
US,VIRAL UPPER RESPIRATORY TRACT INFECTION,68
US,APPLICATION SITE RASH,67
US,EXPOSED BONE IN JAW,67
US,GENERALISED OEDEMA,67
US,HYPERCHOLESTEROLAEMIA,67
US,INTERSTITIAL LUNG DISEASE,67
US,ONYCHOMYCOSIS,67
US,PANCREATITIS ACUTE,67
US,SPONDYLOLISTHESIS,67
US,UPPER-AIRWAY COUGH SYNDROME,67
US,ARTERIOSCLEROSIS CORONARY ARTERY,66
US,DERMATITIS CONTACT,66
US,FIBULA FRACTURE,66
US,GASTROINTESTINAL INFECTION,66
US,HEPATOMEGALY,66
US,HYPOMAGNESAEMIA,66
US,MELAENA,66
US,TRANSAMINASES INCREASED,66
US,ATRIAL FLUTTER,65
US,CATAPLEXY,65
US,FURUNCLE,65
US,OVARIAN CYST,65
US,SKIN HAEMORRHAGE,65
US,APPARENT DEATH,64
US,END STAGE RENAL DISEASE,64
US,ENERGY INCREASED,64
US,GRIP STRENGTH DECREASED,64
US,INCOHERENT,64
US,ONYCHOCLASIS,64
US,TIBIA FRACTURE,64
US,BLOOD GLUCOSE FLUCTUATION,63
US,INADEQUATE ANALGESIA,63
US,LEFT VENTRICULAR HYPERTROPHY,63
US,MUSCLE DISORDER,63
US,NO THERAPEUTIC RESPONSE,63
US,TUBULOINTERSTITIAL NEPHRITIS,63
US,VERTEBRAL FORAMINAL STENOSIS,63
US,BONE LOSS,62
US,EPILEPSY,62
US,HANGOVER,62
US,BONE DENSITY DECREASED,61
US,GINGIVAL PAIN,61
US,INFUSION SITE PAIN,61
US,KYPHOSIS,61
US,PANCREATIC CARCINOMA,61
US,PLATELET COUNT INCREASED,61
US,SPINAL FUSION SURGERY,61
US,TARDIVE DYSKINESIA,61
US,ULCER HAEMORRHAGE,61
US,CHOLECYSTITIS,60
US,FEELING OF BODY TEMPERATURE CHANGE,60
US,HAIR GROWTH ABNORMAL,60
US,SPINAL CORD COMPRESSION,60
US,SQUAMOUS CELL CARCINOMA,60
US,AORTIC ANEURYSM,59
US,ARTERIAL OCCLUSIVE DISEASE,59
US,BLOOD CREATINE PHOSPHOKINASE INCREASED,59
US,BREAKTHROUGH PAIN,59
US,DECREASED ACTIVITY,59
US,DRUG DOSE TITRATION NOT PERFORMED,59
US,ISCHAEMIC STROKE,59
US,NASAL DISCOMFORT,59
US,SEXUAL DYSFUNCTION,59
US,SNORING,59
US,SYNOVITIS,59
US,TRANSFUSION,59
US,ANKYLOSING SPONDYLITIS,58
US,BOWEL MOVEMENT IRREGULARITY,58
US,GINGIVITIS,58
US,HAIR DISORDER,58
US,MULTIPLE ALLERGIES,58
US,MYELODYSPLASTIC SYNDROME,58
US,PHARYNGITIS,58
US,POLYP,58
US,POSTOPERATIVE WOUND INFECTION,58
US,QUALITY OF LIFE DECREASED,58
US,SECRETION DISCHARGE,58
US,SKIN ABRASION,58
US,SKIN INFECTION,58
US,THERAPY NON-RESPONDER,58
US,APPLICATION SITE DISCOLOURATION,57
US,APPLICATION SITE IRRITATION,57
US,COMPLEX REGIONAL PAIN SYNDROME,57
US,HYPERREFLEXIA,57
US,LIBIDO DECREASED,57
US,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,57
US,SHOCK,57
US,SINUS TACHYCARDIA,57
US,ADRENAL INSUFFICIENCY,56
US,ADVERSE REACTION,56
US,BLOOD CALCIUM INCREASED,56
US,FACIAL BONES FRACTURE,56
US,HAEMORRHAGE INTRACRANIAL,56
US,IMMUNODEFICIENCY,56
US,INJECTION SITE DISCOLOURATION,56
US,JAW DISORDER,56
US,LUMBAR RADICULOPATHY,56
US,MYDRIASIS,56
US,POST PROCEDURAL INFECTION,56
US,RESPIRATORY DEPRESSION,56
US,SJOGREN^S SYNDROME,56
US,URINE ODOUR ABNORMAL,56
US,DRUG SCREEN NEGATIVE,55
US,ELECTROLYTE IMBALANCE,55
US,GOITRE,55
US,NECK INJURY,55
US,SINUS HEADACHE,55
US,APPETITE DISORDER,54
US,BONE MARROW FAILURE,54
US,DYSPHORIA,54
US,EJECTION FRACTION DECREASED,54
US,METASTASES TO LUNG,54
US,METASTASES TO SPINE,54
US,SCRATCH,54
US,THERMAL BURN,54
US,WOUND SECRETION,54
US,AFFECTIVE DISORDER,53
US,BREAST CANCER METASTATIC,53
US,CLUMSINESS,53
US,DYSTONIA,53
US,HYPERTHYROIDISM,53
US,INTERVERTEBRAL DISC SPACE NARROWING,53
US,KNEE OPERATION,53
US,MACULAR DEGENERATION,53
US,MULTIPLE ORGAN DYSFUNCTION SYNDROME,53
US,NEUROGENIC BLADDER,53
US,PHYSICAL DISABILITY,53
US,PROTEINURIA,53
US,PURULENT DISCHARGE,53
US,SUPRAVENTRICULAR TACHYCARDIA,53
US,TACHYPHRENIA,53
US,CERVICAL SPINAL STENOSIS,52
US,NEOPLASM,52
US,POLYURIA,52
US,SKIN MASS,52
US,SQUAMOUS CELL CARCINOMA OF SKIN,52
US,WOUND DEHISCENCE,52
US,CYTOPENIA,51
US,DIALYSIS,51
US,GANGRENE,51
US,INJECTION SITE EXTRAVASATION,51
US,PRIMARY SEQUESTRUM,51
US,SUBSTANCE ABUSE,51
US,ABDOMINAL HERNIA,50
US,ARTHROPOD BITE,50
US,CARDIAC FLUTTER,50
US,CEREBRAL INFARCTION,50
US,ENURESIS,50
US,HICCUPS,50
US,HUMERUS FRACTURE,50
US,INJURY ASSOCIATED WITH DEVICE,50
US,METABOLIC ENCEPHALOPATHY,50
US,METASTASES TO CENTRAL NERVOUS SYSTEM,50
US,POST PROCEDURAL HAEMORRHAGE,50
US,VARICOSE VEIN,50
US,VENTRICULAR TACHYCARDIA,50
US,ALTERED STATE OF CONSCIOUSNESS,49
US,CATARACT OPERATION,49
US,CHRONIC SINUSITIS,49
US,DRUG LEVEL INCREASED,49
US,FISTULA,49
US,GLOMERULAR FILTRATION RATE DECREASED,49
US,LIGAMENT RUPTURE,49
US,LOOSE TOOTH,49
US,NEPHROGENIC SYSTEMIC FIBROSIS,49
US,RENAL CANCER,49
US,RENAL INJURY,49
US,TRIGGER FINGER,49
US,CEREBRAL DISORDER,48
US,DEVICE LEAKAGE,48
US,DRUG SCREEN FALSE POSITIVE,48
US,EYE DISCHARGE,48
US,EYELID PTOSIS,48
US,IMMUNOSUPPRESSION,48
US,NYSTAGMUS,48
US,OBSESSIVE-COMPULSIVE DISORDER,48
US,RIGHT VENTRICULAR FAILURE,48
US,STENT PLACEMENT,48
US,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,48
US,AORTIC ARTERIOSCLEROSIS,47
US,CLAVICLE FRACTURE,47
US,FRUSTRATION,47
US,GASTRIC HAEMORRHAGE,47
US,HYPOCALCAEMIA,47
US,INTENTIONAL UNDERDOSE,47
US,LYMPHOMA,47
US,PAROSMIA,47
US,PROCTALGIA,47
US,SCREAMING,47
US,SINUS BRADYCARDIA,47
US,THERAPEUTIC RESPONSE SHORTENED,47
US,VENTRICULAR EXTRASYSTOLES,47
US,ACUTE RESPIRATORY DISTRESS SYNDROME,46
US,APHAGIA,46
US,APPLICATION SITE BURN,46
US,BARRETT^S OESOPHAGUS,46
US,BLINDNESS TRANSIENT,46
US,BLOOD DISORDER,46
US,BREAST MASS,46
US,BRONCHITIS CHRONIC,46
US,CONJUNCTIVITIS,46
US,DRUG EFFECT DELAYED,46
US,DRUG EFFECT INCREASED,46
US,GENERAL SYMPTOM,46
US,MASTICATION DISORDER,46
US,NASAL DRYNESS,46
US,NICOTINE DEPENDENCE,46
US,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,46
US,TENDON DISORDER,46
US,THYROID FUNCTION TEST ABNORMAL,46
US,TOE AMPUTATION,46
US,BENIGN PROSTATIC HYPERPLASIA,45
US,BRADYPHRENIA,45
US,BRUXISM,45
US,FOREIGN BODY,45
US,GLUCOSE TOLERANCE IMPAIRED,45
US,HYPOTONIA,45
US,ODYNOPHAGIA,45
US,PETECHIAE,45
US,RED BLOOD CELL SEDIMENTATION RATE INCREASED,45
US,SUICIDAL BEHAVIOUR,45
US,VITAMIN B12 DEFICIENCY,45
US,ABNORMAL FAECES,44
US,BLOOD CHOLESTEROL ABNORMAL,44
US,CALCIUM DEFICIENCY,44
US,CARDIAC PACEMAKER INSERTION,44
US,CERVICAL VERTEBRAL FRACTURE,44
US,COLITIS ISCHAEMIC,44
US,DYSLIPIDAEMIA,44
US,ELECTROCARDIOGRAM ABNORMAL,44
US,GASTROENTERITIS,44
US,LOSS OF CONTROL OF LEGS,44
US,MADAROSIS,44
US,POST HERPETIC NEURALGIA,44
US,PRODUCT PREPARATION ERROR,44
UM,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
UY,SKIN EXFOLIATION,2
UY,BLISTER,1
UY,CONDITION AGGRAVATED,1
UY,DRY SKIN,1
UY,FEELING HOT,1
UY,HYPOTHYROIDISM,1
UY,IMPAIRED HEALING,1
UY,INFLUENZA,1
UY,MELANOCYTIC NAEVUS,1
UY,NAEVUS HAEMORRHAGE,1
UY,NAIL DISORDER,1
UY,PAIN,1
UY,PAIN IN EXTREMITY,1
UY,PERIPHERAL SWELLING,1
UY,SKIN DISCOLOURATION,1
UY,SKIN HYPERPIGMENTATION,1
UY,WOUND,1
VE,PRODUCT USE ISSUE,3
VE,FALL,2
VE,HEADACHE,2
VE,PERIPHERAL SWELLING,2
VE,PYREXIA,2
VE,ABDOMINAL PAIN LOWER,1
VE,ABORTION SPONTANEOUS,1
VE,ABSCESS,1
VE,ACTIVITIES OF DAILY LIVING IMPAIRED,1
VE,ASTHENIA,1
VE,BACK PAIN,1
VE,BALANCE DISORDER,1
VE,BEDRIDDEN,1
VE,BLOOD IRON INCREASED,1
VE,BLOOD PROLACTIN INCREASED,1
VE,BONE CYST,1
VE,BONE DISORDER,1
VE,CARDIO-RESPIRATORY ARREST,1
VE,CEREBRAL DISORDER,1
VE,CEREBROVASCULAR ACCIDENT,1
VE,CHEST PAIN,1
VE,CONDITION AGGRAVATED,1
VE,DEATH,1
VE,DEPRESSION,1
VE,DISEASE PROGRESSION,1
VE,DIZZINESS,1
VE,DRUG DEPENDENCE,1
VE,DRUG-INDUCED LIVER INJURY,1
VE,ERYSIPELAS,1
VE,FACE INJURY,1
VE,FACIAL PAIN,1
VE,FEELING ABNORMAL,1
VE,FEELING OF BODY TEMPERATURE CHANGE,1
VE,FLATULENCE,1
VE,FLAVIVIRUS INFECTION,1
VE,FOETAL HEART RATE DECREASED,1
VE,FOOT FRACTURE,1
VE,GASTRIC DISORDER,1
VE,GENERALISED TONIC-CLONIC SEIZURE,1
VE,GESTATIONAL DIABETES,1
VE,HAEMATOCHEZIA,1
VE,HAEMOGLOBIN INCREASED,1
VE,HERNIA,1
VE,IMMOBILE,1
VE,INBORN ERROR OF METABOLISM,1
VE,INSOMNIA,1
VE,INTENTIONAL PRODUCT MISUSE,1
VE,LUMBAR VERTEBRAL FRACTURE,1
VE,MALAISE,1
VE,MATERNAL EXPOSURE DURING PREGNANCY,1
VE,MENTAL DISORDER,1
VE,METASTASES TO CENTRAL NERVOUS SYSTEM,1
VE,MULTIPLE SCLEROSIS,1
VE,MULTIPLE SCLEROSIS RELAPSE,1
VE,MUSCLE SPASTICITY,1
VE,MUSCULOSKELETAL DISORDER,1
VE,MYALGIA,1
VE,NERVE ROOT COMPRESSION,1
VE,NERVE ROOT INJURY,1
VE,NEURALGIA,1
VE,PAIN,1
VE,PAIN IN JAW,1
VE,PETECHIAE,1
VE,PLATELET COUNT DECREASED,1
VE,POLYARTHRITIS,1
VE,PRE-EXISTING CONDITION IMPROVED,1
VE,RASH PRURITIC,1
VE,RENAL FAILURE,1
VE,SCIATIC NERVE INJURY,1
VE,SEIZURE,1
VE,SPINAL FRACTURE,1
VE,SPINAL PAIN,1
VE,THERAPEUTIC RESPONSE UNEXPECTED,1
VE,THROMBOCYTOPENIA,1
VE,TOOTHACHE,1
VE,TREMOR,1
VE,UTERINE HYPOTONUS,1
VE,VEIN DISORDER,1
VE,VOCAL CORD PARALYSIS,1
VN,ARTERIOSCLEROSIS,1
VN,ARTHRALGIA,1
VN,FEMUR FRACTURE,1
VN,ILL-DEFINED DISORDER,1
VN,INFLAMMATION,1
VN,INTERNAL FIXATION OF FRACTURE,1
VN,LIMB OPERATION,1
VN,PAIN,1
VN,WALKING AID USER,1
